<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">


<meta name="wpd_version" content="0.2">
<meta name="wpd_baseurl" content="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199709113371101">
<meta name="wpd_url" content="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199709113371101">
<meta name="wpd_date" content="2013-04-29T17:15Z">
<script src="auth013.js" type="text/javascript"></script>

<script src="g" async="" type="text/javascript"></script><script type="text/javascript" src="monetate.js"></script>






<title>A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less — NEJM</title>
<meta name="description" content="Original Article from The New England Journal of Medicine — A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less">

<meta name="pageType" content="Article">
<meta name="evt-pageType" content="Article">








   <meta property="og:title" content="A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less — NEJM">
   <meta property="og:description" content="Original Article from The New England Journal of Medicine — A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less">
   <meta property="og:type" content="article">
   <meta property="og:image" content="http://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1997/nejm_1997.337.issue-11/nejm199709113371101/production/images/small/nejm199709113371101_f3.gif">
   <meta name="twitter:card" content="summary">
   <meta name="twitter:site" content="@NEJM">



















	
	    <meta name="evt-doiPage" content="10.1056/NEJM199709113371101">
	
	
	
	    <meta name="evt-dt" content="1997-09-11">
	
	
	
	    <meta name="evt-ageContent" content="6Months-1990">
	
	
	
	    <meta name="evt-free" content="yes">
	

	
		
				<meta name="evt-artView" content="full">
				
			
	
			
	
		<link rel="canonical" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199709113371101">
		
	
















<meta name="sessionEvt-individual" content="">
<meta name="sessionEvt-idGUID" content="">
<meta name="sessionEvt-freeCntry" content="">
<meta name="sessionEvt-instId" content="1452137">
<meta name="sessionEvt-audSegment" content="">
<meta name="sessionEvt-prodCode" content="">
<meta name="sessionEvt-nejmSource" content="">
<meta name="sessionEvt-offers" content="N-institution-currentArticles">






	








<!-- Load CSS via Ad Placeholders -->
<!-- placeholder id=null, description=N-config-css-global -->
<!-- placeholder id=null, description=N-config-css-ads -->

<script type="text/javascript" src="jquery.js"></script>
<script type="text/javascript" src="siteEditor.js"></script>
<script type="text/javascript" src="jquery.cookie.js"></script>
<script type="text/javascript" src="jquery.bbq.js"></script>
<script type="text/javascript" src="mmsEventMappings.js"></script>
<script type="text/javascript" src="mmsEvents.js"></script>
<script type="text/javascript" src="script.js"></script>
<script type="text/javascript" src="mmsFilterBanks.js"></script>
<script type="text/javascript" src="mmsMenus.js"></script>
<script type="text/javascript" src="mmsClassData.js"></script>
<script type="text/javascript" src="mmsAds.js"></script>
<script type="text/javascript" src="mmsCarousels.js"></script>
<script type="text/javascript" src="mmsUtilities.js"></script>
<script type="text/javascript" src="mmsTabPanel.js"></script>
<script type="text/javascript" src="mmsViews.js"></script>
<script type="text/javascript" src="mmsBoxy.js"></script>
<script type="text/javascript" src="jquery.form.js"></script>
<script type="text/javascript" src="swfobject.js"></script>
<script type="text/javascript" src="jquery.dimensions.js"></script>
<script type="text/javascript" src="jquery.cluetip.js"></script>
<script type="text/javascript" src="jquery.highlight.js"></script>
<script type="text/javascript" src="jquery.jcarousel.js"></script>
<script type="text/javascript" src="jquery-ui-1.7.2.custom.min.js"></script>
<script type="text/javascript" src="mmsLayers.js"></script>
<script type="text/javascript" src="mmsAddThis.js"></script>

<!--[if IE]><script language="javascript" type="text/javascript" src="http://cdn.nejm.org.libgate.library.nuigalway.ie/5.2/js/lib/excanvas.min.js"></script><![endif]-->






<!--[if lte IE 6]><script type="text/javascript" src="http://cdn.nejm.org.libgate.library.nuigalway.ie/5.2/js/DD_belatedPNG.js"></script><![endif]-->
<script type="text/javascript" src="ntpagetag.js"></script><script src="unica_eluminate.js" type="text/javascript"></script>

<script type="text/javascript">var _sf_startpt=(new Date()).getTime()</script>

<!-- Load JS via Ad Placeholders -->
<!-- placeholder id=null, description=N-config-js-global-top -->

<script async="" src="1479937313" type="text/javascript"></script><meta http-equiv="P3P" content="CP=&quot;NOI DSP ADM OUR IND OTC&quot;"><div id="_atssh" style="visibility: hidden; height: 1px; width: 1px; position: absolute; z-index: 100000;"><iframe src="NEJM199709113371101_1.html" style="height: 1px; width: 1px; position: absolute; z-index: 100000; border: 0px none; left: 0px; top: 0px;" title="AddThis utility frame" id="_atssh637"></iframe></div><script src="core079.js" type="text/javascript"></script>
<link rel="stylesheet" type="text/css" href="NEJM199709113371101.css" media="all">
</head>
<body class="article">

<div id="dic_bubble" class="selection_bubble fontSize13 noSelect" style="z-index: 9999; border: 1px solid rgb(74, 174, 222);"></div><noscript>

<img src="http://pt000185.unica.com/ntpagetag.gif?site=nejm&js=0" height="1" width="1" border="0" hspace="0" vspace="0" alt=" ">
</noscript>





<script type="text/javascript">

   
    var servicesURL="http://imc.nejm.org/ExamService/ExamService.asmx";
</script>


















<script type="text/javascript">

    var CM8Server = "web.checkm8.com";
    var CM8Cat = "mms.nej.articles";
    var CM8Profile = "pharma=no&articlecat=research";
</script>
<script type="text/javascript" language="JavaScript" src="cm8adam_1_ajax.js"></script>



<!--[if lte IE 6]><div class="ie6and7" id="ie6"><![endif]-->
<!--[if IE 7]><div class="ie6and7" id="ie7"><![endif]-->
<!--[if IE 8]><div id="ie8"><![endif]-->















<div id="topAdBar">
<div class="bannerAd">
<div class="inner">














<div id="CM8ShowAd1369847718068" title="Topbanner" class="Topbanner CM8">
<noscript><a href="http://web.checkm8.com/adam/ep/click/mms.nej.articles/Topbanner"><img src="http://web.checkm8.com/adam/noscript?cat=mms.nej.articles&amp;page=1369847718068&amp;format=Topbanner" border="0" alt="Advertisement" /></a></noscript>

</div></div>
</div>
</div>






<div style="margin-top: 30px;" align="center">
    <!-- placeholder id=null, description=N-ad-global-top --><div style="background: none repeat ; 0% rgb(255, 255, 255); padding: 0px; width: 970px; height: 20px; margin: 0px auto 10px;" align="left"><p style="font: 11px/15px arial,sans-serif; color: rgb(51, 51, 51);">Learn how NEJM.org uses cookies at the <a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3528&amp;url=%2Fpage%2Fabout-nejm%2Fcookie-information&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Cookie Information</a> page.</p></div>
</div>











<script type="text/javascript">

    $(document).ready(function() {
        $("#lnkSignOut").click(function(){
            $.cookie("redirectUri",null, {path: '/', domain: '.nejm.org'});
        });
    })
</script>

<div id="authInfo">

    <!-- placeholder id=null, description=N-ad-global-top-left -->
        <!-- topLeftAniv -->
            <div class="topLeftAniv">
             
            </div>
        <!-- /topLeftAniv -->
    

    <ul>
        
        
                
                        <li class="status firstChild">Welcome</li>
                    
            

        
        <!-- placeholder id=null, description=N-ad-authstring -->
            <li class="authOptions">
            <span class="renewSubscribe"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=4972&amp;url=%2Faction%2FcdfProxy%3Faction%3Drenew%26promo%3DONFLRNA2&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" class="renew">Renew</a>, <a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=4972&amp;url=%2Faction%2FcdfProxy%3Faction%3Dsubscribe%26promo%3DONFQN1A2&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" class="subscribe">Subscribe</a> or <a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=4972&amp;url=%2Faction%2FcdfProxy%3Faction%3Dregister%26promo%3DONFLNAR3&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" class="createAccount">Create Account</a></span>
            </li>
        

        
        
                <li class="signin lastChild">
                    
                            <a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showLogin?uri=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101" class="viewType-Layer viewClass-WideLayer signin-header">

                                
                                        
                                    
                                Sign In
                            </a>
                        
                </li>
            

    </ul>
</div>






<div id="header" class="withAd">
	<h1><a href="http://www.nejm.org.libgate.library.nuigalway.ie/">The New England Journal of Medicine</a></h1>
    
        <!-- placeholder id=null, description=N-ad-header-1 -->
            <div class="ad"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=4270&amp;url=%2Faction%2FcdfProxy%3Faction%3Dcampaign%26url%3Dhttp%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJM199709113371101%26cpc%3DFMAAALLV1012A%26promo%3DONFQPP02&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258"><img src="InstPPTAccess_280x83.jpg"></a>

</div>
        
    
</div>






	

<div style="position: relative;" id="topNav">
<ul>
<li class="firstChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/">Home</a></li>
<li class="menu dropDownTrigger-articles"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-article-index">Articles &amp; Multimedia</a></li>
<li class="menu dropDownTrigger-issueArchive"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-index">Issues</a></li>
<li class="menu dropDownTrigger-topics"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-specialties">Specialties &amp; Topics</a></li>
<li class="menu authors dropDownTrigger-authors"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/cdfProxy?action=authorCenter">For Authors</a></li>
<li class="menu cmeButton lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/continuing-medical-education">CME</a></li>
</ul>
    <form action="http://www.nejm.org.libgate.library.nuigalway.ie/search?pageType=search" class="search" method="get"><fieldset>
    <div style="position: absolute; left: 654px; top: 23px; width: 225px; visibility: hidden; z-index: 99999999;" class="autocomplete"></div><input id="sli_search_1" class="text" name="q" value="Keyword, Title, Author, or Citation" size="15" maxlength="450" autocomplete="off" type="text">	
	<input class="searchSubmit" value="Search" src="search_icon.gif" type="image">
    <input disabled="" name="asug" value="" type="hidden">
    <a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-search" class="more advSearch">Advanced<br>Search</a>
    </fieldset></form>
</div>

<div id="main">

    <div id="content">

    
    




    <a name="articleTop" rel="10.1056/NEJM199709113371101"></a><p class="articleType">Original Article</p><h1>A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less</h1><p class="authors">Scott M. Hammer, M.D., Kathleen E. Squires, M.D., Michael D. Hughes, Ph.D., Janet M. Grimes, M.S., Lisa M. Demeter, M.D., Judith S. Currier, M.D., Joseph J. Eron, Jr., M.D., Judith E. Feinberg, M.D., Henry H. Balfour, Jr., M.D., Lawrence R. Deyton, M.D., Jeffrey A. Chodakewitz, M.D., Margaret A. Fischl, M.D., John P. Phair, M.D., Louise Pedneault, M.D., Bach-Yen Nguyen, M.D., and Jon C. Cook, B.Sc. for <span class="NLM_on-behalf-of">the AIDS Clinical Trials Group 320 Study Team</span></p><p class="citationLine"><span class="citation">N Engl J Med 1997;  337:725-733</span><a href="http://www.nejm.org.libgate.library.nuigalway.ie/toc/nejm/337/11/">September 11, 1997</a><span class="doi">DOI:  10.1056/NEJM199709113371101</span></p><!--DiscussionPollOpenDateReplacer--><!-- share -->
<div class="share addthis_toolbox no-pad-bot" addthis:url="http://www.nejm.org/doi/full/10.1056/NEJM199709113371101">
    <div class="cols">
        <div class="col"><span class="label">Share:</span></div>
        <div class="col">
            <a href="#" title="Facebook" class="addthis_button_facebook at300b"><span class="icon add facebook"></span></a>
        </div>
        <div class="col">
            <a href="#" title="Tweet" class="addthis_button_twitter at300b"><span class="icon add twitter"></span></a>
        </div>
        <div class="col">
            <a title="Google+" target="_top" href="http://www.addthis.com/bookmark.php?v=300&amp;winname=addthis&amp;pub=ra-4ddfaaf00b1e6fbf&amp;source=tbx-300&amp;lng=en-US&amp;s=google_plusone_share&amp;url=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;title=A%20Controlled%20Trial%20of%20Two%20Nucleoside%20Analogues%20plus%20Indinavir%20in%20Persons%20with%20Human%20Immunodeficiency%20Virus%20Infection%20and%20CD4%20Cell%20Counts%20of%20200%20per%20Cubic%20Millimeter%20or%20Less%20%E2%80%94%20NEJM&amp;ate=AT-ra-4ddfaaf00b1e6fbf/-/-/51a637b2d3bb43c4/2&amp;frommenu=1&amp;uid=51a637b22ceb6ebc&amp;ct=1&amp;ui_cobrand=NEJM.org&amp;pre=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;tt=0&amp;captcha_provider=nucaptcha" class="addthis_button_google_plusone_share at300b"><span class="icon add google"></span></a>
        </div>
        <div class="col">
            <a title="Linkedin" target="_top" href="http://www.addthis.com/bookmark.php?v=300&amp;winname=addthis&amp;pub=ra-4ddfaaf00b1e6fbf&amp;source=tbx-300&amp;lng=en-US&amp;s=linkedin&amp;url=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;title=A%20Controlled%20Trial%20of%20Two%20Nucleoside%20Analogues%20plus%20Indinavir%20in%20Persons%20with%20Human%20Immunodeficiency%20Virus%20Infection%20and%20CD4%20Cell%20Counts%20of%20200%20per%20Cubic%20Millimeter%20or%20Less%20%E2%80%94%20NEJM&amp;ate=AT-ra-4ddfaaf00b1e6fbf/-/-/51a637b2d3bb43c4/3&amp;frommenu=1&amp;uid=51a637b202bc0a5e&amp;shortener=bitly&amp;bitly.login=nejm&amp;bitly.apiKey=R_644f2c9aae1c9bcb164b6f24392c94f4&amp;ct=1&amp;ui_cobrand=NEJM.org&amp;pre=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;tt=0&amp;captcha_provider=nucaptcha" class="addthis_button_linkedin at300b"><span class="icon add linkedin"></span></a>
        </div>
        <div class="col">
            <a class="addthis_button"><span class="icon add addmore"></span></a>
        </div>
    </div>
<div class="atclear"></div></div>
<!-- /share --><dl class="articleTabs tabPanel lastChild"><dt class="active abstract firstChild sideBySide" id="abstractTab">Abstract</dt><dt class="article sideBySide inactive" id="articleTab">Article</dt><dt class="references sideBySide inactive" id="referencesTab">References</dt><dt class="citedby sideBySide inactive" id="citedbyTab">Citing Articles <span>(1189) </span></dt><!--DiscussionReplacer_Tab_--><dt class="letters sideBySide inactive" id="lettersTab">Letters</dt><dd style="display: block;" id="abstract"><div class="left section"><div class="section"> </div><div class="section"> <h3 id="abstractBackground">Background</h3> <p>The efficacy and safety of adding a protease inhibitor to two nucleoside analogues to treat human immunodeficiency virus type 1 (HIV-1) infection are not clear. We compared treatment with the protease inhibitor indinavir in addition to zidovudine and lamivudine with treatment with the two nucleosides alone in HIV-infected adults previously treated with zidovudine.</p> <p class="fullTextLink"><a rel="gotofulltext" href="#Background" id="Background">Full Text of Background...</a></p></div><div class="section"> </div><div class="section"> <h3 id="abstractMethods">Methods</h3> <p>A total of 1156 patients not previously treated with lamivudine or protease inhibitors were stratified according to CD4 cell count (50 or fewer vs. 51 to 200 cells per cubic millimeter) and randomly assigned to one of two daily regimens: 600 mg of zidovudine and 300 mg of lamivudine, or that regimen with 2400 mg of indinavir. Stavudine could be substituted for zidovudine. The primary end point was the time to the development of the acquired immunodeficiency syndrome (AIDS) or death.</p> <p class="fullTextLink"><a rel="gotofulltext" href="#Methods" id="Methods">Full Text of Methods...</a></p></div><div class="section"> </div><div class="section"> <h3 id="abstractResults">Results</h3> <p>The proportion of patients whose disease progressed to AIDS or death was lower with indinavir, zidovudine (or stavudine), and lamivudine (6 percent) than with zidovudine (or stavudine) and lamivudine alone (11 percent; estimated hazard ratio, 0.50; 95 percent confidence interval, 0.33 to 0.76; P = 0.001). Mortality in the two groups was 1.4 percent and 3.1 percent, respectively (estimated hazard ratio, 0.43; 95 percent confidence interval, 0.19 to 0.99; P = 0.04). The effects of treatment were similar in both CD4 cell strata. The responses of CD4 cells and plasma HIV-1 RNA paralleled the clinical results.</p> <p class="fullTextLink"><a rel="gotofulltext" href="#Results" id="Results">Full Text of Results...</a></p></div><div class="section"> </div><div class="section"> <h3 id="abstractConclusions">Conclusions</h3> <p>Treatment with indinavir, zidovudine, and lamivudine as compared with zidovudine and lamivudine alone significantly slows the progression of HIV-1 disease in patients with 200 CD4 cells or fewer per cubic millimeter and prior exposure to zidovudine. </p> <p class="fullTextLink"><a rel="gotofulltext" href="#Discussion" id="Conclusions">Full Text of Discussion...</a></p></div><div class="section"> </div><p class="fullTextLink"><a rel="gotofulltext" href="#Top">Read the Full Article...</a></p></div><div class="right section"><div class="articleMedia"><h3 class="title">Media in This Article</h3><div class="mediaRefs"><div class="mediaRef"><span class="fig"><span class="figureTitle">Figure 3</span><a class="figureLink viewType-Layer viewClass-ImageViewerLayer event-articleThumb" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=f03"><img src="nejm199709113371101_f3.gif" alt=""></a><span class="figureCaption">Mean Change from Base Line in the Plasma HIV-1 RNA Concentration.</span></span></div><div class="mediaRef"><span class="fig"><span class="figureTitle">Figure 2</span><a class="figureLink viewType-Layer viewClass-ImageViewerLayer event-articleThumb" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=f02"><img src="nejm199709113371101_f2.gif" alt=""></a><span class="figureCaption">Mean Changes from Base Line in the CD4 Cell Count.</span></span></div></div></div><div class="articleActivity"><h3 class="title">Article Activity</h3><p><a href="#citedby" class="articleActivity-citedby more">1189 articles have cited this article</a></p></div></div></dd><dd style="display: none;" id="article"><div class="section"> <p>Progress in the field of antiretroviral therapy for human immunodeficiency virus type 1 (HIV-1) infection has brought the end of the zidovudine-monotherapy era,<span class="ref"><a href="#ref1" class="showRefLayer" rel="#refLayer">1-3</a></span> an improved understanding of the pathogenesis of HIV-1 disease,<span class="ref"><a href="#ref4" class="showRefLayer" rel="#refLayer">4-9</a></span> demonstrations of the prognostic importance of plasma HIV-1 RNA quantification,<span class="ref"><a href="#ref10" class="showRefLayer" rel="#refLayer">10-17</a></span> and the availability of increasingly potent therapeutic agents. Much of this progress is linked to the introduction of the HIV-protease inhibitors, drugs that inhibit the processing of Gag and Gag–Pol polyprotein precursors and thus prevent the maturation of virions.<span class="ref"><a href="#ref18" class="showRefLayer" rel="#refLayer">18-20</a></span> Trials of HIV-protease inhibitors have shown beneficial effects on CD4 cell counts and plasma HIV-1 RNA concentrations to a degree not previously described with approved reverse-transcriptase inhibitors.<span class="ref"><a href="#ref21" class="showRefLayer" rel="#refLayer">21-26</a></span> The most notable findings have involved three-drug combinations that include a potent HIV-protease inhibitor and two nucleoside analogues. Specifically, when patients previously exposed to zidovudine who had either 50 to 400 or 50 or fewer CD4 cells per cubic millimeter were treated with indinavir, zidovudine, and lamivudine, plasma HIV-1 RNA concentrations were suppressed to less than 500 copies per milliliter in 85 percent and 65 percent of patients, respectively.<span class="ref"><a href="#ref24" class="showRefLayer" rel="#refLayer">24,25</a></span> These findings have raised the important question of the clinical efficacy and safety of a three-drug regimen containing indinavir. We addressed that issue in this study.</p> </div><div class="section"> <h3 id="articleMethods">Methods</h3> <div class="subSection"> <h3 id="articleStudy Design and Patients">Study Design and Patients</h3> <p>The AIDS Clinical Trials Group 320 Study was a randomized, double-blind, placebo-controlled trial that compared the three-drug regimen of indinavir (Crixivan), open-label zidovudine (Retrovir) or stavudine (Zerit), and lamivudine (Epivir) with the two-drug regimen of zidovudine (or stavudine) and lamivudine in HIV-infected patients who had no more than 200 CD4 cells per cubic millimeter and at least three months of prior zidovudine therapy. The randomization was stratified according to the CD4 cell count obtained at the time of screening (50 or fewer cells per cubic millimeter as compared with 51 to 200 cells per cubic millimeter). The study was designed to enroll 1750 patients, with 40 percent of them in the stratum with 50 or fewer CD4 cells per cubic millimeter. The primary outcome measure in the assessment of efficacy was the development of a new acquired immunodeficiency syndrome (AIDS)–defining event (except when the AIDS-defining event was the development of <em>Pneumocystis carinii</em> pneumonia, in which case both new and recurrent events were accepted as outcome measures) or death; in the assessment of safety, the outcome measure was the occurrence of adverse events (signs, symptoms, or laboratory abnormalities) defined as severe or worse according to the grading scheme of the AIDS Clinical Trials Group.<span class="ref"><a href="#ref27" class="showRefLayer" rel="#refLayer">27</a></span> The secondary outcome measures studied were death and changes in CD4 cell counts and plasma HIV-1 RNA concentrations.</p> <p>The patients, recruited from 33 AIDS Clinical Trials Units and 7 National Hemophilia Foundation sites in the United States and Puerto Rico (see the Appendix), had to be more than 16 years old and had to have laboratory documentation of HIV-1 infection, a CD4 cell count of 200 per cubic millimeter or less within the 60 days before entry into the study, at least 3 months of prior zidovudine treatment, no more than 1 week of prior lamivudine treatment, no prior treatment with protease inhibitors, a Karnofsky performance score of at least 70, and acceptable laboratory values. The study was approved by the institutional review boards of the participating institutions, and all the patients gave written informed consent.</p> <p>The patients received open-label zidovudine (200 mg three times daily) and lamivudine (150 mg two times daily) and were randomly assigned to receive indinavir (800 mg) or matching placebo every eight hours. In the first version of the protocol, only patients who could tolerate zidovudine and who had had at least 6 months of prior zidovudine therapy were enrolled, and the substitution of stavudine for zidovudine was permitted in the event of drug-associated toxicity at any point after randomization or if clinical progression of HIV-1 disease occurred that did not fulfill the criteria for a protocol-defined AIDS event at or beyond 24 weeks of study. The dose of stavudine was 40 mg two times daily (or 30 mg two times daily for patients weighing less than 60 kg). A protocol modification in October 1996 reduced the required prior exposure to zidovudine to at least three months and permitted patients who could not tolerate zidovudine to enter the study with stavudine substituted for zidovudine at the time of randomization. Prophylaxis for <em>P. carinii</em> pneumonia was mandated. Prophylaxis for other opportunistic infections was permitted, although the use of rifabutin was prohibited.</p> <p>Patients who had verified AIDS-defining events were offered open-label indinavir therapy with the approval of the study chairs and without having their initial treatment assignments revealed. All potential AIDS-defining events were reviewed in a blinded fashion by the study chair; only those that met the criteria defined in the study protocol were included in the analysis.</p> </div> <div class="subSection"> <h3 id="articleMonitoring and Enrollment">Monitoring and Enrollment</h3> <p>The patients were followed at weeks 4, 8, and 16 and every eight weeks thereafter with a clinical assessment and routine laboratory monitoring. CD4 cell counts were determined twice at base line and at weeks 4, 8, 24, and 40. Enrollment began in January 1996. The study was reviewed twice by a data and safety monitoring board. At the second such review, on February 18, 1997, the comparison of the groups based on data on the patients randomized by January 27, 1997, showed a significant difference between groups that met the prespecified guideline for stopping the study.<span class="ref"><a href="#ref28" class="showRefLayer" rel="#refLayer">28</a></span> At that time, the board recommended that the accrual of patients be terminated and the study closed.</p> <p>Plasma HIV-1 RNA concentrations were determined retrospectively in appropriately stored specimens from 190 randomly selected patients. These concentrations were measured twice at base line and at weeks 4, 8, 24, and 40 (Roche Amplicor HIV-1 Monitor assay).<span class="ref"><a href="#ref29" class="showRefLayer" rel="#refLayer">29</a></span> </p> </div> <div class="subSection"> <h3 id="articleStatistical Analysis">Statistical Analysis</h3> <p>The times to events were compared between treatment groups by Kaplan–Meier estimates, log-rank tests, and proportional-hazards models stratified according to the CD4 cell count obtained at the time of screening (50 or fewer vs. 51 to 200 cells per cubic millimeter).<span class="ref"><a href="#ref30" class="showRefLayer" rel="#refLayer">30</a></span> Changes in CD4 cell counts over time were compared in a mixed-effects regression model.<span class="ref"><a href="#ref31" class="showRefLayer" rel="#refLayer">31</a></span> An analysis of covariance adjusted for the screening CD4 cell count and the AIDS Clinical Trials Unit was used to compare changes in the CD4 cell count and the HIV-1 RNA concentration at each measurement.<span class="ref"><a href="#ref32" class="showRefLayer" rel="#refLayer">32</a></span> With regard to changes in HIV-1 RNA, this calculation used a regression for censored data: concentrations below the limit of quantification, 500 copies per milliliter, were censored.<span class="ref"><a href="#ref33" class="showRefLayer" rel="#refLayer">33</a></span> Analyses of all the variables pertaining to efficacy were performed on an intention-to-treat basis that included data on all patients randomized and all available follow-up data (including that obtained after the discontinuation of the study treatment). In the analyses of adverse events, the treatments were compared by a chi-square test; the follow-up data were censored either when a patient began receiving open-label indinavir or 56 days after the permanent discontinuation of the study treatment, whichever came first, and were restricted to patients for whom the study treatment was dispensed. All reported P values are two-sided. P values, estimates of differences between treatments, and 95 percent confidence intervals are unadjusted for the repeated interim analyses.</p> </div> </div><div class="section"> </div><div class="section"> <h3 id="articleResults">Results</h3> <div class="subSection"> <h3 id="articleAccrual and Characteristics of the Patients">Accrual and Characteristics of the Patients</h3> <p>There were 1156 patients randomized between January 29, 1996, and January 27, 1997. Of these, 439 (38 percent) had 50 CD4 cells or fewer per cubic millimeter and 717 (62 percent) had 51 to 200 CD4 cells per cubic millimeter. The base-line characteristics of the study patients (<a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=t01">Table 1</a><span class="table"><span class="figureTitle">Table 1</span><a class="figureLink viewType-Layer viewClass-ImageViewerLayer event-articleThumb" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=t01"><img src="nejm199709113371101_t1.gif" alt=""></a><span class="figureCaption">Base-Line Characteristics of the Patients According to CD4 Cell Count at the Time of Screening.</span></span>) were well balanced between treatment groups.</p> </div> <div class="subSection"> <h3 id="articleDuration of Follow-up and Study Treatment">Duration of Follow-up and Study Treatment</h3> <p>The median duration of follow-up was 38 weeks. Five percent of the patients were lost to follow-up; the duration of follow-up and the percentage of patients lost to follow-up were similar in both treatment groups and both CD4-cell strata.</p> <p>Ten patients did not have any study treatment. Of the remaining 1146 patients, 227 (20 percent) discontinued the study treatment prematurely, more than seven days before reaching a study end point. The proportion who discontinued the study treatment was higher in the group receiving zidovudine (or stavudine) and lamivudine (28 percent) than in the group receiving indinavir, zidovudine (or stavudine), and lamivudine (12 percent, P&lt;0.001). In the stratum with 50 CD4 cells or fewer per cubic millimeter, the proportions of patients discontinuing the study treatment in the two groups were 32 percent and 16 percent, respectively (P&lt;0.001), and in the stratum with 51 to 200 CD4 cells per cubic millimeter, these proportions were 26 percent and 9 percent (P&lt;0.001). Only 4 percent of patients (10 of 227) discontinued the study treatment prematurely because of protocol-defined adverse events: 4 patients assigned to zidovudine (or stavudine) and lamivudine and 6 patients assigned to indinavir, zidovudine (or stavudine), and lamivudine. Among the premature discontinuations, 52 percent (117 of 227) were initiated by the patients, and for approximately half these patients the reasons given included a desire to seek open-label therapy with protease inhibitors, concern about the plasma HIV-1 RNA concentration (on the basis of determinations made outside the study), or both.</p> </div> <div class="subSection"> <h3 id="articleProgression of Disease">Progression of Disease</h3> <p>Ninety-six patients (8 percent) had AIDS-defining events or died (<a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=t02">Table 2</a><span class="table"><span class="figureTitle">Table 2</span><a class="figureLink viewType-Layer viewClass-ImageViewerLayer event-articleThumb" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=t02"><img src="nejm199709113371101_t2.gif" alt=""></a><span class="figureCaption">Rates of Disease Progression According to CD4 Cell Count at the Time of Screening.</span></span>). Sixty-three patients (11 percent) assigned to zidovudine (or stavudine) and lamivudine had disease progression, as compared with 33 patients (6 percent) assigned to indinavir, zidovudine (or stavudine), and lamivudine (P = 0.001; estimated hazard ratio, 0.50; 95 percent confidence interval, 0.33 to 0.76) (<a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=f01">Figure 1A</a><span class="fig"><span class="figureTitle">Figure 1</span><a class="figureLink viewType-Layer viewClass-ImageViewerLayer event-articleThumb" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=f01"><img src="nejm199709113371101_f1.gif" alt=""></a><span class="figureCaption">Kaplan–Meier Estimates of the Proportion of Patients Who Did Not Reach the Primary Study End Point of AIDS or Death.</span></span>). There was no significant difference in the relative effects of the two treatments between the patients with 50 CD4 cells or fewer per cubic millimeter and the patients with 51 to 200 CD4 cells per cubic millimeter. Forty-four patients in the former stratum (20 percent) had AIDS-defining events or died in the group assigned to zidovudine (or stavudine) and lamivudine, as compared with 23 patients (11 percent) in the group assigned to indinavir, zidovudine (or stavudine), and lamivudine (P = 0.005; estimated hazard ratio, 0.49; 95 percent confidence interval, 0.30 to 0.82) (<a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=f01">Figure 1B</a>). In the stratum with 51 to 200 CD4 cells per cubic millimeter, 19 patients (5 percent) had AIDS-defining events or died in the group assigned to zidovudine (or stavudine) and lamivudine, as compared with 10 patients (3 percent) in the group assigned to indinavir, zidovudine (or stavudine), and lamivudine (P = 0.08; estimated hazard ratio, 0.51; 95 percent confidence interval, 0.24 to 1.10) (<a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=f01">Figure 1C</a>).</p> <p>Overall, 26 patients died (2.2 percent) (<a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=t02">Table 2</a>). Eighteen patients (3.1 percent) died in the group assigned to zidovudine (or stavudine) and lamivudine, as compared with eight (1.4 percent) in the group assigned to indinavir, zidovudine (or stavudine), and lamivudine (P = 0.04; estimated hazard ratio, 0.43; 95 percent confidence interval, 0.19 to 0.99). There was no significant difference in the relative effects of the two treatments between the two strata. Among the patients with 50 CD4 cells or fewer per cubic millimeter, 13 patients receiving only the two nucleoside analogues died (5.9 percent), as compared with 5 patients receiving all three drugs (2.3 percent; P = 0.05; estimated hazard ratio, 0.37; 95 percent confidence interval, 0.13 to 1.04). Among the patients with 51 to 200 CD4 cells per cubic millimeter, five patients assigned to zidovudine (or stavudine) and lamivudine (1.4 percent) died, as compared with three patients assigned to indinavir, zidovudine (or stavudine), and lamivudine (0.8 percent).</p> <p>A total of 109 of the 1156 patients (9.4 percent) were treated with stavudine instead of zidovudine before the development of an AIDS-defining event or death. None of the three patients who were initially assigned to stavudine had a protocol-defined end point. Among the 106 patients in whom stavudine was substituted for zidovudine after randomization, 3 (all in the two-nucleoside group) had AIDS-defining events, and none died.</p> </div> <div class="subSection"> <h3 id="articleAIDS-Defining Events">AIDS-Defining Events</h3> <p>In all, there were 91 AIDS-defining events (including multiple events per patient). Sixty of these occurred among the patients assigned to receive zidovudine (or stavudine) and lamivudine, as compared with 31 among the patients assigned to indinavir, zidovudine (or stavudine), and lamivudine. The most common events were infections with <em>P. carinii,</em> cytomegalovirus, and <em>Mycobacterium avium</em> complex (constituting 25 percent, 20 percent, and 16 percent of events, respectively).</p> </div> <div class="subSection"> <h3 id="articleChanges in CD4 Cell Counts">Changes in CD4 Cell Counts</h3> <p>Increased CD4 cell counts that persisted above base-line values were seen in both treatment groups, with superior responses in the group receiving indinavir. At weeks 4, 8, 24, and 40, the mean CD4 cell count in the patients assigned to zidovudine (or stavudine) and lamivudine increased by 27, 30, 18, and 40 cells per cubic millimeter, respectively. The corresponding mean increases in the patients assigned to indinavir, zidovudine (or stavudine), and lamivudine were 46, 65, 91, and 121 cells per cubic millimeter (<a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=f02">Figure 2A</a><span class="fig"><span class="figureTitle">Figure 2</span><a class="figureLink viewType-Layer viewClass-ImageViewerLayer event-articleThumb" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=f02"><img src="nejm199709113371101_f2.gif" alt=""></a><span class="figureCaption">Mean Changes from Base Line in the CD4 Cell Count.</span></span>). Thus, the change at week 4 was greater by 19 cells per cubic millimeter (P&lt;0.001) in the group that received indinavir, and the difference increased with time (P&lt;0.001), to 36, 73, and 82 cells per cubic millimeter at weeks 8, 24, and 40, respectively.</p> <p>The responses of the CD4 cell count to treatment are shown in <a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=f02">Figure 2B</a> and <a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=f02">Figure 2C</a>. In the group receiving zidovudine (or stavudine) and lamivudine, the early increases from base line — those at weeks 4 and 8 — were smaller in the stratum with 50 CD4 cells or fewer per cubic millimeter than in the stratum with 51 to 200 CD4 cells per cubic millimeter. However, the changes from base line in the longer term — those at weeks 24 and 40 — were similar in the two strata. Exploratory analyses of the CD4 cell counts in the two treatment groups when the data were censored at the times patients changed from the treatment to which they were initially assigned showed increases from base line that were similar to those in the intention-to-treat analyses at weeks 4, 8, and 24 (data not shown). At week 40, the difference between the two treatment groups was smaller in the intention-to-treat analysis than in the censored analysis (difference in mean change, 82 vs. 115 cells per cubic millimeter), suggesting that the difference may have been reduced by the greater proportion of subjects who changed treatment in the group receiving zidovudine (or stavudine) and lamivudine.</p> </div> <div class="subSection"> <h3 id="articleChanges in Plasma HIV-1 RNA Concentrations">Changes in Plasma HIV-1 RNA Concentrations</h3> <p>The responses of the plasma HIV-1 RNA concentrations to treatment were studied in 190 randomly selected patients. There were persistent decreases from the base-line values in both treatment groups, with significantly better responses in the group whose treatment included indinavir (P&lt;0.001 in an area-under-the-curve analysis). At weeks 4, 8, 24, and 40, the mean decreases in plasma HIV-1 RNA in the group receiving zidovudine (or stavudine) and lamivudine were 0.9, 0.6, 0.6, and 1.0 log<sub>10</sub> copies per milliliter, respectively. The corresponding decreases in the group receiving indinavir, zidovudine (or stavudine), and lamivudine were 1.8, 2.3, 2.8, and 2.1 log<sub>10</sub> copies per milliliter (<a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=f03">Figure 3A</a><span class="fig"><span class="figureTitle">Figure 3</span><a class="figureLink viewType-Layer viewClass-ImageViewerLayer event-articleThumb" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=f03"><img src="nejm199709113371101_f3.gif" alt=""></a><span class="figureCaption">Mean Change from Base Line in the Plasma HIV-1 RNA Concentration.</span></span>). The changes from base line were significantly greater at each time point in the group treated with indinavir (P&lt;0.001 at weeks 4, 8, and 24; P = 0.007 at week 40). At week 24, the proportion of patients with plasma HIV-1 RNA concentrations of less than 500 copies per milliliter was 9 percent in the two-nucleoside group, as compared with 60 percent in the group treated with indinavir.</p> <p>The plasma HIV-1 RNA responses according to the CD4 cell count are shown in <a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=f03">Figure 3B</a> and <a class="viewType-Layer viewClass-ImageViewerLayer" href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showImage?doi=10.1056%2FNEJM199709113371101&amp;iid=f03">Figure 3C</a>. In the patients with 50 CD4 cells or fewer per cubic millimeter, the decreases in plasma HIV-1 RNA appeared to be smaller than those in the patients with 51 to 200 CD4 cells per cubic millimeter. However, conclusions about stratum-specific plasma HIV-1 RNA responses need to be made cautiously because of the small numbers of patients followed through week 40.</p> </div> <div class="subSection"> <h3 id="articleAdverse Events">Adverse Events</h3> <p>The proportion of patients with signs and symptoms that were severe (grade 3) or worse (grade 4) in the group receiving zidovudine (or stavudine) and lamivudine was 18 percent, as compared with 21 percent in the group receiving indinavir, zidovudine (or stavudine), and lamivudine (P = 0.17). The most common symptoms were nonspecific discomfort, malaise, fever, headache, and nausea and vomiting, with no difference in the reporting of symptoms between treatment groups.</p> <p>The proportion of patients with severe laboratory abnormalities or worse in the group receiving zidovudine (or stavudine) and lamivudine was 26 percent, as compared with 21 percent in the group receiving indinavir, zidovudine (or stavudine), and lamivudine (P = 0.06). This difference primarily reflected a difference between the groups in the incidence of neutropenia (15 percent and 5 percent, respectively; P&lt;0.001). In contrast, the proportion of patients with hyperbilirubinemia was 1 percent in the two-nucleoside group, as compared with 6 percent in the group treated with indinavir (P&lt;0.001), a finding compatible with the known elevation of indirect bilirubin associated with the use of indinavir. Two percent of the patients in each treatment group had hyperglycemia.</p> <p>Five patients receiving zidovudine (or stavudine) and lamivudine (1 percent) had episodes of renal colic or nephrolithiasis (irrespective of grade), as compared with 21 patients receiving indinavir, zidovudine (or stavudine), and lamivudine (4 percent, P = 0.001). Three of the five patients in the two-nucleoside group in whom renal colic or nephrolithiasis developed had that condition after discontinuing the study treatment and starting open-label indinavir treatment.</p> <p>Five new diagnoses of diabetes mellitus were recorded: two in the two-nucleoside group and three in the group treated with indinavir.</p> </div> </div><div class="section"> </div><div class="section"> <h3 id="articleDiscussion">Discussion</h3> <p>This study showed the clinical superiority of the three-drug regimen containing indinavir over the two-nucleoside combination in patients previously treated with zidovudine who had CD4 cell counts of 200 per cubic millimeter or less. The proportion of patients whose disease progressed to AIDS or death was reduced from 11 percent to 6 percent by the three-drug combination, a 50 percent reduction (P = 0.001). The hazard ratios in the study patients as a whole (0.50), those with CD4 cell counts of 50 per cubic millimeter or less (0.49), and those with counts of 51 to 200 per cubic millimeter (0.51) were very similar, suggesting that the effect of treatment was similar across the study population, although the possibility of differential effects cannot be ruled out. Mortality, low in both groups, was reduced from 3.1 percent to 1.4 percent with the three-drug regimen (P = 0.04). Thus, there was evidence of a reduction in mortality that was consistent with the reduced risk of progression to the primary outcome measure of AIDS or death.</p> <p>The rate of loss to follow-up in this study was low (5 percent), and the overall rate of premature discontinuation of treatment was moderate (20 percent). Seventy-nine percent of the 96 AIDS-defining events or deaths occurred while the patients were receiving the study treatment or within seven days of its discontinuation. Although rates of withdrawal from treatment differed between the two study groups, the tendency for patients who withdrew prematurely from the two-nucleoside group to seek treatment with protease inhibitors would tend to narrow the differences between the groups in rates of disease progression and therefore should not affect the conclusions of the study. Conversely, when a study is terminated early because a stopping guideline is used, differences between the treatment groups tend to be overestimated because of random variation.<span class="ref"><a href="#ref34" class="showRefLayer" rel="#refLayer">34</a></span> However, it is impossible to determine the relative magnitude of these effects.</p> <p>These findings confirm on the basis of clinical end points the results of earlier trials of the combination of indinavir, zidovudine, and lamivudine in patients previously treated with zidovudine, trials that showed that the three-drug combination produces superior responses in plasma HIV-1 RNA concentrations and CD4 cell counts.<span class="ref"><a href="#ref24" class="showRefLayer" rel="#refLayer">24,25</a></span> The suppression of plasma HIV-1 RNA to unquantifiable levels in the majority of subjects with this drug combination is accompanied by greater suppression of HIV-1 RNA expression in lymphoid tissue<span class="ref"><a href="#ref35" class="showRefLayer" rel="#refLayer">35</a></span> and may prevent the emergence of resistance — factors that may add to the clinical benefit now established for this regimen. Our study also found superior responses of CD4 cells and plasma HIV-1 RNA with the three-drug regimen.</p> <p>We chose the combination of zidovudine and lamivudine as the control treatment because of the unique interactions between these two agents with respect to mutations conferring resistance, the results of phase 2 trials, the tolerance associated with the regimen, and its widespread use in clinical practice.<span class="ref"><a href="#ref36" class="showRefLayer" rel="#refLayer">36-40</a></span> The clinical benefit of lamivudine when that drug is added to previously available nucleoside analogues to treat patients with 25 to 250 CD4 cells per cubic millimeter was recently confirmed in the CAESAR trial, in which the risk of AIDS or death was reduced by approximately 50 percent.<span class="ref"><a href="#ref41" class="showRefLayer" rel="#refLayer">41</a></span> In the control group in our study, there was a relatively low rate of disease progression, as well as a moderate increase in the CD4 cell count and a decline in plasma HIV-1 RNA; these persisted throughout the study, even though it is now recognized that simply adding lamivudine to a preexisting regimen is not a standard clinical approach. The strength of the control group in this study is also an important difference between this study and previously reported studies of other HIV-protease inhibitors that have assessed clinical end points.<span class="ref"><a href="#ref42" class="showRefLayer" rel="#refLayer">42,43</a></span> In the Abbott M94-247 trial, ritonavir or placebo was added to stable prior nucleoside-analogue therapy or no therapy.<span class="ref"><a href="#ref42" class="showRefLayer" rel="#refLayer">42</a></span> In the Hoffmann–La Roche NV14256 trial, a regimen of saquinavir plus zalcitabine was compared with zalcitabine monotherapy.<span class="ref"><a href="#ref43" class="showRefLayer" rel="#refLayer">43</a></span> In the context of these other trials, our study makes it clear that more potent therapies, now represented by three-drug regimens containing a protease inhibitor, are preferable in patients with advanced disease. The durability of the clinical benefit conferred by indinavir as part of a three-drug regimen has not been fully defined, however.</p> <p>Improving the use of the currently approved agents to treat HIV-1 infection, and the promising drugs on the clinical horizon,<span class="ref"><a href="#ref44" class="showRefLayer" rel="#refLayer">44-46</a></span> in the management of HIV-1 disease remains a challenge.<span class="ref"><a href="#ref47" class="showRefLayer" rel="#refLayer">47</a></span> However, this study supports the view that employing well-tolerated regimens of increasing potency will translate into greater clinical benefits for patients with HIV-1 infection.</p> </div><div class="section"> </div><div class="section section-hr"></div><div class="section section-back"> <p>Supported in part by the AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases; by the General Clinical Research Center units funded by the National Center for Research Resources; and by Merck and Co. (for institutions enrolling more than 30 patients).</p>  <p>Drs. Hammer, Squires, Hughes, Demeter, Currier, Eron, Feinberg, Balfour, Fischl, and Phair have served as ad hoc consultants for, or received honorariums or research grants from, one or more of the pharmaceutical firms whose products were studied (Merck, Glaxo–Wellcome, and Bristol-Myers Squibb).</p> </div><div class="section section-back"><div class="sourceInfo"><h3>Source Information</h3><p>From Harvard Medical School, Boston (S.M.H.); the University of Alabama at Birmingham, Birmingham (K.E.S.); the London School of Hygiene and Tropical Medicine, London (M.D.H.); Harvard School of Public Health, Boston (M.D.H., J.M.G.); the University of Rochester, Rochester, N.Y. (L.M.D.); the University of Southern California, Los Angeles (J.S.C.); the University of North Carolina, Chapel Hill (J.J.E.); the University of Cincinnati, Cincinnati (J.E.F.); the University of Minnesota, Minneapolis (H.H.B.); the Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Md. (L.R.D.); Merck and Co., West Point, Pa. (J.A.C.); and the University of Miami, Miami (M.A.F.).</p><p>Address reprint requests to Dr. Hammer at the Division of Infectious Diseases, Beth Israel Deaconess Medical Center, 1 Deaconess Rd., Boston, MA 02215.</p> <p>The institutions and investigators participating in the AIDS Clinical Trials Group 320 Study are listed in the Appendix.</p> <p>Other authors were John P. Phair, M.D. (Northwestern University), William Spreen, Pharm.D. (Glaxo–Wellcome), Louise Pedneault, M.D. (Bristol-Myers Squibb), Bach-Yen Nguyen, M.D. (Merck), and Jon C. Cook, B.Sc. (AIDS Clinical Trials Group Operations Center).</p> </div></div><div class="section section-back lastChild"> <h3 id="articleAppendix">Appendix</h3> <p>The following institutions and investigators participated in the AIDS Clinical Trials Group 320 Study: <em>University of North Carolina</em> — T. Lane and J. Horton; <em>University of Cincinnati</em> — D. Neumann and B. Letcher; <em>University of Puerto Rico</em> — G. Vazquez, M. Cruz-Ortiz, and I. Lopes; <em>University of Minnesota</em> — C. Kumekawa, R. Schut, and S. Swindells; <em>Washington University</em> — P. Tebas, W. Powderly, and A. Slack; <em>Ohio State University College of Medicine</em> — M. Para, R. Fass, and J. Neidig; <em>Northwestern University</em> — J. Pulvirenti and J. Pottage, Jr.; <em>University of Alabama and Emory University</em> — J. Lennox and K. Tamburello; <em>New York</em> <em>University Medical Center and Bellevue Hospital</em> — R. Gulick, J. Dowling, and M. Laverty; <em>University of Miami</em> — E. Scerpella and A. Rodriguez; <em>University of Texas at Galveston</em> — R. Pollard, S. Hausrath, and M. Pickthall; <em>Case Western Reserve University</em> — B. Gripshover, H. Valdez, and M. Chance; <em>Howard University</em> — R. Delapenha, J. McNeil, and Y. Butler; <em>Harvard University and Boston Medical Center</em> — L. Jackson-Pope and T. Cooley; <em>University of Rochester</em> — R. Hewitt and C. Greisberger; <em>University of California, Los Angeles</em> — R. Mitsuyasu, M. Guerrero, and P. Miller; <em>Indiana University Hospital</em> — K. Fife, H. Nixon, and D. Heise; <em>Meharry Medical College and Vanderbilt University Medical Center</em> — M.A. South, D. Haas, and S. Raffanti; <em>Duke University</em> — C. Hicks, P. Robinson, and K. Shipp; <em>University of California, San Diego</em> — C. Fegan, T.-C. Meng, and S. Little; <em>Johns Hopkins University</em> — R. Becker, M. Higgins, L. Apuzzo, and J.B. Jackson; <em>Mount Sinai Medical Center</em> — P. Gerits, H. Mendoza, and D. Mildvan; <em>University of Pennsylvania</em> — R.R. MacGregor, I. Matozzo, and E. McCann; <em>University of Southern California</em> — M. Dube and C. Olsen; <em>University of Colorado</em> — D. Kuritzkes, B. Putnam, and D. Torre; <em>Tulane University and Louisiana State University</em> — J. Lertora, R. Clark, and M. Beilke; <em>University of Hawaii</em> — S. Souza, M. Millard, and L. Oshita; <em>Stanford University</em> — T. Merigan, Jr., J. Fessel, and D. Israelski; <em>Memorial Sloan-Kettering Cancer Center</em> — M. Giordano, P. Ristau, and M. Granville; <em>University of Washington, Seattle</em> — A. Collier, R. Vasquez, B. Royer, and R. Coombs; <em>New York University Medical Center and Bellevue Hospital (pediatric</em> <em>site)</em> — W. Borkowsky, S. Chandwani, and M. Minter; <em>Columbus Children's Hospital</em> — M. Brady, J. Hunkler, and C. Callaway; <em>Medical University of South Carolina</em> — G. Johnson and E. Matters; <em>National Hemophilia Foundation</em> — T. Coates, T. Hofstra, W.-Y. Wong, E. Eyster, S. Seremetis, C. Kessler, S. Stabler, W. Hanna, C. Leissenger, J. Gill, P. Timmons, W.K. Hoots, and M. Cantini; <em>Division of AIDS, National Institute of Allergy and Infectious Diseases</em> — J. Ioannidis and A. Martinez; <em>Statistical and Data Management Center</em> — K. Kazial; <em>Harvard School of Public Health</em> — S.-H. Liou; <em>Community Constituency Group</em> — H. Chang; <em>Bristol-Myers Squibb</em> — J. Skovronski and L. Dunkle; <em>Merck and Co.</em> — A. Meibohm.</p> </div></dd><dd style="display: none;" id="references"><div class="section"><h3>References</h3><ol class="striped"><a name="ref1"></a><li class="odd" id="refItem1"><p class="number">1</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hammer SM</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Katzenstein DA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hughes MD</contrib>, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. <span class="NLM_source">N Engl J Med</span> 1996;335:1081-1090<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r001&amp;dbid=20&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1056%2FNEJM199610103351501" onclick="newWindow(this.href);return false">Free Full Text</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r001&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1996VN39900001" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r001&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=8813038" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref2"></a><li class="even" id="refItem2"><p class="number">2</p><p class="content"><contrib-group xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><contrib contrib-type="author">The Delta Coordinating Committee</contrib></contrib-group>. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. <span class="NLM_source">Lancet</span> 1996;348:283-291<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r002&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1016%2FS0140-6736%2896%2905387-1" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r002&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1996VA25000007" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r002&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=8709686" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref3"></a><li class="odd" id="refItem3"><p class="number">3</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Englund JA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Baker CJ</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Raskino C</contrib>, et al. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. <span class="NLM_source">N Engl J Med</span> 1997;336:1704-1712<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r003&amp;dbid=20&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1056%2FNEJM199706123362403" onclick="newWindow(this.href);return false">Free Full Text</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r003&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1997XD54300003" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r003&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=9182213" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref4"></a><li class="even" id="refItem4"><p class="number">4</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Wei X</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Ghosh SK</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Taylor ME</contrib>, et al. Viral dynamics in human immunodeficiency virus type 1 infection. <span class="NLM_source">Nature</span> 1995;373:117-122<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r004&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1038%2F373117a0" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r004&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1995QB06300048" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r004&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=7529365" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref5"></a><li class="odd" id="refItem5"><p class="number">5</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Ho DD</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Neumann AU</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Perelson AS</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Chem W</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Leonard JM</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Markowitz M</contrib>. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. <span class="NLM_source">Nature</span> 1995;373:123-126<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r005&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1038%2F373123a0" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r005&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1995QB06300049" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r005&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=7816094" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref6"></a><li class="even" id="refItem6"><p class="number">6</p><p class="content">Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271:1582-6.<br></p></li><a name="ref7"></a><li class="odd" id="refItem7"><p class="number">7</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Havlir DV</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Richman DD</contrib>. Viral dynamics of HIV: implications for drug development and therapeutic strategies. <span class="NLM_source">Ann Intern Med</span> 1996;124:984-994<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r007&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1996UL90500006" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r007&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=8624066" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref8"></a><li class="even" id="refItem8"><p class="number">8</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Haase AT</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Henry K</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Zupancic M</contrib>, et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. <span class="NLM_source">Science</span> 1996;274:985-989<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r008&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1126%2Fscience.274.5289.985" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r008&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1996VR79200050" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r008&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=8875941" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref9"></a><li class="odd" id="refItem9"><p class="number">9</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Fauci AS</contrib>. Host factors and the pathogenesis of HIV-induced disease. <span class="NLM_source">Nature</span> 1996;384:529-534<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r009&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1038%2F384529a0" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r009&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1996VX76900048" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r009&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=8955267" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref10"></a><li class="even" id="refItem10"><p class="number">10</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Katzenstein DA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hammer SM</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hughes MD</contrib>, et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. <span class="NLM_source">N Engl J Med</span> 1996;335:1091-1098<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r010&amp;dbid=20&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1056%2FNEJM199610103351502" onclick="newWindow(this.href);return false">Free Full Text</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r010&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1996VN39900002" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r010&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=8813039" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref11"></a><li class="odd" id="refItem11"><p class="number">11</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Mellors JW</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Kingsley LA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Rinaldo CR Jr</contrib>, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. <span class="NLM_source">Ann Intern Med</span> 1995;122:573-579<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r011&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1995QR52500003" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r011&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=7887550" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref12"></a><li class="even" id="refItem12"><p class="number">12</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Mellors JW</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Rinaldo CR Jr</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Gupta P</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">White RM</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Todd JA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Kingsley LA</contrib>. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. <span class="NLM_source">Science</span> 1996;272:1167-1170<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r012&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1126%2Fscience.272.5265.1167" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r012&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1996UM88900049" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r012&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=8638160" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref13"></a><li class="odd" id="refItem13"><p class="number">13</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Mellors JW</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Munoz A</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Giorgi JV</contrib>, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. <span class="NLM_source">Ann Intern Med</span> 1997;126:946-954<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r013&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1997XE54900006" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r013&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=9182471" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref14"></a><li class="even" id="refItem14"><p class="number">14</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Welles SL</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Jackson JB</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Yen-Lieberman B</contrib>, et al. Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no zidovudine therapy. <span class="NLM_source">J Infect Dis</span> 1996;174:696-703<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r014&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1093%2Finfdis%2F174.4.696" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r014&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1996VK04500003" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r014&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=8843205" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref15"></a><li class="odd" id="refItem15"><p class="number">15</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Coombs RW</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Welles SL</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hooper C</contrib>, et al. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. <span class="NLM_source">J Infect Dis</span> 1996;174:704-712<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r015&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1093%2Finfdis%2F174.4.704" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r015&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1996VK04500004" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r015&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=8843206" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref16"></a><li class="even" id="refItem16"><p class="number">16</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hughes MD</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Johnson VA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hirsch MS</contrib>, et al. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. <span class="NLM_source">Ann Intern Med</span> 1997;126:929-938<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r016&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1997XE54900004" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r016&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=9182469" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref17"></a><li class="odd" id="refItem17"><p class="number">17</p><p class="content"><contrib-group xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><contrib contrib-type="author">O'Brien WA, Hartigan PM, Daar ES, Simberkoff MS, Hamilton JD, The VA Cooperative Study Group on AIDS</contrib></contrib-group>. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. <span class="NLM_source">Ann Intern Med</span> 1997;126:939-945<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r017&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1997XE54900005" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r017&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=9182470" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref18"></a><li class="even" id="refItem18"><p class="number">18</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Kohl NE</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Emini EA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Schleif WA</contrib>, et al. Active human immunodeficiency virus protease is required for viral infectivity. <span class="NLM_source">Proc Natl Acad Sci U S A</span> 1988;85:4686-4690<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r018&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1073%2Fpnas.85.13.4686" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r018&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1988P227700024" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r018&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=3290901" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref19"></a><li class="odd" id="refItem19"><p class="number">19</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Peng C</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Ho BK</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Chang TW</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Chang NT</contrib>. Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. <span class="NLM_source">J Virol</span> 1989;63:2550-2556<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r019&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1989U609600020" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r019&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=2657099" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref20"></a><li class="even" id="refItem20"><p class="number">20</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Seelmeier S</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Schmidt H</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Turk V</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">von der Helm K</contrib>. Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A. <span class="NLM_source">Proc Natl Acad Sci U S A</span> 1988;85:6612-6616<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r020&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1073%2Fpnas.85.18.6612" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r020&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1988Q138700009" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r020&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=3045820" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref21"></a><li class="odd" id="refItem21"><p class="number">21</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Danner SA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Carr A</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Leonard JM</contrib>, et al. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. <span class="NLM_source">N Engl J Med</span> 1995;333:1528-1533<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r021&amp;dbid=20&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1056%2FNEJM199512073332303" onclick="newWindow(this.href);return false">Free Full Text</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r021&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1995TH15700003" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r021&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=7477167" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref22"></a><li class="even" id="refItem22"><p class="number">22</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Markowitz M</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Saag M</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Powderly WG</contrib>, et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. <span class="NLM_source">N Engl J Med</span> 1995;333:1534-1539<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r022&amp;dbid=20&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1056%2FNEJM199512073332204" onclick="newWindow(this.href);return false">Free Full Text</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r022&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1995TH15700004" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r022&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=7477168" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref23"></a><li class="odd" id="refItem23"><p class="number">23</p><p class="content">Stein D, Drusano G, Steigbigel R, et al. Two year follow-up of patients treated with indinavir 800 mg q 8 h. In: Program and abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, D.C., January 22–26, 1997:100. abstract.<br></p></li><a name="ref24"></a><li class="even" id="refItem24"><p class="number">24</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Gulick RM</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Mellors JW</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Havlir D</contrib>, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. <span class="NLM_source">N Engl J Med</span> 1997;337:734-739<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r024&amp;dbid=20&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1056%2FNEJM199709113371102" onclick="newWindow(this.href);return false">Free Full Text</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r024&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1997XV17400002" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r024&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=9287228" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref25"></a><li class="odd" id="refItem25"><p class="number">25</p><p class="content">Hirsch M, Protocol 039 (Indinavir) Study Group, Meibohm A, Rawlins S, Leavitt R. Indinavir in combination with zidovudine and lamivudine in ZDV-experienced patients with CD4 cell counts &lt;50 cells/mm<sup>3</sup>. In: Program and abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, D.C., January 22–26, 1997:207. abstract.<br></p></li><a name="ref26"></a><li class="even" id="refItem26"><p class="number">26</p><p class="content">Powderly W, Sension M, Conant M, Stein A, Clendeninn N. The efficacy of Viracept (nelfinavir mesylate, NFV) in pivotal phase II/III double-blind randomized controlled trials as monotherapy and in combination with d4T or AZT/3TC. In: Program and abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, D.C., January 22–26, 1997:132. abstract.<br></p></li><a name="ref27"></a><li class="odd" id="refItem27"><p class="number">27</p><p class="content">Division of AIDS. Division of AIDS table for grading severity of adult adverse experiences. Rockville, Md.: National Institute of Allergy and Infectious Diseases, 1996.<br></p></li><a name="ref28"></a><li class="even" id="refItem28"><p class="number">28</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Peto R</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Pike MC</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Armitage P</contrib>, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. <span class="NLM_source">Br J Cancer</span> 1976;34:585-612<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r028&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1038%2Fbjc.1976.220" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r028&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1976CQ95300002" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r028&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=795448" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref29"></a><li class="odd" id="refItem29"><p class="number">29</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Mulder J</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">McKinney N</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Christopherson C</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Sninsky J</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Greenfield L</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Kwok S</contrib>. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. <span class="NLM_source">J Clin Microbiol</span> 1994;32:292-300<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r029&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1994MR79200003" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r029&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=8150937" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref30"></a><li class="even" id="refItem30"><p class="number">30</p><p class="content">Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.<br></p></li><a name="ref31"></a><li class="odd" id="refItem31"><p class="number">31</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Laird NM</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Ware JH</contrib>. Random-effects models for longitudinal data. <span class="NLM_source">Biometrics</span> 1982;38:963-974<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r031&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.2307%2F2529876" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r031&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1982QF89700008" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r031&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=7168798" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref32"></a><li class="even" id="refItem32"><p class="number">32</p><p class="content">Pocock SJ. Clinical trials: a practical approach. Chichester, England: John Wiley, 1983.<br></p></li><a name="ref33"></a><li class="odd" id="refItem33"><p class="number">33</p><p class="content">The Lifereg procedure. In: SAS/STAT user's guide. 4th ed. Cary, N.C.: SAS Institute, 1989:997-1025.<br></p></li><a name="ref34"></a><li class="even" id="refItem34"><p class="number">34</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hughes MD</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Pocock SJ</contrib>. Stopping rules and estimation problems in clinical trials. <span class="NLM_source">Stat Med</span> 1988;7:1231-1242<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r034&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1002%2Fsim.4780071204" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r034&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1988R444200003" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r034&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=3231947" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref35"></a><li class="odd" id="refItem35"><p class="number">35</p><p class="content">Wong JK, Gunthard HF, Havlir DV, et al. Reduction of HIV in blood and lymph nodes after potent antiretroviral therapy. In: Program and abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, D.C., January 22–26, 1997:207. abstract.<br></p></li><a name="ref36"></a><li class="even" id="refItem36"><p class="number">36</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Larder BA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Kemp SD</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Harrigan PR</contrib>. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. <span class="NLM_source">Science</span> 1995;269:696-699<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r036&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1126%2Fscience.7542804" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r036&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1995RM70200036" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r036&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=7542804" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref37"></a><li class="odd" id="refItem37"><p class="number">37</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Eron JJ</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Benoit SL</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Jemsek J</contrib>, et al. Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. <span class="NLM_source">N Engl J Med</span> 1995;333:1662-1669<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r037&amp;dbid=20&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1056%2FNEJM199512213332502" onclick="newWindow(this.href);return false">Free Full Text</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r037&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1995TL40100002" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r037&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=7477218" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref38"></a><li class="even" id="refItem38"><p class="number">38</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Katlama C</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Ingrand D</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Loveday C</contrib>, et al. Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients: a randomized controlled comparison with zidovudine monotherapy. <span class="NLM_source">JAMA</span> 1996;276:118-125<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r038&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1001%2Fjama.276.2.118" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r038&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1996UV48500026" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r038&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=8656503" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref39"></a><li class="odd" id="refItem39"><p class="number">39</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Staszewski S</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Loveday C</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Picazo JJ</contrib>, et al. Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients: a randomized controlled comparison with zidovudine monotherapy. <span class="NLM_source">JAMA</span> 1996;276:111-117<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r039&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1001%2Fjama.276.2.111" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r039&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1996UV48500025" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r039&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=8656502" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref40"></a><li class="even" id="refItem40"><p class="number">40</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Bartlett JA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Benoit SL</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Johnson VA</contrib>, et al. Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection: a randomized, double-blind, placebo-controlled trial. <span class="NLM_source">Ann Intern Med</span> 1996;125:161-172<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r040&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1996UZ28700001" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r040&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=8686973" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref41"></a><li class="odd" id="refItem41"><p class="number">41</p><p class="content"><contrib-group xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><contrib contrib-type="author">CAESAR Coordinating Committee</contrib></contrib-group>. Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial. <span class="NLM_source">Lancet</span> 1997;349:1413-1421<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r041&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1016%2FS0140-6736%2897%2904441-3" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r041&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1997WZ76500008" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r041&amp;dbid=8&amp;doi=10.1056%2FNEJM199709113371101&amp;key=9164314" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref42"></a><li class="even" id="refItem42"><p class="number">42</p><p class="content">Cameron DW, Heath-Chiozzi M, Kravcik S, et al. Prolongation of life and prevention of AIDS complications in advanced HIV immunodeficiency with ritonavir: update. In: Volume 1 of the Abstracts of the XI International Conference on AIDS, Vancouver, B.C., July 7–12, 1996:24. abstract.<br></p></li><a name="ref43"></a><li class="odd" id="refItem43"><p class="number">43</p><p class="content">Salgo M, Beattie D, Bragman K, et al. Saquinavir (Invirase, SQV) vs. HIVID (zalcitabine, ddC) vs. combination as treatment for advanced HIV infection in patients discontinuing/unable to take retrovir (zidovudine ZDV). In: Volume 1 of the Abstracts of the XI International Conference on AIDS, Vancouver, B.C., July 7–12, 1996:24. abstract.<br></p></li><a name="ref44"></a><li class="even" id="refItem44"><p class="number">44</p><p class="content">Harrigan R, Stone C, Griffin P, et al. Antiretroviral activity and resistance profile of the carbocyclic nucleoside HIV reverse transcriptase inhibitor 1592U89. In: Program and abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, D.C., January 22–26, 1997:67. abstract.<br></p></li><a name="ref45"></a><li class="odd" id="refItem45"><p class="number">45</p><p class="content">Schooley RT, 141W94 International Study Group. Preliminary data from a phase I/II study on the safety and antiviral efficacy of the combination of 141W94 plus 1592U89 in HIV-infected patients with 150 to 400 CD4+ cells/mm<sup>3</sup>. In: Program and abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, D.C., January 22–26, 1997:206. abstract.<br></p></li><a name="ref46"></a><li class="even" id="refItem46"><p class="number">46</p><p class="content">Ruiz N, DuPont Merck Study Group. A double-blind pilot study to evaluate the antiretroviral activity, tolerability of DMP 266 in combination with indinavir (cohort III). In: Program and abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, D.C., January 22–26, 1997:206. abstract.<br></p></li><a name="ref47"></a><li class="lastChild odd" id="refItem47"><p class="number">47</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Carpenter CCJ</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Fischl MA</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hammer SM</contrib>, et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society-USA panel. <span class="NLM_source">JAMA</span> 1997;77:1962-1969<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r047&amp;dbid=16&amp;doi=10.1056%2FNEJM199709113371101&amp;key=10.1001%2Fjama.277.24.1962" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r047&amp;dbid=128&amp;doi=10.1056%2FNEJM199709113371101&amp;key=A1997XF08700042" onclick="newWindow(this.href);return false">Web of Science</a></p></li></ol></div></dd><dd style="display: none;" id="citedby"><div class="section"><h3>Citing Articles</h3><ol class="striped"><li class="firstChild odd"><p class="number">1</p><p class="content">Donglin Ding, Xiying Qu, Lin Li, Xin Zhou, Sijie Liu, Shiguan Lin, Pengfei Wang, Shaohui Liu, Chuijin Kong, Xiaohui Wang, Lin Liu, Huanzhang Zhu.  (2013) Involvement of histone methyltransferase GLP in HIV-1 latency through catalysis of H3K9 dimethylation. <i><span class="NLM_source">Virology</span></i> <b>440</b>:2, 182-189<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.virol.2013.02.022" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">2</p><p class="content">Zheng Zhang, Junliang Fu, Xiangsheng Xu, Siyu Wang, Ruonan Xu, Min Zhao, Weimin Nie, Xicheng Wang, Jiyuan Zhang, Taisheng Li, Lishan Su, Fu-Sheng Wang.  (2013) Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>27</b>:8, 1283-1293<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32835fab77" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">3</p><p class="content">Harleen Gakhar, Amanda Kamali, Mark Holodniy.  (2013) Health-related Quality of Life Assessment after Antiretroviral Therapy: A Review of the Literature. <i><span class="NLM_source">Drugs</span></i> <b>73</b>:7, 651-672<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s40265-013-0040-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">4</p><p class="content">Kit N. Simpson, Pamela P. Pei, Jörgen Möller, Robert W. Baran, Birgitta Dietz, William Woodward, Kristen Migliaccio-Walle, J. Jaime Caro.  (2013) Lopinavir/Ritonavir Versus Darunavir Plus Ritonavir for HIV Infection: A Cost-Effectiveness Analysis for the United States. <i><span class="NLM_source">PharmacoEconomics</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s40273-013-0048-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">5</p><p class="content">O Gasser, C Brander, M Wolbers, NV Brown, A Rauch, HF Günthard, M Battegay, C Hess, .  (2013) Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy. <i><span class="NLM_source">HIV Medicine</span></i> <b>14</b>:4, 241-246<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2012.01040.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">6</p><p class="content">Adriana S.A. Andrade, Reena Deutsch, Shivaun A. Celano, Nichole A. Duarte, Thomas D. Marcotte, Anya Umlauf, J. Hampton Atkinson, J. Allen McCutchan, Donald Franklin, Terry J. Alexander, Justin C. McArthur, Christina Marra, Igor Grant, Ann C. Collier.  (2013) Relationships Among Neurocognitive Status, Medication Adherence Measured by Pharmacy Refill Records, and Virologic Suppression in HIV-Infected Persons. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>62</b>:3, 282-292<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e31827ed678" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">7</p><p class="content">Conrad Kabali, Lillian Mtei, Daniel R. Brooks, Richard Waddell, Muhammad Bakari, Mecky Matee, Robert D. Arbeit, Kisali Pallangyo, C. Fordham von Reyn, C. Robert Horsburgh.  (2013) Increased mortality associated with treated active tuberculosis in HIV-infected adults in Tanzania. <i><span class="NLM_source">Tuberculosis</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.tube.2013.01.001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">8</p><p class="content">Jean-Philippe Chaput, Margot Shields, Mark S. Tremblay. Statistics in Childhood Obesity. In: Encyclopedia of Statistical Sciences. John Wiley &amp; Sons, Inc., 2013.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/0471667196.ess7156" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">9</p><p class="content">Haralambos Tzoupis, Georgios Leonis, Thomas Mavromoustakos, Manthos G. Papadopoulos.  (2013) A Comparative Molecular Dynamics, MM–PBSA and Thermodynamic Integration Study of Saquinavir Complexes with Wild-Type HIV-1 PR and L10I, G48V, L63P, A71V, G73S, V82A and I84V Single Mutants. <i><span class="NLM_source">Journal of Chemical Theory and Computation</span></i>130220071949005<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1021/ct301063k" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">10</p><p class="content">C. Lozupone, A. Cota-Gomez, B. E. Palmer, D. J. Linderman, E. S. Charlson, E. Sodergren, M. Mitreva, S. Abubucker, J. Martin, G. Yao, T. B. Campbell, S. C. Flores, G. Ackerman, J. Stombaugh, L. Ursell, J. M. Beck, J. L. Curtis, V. B. Young, S. V. Lynch, L. Huang, G. M. Weinstock, K. S. Knox, H. Twigg, A. Morris, E. Ghedin, F. D. Bushman, R. G. Collman, R. Knight, A. P. Fontenot, .  (2013) Widespread Colonization of the Lung by Tropheryma whipplei in HIV Infection. <i><span class="NLM_source">American Journal of Respiratory and Critical Care Medicine</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1164/rccm.201211-2145OC" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">11</p><p class="content">Lihui Zhao, Lu Tian, Tianxi Cai, Brian Claggett, L. J. Wei.  (2013) Effectively selecting a target population for a future comparative study. <i><span class="NLM_source">Journal of the American Statistical Association</span></i>130204062200005<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/01621459.2013.770705" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">12</p><p class="content">Leilani Schwarcz, Miao-Jung Chen, Eric Vittinghoff, Ling Hsu, Sandra Schwarcz.  (2013) Declining incidence of AIDS-defining opportunistic illnesses. <i><span class="NLM_source">AIDS</span></i> <b>27</b>:4, 597-605<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32835b0fa2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">13</p><p class="content">Zachary Y. Kerr, Katye R. Miller, Dylan Galos, Randi Love, Charles Poole.  (2013) Challenges, Coping Strategies, and Recommendations Related to the HIV Services Field in the HAART Era: A Systematic Literature Review of Qualitative Studies from the United States and Canada. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>27</b>:2, 85-95<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.2012.0356" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">14</p><p class="content">Omar Galárraga, Becky L. Genberg, Rosemarie A. Martin, M. Barton Laws, Ira B. Wilson.  (2013) Conditional Economic Incentives to Improve HIV Treatment Adherence: Literature Review and Theoretical Considerations. <i><span class="NLM_source">AIDS and Behavior</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10461-013-0415-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">15</p><p class="content">Igor Kozak, J. Allen McCutchan, William R. Freeman. HIV-Associated Infections. In: Retina. Elsevier, 2013:1441-1472.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-1-4557-0737-9.00081-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">16</p><p class="content">Xinyan Zhang, Peter W. Hunt, Scott M. Hammer, Michelle S. Cespedes, Kristine B. Patterson, Ronald J. Bosch.  (2013) Immune Activation While on Potent Antiretroviral Therapy Can Predict Subsequent CD4+ T-Cell Increases Through 15 Years of Treatment. <i><span class="NLM_source">HIV Clinical Trials</span></i> <b>14</b>:2, 61-67<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1310/hct1402-61" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">17</p><p class="content">Sunil S. Solomon, Gregory M. Lucas, Nagalingeswaran Kumarasamy, Tokugha Yepthomi, Pachamuthu Balakrishnan, Aylur K. Ganesh, Santhanam Anand, Richard D. Moore, Suniti Solomon, Shruti H. Mehta.  (2012) Impact of generic antiretroviral therapy (ART) and free ART programs on time to initiation of ART at a tertiary HIV care center in Chennai, India. <i><span class="NLM_source">AIDS Care</span></i>1-6<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/09540121.2012.748160" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">18</p><p class="content">Katherine C. Groves, David F. Bibby, Duncan A. Clark, Are Isaksen, Jane R. Deayton, Jane Anderson, Chloe Orkin, Andrew J. Stagg, Áine McKnight.  (2012) Disease Progression in HIV-1–Infected Viremic Controllers. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>61</b>:4, 407-416<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e318269c414" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">19</p><p class="content">M. S. Shiels, O. Landgren, R. Costello, A. Zingone, J. J. Goedert, E. A. Engels.  (2012) Free Light Chains and the Risk of AIDS-Defining Opportunistic Infections in HIV-Infected Individuals. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>55</b>:10, e103-e108<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/cid/cis692" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">20</p><p class="content">J. Y. Chen, H. J. Ribaudo, S. Souda, N. Parekh, A. Ogwu, S. Lockman, K. Powis, S. Dryden-Peterson, T. Creek, W. Jimbo, T. Madidimalo, J. Makhema, M. Essex, R. L. Shapiro.  (2012) Highly Active Antiretroviral Therapy and Adverse Birth Outcomes Among HIV-Infected Women in Botswana. <i><span class="NLM_source">Journal of Infectious Diseases</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/infdis/jis553" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">21</p><p class="content">M. Stöckle, L. Elzi, J.K. Rockstroh, M. Battegay.  (2012) Morbidität und Mortalität der HIV-Infektion. <i><span class="NLM_source">Der Internist</span></i> <b>53</b>:10, 1151-1156<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s00108-011-2990-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">22</p><p class="content">Michael P. Carey, Lori A. J. Scott-Sheldon, Peter A. Vanable. HIV/AIDS. In: Handbook of Psychology, Second Edition. John Wiley &amp; Sons, Inc., 2012.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/9781118133880.hop209010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">23</p><p class="content">Philip M. Grant, Andrew R. Zolopa.  (2012) When to Start ART in the Setting of Acute AIDS-Related Opportunistic Infections: The Time Is Now!. <i><span class="NLM_source">Current HIV/AIDS Reports</span></i> <b>9</b>:3, 251-258<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11904-012-0126-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">24</p><p class="content"> (2012) 4.0 When to start. <i><span class="NLM_source">HIV Medicine</span></i> <b>13</b>, 21-27<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2012.01029_5.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">25</p><p class="content">Corwin M. Zigler, Thomas R. Belin.  (2012) A Bayesian Approach to Improved Estimation of Causal Effect Predictiveness for a Principal Surrogate Endpoint. <i><span class="NLM_source">Biometrics</span></i> <b>68</b>:3, 922-932<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1541-0420.2011.01736.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">26</p><p class="content">Andrew Edmonds, Marcel Yotebieng, Jean Lusiama, Yori Matumona, Faustin Kitetele, David Nku, Sonia Napravnik, Stephen R. Cole, Annelies Van Rie, Frieda Behets.  (2012) Quantification of CD4 Responses to Combined Antiretroviral Therapy Over 5 Years Among HIV-Infected Children in Kinshasa, Democratic Republic of Congo. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>61</b>:1, 90-98<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e31825bd9b7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">27</p><p class="content">Daniel Westreich, Stephen R. Cole, Enrique F. Schisterman, Robert W. Platt.  (2012) A simulation study of finite-sample properties of marginal structural Cox proportional hazards models. <i><span class="NLM_source">Statistics in Medicine</span></i> <b>31</b>:19, 2098-2109<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/sim.5317" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">28</p><p class="content">Daniel Westreich, Stephen R. Cole, Jessica G. Young, Frank Palella, Phyllis C. Tien, Lawrence Kingsley, Stephen J Gange, Miguel A. Hernán.  (2012) The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. <i><span class="NLM_source">Statistics in Medicine</span></i> <b>31</b>:18, 2000-2009<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/sim.5316" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">29</p><p class="content">William N. Evans, Craig Garthwaite.  (2012) Estimating Heterogeneity in the Benefits of Medical Treatment Intensity. <i><span class="NLM_source">Review of Economics and Statistics</span></i> <b>94</b>:3, 635-649<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1162/REST_a_00198" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">30</p><p class="content">Rozaini Mat Shah, Awang Bulgiba, Christopher K.C. Lee, Jamaiyah Haniff, Mariana Mohamad Ali.  (2012) Highly Active Antiretroviral Therapy Reduces Mortality and Morbidity in Patients with AIDS in Sungai Buloh Hospital. <i><span class="NLM_source">Journal of Experimental &amp; Clinical Medicine</span></i> <b>4</b>:4, 239-244<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jecm.2012.06.011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">31</p><p class="content">Vikram Arya, Sarah M. Robertson, Kimberly A. Struble, Jeffrey S. Murray.  (2012) Scientific Considerations for Pharmacoenhancers in Antiretroviral Therapy. <i><span class="NLM_source">The Journal of Clinical Pharmacology</span></i> <b>52</b>:8, 1128-1133<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1177/0091270011410569" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">32</p><p class="content">Thomas Kerr, Brandon D.L. Marshall, M.-J. Milloy, Ruth Zhang, Silvia Guillemi, Julio S.G. Montaner, Evan Wood.  (2012) Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users. <i><span class="NLM_source">Drug and Alcohol Dependence</span></i> <b>124</b>:1-2, 108-112<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.drugalcdep.2011.12.019" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">33</p><p class="content">Guillaume Mousseau, Mark&nbsp;A. Clementz, Wendy&nbsp;N. Bakeman, Nisha Nagarsheth, Michael Cameron, Jun Shi, Phil Baran, Rémi Fromentin, Nicolas Chomont, Susana&nbsp;T. Valente.  (2012) An Analog of the Natural Steroidal Alkaloid Cortistatin A Potently Suppresses Tat-Dependent HIV Transcription. <i><span class="NLM_source">Cell Host &amp; Microbe</span></i> <b>12</b>:1, 97-108<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.chom.2012.05.016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">34</p><p class="content">, David A. Martinez, Kathy Goggin, Delwyn Catley, Mary M. Gerkovich, Karen Williams, Julie Wright, Jannette Berkley-Patton.  (2012) Do Coping Styles Mediate the Relationship Between Substance Use and Educational Attainment and Antiretroviral Adherence?. <i><span class="NLM_source">AIDS and Behavior</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10461-012-0222-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">35</p><p class="content">B Mann, M-J Milloy, T Kerr, R Zhang, J Montaner, E Wood.  (2012) Improved adherence to modern antiretroviral therapy among HIV-infected injecting drug users. <i><span class="NLM_source">HIV Medicine</span></i>n/a-n/a<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2012.01021.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">36</p><p class="content">Tae-Wook Chun, Anthony S. Fauci.  (2012) HIV reservoirs. <i><span class="NLM_source">AIDS</span></i> <b>26</b>:10, 1261-1268<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e328353f3f1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">37</p><p class="content">Stefano Vella, Bernard Schwartländer, Salif Papa Sow, Serge Paul Eholie, Robert L. Murphy.  (2012) The history of antiretroviral therapy and of its implementation in resource-limited areas of the world. <i><span class="NLM_source">AIDS</span></i> <b>26</b>:10, 1231-1241<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32835521a3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">38</p><p class="content">D. E. Bennett, M. R. Jordan, S. Bertagnolio, S. Y. Hong, G. Ravasi, J. H. McMahon, A. Saadani, K. F. Kelley.  (2012) HIV Drug Resistance Early Warning Indicators in Cohorts of Individuals Starting Antiretroviral Therapy Between 2004 and 2009: World Health Organization Global Report From 50 Countries. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>54</b>:suppl 4, S280-S289<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/cid/cis207" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">39</p><p class="content">V. Le Douce, A. Janossy, H. Hallay, S. Ali, R. Riclet, O. Rohr, C. Schwartz.  (2012) Achieving a cure for HIV infection: do we have reasons to be optimistic?. <i><span class="NLM_source">Journal of Antimicrobial Chemotherapy</span></i> <b>67</b>:5, 1063-1074<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/jac/dkr599" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">40</p><p class="content">A. Hussein, H. A. Muttlak, E. Al-Sawi.  (2012) Group sequential methods based on ranked set samples. <i><span class="NLM_source">Statistical Papers</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s00362-012-0448-z" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">41</p><p class="content">Xiongyu Wu, Per Öhrngren, Advait A. Joshi, Alejandro Trejos, Magnus Persson, Riina K. Arvela, Hans Wallberg, Lotta Vrang, Åsa Rosenquist, Bertil B. Samuelsson, Johan Unge, Mats Larhed.  (2012) Synthesis, X-ray Analysis, and Biological Evaluation of a New Class of Stereopure Lactam-Based HIV-1 Protease Inhibitors. <i><span class="NLM_source">Journal of Medicinal Chemistry</span></i>120313102751007<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1021/jm201620t" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">42</p><p class="content">Daniel&nbsp;E. Goldberg, Robert&nbsp;F. Siliciano, William&nbsp;R. Jacobs.  (2012) Outwitting Evolution: Fighting Drug-Resistant TB, Malaria, and HIV. <i><span class="NLM_source">Cell</span></i> <b>148</b>:6, 1271-1283<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.cell.2012.02.021" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">43</p><p class="content">Michael&nbsp;S. Glickman, Charles&nbsp;L. Sawyers.  (2012) Converting Cancer Therapies into Cures: Lessons from Infectious Diseases. <i><span class="NLM_source">Cell</span></i> <b>148</b>:6, 1089-1098<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.cell.2012.02.015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">44</p><p class="content">Benjamin L Jilek, Melissa Zarr, Maame E Sampah, S Alireza Rabi, Cynthia K Bullen, Jun Lai, Lin Shen, Robert F Siliciano.  (2012) A quantitative basis for antiretroviral therapy for HIV-1 infection. <i><span class="NLM_source">Nature Medicine</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/nm.2649" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">45</p><p class="content">Ingrid A. Beck, Minyoung Jang, Jennifer McKernan-Mullin, Marta Bull, Thor Wagner, Sharon Huang, Lin-Ye Song, Sharon Nachman, Paul Krogstad, Susan H. Eshleman, Andrew Wiznia, Lisa M. Frenkel.  (2012) Monitoring of HIV Type 1 DNA Load and Drug Resistance in Peripheral Blood Mononuclear Cells During Suppressive Antiretroviral Therapy Does Not Predict Virologic Failure. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i>120127074704008<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2011.0039" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">46</p><p class="content">Jun Yong Choi, June Myung Kim.  (2012) Updates on the prevention and treatment of AIDS. <i><span class="NLM_source">Journal of the Korean Medical Association</span></i> <b>55</b>:2, 146<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.5124/jkma.2012.55.2.146" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">47</p><p class="content">Karen J. Towgood, Mervi Pitkanen, Ranjababu Kulasegaram, Alex Fradera, Suneeta Soni, Naomi Sibtain, Laurence J. Reed, Caroline Bradbeer, Gareth J. Barker, Joel T. Dunn, Fernando Zelaya, Michael D. Kopelman.  (2012) Regional cerebral blood flow and FDG uptake in asymptomatic HIV-1 men. <i><span class="NLM_source">Human Brain Mapping</span></i>n/a-n/a<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/hbm.22078" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">48</p><p class="content">Catherine S. Adamson.  (2012) Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process. <i><span class="NLM_source">Molecular Biology International</span></i> <b>2012</b>, 1-13<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1155/2012/604261" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">49</p><p class="content">Marilia Rita Pinzone, Michelino Di Rosa, Bruno Cacopardo, Giuseppe Nunnari.  (2012) HIV RNA Suppression and Immune Restoration: Can We Do Better?. <i><span class="NLM_source">Clinical and Developmental Immunology</span></i> <b>2012</b>, 1-12<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1155/2012/515962" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">50</p><p class="content">Praveen K. Mullangi, Lokesh Shahani, Janak Koirala.  (2011) Role of Endogenous Biological Response Modifiers in Pathogenesis of Infectious Diseases. <i><span class="NLM_source">Infectious Disease Clinics of North America</span></i> <b>25</b>:4, 733-754<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.idc.2011.07.003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">51</p><p class="content">Till Bärnighausen, Krisda Chaiyachati, Natsayi Chimbindi, Ashleigh Peoples, Jessica Haberer, Marie-Louise Newell.  (2011) Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. <i><span class="NLM_source">The Lancet Infectious Diseases</span></i> <b>11</b>:12, 942-951<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1473-3099(11)70181-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">52</p><p class="content">Yan Wei, Amy Kirby, Bruce R. Levin.  (2011) The Population and Evolutionary Dynamics of
              <i>Vibrio cholerae</i>
              and Its Bacteriophage: Conditions for Maintaining Phage-Limited Communities. <i><span class="NLM_source">The American Naturalist</span></i> <b>178</b>:6, 715-725<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/662677" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">53</p><p class="content">Ingrid A Beck, Minyoung Jang, Jennifer McKernan, Marta Bull, Thor A Wagner, Sharon Huang, Lin-Ye Song, Sharon Nachman, Paul Krogstad, Susan Eshleman, Andrew Wiznia, Lisa Marie Frenkel.  (2011) Monitoring of HIV-1 DNA Load and Drug Resistance in Peripheral Blood Mononuclear Cells during Suppressive Antiretroviral Therapy does not Predict Virologic Failure. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i>111115031133002<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/AID.2011.0039" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">54</p><p class="content">Dean G. Cruess, Seth C. Kalichman, Christine Amaral, Connie Swetzes, Chauncey Cherry, Moira O. Kalichman.  (2011) Benefits of Adherence to Psychotropic Medications on Depressive Symptoms and Antiretroviral Medication Adherence Among Men and Women Living with HIV/AIDS. <i><span class="NLM_source">Annals of Behavioral Medicine</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s12160-011-9322-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">55</p><p class="content">D. F. Tate, A. DeLong, D. E. McCaffrey, K. Kertesz, R. H. Paul, J. Conley, T. Russell, K. Coop, F. Gillani, T. Flanigan, K. Tashima, J. W. Hogan.  (2011) Recent Clinical History and Cognitive Dysfunction for Attention and Executive Function among Human Immunodeficiency Virus-Infected Patients. <i><span class="NLM_source">Archives of Clinical Neuropsychology</span></i> <b>26</b>:7, 614-623<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/arclin/acr065" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">56</p><p class="content">Timour Al-Khindi, Konstantine K. Zakzanis, Wilfred G. van Gorp.  (2011) Does Antiretroviral Therapy Improve HIV-Associated Cognitive Impairment? A Quantitative Review of the Literature. <i><span class="NLM_source">Journal of the International Neuropsychological Society</span></i> <b>17</b>:06, 956-969<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1017/S1355617711000968" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">57</p><p class="content">P. Volberding.  (2011) The impact of HIV research on health outcome and healthcare policy. <i><span class="NLM_source">Annals of Oncology</span></i> <b>22</b>:Suppl 7, vii50-vii53<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/annonc/mdr426" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">58</p><p class="content">Donald M Coen, Richard Whitley.  (2011) Antiviral drugs and antiviral drug resistance. <i><span class="NLM_source">Current Opinion in Virology</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.coviro.2011.10.024" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">59</p><p class="content">References. John Wiley &amp; Sons, Inc., 2011:365-381.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/9780470258019.refs" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">60</p><p class="content">Xiaobin Zhang, Hao Wu, Fengshan Wang. Sifuvirtide, A Novel HIV-1 Fusion Inhibitor. In: Peptide Drug Discovery and Development. Wiley-VCH Verlag GmbH &amp; Co. KGaA, 2011:231-243.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/9783527636730.ch11" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">61</p><p class="content">Molly F. Franke, Megan B. Murray, Maribel Muñoz, Sonia Hernández-Díaz, José Luís Sebastián, Sidney Atwood, Adolfo Caldas, Jaime Bayona, Sonya S. Shin.  (2011) Food Insufficiency is a Risk Factor for Suboptimal Antiretroviral Therapy Adherence among HIV-Infected Adults in Urban Peru. <i><span class="NLM_source">AIDS and Behavior</span></i> <b>15</b>:7, 1483-1489<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10461-010-9789-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">62</p><p class="content">James McMahon, Christine Wanke, Norma Terrin, Sally Skinner, Tamsin Knox.  (2011) Poverty, Hunger, Education, and Residential Status Impact Survival in HIV. <i><span class="NLM_source">AIDS and Behavior</span></i> <b>15</b>:7, 1503-1511<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10461-010-9759-z" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">63</p><p class="content">P. E. Sax.  (2011) Antiretroviral Therapy: Now "It Just Works". <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>53</b>:6, 605-608<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/cid/cir470" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">64</p><p class="content">Jessica G. Young, Lauren E. Cain, James M. Robins, Eilis J. O’Reilly, Miguel A. Hernán.  (2011) Comparative Effectiveness of Dynamic Treatment Regimes: An Application of the Parametric G-Formula. <i><span class="NLM_source">Statistics in Biosciences</span></i> <b>3</b>:1, 119-143<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s12561-011-9040-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">65</p><p class="content">Stephen T Wright, Andrew Carr, Ian Woolley, Michelle Giles, Jennifer Hoy, David A Cooper, Matthew G Law.  (2011) CD4 Cell Responses to Combination Antiretroviral Therapy in Patients Starting Therapy at High CD4 Cell Counts. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>58</b>:1, 72-79<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e318225ba62" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">66</p><p class="content">John F. Kadow, John Bender, Alicia Regueiro-Ren, Yasutsugu Ueda, Tao Wang, Kap-Sun Yeung, Nicholas A. Meanwell. Discovery and Development of HIV-1 Entry Inhibitors That Target gp120. In: Antiviral Drugs. John Wiley &amp; Sons, Inc., 2011:149-162.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/9780470929353.ch11" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">67</p><p class="content">Seonaid Nolan, M-J. Milloy, Ruth Zhang, Thomas Kerr, Robert S. Hogg, Julio S.G. Montaner, Evan Wood.  (2011) Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting. <i><span class="NLM_source">AIDS Care</span></i> <b>23</b>:8, 980-987<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/09540121.2010.543882" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">68</p><p class="content">Mark W. Hull, Julio S. G. Montaner.  (2011) Ritonavir-boosted protease inhibitors in HIV therapy. <i><span class="NLM_source">Annals of Medicine</span></i> <b>43</b>:5, 375-388<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.3109/07853890.2011.572905" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">69</p><p class="content">A. S. Perelson, S. G. Deeks.  (2011) Drug Effectiveness Explained: The Mathematics of Antiviral Agents for HIV. <i><span class="NLM_source">Science Translational Medicine</span></i> <b>3</b>:91, 91ps30-91ps30<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1126/scitranslmed.3002656" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">70</p><p class="content">L. Shen, S. A. Rabi, A. R. Sedaghat, L. Shan, J. Lai, S. Xing, R. F. Siliciano.  (2011) A Critical Subset Model Provides a Conceptual Basis for the High Antiviral Activity of Major HIV Drugs. <i><span class="NLM_source">Science Translational Medicine</span></i> <b>3</b>:91, 91ra63-91ra63<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1126/scitranslmed.3002304" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">71</p><p class="content">Nandi Siegfried, Lize van der Merwe, Peter Brocklehurst, Tin Tin Sint, Nandi Siegfried. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. In: Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2011.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/14651858.CD003510.pub3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">72</p><p class="content">Marianne Strazza, Vanessa Pirrone, Brian Wigdahl, Michael R. Nonnemacher.  (2011) Breaking down the barrier: The effects of HIV-1 on the blood–brain barrier. <i><span class="NLM_source">Brain Research</span></i> <b>1399</b>, 96-115<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.brainres.2011.05.015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">73</p><p class="content">Jose M. Almeida, Emilio Letang, Tacilta Nhampossa, Edgar Ayala, Catarina David, Clara Menendez, Joaquim Gascon, Pedro Alonso, Denise Naniche.  (2011) Rapid Suppression of HIV-RNA Is Associated with Improved Control of Immune Activation in Mozambican Adults Initiating Antiretroviral Therapy with Low CD4 Counts. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>27</b>:7, 705-711<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2010.0200" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">74</p><p class="content">R. Rauso, G. Gherardini, V. Parlato, R. Amore, G. Tartaro.  (2011) Polyacrylamide Gel for Facial Wasting Rehabilitation: How Many Milliliters per Session?. <i><span class="NLM_source">Aesthetic Plastic Surgery</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s00266-011-9757-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">75</p><p class="content">Mark W. Hull, Julio Montaner.  (2011) Antiretroviral Therapy: A Key Component of a Comprehensive HIV Prevention Strategy. <i><span class="NLM_source">Current HIV/AIDS Reports</span></i> <b>8</b>:2, 85-93<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11904-011-0076-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">76</p><p class="content">Shih-Fen Hsu, Su-Pen Yang, Yu-Jiun Chan, Yung-Wei Wang.  (2011) Clinical manifestations of treatment-naive patients with acquired immunodeficiency syndrome and responses to highly active antiretroviral therapy in the Taipei Veterans General Hospital: A 5-year prospective study. <i><span class="NLM_source">Journal of Microbiology, Immunology and Infection</span></i> <b>44</b>:3, 198-203<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jmii.2011.01.022" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">77</p><p class="content">Anita Palepu, M-J Milloy, Thomas Kerr, Ruth Zhang, Evan Wood.  (2011) Homelessness and Adherence to Antiretroviral Therapy among a Cohort of HIV-Infected Injection Drug Users. <i><span class="NLM_source">Journal of Urban Health</span></i> <b>88</b>:3, 545-555<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11524-011-9562-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">78</p><p class="content">Arnout R. D. Voet, Marc De Maeyer, Frauke Christ, Zeger Debyser. Targeting Integration beyond Strand Transfer: Development of Second-Generation HIV Integrase Inhibitors. Wiley-VCH Verlag GmbH &amp; Co. KGaA, 2011:51-71.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/9783527635955.ch3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">79</p><p class="content">Pere Domingo, Francesc Vidal.  (2011) Combination antiretroviral therapy. <i><span class="NLM_source">Expert Opinion on Pharmacotherapy</span></i> <b>12</b>:7, 995-998<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/14656566.2011.567001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">80</p><p class="content">T. Cai, L. Tian, P. H. Wong, L. J. Wei.  (2011) Analysis of randomized comparative clinical trial data for personalized treatment selections. <i><span class="NLM_source">Biostatistics</span></i> <b>12</b>:2, 270-282<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/biostatistics/kxq060" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">81</p><p class="content">Richard C Waters, Jan Ostermann, Travis D Reeves, Max F Masnick, Nathan M Thielman, John A Bartlett, John A Crump.  (2011) A Cost-Effectiveness Analysis of Alternative HIV Retesting Strategies in Sub-Saharan Africa. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>56</b>:5, 443-452<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3182118f8c" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">82</p><p class="content">W. P. Bannister, A. Cozzi-Lepri, J. Kjaer, B. Clotet, A. Lazzarin, J.-P. Viard, G. Kronborg, D. Duiculescu, M. Beniowski, L. Machala, A. Phillips, , M. Losso, C. Elias, N. Vetter, R. Zangerle, I. Karpov, A. Vassilenko, V. M. Mitsura, O. Suetnov, N. Clumeck, S. De Wit, M. Delforge, R. Colebunders, L. Vandekerckhove, V. Hadziosmanovic, K. Kostov, J. Begovac, L. Machala, H. Rozsypal, D. Sedlacek, J. Nielsen, G. Kronborg, T. Benfield, M. Larsen, J. Gerstoft, T. Katzenstein, B. A.- E. Hansen, P. Skinhoj, C. Pedersen, L. Oestergaard, K. Zilmer, J. Smidt, M. Ristola, C. Katlama, J.- P. Viard, P.- M. Girard, J. M. Livrozet, P. Vanhems, C. Pradier, F. Dabis, D. Neau, J. Rockstroh, R. Schmidt, J. van Lunzen, O. Degen, H. J. Stellbrink, S. Staszewski, J. W. Goethe, J. Bogner, G. Fatkenheuer, J. Kosmidis, P. Gargalianos, G. Xylomenos, J. Perdios, G. Panos, A. Filandras, E. Karabatsaki, D. Banhegyi, F. Mulcahy, I. Yust, D. Turner, M. Burke, S. Pollack, G. Hassoun, S. Maayan, A. Chiesi, R. Esposito, I. Mazeu, C. Mussini, C. Arici, R. Pristera, F. Mazzotta, A. Gabbuti, V. Vullo, M. Lichtner, A. Chirianni, E. Montesarchio, M. Gargiulo, G. Antonucci, F. Iacomi, P. Narciso, C. Vlassi, M. Zaccarelli,, A. Lazzarin, R. Finazzi, M. Galli, A. Ridolfo, A. d'Arminio Monforte, B. Rozentale, I. Zeltina, S. Chaplinskas, R. Hemmer, T. Staub, P. Reiss, J. Bruun, A. Maeland, V. Ormaasen, B. Knysz, J. Gasiorowski, A. Horban, E. Bakowska, A. Grzeszczuk, R. Flisiak, A. Boron-Kaczmarska, M. Pynka, M. Beniowski, E. Mularska, H. Trocha, E. Jablonowska, E. Malolepsza, K. Wojcik, F. Antunes, E. Valadas, K. Mansinho, F. Maltez, D. Duiculescu, A. Rakhmanova, E. Vinogradova, D. Jevtovic, M. Mokras, D. Stanekova, J. Tomazic, J. Gonzalez-Lahoz, V. Soriano, P. Labarga, J. Medrano, S. Moreno, B. Clotet, A. Jou, R. Paredes, C. Tural, J. Puig, I. Bravo, J. M. Gatell, J. M. Miro, P. Domingo, M. Gutierrez, G. Mateo, M. A. Sambeat, A. Karlsson, B. Ledergerber, R. Weber, B. Hirschel, E. Boffi, H. Furrer, M. Battegay, L. Elzi, E. Kravchenko, N. Chentsova, S. Servitskiy, S. Antoniak, M. Krasnov, S. Barton, A. M. Johnson, D. Mercey, A. Phillips, M. A. Johnson, A. Mocroft, M. Murphy, J. Weber, G. Scullard, M. Fisher, C. Leen, B. Clotet, R. Paredes, F. Antunes, B. Clotet, D. Duiculescu, J. Gatell, B. Gazzard, A. Horban, A. Karlsson, C. Katlama, B. Ledergerber, A. D'Arminio Montforte, A. Phillips, A. Rakhmanova, P. Reiss, J. Rockstroh, J. Lundgren, O. Kirk, A. Mocroft, N. Friis-Moller, A. Cozzi-Lepri, W. Bannister, M. Ellefson, A. Borch, D. Podlekareva, J. Kjaer, L. Peters, J. Reekie, J. Kowalska.  (2011) Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy. <i><span class="NLM_source">Journal of Antimicrobial Chemotherapy</span></i> <b>66</b>:4, 901-911<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/jac/dkr006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">83</p><p class="content">Valentina Cambiano, Andrew N Phillips.  (2011) Modelling the impact of treatment with individual antiretrovirals. <i><span class="NLM_source">Current Opinion in HIV and AIDS</span></i> <b>6</b>:2, 124-130<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/COH.0b013e328343ad66" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">84</p><p class="content">Inmaculada Ferreros, Isabel Hurtado, Julia del Amo, Roberto Muga, Jorge del Romero, Patricia García, Ignacio Alastrué, Josefina Belda, Marcela Guevara, Santiago Pérez.  (2011) Efectividad del tratamiento antirretroviral combinado de gran actividad en eventos recurrentes de sida en una cohorte de seroconvertores al virus de la inmunodeficiencia humana. <i><span class="NLM_source">Enfermedades Infecciosas y Microbiología Clínica</span></i> <b>29</b>:3, 179-184<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.eimc.2010.10.005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">85</p><p class="content">Karren J. Towgood, Mervi Pitkanen, Ranjababu Kulasegaram, Alex Fradera, Atul Kumar, Suneetha Soni, Naomi A. Sibtain, Laurence Reed, Caroline Bradbeer, Gareth J. Barker, Michael D. Kopelman.  (2011) Mapping the brain in younger and older asymptomatic HIV-1 men: Frontal volume changes in the absence of other cortical or diffusion tensor abnormalities. <i><span class="NLM_source">Cortex</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.cortex.2011.03.006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">86</p><p class="content">Matthew J. Pace, Luis Agosto, Erin H. Graf, Una O'Doherty.  (2011) HIV reservoirs and latency models. <i><span class="NLM_source">Virology</span></i> <b>411</b>:2, 344-354<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.virol.2010.12.041" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">87</p><p class="content">Valentina Cambiano, Alison J Rodger, Andrew N Phillips.  (2011) ‘Test-and-treat’: the end of the HIV epidemic?. <i><span class="NLM_source">Current Opinion in Infectious Diseases</span></i> <b>24</b>:1, 19-26<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QCO.0b013e3283422c8c" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">88</p><p class="content">Tim R Cressey, Saik Urien, Deborah Hirt, Guttiga Halue, Malee Techapornroong, Chureeratana Bowonwatanuwong, Prattana Leenasirimakul, Jean-Marc Treluyer, Gonzague Jourdain, Marc Lallemant.  (2011) Influence of Body Weight on Achieving Indinavir Concentrations Within Its Therapeutic Window in HIV-Infected Thai Patients Receiving Indinavir Boosted With Ritonavir. <i><span class="NLM_source">Therapeutic Drug Monitoring</span></i> <b>33</b>:1, 25-31<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/FTD.0b013e3182057f6f" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">89</p><p class="content">Janice E Clements, Lucio Gama, David R Graham, Joseph L Mankowski, MC Zink.  (2011) A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system. <i><span class="NLM_source">Current Opinion in HIV and AIDS</span></i> <b>6</b>:1, 37-42<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/COH.0b013e3283412413" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">90</p><p class="content">Mary Albrecht, A. Lisa Mukherjee, Camlin Tierney, Gene D. Morse, Carrie Dykes, Karin L. Klingman, Lisa M. Demeter.  (2011) A Randomized Clinical Trial Evaluating Therapeutic Drug Monitoring (TDM) for Protease Inhibitor–Based Regimens in Antiretroviral-Experienced HIV-Infected Individuals: Week 48 Results of the A5146 Study. <i><span class="NLM_source">HIV Clinical Trials</span></i> <b>12</b>:4, 201-214<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1310/HCT1204-201" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">91</p><p class="content">DeAnn Gruber, Peter Campos, Marcia Dutcher, Laurie Safford, Karen Phillips, Jason Craw, Lytt Gardner.  (2011) Linking recently diagnosed HIV-positive persons to medical care: perspectives of referring providers. <i><span class="NLM_source">AIDS Care</span></i> <b>23</b>:1, 16-24<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/09540121.2010.498865" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">92</p><p class="content">Celine S. Yan, Imelda Hanafi, Anthony D. Kelleher, Andrew D. Carr, Janaki Amin, Leon P. McNally, Philip H. Cunningham.  (2010) Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification. <i><span class="NLM_source">Journal of Clinical Virology</span></i> <b>49</b>:4, 249-253<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jcv.2010.08.016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">93</p><p class="content">Roy M Gulick.  (2010) Antiretroviral Treatment 2010: Progress and Controversies. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>55</b>, S43-S48<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181f9c09e" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">94</p><p class="content">Iris Contreras-Hernandez, Debbie Becker, Jeremy Chancellor, Felicitas Kühne, Joaquin Mould-Quevedo, Gabriela Vega, Shalaka Marfatia.  (2010) Cost-Effectiveness of Maraviroc for Antiretroviral Treatment-Experienced HIV-infected Individuals in Mexico. <i><span class="NLM_source">Value in Health</span></i> <b>13</b>:8, 903-914<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1524-4733.2010.00798.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">95</p><p class="content">Janet D Siliciano, Robert F Siliciano.  (2010) Biomarkers of HIV replication. <i><span class="NLM_source">Current Opinion in HIV and AIDS</span></i> <b>5</b>:6, 491-497<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/COH.0b013e32833f206f" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">96</p><p class="content">John Hornberger, Kit Simpson, Ashwini Shewade, Birgitta Dietz, Robert Baran, Thomas Podsadecki.  (2010) Broadening the perspective when assessing evidence on boosted protease inhibitor-based regimens for initial antiretroviral therapy. <i><span class="NLM_source">Advances in Therapy</span></i> <b>27</b>:11, 763-773<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s12325-010-0075-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">97</p><p class="content">Brandon DL Marshall, M-J Milloy, Thomas Kerr, Ruth Zhang, Julio SG Montaner, Evan Wood.  (2010) No evidence of increased sexual risk behaviour after initiating antiretroviral therapy among people who inject drugs. <i><span class="NLM_source">AIDS</span></i> <b>24</b>:14, 2271-2278<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32833dd101" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">98</p><p class="content">Venanzio Vella, Thiloshini Govender, Sicelo Dlamini, Myra Taylor, Indres Moodley, Verona David, Champaklal Jinabhai.  (2010) Retrospective Study on the Critical Factors for Retaining Patients on Antiretroviral Therapy in KwaZulu-Natal, South Africa. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>55</b>:1, 109-116<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181e7744e" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">99</p><p class="content">Arun K. Ghosh, David D. Anderson, Hiroaki Mitsuya. The FDA Approved HIV-1 Protease Inhibitors for Treatment of HIV/AIDS. In: Burger's Medicinal Chemistry and Drug Discovery. John Wiley &amp; Sons, Inc., 2010.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/0471266949.bmc224" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">100</p><p class="content">Erika Coria-Ramirez, Leopoldo Nieto Cisneros, Sandra Treviño-Perez, Isabel Ibarra-Gonzalez, Jesus Casillas-Rodriguez, Abraham Majluf-Cruz.  (2010) Effect of Highly Active Antiretroviral Therapy on Homocysteine Plasma Concentrations in HIV-1–Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>54</b>:5, 477-481<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181d91088" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">101</p><p class="content">Tanushree Banerjee, Tripti Pensi, Dipankar Banerjee.  (2010) HRQoL in HIV-infected children using PedsQL™ 4.0 and comparison with uninfected children. <i><span class="NLM_source">Quality of Life Research</span></i> <b>19</b>:6, 803-812<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11136-010-9643-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">102</p><p class="content">S. Tsiodras, A. Perelas, C. Wanke, C.S. Mantzoros.  (2010) The HIV-1/HAART associated metabolic syndrome – Novel adipokines, molecular associations and therapeutic implications. <i><span class="NLM_source">Journal of Infection</span></i> <b>61</b>:2, 101-113<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jinf.2010.06.002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">103</p><p class="content">Kaori Sango, Aviva Joseph, Mahesh Patel, Kristin Osiecki, Monica Dutta, Harris Goldstein.  (2010) Highly Active Antiretroviral Therapy Potently Suppresses HIV Infection in Humanized Rag2
              <sup>-/-</sup>
              γ
              <sub>c</sub>
              <sup>-/-</sup>
              Mice. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>26</b>:7, 735-746<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2009.0136" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">104</p><p class="content">Haitao Chu, Stephen J. Gange, Xiuhong Li, Donald R. Hoover, Chenglong Liu, Joan S. Chmiel, Lisa P. Jacobson.  (2010) The Effect of HAART on HIV RNA Trajectory Among Treatment-naïve Men and Women. <i><span class="NLM_source">Epidemiology</span></i> <b>21</b>:Supplement, S25-S34<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/EDE.0b013e3181ce9950" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">105</p><p class="content">S. R. Cole, E. A. Stuart.  (2010) Generalizing Evidence From Randomized Clinical Trials to Target Populations: The ACTG 320 Trial. <i><span class="NLM_source">American Journal of Epidemiology</span></i> <b>172</b>:1, 107-115<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/aje/kwq084" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">106</p><p class="content">Eugene Athan, Daniel P OʼBrien, Rosa Legood.  (2010) Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settings. <i><span class="NLM_source">AIDS</span></i> <b>24</b>:12, 1887-1895<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32833b25ed" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">107</p><p class="content">Dirk Meyer-Olson, Reinhold E Schmidt, Benjamin A Bollmann.  (2010) Treatment and prevention of cytomegalovirus-associated diseases in HIV-1 infection in the era of HAART. <i><span class="NLM_source">HIV Therapy</span></i> <b>4</b>:4, 413-436<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2217/hiv.10.30" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">108</p><p class="content">Tsutomu Murakami, Naoki Yamamoto.  (2010) Role of CXCR4 in HIV infection and its potential as a therapeutic target. <i><span class="NLM_source">Future Microbiology</span></i> <b>5</b>:7, 1025-1039<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2217/fmb.10.67" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">109</p><p class="content">D. L. Wyles, R. T. Schooley.  (2010) Rong's Numbers: Accelerating Progress in HCV Therapeutic Research. <i><span class="NLM_source">Science Translational Medicine</span></i> <b>2</b>:33, 33ps25-33ps25<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1126/scitranslmed.3001183" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">110</p><p class="content">Martin Delaney.  (2010) The Development of Combination Therapies for HIV Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>26</b>:5, 501-509<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2010.0064" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">111</p><p class="content">Vivek Jain, Steven G. Deeks.  (2010) When to Start Antiretroviral Therapy. <i><span class="NLM_source">Current HIV/AIDS Reports</span></i> <b>7</b>:2, 60-68<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11904-010-0044-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">112</p><p class="content">Pride Chigwedere, M. Essex.  (2010) AIDS Denialism and Public Health Practice. <i><span class="NLM_source">AIDS and Behavior</span></i> <b>14</b>:2, 237-247<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10461-009-9654-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">113</p><p class="content">Manuel Battegay, Heiner C Bucher.  (2010) Antiretroviral monotherapy: should we abandon the principles of successful antiretroviral therapy?. <i><span class="NLM_source">AIDS</span></i> <b>24</b>:7, 1057-1059<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32833609a2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">114</p><p class="content">John F. Miller, Elizabeth M. Turner, Kristjan S. Gudmundsson, Stephen Jenkinson, Andrew Spaltenstein, Michael Thomson, Pat Wheelan.  (2010) Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents. <i><span class="NLM_source">Bioorganic &amp; Medicinal Chemistry Letters</span></i> <b>20</b>:7, 2125-2128<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.bmcl.2010.02.053" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">115</p><p class="content">D. Westreich, S. R. Cole, P. C. Tien, J. S. Chmiel, L. Kingsley, M. J. Funk, K. Anastos, L. P. Jacobson.  (2010) Time Scale and Adjusted Survival Curves for Marginal Structural Cox Models. <i><span class="NLM_source">American Journal of Epidemiology</span></i> <b>171</b>:6, 691-700<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/aje/kwp418" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">116</p><p class="content">Christian Erikstrup, Gitte Kronborg, Nicolai Lohse, Ostrowski Sisse Rye, Jan Gerstoft, Henrik Ullum.  (2010) T-Cell Dysfunction in HIV-1-Infected Patients With Impaired Recovery of CD4 Cells Despite Suppression of Viral Replication. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>53</b>:3, 303-310<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181ca3f7c" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">117</p><p class="content">Min Liang, Masakazu Kamata, Kevin N. Chen, Nonia Pariente, Dong Sung An, Irvin S. Y. Chen.  (2010) Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction. <i><span class="NLM_source">The Journal of Gene Medicine</span></i> <b>12</b>:3, 255-265<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jgm.1440" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">118</p><p class="content">Kazuo Suzuki, Anthony D Kelleher.  (2010) Lessons from viral latency in T cells: manipulating HIV-1 transcription by siRNA. <i><span class="NLM_source">HIV Therapy</span></i> <b>4</b>:2, 199-213<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2217/hiv.10.1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">119</p><p class="content">G. Miiro, S. Nakubulwa, C. Watera, P. Munderi, S. Floyd, H. Grosskurth.  (2010) Evaluation of affordable screening markers to detect CD4+ T-cell counts below 200 cells/μl among HIV-1-infected Ugandan adults. <i><span class="NLM_source">Tropical Medicine &amp; International Health</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1365-3156.2010.02471.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">120</p><p class="content">Suely Hiromi Tuboi, Antonio Guilherme Pacheco, Lee H Harrison, Roslyn A Stone, Margaret May, Martin W G Brinkhof, François Dabis, Matthias Egger, Denis Nash, David Bangsberg, Paula Braitstein, Constantin T Yiannoutsos, Robin Wood, Eduardo Sprinz, Mauro Schechter.  (2010) Mortality Associated With Discordant Responses to Antiretroviral Therapy in Resource-Constrained Settings. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>53</b>:1, 70-77<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181c22d19" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">121</p><p class="content"> (2010) The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. <i><span class="NLM_source">AIDS</span></i> <b>24</b>:1, 123-137<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e3283324283" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">122</p><p class="content">Andrea Krüsi, Evan Wood, Julio Montaner, Thomas Kerr.  (2010) Social and structural determinants of HAART access and adherence among injection drug users. <i><span class="NLM_source">International Journal of Drug Policy</span></i> <b>21</b>:1, 4-9<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.drugpo.2009.08.003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">123</p><p class="content">S. R. Cole, L. P. Jacobson, P. C. Tien, L. Kingsley, J. S. Chmiel, K. Anastos.  (2010) Using Marginal Structural Measurement-Error Models to Estimate the Long-term Effect of Antiretroviral Therapy on Incident AIDS or Death. <i><span class="NLM_source">American Journal of Epidemiology</span></i> <b>171</b>:1, 113-122<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/aje/kwp329" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">124</p><p class="content">Annemarie M.J. Wensing, Noortje M. van Maarseveen, Monique Nijhuis.  (2010) Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance. <i><span class="NLM_source">Antiviral Research</span></i> <b>85</b>:1, 59-74<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.antiviral.2009.10.003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">125</p><p class="content">Andrew R. Zolopa.  (2010) The evolution of HIV treatment guidelines: Current state-of-the-art of ART. <i><span class="NLM_source">Antiviral Research</span></i> <b>85</b>:1, 241-244<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.antiviral.2009.10.018" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">126</p><p class="content">JS Josephs, JA Fleishman, PT Korthuis, RD Moore, KA Gebo, .  (2010) Emergency department utilization among HIV-infected patients in a multisite multistate study*. <i><span class="NLM_source">HIV Medicine</span></i> <b>11</b>:1, 74-84<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2009.00748.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">127</p><p class="content">Scott M. Hammer, Heather Ribaudo, Roland Bassett, John W. Mellors, Lisa M. Demeter, Robert W. Coombs, Judith Currier, Gene D. Morse, John G. Gerber, Ana I. Martinez, William Spreen, Margaret A. Fischl, Kathleen E. Squires.  (2010) A Randomized, Placebo-Controlled Trial of Abacavir Intensification in HIV-1–Infected Adults With Virologic Suppression on a Protease Inhibitor–Containing Regimen. <i><span class="NLM_source">HIV Clinical Trials</span></i> <b>11</b>:6, 312-324<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1310/hct1106-312" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">128</p><p class="content">Lisa K. Naeger, Kimberly A. Struble, Jeffrey S. Murray, Debra B. Birnkrant.  (2010) Running a tightrope: Regulatory challenges in the development of antiretrovirals. <i><span class="NLM_source">Antiviral Research</span></i> <b>85</b>:1, 232-240<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.antiviral.2009.07.016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">129</p><p class="content">Felicitas C. Kühne, Jeremy Chancellor, Patrick Mollon, Daniela E. Myers, Michael Louie, William G. Powderly.  (2010) A Microsimulation of the Cost-effectiveness of Maraviroc for Antiretroviral Treatment-Experienced HIV-Infected Individuals. <i><span class="NLM_source">HIV Clinical Trials</span></i> <b>11</b>:2, 80-99<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1310/hct1102-80" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">130</p><p class="content">R.W. Coombs. Human Immunodeficiency Virus Infection and the Acquired Immunodeficiency Syndrome. In: Atlas of Sexually Transmitted Diseases and AIDS. Elsevier, 2010:240-255.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-0-7020-4060-3.00014-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">131</p><p class="content">IGOR J. KORALNIK. Neurologic Diseases Caused by Human Immunodeficiency Virus Type 1 and Opportunistic Infections. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier, 2010:1745-1764.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-0-443-06839-3.00124-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">132</p><p class="content">CLYDE S. CRUMPACKER II, JIE LIN ZHANG. Cytomegalovirus. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier, 2010:1971-1987.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-0-443-06839-3.00138-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">133</p><p class="content">Matthew D Marsden, Jerome A Zack.  (2010) Establishment and maintenance of HIV latency: model systems and opportunities for intervention. <i><span class="NLM_source">Future Virology</span></i> <b>5</b>:1, 97-109<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2217/fvl.09.70" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">134</p><p class="content">Princy N Kumar, Parul Patel.  (2010) Lamivudine for the treatment of HIV. <i><span class="NLM_source">Expert Opinion on Drug Metabolism &amp; Toxicology</span></i> <b>6</b>:1, 105-114<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/17425250903490418" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">135</p><p class="content">Lin Shen, S. Alireza Rabi, Robert F. Siliciano.  (2009) A novel method for determining the inhibitory potential of anti-HIV drugs. <i><span class="NLM_source">Trends in Pharmacological Sciences</span></i> <b>30</b>:12, 610-616<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.tips.2009.09.003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">136</p><p class="content">Julien Paccou, Nathalie Viget, Isabelle Legrout-Gérot, Yazdan Yazdanpanah, Bernard Cortet.  (2009) Bone loss in patients with HIV infection. <i><span class="NLM_source">Joint Bone Spine</span></i> <b>76</b>:6, 637-641<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jbspin.2009.10.003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">137</p><p class="content">Moira A McMahon, Lin Shen, Robert F Siliciano.  (2009) New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo. <i><span class="NLM_source">Current Opinion in Infectious Diseases</span></i> <b>22</b>:6, 574-582<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QCO.0b013e328332c54d" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">138</p><p class="content">Humphrey J. Shao, John A. Crump, Habib O. Ramadhani, Leonard O. Uiso, Sendui Ole-Nguyaine, Andrew M. Moon, Rehema A. Kiwera, Christopher W. Woods, John F. Shao, John A. Bartlett, Nathan M. Thielman.  (2009) Early versus Delayed Fixed Dose Combination Abacavir/Lamivudine/Zidovudine in Patients with HIV and Tuberculosis in Tanzania. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>25</b>:12, 1277-1285<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2009.0100" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">139</p><p class="content">S. R Cole, H. Chu, L. Nie, E. F Schisterman.  (2009) Estimating the odds ratio when exposure has a limit of detection. <i><span class="NLM_source">International Journal of Epidemiology</span></i> <b>38</b>:6, 1674-1680<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/ije/dyp269" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">140</p><p class="content">Lingling Li.  (2009) Predicted Interval Plots (PIPS): A Graphical Tool for Data Monitoring of Clinical Trials. <i><span class="NLM_source">Statistics in Biopharmaceutical Research</span></i> <b>1</b>:4, 348-355<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1198/sbr.2009.0041" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">141</p><p class="content">Piyamat Jinnopat, Panasda Isarangkura-na-ayuthaya, Piraporn Utachee, Yukiko Kitagawa, U Chandimal de Silva, Uamporn Siripanyaphinyo, Yoko Kameoka, Kenzo Tokunaga, Pathom Sawanpanyalert, Kazuyoshi Ikuta, Wattana Auwanit, Masanori Kameoka.  (2009) Impact of Amino Acid Variations in Gag and Protease of HIV Type 1 CRF01_AE Strains on Drug Susceptibility of Virus to Protease Inhibitors. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>52</b>:3, 320-328<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181b4b18c" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">142</p><p class="content">Arnout RD Voet, Marc De Maeyer, Zeger Debyser, Frauke Christ.  (2009) In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer. <i><span class="NLM_source">Future Medicinal Chemistry</span></i> <b>1</b>:7, 1259-1274<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.4155/fmc.09.86" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">143</p><p class="content">Mariona Parera, Nuria Perez-Alvarez, Bonaventura Clotet, Miguel Angel Martínez.  (2009) Epistasis among Deleterious Mutations in the HIV-1 Protease. <i><span class="NLM_source">Journal of Molecular Biology</span></i> <b>392</b>:2, 243-250<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jmb.2009.07.015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">144</p><p class="content">Jeffrey B. Bingenheimer, Arline T. Geronimus.  (2009) Behavioral Mechanisms in HIV Epidemiology and Prevention: Past, Present, and Future Roles. <i><span class="NLM_source">Studies in Family Planning</span></i> <b>40</b>:3, 187-204<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1728-4465.2009.00202.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">145</p><p class="content">Libin Rong, Alan S. Perelson.  (2009) Modeling HIV persistence, the latent reservoir, and viral blips. <i><span class="NLM_source">Journal of Theoretical Biology</span></i> <b>260</b>:2, 308-331<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jtbi.2009.06.011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">146</p><p class="content">S. Molina-Pinelo, A. Vallejo, L. Diaz, N. Soriano-Sarabia, S. Ferrando-Martinez, S. Resino, M. A. Munoz-Fernandez, M. Leal.  (2009) Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation. <i><span class="NLM_source">Journal of Antimicrobial Chemotherapy</span></i> <b>64</b>:3, 579-588<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/jac/dkp248" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">147</p><p class="content">L. Tian, T. Cai, L. J. Wei.  (2009) Identifying Subjects Who Benefit from Additional Information for Better Prediction of the Outcome Variables. <i><span class="NLM_source">Biometrics</span></i> <b>65</b>:3, 894-902<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1541-0420.2008.01125.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">148</p><p class="content">Tamara Kredo, Jan-Stefan Van der Walt, Nandi Siegfried, Karen Cohen, Tamara Kredo. Therapeutic drug monitoring of antiretrovirals for people with HIV. In: Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2009.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/14651858.CD007268.pub2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">149</p><p class="content">Kenneth H Fife, Julia W Wu, Kathleen E Squires, D Heather Watts, Janet W Andersen, Darron R Brown.  (2009) Prevalence and Persistence of Cervical Human Papillomavirus Infection in HIV-Positive Women Initiating Highly Active Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>51</b>:3, 274-282<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181a97be5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">150</p><p class="content">J. B. Dinoso, S. Y. Kim, A. M. Wiegand, S. E. Palmer, S. J. Gange, L. Cranmer, A. O'Shea, M. Callender, A. Spivak, T. Brennan, M. F. Kearney, M. A. Proschan, J. M. Mican, C. A. Rehm, J. M. Coffin, J. W. Mellors, R. F. Siliciano, F. Maldarelli.  (2009) Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>106</b>:23, 9403-9408<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.0903107106" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">151</p><p class="content">Wattana Auwanit, Panasda Isarangkura-Na-Ayuthaya, Dao Kasornpikul, Kazuyoshi Ikuta, Pathom Sawanpanyalert, Masanori Kameoka.  (2009) Detection of Drug Resistance-Associated and Background Mutations in Human Immunodeficiency Virus Type 1 CRF01_AE Protease and Reverse Transcriptase Derived from Drug Treatment-Naive Patients Residing in Central Thailand. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>25</b>:6, 625-631<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2008.0298" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">152</p><p class="content">Narat Punyacharoensin, Chukiat Viwatwongkasem.  (2009) Trends in three decades of HIV/AIDS epidemic in Thailand by nonparametric backcalculation method. <i><span class="NLM_source">AIDS</span></i> <b>23</b>:9, 1143-1152<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32832baa1c" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">153</p><p class="content">Will Small, Evan Wood, Glenn Betteridge, Julio Montaner, Thomas Kerr.  (2009) The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. <i><span class="NLM_source">AIDS Care</span></i> <b>21</b>:6, 708-714<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/09540120802511869" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">154</p><p class="content">Lauren E. Cain, Stephen R. Cole.  (2009) Inverse probability-of-censoring weights for the correction of time-varying noncompliance in the effect of randomized highly active antiretroviral therapy on incident AIDS or death. <i><span class="NLM_source">Statistics in Medicine</span></i> <b>28</b>:12, 1725-1738<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/sim.3585" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">155</p><p class="content">Andrea Krüsi, Will Small, Evan Wood, Thomas Kerr.  (2009) An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation. <i><span class="NLM_source">AIDS Care</span></i> <b>21</b>:5, 638-644<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/09540120802385645" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">156</p><p class="content">T. E. Madiba, D. J. J. Muckart, S. R. Thomson.  (2009) Human Immunodeficiency Disease: How Should It Affect Surgical Decision Making?. <i><span class="NLM_source">World Journal of Surgery</span></i> <b>33</b>:5, 899-909<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s00268-009-9969-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">157</p><p class="content"> (2009) Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. <i><span class="NLM_source">The Lancet</span></i> <b>373</b>:9672, 1352-1363<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(09)60612-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">158</p><p class="content">Hans S L M Nottet, Sabine J van Dijk, Ewout B Fanoy, Irma W Goedegebuure, Dorien de Jong, Nienke Vrisekoop, Debbie van Baarle, Valerie Boltz, Sarah Palmer, Jan C C Borleffs, Charles A B Boucher.  (2009) HIV-1 Can Persist in Aged Memory CD4+ T Lymphocytes With Minimal Signs of Evolution After 8.3 Years of Effective Highly Active Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>50</b>:4, 345-353<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e318197eb04" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">159</p><p class="content">Giovanna d’Adda, Markus Goldstein, Joshua Graff Zivin, Mabel Nangami, Harsha Thirumurthy.  (2009) ARV Treatment and Time Allocation to Household Tasks: Evidence from Kenya. <i><span class="NLM_source">African Development Review</span></i> <b>21</b>:1, 180-208<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1467-8268.2009.00207.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">160</p><p class="content">L. E. Cain, S. R. Cole, S. Greenland, T. T. Brown, J. S. Chmiel, L. Kingsley, R. Detels.  (2009) Effect of Highly Active Antiretroviral Therapy on Incident AIDS Using Calendar Period as an Instrumental Variable. <i><span class="NLM_source">American Journal of Epidemiology</span></i> <b>169</b>:9, 1124-1132<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/aje/kwp002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">161</p><p class="content">Yves Levy, Christine Lacabaratz, Laurence Weiss, Jean-Paul Viard, Cecile Goujard, Jean-Daniel Lelièvre, François Boué, Jean-Michel Molina, Christine Rouzioux, Véronique Avettand-Fénoêl, Thérèse Croughs, Stéphanie Beq, Rodolphe Thiébaut, Geneviève Chêne, Michel Morre, Jean-François Delfraissy.  (2009) Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment. <i><span class="NLM_source">Journal of Clinical Investigation</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1172/JCI38052" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">162</p><p class="content">Gregory&nbsp;K. Robbins, John&nbsp;G. Spritzler, Ellen&nbsp;S. Chan, David&nbsp;M. Asmuth, Rajesh&nbsp;T. Gandhi, Benigno&nbsp;A. Rodriguez, Gail Skowron, Paul&nbsp;R. Skolnik, Robert&nbsp;W. Shafer, Richard&nbsp;B. Pollard, .  (2009) Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>48</b>:3, 350-361<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/595888" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">163</p><p class="content">Vilija R Joyce, Paul G Barnett, Ahmed M Bayoumi, Susan C Griffin, Tassos C Kyriakides, Wei Yu, Vandana Sundaram, Mark Holodniy, Sheldon T Brown, William Cameron, Mike Youle, Mark Sculpher, Aslam H Anis, Douglas K Owens.  (2009) Health-Related Quality of Life in a Randomized Trial of Antiretroviral Therapy for Advanced HIV Disease. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>50</b>:1, 27-36<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e31818ce6f3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">164</p><p class="content">Gautam K. Sahu, David Paar, Simon D.W. Frost, Melissa M. Smith, Scott Weaver, Miles W. Cloyd.  (2009) Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>81</b>:1, 9-15<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jmv.21366" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">165</p><p class="content">Tobias Bergroth, Halime Ekici, Magnus Gisslén, Sabine Kinloch-de Loes, Li-Ean Goh, Andrew Freedman, Fiona Lampe, Margaret A. Johnson, Anders Sönnerborg.  (2009) Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naïve patients initiated on a three- or four-drug antiretroviral regimen including lamivudine. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>81</b>:1, 1-8<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jmv.21363" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">166</p><p class="content">Zhi-wei Ye, Jos Van Pelt, Sandrine Camus, Jan Snoeys, Patrick Augustijns, Pieter Annaert.  (2009) Species-specific interaction of HIV protease inhibitors with accumulation of cholyl-glycylamido-fluorescein (CGamF) in sandwich-cultured hepatocytes. <i><span class="NLM_source">Journal of Pharmaceutical Sciences</span></i>n/a-n/a<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jps.22018" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">167</p><p class="content">Timothy&nbsp;J. Wilkin, Roy&nbsp;M. Gulick.  (2008) HIV/AIDS: When to Start Antiretroviral Therapy?. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>47</b>:12, 1580-1586<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/593311" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">168</p><p class="content">Giota Touloumi, Nikos Pantazis, Heide A Stirnadel, A Sarah Walker, Faroudy Boufassa, Philippe Vanhems, Kholoud Porter.  (2008) Rates and Determinants of Virologic and Immunological Response to HAART Resumption After Treatment Interruption in HIV-1 Clinical Practice. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>49</b>:5, 492-498<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e318186ead2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">169</p><p class="content">Pride Chigwedere, George R Seage, Sofia Gruskin, Tun-Hou Lee, M Essex.  (2008) Estimating the Lost Benefits of Antiretroviral Drug Use in South Africa. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>49</b>:4, 410-415<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e31818a6cd5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">170</p><p class="content">José M. Gatell.  (2008) Introducción. <i><span class="NLM_source">Enfermedades Infecciosas y Microbiología Clínica</span></i> <b>26</b>, 1-2<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0213-005X(08)76565-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">171</p><p class="content">Lily W Y Tam, Celia K S Chui, Chanson J Brumme, David R Bangsberg, Julio S G Montaner, Robert S Hogg, P Richard Harrigan.  (2008) The Relationship Between Resistance and Adherence in Drug-Naive Individuals Initiating HAART Is Specific to Individual Drug Classes. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>49</b>:3, 266-271<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e318189a753" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">172</p><p class="content">Mohamed G. Atta, Gilbert Deray, Gregory M. Lucas.  (2008) Antiretroviral Nephrotoxicities. <i><span class="NLM_source">Seminars in Nephrology</span></i> <b>28</b>:6, 563-575<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.semnephrol.2008.08.009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">173</p><p class="content">Janet W. Andersen. AIDS Clinical Trials Group (ACTG). In: Wiley Encyclopedia of Clinical Trials. John Wiley &amp; Sons, Inc., 2008.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/9780471462422.eoct446" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">174</p><p class="content">William J. BURMAN.  (2008) Treatment of HIV-related tuberculosis-unresolved issues. <i><span class="NLM_source">Respirology</span></i> <b>13</b>, S88-S99<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1440-1843.2008.01339.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">175</p><p class="content">Devon J. Shedlock, Daniel Hwang, Andy Y. Choo, Christopher W. Chung, Karuppiah Muthumani, David B. Weiner.  (2008) HIV-1 viral genes and mitochondrial apoptosis. <i><span class="NLM_source">Apoptosis</span></i> <b>13</b>:9, 1088-1099<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10495-008-0239-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">176</p><p class="content">Jason V Baker, Grace Peng, Joshua Rapkin, David Krason, Cavan Reilly, Winston P Cavert, Donald I Abrams, Rodger D MacArthur, Keith Henry, James D Neaton.  (2008) Poor Initial CD4+ Recovery With Antiretroviral Therapy Prolongs Immune Depletion and Increases Risk for AIDS and Non-AIDS Diseases. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>48</b>:5, 541-546<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e31817bebb3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">177</p><p class="content">Yefei Han, Yijie B. Lin, Wenfeng An, Jie Xu, Hung-Chih Yang, Karen O'Connell, Dominic Dordai, Jef D. Boeke, Janet D. Siliciano, Robert F. Siliciano.  (2008) Orientation-Dependent Regulation of Integrated HIV-1 Expression by Host Gene Transcriptional Readthrough. <i><span class="NLM_source">Cell Host &amp; Microbe</span></i> <b>4</b>:2, 134-146<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.chom.2008.06.008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">178</p><p class="content">Meredith S Shiels, Stephen R Cole, Scott Wegner, Haroutune Armenian, Joan S Chmiel, Anuradha Ganesan, Vincent C Marconi, Otoniel Martinez-Maza, Jeremy Martinson, Amy Weintrob, Lisa P Jacobson, Nancy F Crum-Cianflone.  (2008) Effect of HAART on Incident Cancer and Noncancer AIDS Events Among Male HIV Seroconverters. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>48</b>:4, 485-490<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e31817dc42b" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">179</p><p class="content">Tamara Kredo, Jan-Stefan Van der Walt, Nandi Siegfried, Karen Cohen, Phumla Sinxadi, Tamara Kredo. Therapeutic drug monitoring of antiretrovirals for people with HIV. In: Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2008.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/14651858.CD007268" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">180</p><p class="content">Lin Shen, Robert F. Siliciano.  (2008) Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. <i><span class="NLM_source">Journal of Allergy and Clinical Immunology</span></i> <b>122</b>:1, 22-28<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jaci.2008.05.033" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">181</p><p class="content">C.J. Hochhauser, S. Gaur, R. Marone, M. Lewis.  (2008) The impact of environmental risk factors on HIV-associated cognitive decline in children. <i><span class="NLM_source">AIDS Care</span></i> <b>20</b>:6, 692-699<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/09540120701693982" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">182</p><p class="content">Zhijian Lu.  (2008) Second generation HIV protease inhibitors against resistant virus. <i><span class="NLM_source">Expert Opinion on Drug Discovery</span></i> <b>3</b>:7, 775-786<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/17460441.3.7.775" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">183</p><p class="content">Kathryn L Nash, Graeme JM Alexander.  (2008) The case for combination antiviral therapy for chronic hepatitis B virus infection. <i><span class="NLM_source">The Lancet Infectious Diseases</span></i> <b>8</b>:7, 444-448<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1473-3099(08)70102-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">184</p><p class="content">Lin Shen, Susan Peterson, Ahmad R Sedaghat, Moira A McMahon, Marc Callender, Haili Zhang, Yan Zhou, Eleanor Pitt, Karen S Anderson, Edward P Acosta, Robert F Siliciano.  (2008) Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs. <i><span class="NLM_source">Nature Medicine</span></i> <b>14</b>:7, 762-766<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/nm1777" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">185</p><p class="content">I. Jimenez-Nacher, B. Garcia, P. Barreiro, S. Rodriguez-Novoa, J. Morello, J. Gonzalez-Lahoz, C. de Mendoza, V. Soriano.  (2008) Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements. <i><span class="NLM_source">Journal of Antimicrobial Chemotherapy</span></i> <b>62</b>:4, 816-822<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/jac/dkn252" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">186</p><p class="content">Antonella Isgrò, Wilma Leti, Wladimiro De Santis, Marco Marziali, Antonella Esposito, Caterina Fimiani, Giuseppe Luzi, Marcello Pinti, Andrea Cossarizza, Fernando Aiuti, Ivano Mezzaroma.  (2008) Altered Clonogenic Capability and Stromal Cell Function Characterize Bone Marrow of HIV‐Infected Subjects with Low CD4
              <sup>+</sup>
              T Cell Counts Despite Viral Suppression during HAART. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>46</b>:12, 1902-1910<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/588480" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">187</p><p class="content">Minoli A Perera, Federico Innocenti, Mark J Ratain.  (2008) Pharmacogenetic Testing for Uridine Diphosphate Glucuronosyltransferase 1A1 Polymorphisms: Are We There Yet?. <i><span class="NLM_source">Pharmacotherapy</span></i> <b>28</b>:6, 755-768<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1592/phco.28.6.755" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">188</p><p class="content">H.C. Bucher.  (2008) Studien mit Surrogatendpunkten. <i><span class="NLM_source">Der Internist</span></i> <b>49</b>:6, 681-687<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s00108-008-2126-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">189</p><p class="content">Hans Heiken.  (2008) Treatment of HIV-1 infection: is it time to hit early again?. <i><span class="NLM_source">Expert Review of Anti-infective Therapy</span></i> <b>6</b>:3, 273-275<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1586/14787210.6.3.273" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">190</p><p class="content">Jeffrey A. Anderson, Hongyu Jiang, Xiao Ding, Leslie Petch, Terri Journigan, Susan A. Fiscus, Richard Haubrich, David Katzenstein, Ronald Swanstrom, Roy M. Gulick.  (2008) Genotypic Susceptibility Scores and HIV Type 1 RNA Responses in Treatment-Experienced Subjects with HIV Type 1 Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>24</b>:5, 685-694<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2007.0127" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">191</p><p class="content">Déborah Hirt, France Mentré, Agnès Tran, Elisabeth Rey, Solange Auleley, Dominique Salmon, Xavier Duval, Jean-Marc Tréluyer, .  (2008) Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients. <i><span class="NLM_source">British Journal of Clinical Pharmacology</span></i> <b>65</b>:4, 548-557<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1365-2125.2007.03039.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">192</p><p class="content">M. Battegay, J. Fehr, U. Fluckiger, L. Elzi.  (2008) Antiretroviral therapy of late presenters with advanced HIV disease. <i><span class="NLM_source">Journal of Antimicrobial Chemotherapy</span></i> <b>62</b>:1, 41-44<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/jac/dkn169" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">193</p><p class="content">Ruth Joy, Eric F Druyts, Eirikka K Brandson, Viviane D Lima, Clare A Rustad, Wendy Zhang, Evan Wood, Julio S G Montaner, Robert S Hogg.  (2008) Impact of Neighborhood-Level Socioeconomic Status on HIV Disease Progression in a Universal Health Care Setting. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>47</b>:4, 500-505<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e3181648dfd" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">194</p><p class="content">Timothy J. Henrich, Naudia Lauder, Mayur M. Desai, Andre N. Sofair.  (2008) Association of Alcohol Abuse and Injection Drug Use with Immunologic and Virologic Responses to HAART in HIV-positive Patients from Urban Community Health Clinics. <i><span class="NLM_source">Journal of Community Health</span></i> <b>33</b>:2, 69-77<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10900-007-9069-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">195</p><p class="content">A. R. Sedaghat, J. B. Dinoso, L. Shen, C. O. Wilke, R. F. Siliciano.  (2008) Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>105</b>:12, 4832-4837<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.0711372105" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">196</p><p class="content">Roberto Ravasio.  (2008) Costo efficacia di peginterferone α-2a + ribavirina versus peginterferone α-2b + ribavirina nel trattamento dell’epatite cronica di tipo C in pazienti HIV co-infetti. <i><span class="NLM_source">PharmacoEconomics Italian Research Articles</span></i> <b>10</b>:1, 37-47<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF03320639" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">197</p><p class="content">K. Patel, M. A. Herna n, P. L. Williams, J. D. Seeger, K. McIntosh, R. B. V. Dyke, G. R. Seage, .  (2008) Long-Term Effectiveness of Highly Active Antiretroviral Therapy on the Survival of Children and Adolescents with HIV Infection: A 10-Year Follow-Up Study. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>46</b>:4, 507-515<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/526524" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">198</p><p class="content">Sung-Up Choi, Tot Bui, Rodney J.Y. Ho.  (2008) pH-dependent interactions of indinavir and lipids in nanoparticles and their ability to entrap a solute. <i><span class="NLM_source">Journal of Pharmaceutical Sciences</span></i> <b>97</b>:2, 931-943<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jps.21020" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">199</p><p class="content">Kersten&nbsp;K. Koelsch, Lin Liu, Richard Haubrich, Susanne May, Diane Havlir, Huldrych&nbsp;F. Günthard, Caroline&nbsp;C. Ignacio, Paula Campos‐Soto, Susan&nbsp;J. Little, Robert Shafer, Gregory&nbsp;K. Robbins, Richard&nbsp;T. D’Aquila, Yuji Kawano, Karen Young, Phillip Dao, Celsa&nbsp;A. Spina, Douglas&nbsp;D. Richman, Joseph&nbsp;K. Wong.  (2008) Dynamics of Total, Linear Nonintegrated, and Integrated HIV‐1 DNA In Vivo and In Vitro. <i><span class="NLM_source">The Journal of Infectious Diseases</span></i> <b>197</b>:3, 411-419<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/525283" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">200</p><p class="content">Shiro Ibe, Junko Hattori, Seiichiro Fujisaki, Urara Shigemi, Saeko Fujisaki, Kayoko Shimizu, Kazuyo Nakamura, Takejiro Kazumi, Yoshiyuki Yokomaku, Naoto Mamiya, Motohiro Hamaguchi, Tsuguhiro Kaneda.  (2008) Trend of Drug-Resistant HIV Type 1 Emergence among Therapy-Naive Patients in Nagoya, Japan: An 8-Year Surveillance from 1999 to 2006. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>24</b>:1, 7-14<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2007.0129" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">201</p><p class="content">Toru Murakami, Hideki Harada, Mary Ann Suico, Tsuyoshi Shuto, Shinya Suzu, Hirofumi Kai, Seiji Okada.  (2008) Ephedrae Herba, a Component of Japanese Herbal Medicine Mao-to, Efficiently Activates the Replication of Latent Human Immunodeficiency Virus Type 1 (HIV-1) in a Monocytic Cell Line. <i><span class="NLM_source">Biological &amp; Pharmaceutical Bulletin</span></i> <b>31</b>:12, 2334-2337<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1248/bpb.31.2334" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">202</p><p class="content">Toshimitsu HAYASHI.  (2008) Studies on Evaluation of Natural Products for Antiviral Effects and Their Applications. <i><span class="NLM_source">YAKUGAKU ZASSHI</span></i> <b>128</b>:1, 61-79<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1248/yakushi.128.61" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">203</p><p class="content">Karen Tashima, Schlomo Staszewski, Mark Nelson, Anita Rachlis, Daniel Skiest, Richard Stryker, Laura Bessen, Sandra Overfield, Nancy Ruiz, Victoria Wirtz.  (2008) Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection. <i><span class="NLM_source">AIDS</span></i> <b>22</b>:2, 275-279<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e3282f21b9d" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">204</p><p class="content">Milos Opravil, Joe Sasadeusz, David A Cooper, Jürgen K Rockstroh, Nathan Clumeck, Bonaventura Clotet, Julio Montaner, Francesca J Torriani, Jean DePamphilis, Douglas T Dieterich.  (2008) Effect of Baseline CD4 Cell Count on the Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Patients With HIV/Hepatitis C Virus Coinfection. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>47</b>:1, 36-49<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e31815ac47d" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">205</p><p class="content">Maria Jose Miguez-Burbano, Luis Espinoza, John E. Lewis.  (2008) HIV Treatment Adherence and Sexual Functioning. <i><span class="NLM_source">AIDS and Behavior</span></i> <b>12</b>:1, 78-85<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10461-006-9197-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">206</p><p class="content">Erin‐Margaret Murphy, Humberto R. Jimenez, Stephen M. Smith. Current Clinical Treatments of AIDS. Elsevier, 2008:27-73.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1054-3589(07)56002-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">207</p><p class="content">Janet Darbyshire. Combination Therapy. In: Wiley Encyclopedia of Clinical Trials. John Wiley &amp; Sons, Inc., 2007.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/9780471462422.eoct068" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">208</p><p class="content">Chenglong Liu, Virginia Lerch, Kathleen Weber, Michael F. Schneider, Gerald B. Sharp, Lakshmi Gorapaju, Anjali Sharma, Alexandra Levine, Monica Gandhi, Daniel Merenstein.  (2007) Association Between Complementary and Alternative Medicine Use and Adherence to Highly Active Antiretroviral Therapy in the Women's Interagency HIV Study. <i><span class="NLM_source">The Journal of Alternative and Complementary Medicine</span></i> <b>13</b>:10, 1053-1056<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/acm.2007.0590" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">209</p><p class="content">Ren-rong Tian, Qing-jiao Liao, Xu-lin Chen.  (2007) Current status of targets and assays for anti-HIV drug screening. <i><span class="NLM_source">Virologica Sinica</span></i> <b>22</b>:6, 476-485<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s12250-007-0049-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">210</p><p class="content">Ning Tang, Shihai Huang, John Salituro, Wai-Bing Mak, Gavin Cloherty, Julie Johanson, Yu Hong Li, George Schneider, John Robinson, John Hackett, Priscilla Swanson, Klara Abravaya.  (2007) A RealTime HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M subtypes A–H, group O and group N samples. <i><span class="NLM_source">Journal of Virological Methods</span></i> <b>146</b>:1-2, 236-245<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jviromet.2007.07.003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">211</p><p class="content"> (2007) Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>46</b>:5, 607-615<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e31815b7dba" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">212</p><p class="content">Zehua Chen.  (2007) Ranked set sampling: its essence and some new applications. <i><span class="NLM_source">Environmental and Ecological Statistics</span></i> <b>14</b>:4, 355-363<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10651-007-0025-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">213</p><p class="content">Omer Ozturk, Steven N. MacEachern.  (2007) Order restricted randomized designs and two sample inference. <i><span class="NLM_source">Environmental and Ecological Statistics</span></i> <b>14</b>:4, 365-381<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10651-007-0023-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">214</p><p class="content">Ulrik S. Justesen, Zoe Fox, Court Pedersen, Pedro Cahn, Jan Gerstoft, Nathan Clumeck, Marcello Losso, Barry Peters, Niels Obel, Antonella Castagna, Ulrik B. Dragsted, Jens D. Lundgren, .  (2007) Pharmacokinetics of Two Randomized Trials Evaluating the Safety and Efficacy of Indinavir, Saquinavir and Lopinavir in Combination with Low-Dose Ritonavir: The MaxCmin1 and 2 Trials. <i><span class="NLM_source">Basic &amp; Clinical Pharmacology &amp; Toxicology</span></i> <b>101</b>:5, 339-344<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1742-7843.2007.00117.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">215</p><p class="content">Y Yazdanpanah, M Vray, J Meynard, E Losina, MC Weinstein, L Morand-Joubert, SJ Goldie, HE Hsu, RP Walensky, C Dalban, PE Sax, PM Girard, KA Freedberg.  (2007) The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach. <i><span class="NLM_source">HIV Medicine</span></i> <b>8</b>:7, 439-450<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2007.00491.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">216</p><p class="content">Susan C. Morpeth, John A. Crump, Humphrey J. Shao, Habib O. Ramadhani, Peter R. Kisenge, Cindy A. Moylan, Susanna Naggie, L. Brett Caram, Keren Z. Landman, Noel E. Sam, Dafrosa K. Itemba, John F. Shao, John A. Bartlett, Nathan M. Thielman.  (2007) Predicting CD4 Lymphocyte Count &lt;200 Cells/mm
              <sup>3</sup>
              in an HIV Type 1-Infected African Population. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>23</b>:10, 1230-1236<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2007.0053" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">217</p><p class="content">Giovanni Schifitto, Bradford A Navia, Constantin T Yiannoutsos, Christina M Marra, Linda Chang, Thomas Ernst, Jeffrey G Jarvik, Eric N Miller, Elyse J Singer, Ronald J Ellis, Dennis L Kolson, David Simpson, Avindra Nath, Joseph Berger, Sharon L Shriver, Linda L Millar, Dodi Colquhoun, Robert Lenkinski, R Gilberto Gonzalez, Stuart A Lipton.  (2007) Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. <i><span class="NLM_source">AIDS</span></i> <b>21</b>:14, 1877-1886<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32813384e8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">218</p><p class="content">Naoaki Kuji, Yuri Mizusawa, Miwa Naganishi, Toshio Hamatani, Sokichi Iwata, Yasunori Yoshimura.  (2007) Elimination of HIV-1 from semen and application of the processed semen to assisted reproductive technology. <i><span class="NLM_source">Reproductive Medicine and Biology</span></i> <b>6</b>:3, 151-156<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1447-0578.2007.00178.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">219</p><p class="content">B. Dogan-Topal, S. A. Ozkan, B. Uslu.  (2007) Simultaneous Determination of Abacavir, Efavirenz and Valganciclovir in Human Serum Samples by Isocratic HPLC-DAD Detection. <i><span class="NLM_source">Chromatographia</span></i> <b>66</b>:S1, 25-30<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1365/s10337-007-0302-y" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">220</p><p class="content">Kevin R Robertson, Marlene Smurzynski, Thomas D Parsons, Kunling Wu, Ronald J Bosch, Julia Wu, Justin C McArthur, Ann C Collier, Scott R Evans, Ron J Ellis.  (2007) The prevalence and incidence of neurocognitive impairment in the HAART era. <i><span class="NLM_source">AIDS</span></i> <b>21</b>:14, 1915-1921<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32828e4e27" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">221</p><p class="content">Monica Merito, Andrea Bonaccorsi.  (2007) Co-evolution of physical and social technologies in clinical practice: The case of HIV treatments. <i><span class="NLM_source">Research Policy</span></i> <b>36</b>:7, 1070-1087<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.respol.2007.04.005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">222</p><p class="content">Joanne Reekie, Amanda Mocroft, James Neaton, Jens D Lundgren.  (2007) Clinical outcomes in clinical trials of anti-HIV treatment. <i><span class="NLM_source">Future HIV Therapy</span></i> <b>1</b>:3, 251-258<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2217/17469600.1.3.251" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">223</p><p class="content">Sripriya Chellappan, Visvaldas Kairys, Miguel X. Fernandes, Celia Schiffer, Michael K. Gilson.  (2007) Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease. <i><span class="NLM_source">Proteins: Structure, Function, and Bioinformatics</span></i> <b>68</b>:2, 561-567<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/prot.21431" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">224</p><p class="content">Mamta K. Jain.  (2007) Drug-Induced Liver Injury Associated with HIV Medications. <i><span class="NLM_source">Clinics in Liver Disease</span></i> <b>11</b>:3, 615-639<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.cld.2007.06.008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">225</p><p class="content">Evan Wood, Julio S.G Montaner.  (2007) When To Initiate HIV Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>45</b>:2, 131-132<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAI.0b013e31804d684b" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">226</p><p class="content">José Moltó, Asunción Blanco, Cristina Miranda, José Miranda, Jordi Puig, Marta Valle, Meritxell DelaVarga, Carmina R. Fumaz, Manuel José Barbanoj, Bonaventura Clotet.  (2007) Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice. <i><span class="NLM_source">British Journal of Clinical Pharmacology</span></i> <b>63</b>:6, 715-721<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1365-2125.2006.02834.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">227</p><p class="content">Sonia Melino, Maurizio Paci.  (2007) Progress for dengue virus diseases.. <i><span class="NLM_source">FEBS Journal</span></i> <b>274</b>:12, 2986-3002<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1742-4658.2007.05831.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">228</p><p class="content">Tim R Cressey, Nottasorn Plipat, Federica Fregonese, Kulkanya Chokephaibulkit.  (2007) Indinavir/ritonavir remains an important component of HAART for the treatment of HIV/AIDS, particularly in resource-limited settings. <i><span class="NLM_source">Expert Opinion on Drug Metabolism &amp; Toxicology</span></i> <b>3</b>:3, 347-361<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/17425255.3.3.347" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">229</p><p class="content">Uma Sriram, Michael Wong, Stacy J. Caillier, Frederick M. Hecht, Mary K. Elkins, Jay A. Levy, Jorge R. Oksenberg, Sergio E. Baranzini.  (2007) Quantitative Longitudinal Analysis of T Cell Receptor Repertoire Expression in HIV-Infected Patients on Antiretroviral and Interleukin-2 Therapy. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>23</b>:5, 741-747<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2007.0209" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">230</p><p class="content">B. Shah, L. Walshe, D. G. Saple, S. H. Mehta, J. P. Ramnani, R. D. Kharkar, R. C. Bollinger, A. Gupta.  (2007) Adherence to Antiretroviral Therapy and Virologic Suppression among HIV-Infected Persons Receiving Care in Private Clinics in Mumbai, India. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>44</b>:9, 1235-1244<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/513429" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">231</p><p class="content">Mark Boyd.  (2007) Indinavir: the forgotten HIV-protease inhibitor. Does it still have a role?. <i><span class="NLM_source">Expert Opinion on Pharmacotherapy</span></i> <b>8</b>:7, 957-964<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/14656566.8.7.957" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">232</p><p class="content">JJ Laurichesse, A Persoz, I Theodorou, C Rouzioux, JF Delfraissy, L Meyer.  (2007) Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 ?32 deletion. <i><span class="NLM_source">HIV Medicine</span></i> <b>8</b>:4, 213-219<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2007.00455.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">233</p><p class="content">A Hill, J Montaner, C Smith.  (2007) Prediction of clinical benefits of ritonavir-boosted TMC114 from treatment effects on CD4 counts and HIV RNA. <i><span class="NLM_source">HIV Medicine</span></i> <b>8</b>:4, 234-240<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2007.00466.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">234</p><p class="content">A. W. McCormick, R. P. Walensky, M. Lipsitch, E. Losina, H. Hsu, M. C. Weinstein, A. D. Paltiel, K. A. Freedberg, G. R. Seage.  (2007) The Effect of Antiretroviral Therapy on Secondary Transmission of HIV among Men Who Have Sex with Men. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>44</b>:8, 1115-1122<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/512816" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">235</p><p class="content">Roy M Gulick, Christina M Lalama, Heather J Ribaudo, Cecilia M Shikuma, Bruce R Schackman, Jeffrey Schouten, Kathleen E Squires, Susan L Koletar, Christopher D Pilcher, Richard C Reichman, Karin L Klingman, Daniel R Kuritzkes.  (2007) Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression. <i><span class="NLM_source">AIDS</span></i> <b>21</b>:7, 813-823<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32805e8753" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">236</p><p class="content">Roy M. Gulick.  (2007) Antiretroviral Management of Treatment-Naive Patients. <i><span class="NLM_source">Infectious Disease Clinics of North America</span></i> <b>21</b>:1, 71-84<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.idc.2007.01.002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">237</p><p class="content">Deborah Persaud, Stuart C. Ray, Joleen Kajdas, Aima Ahonkhai, George K. Siberry, Kimberly Ferguson, Carrie Ziemniak, Thomas C. Quinn, Joseph P. Casazza, Steven Zeichner, Stephen J. Gange, Douglas C. Watson.  (2007) Slow Human Immunodeficiency Virus Type 1 Evolution in Viral Reservoirs in Infants Treated with Effective Antiretroviral Therapy. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>23</b>:3, 381-390<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2006.0175" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">238</p><p class="content">Viviane D Lima, Robert S Hogg, P Richard Harrigan, David Moore, Benita Yip, Evan Wood, Julio SG Montaner.  (2007) Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>21</b>:6, 685-692<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e32802ef30c" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">239</p><p class="content">Karin J Metzner, Kristina Allers, Pia Rauch, Thomas Harrer.  (2007) Rapid selection of drug-resistant HIV-1 during the first months of suppressive ART in treatment-naive patients. <i><span class="NLM_source">AIDS</span></i> <b>21</b>:6, 703-711<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e3280121ac6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">240</p><p class="content">E Wood, RS Hogg, B Yip, D Moore, PR Harrigan, JSG Montaner.  (2007) Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programme. <i><span class="NLM_source">HIV Medicine</span></i> <b>8</b>:2, 80-85<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2007.00430.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">241</p><p class="content">Laurent Balvay, Marcelo Lopez Lastra, Bruno Sargueil, Jean-Luc Darlix, Théophile Ohlmann.  (2007) Translational control of retroviruses. <i><span class="NLM_source">Nature Reviews Microbiology</span></i> <b>5</b>:2, 128-140<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/nrmicro1599" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">242</p><p class="content">Masaki Imai, Lajos Baranyi, Noriko Okada, Hidechika Okada.  (2007) Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments. <i><span class="NLM_source">Biochemical and Biophysical Research Communications</span></i> <b>353</b>:4, 851-856<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.bbrc.2006.12.084" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">243</p><p class="content">Ting Zhang, Yuan Li, Yan-Jian Wang, Xu Wang, Mike Young, Steven D. Douglas, Wen-Zhe Ho.  (2007) Natural killer cell inhibits human immunodeficiency virus replication in chronically infected immune cells. <i><span class="NLM_source">Antiviral Research</span></i> <b>73</b>:2, 132-139<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.antiviral.2006.08.006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">244</p><p class="content">Andrea P. Malizia, Eoin Cotter, Nicholas Chew, William G. Powderly, Peter P. Doran.  (2007) HIV Protease Inhibitors Selectively Induce Gene Expression Alterations Associated with Reduced Calcium Deposition in Primary Human Osteoblasts. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>23</b>:2, 243-250<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2006.0084" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">245</p><p class="content">Lucia Palmisano.  (2007) Role of integrase inhibitors in the treatment of HIV disease. <i><span class="NLM_source">Expert Review of Anti-infective Therapy</span></i> <b>5</b>:1, 67-75<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1586/14787210.5.1.67" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">246</p><p class="content">Jimmy Volmink, Nandi Siegfried, Lize van der Merwe, Peter Brocklehurst, Jimmy Volmink. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. In: Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2007.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/14651858.CD003510.pub2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">247</p><p class="content">Tsuyoshi Yoshida, Vickie C Jones, Makiko Kobayashi, Xiao-Dong Li, Richard B Pollard, Fujio Suzuki.  (2007) Acceleration of R5 HIV replication by polymorphonuclear neutrophils in cultures of macrophages. <i><span class="NLM_source">Immunology and Cell Biology</span></i><br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/sj.icb.7100024" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">248</p><p class="content">Margaret A Fischl, Ann C Collier, A Lisa Mukherjee, Judith E Feinberg, Lisa M Demeter, Pablo Tebas, Marina Giuliano, Marjorie Dehlinger, Kevin Garren, Barbara Brizz, Roland Bassett.  (2007) Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen. <i><span class="NLM_source">AIDS</span></i> <b>21</b>:3, 325-333<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e328011ddfa" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">249</p><p class="content">Javier Martinez-Picado, Lily Wai Yan Tam.  (2007) Risk of selecting resistance mutations during treatment interruption. <i><span class="NLM_source">Current Opinion in HIV and AIDS</span></i> <b>2</b>:1, 6-13<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/COH.0b013e328011a1f4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">250</p><p class="content">Soham G. Sheth, Chitharanjan V. Rao, Alexandros Tselis, Richard A. Lewis.  (2007) HIV-Related Peripheral Neuropathy and Glucose Dysmetabolism: Study of a Public Dataset. <i><span class="NLM_source">Neuroepidemiology</span></i> <b>29</b>:1-2, 121-124<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1159/000109826" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">251</p><p class="content">Santiago Pérez-Hoyos, Inmaculada Ferreros, Miguel A. Hernán.  (2007) Aplicación de modelos estructurales marginales para estimar los efectos de la terapia antirretroviral en 5 cohortes de seroconvertores al virus de la inmunodeficiencia humana. <i><span class="NLM_source">Gaceta Sanitaria</span></i> <b>21</b>:1, 76-83<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0213-9111(07)71974-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">252</p><p class="content">Michael Rittweger, Keikawus Arast??h.  (2007) Clinical Pharmacokinetics of Darunavir. <i><span class="NLM_source">Clinical Pharmacokinetics</span></i> <b>46</b>:9, 739-756<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00003088-200746090-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">253</p><p class="content">Livio Azzoni, Jihed Chehimi, Lan Zhou, Andrea S Foulkes, Rayford June, Vernon C Maino, Alan Landay, Charles Rinaldo, Lisa P Jacobson, Luis J Montaner.  (2007) Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells. <i><span class="NLM_source">AIDS</span></i> <b>21</b>:3, 293-305<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/QAD.0b013e328012b85f" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">254</p><p class="content">Kenneth A Freedberg, Lisa R Hirschhorn, Bruce R Schackman, Lindsey L Wolf, Lindsay A Martin, Milton C Weinstein, Susan Goldin, A David Paltiel, Carol Katz, Sue J Goldie, Elena Losina.  (2006) Cost-Effectiveness of an Intervention to Improve Adherence to Antiretroviral Therapy in HIV-Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>43</b>:Supplement 1, S113-S118<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000248334.52072.25" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">255</p><p class="content">Anton Pozniak.  (2006) Initiation of antiretroviral therapy. <i><span class="NLM_source">Current Opinion in Internal Medicine</span></i> <b>5</b>:6, 594-604<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.COH.0000239852.22614.b1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">256</p><p class="content">José Moltó, Asunción Blanco, Cristina Miranda, José Miranda, Jordi Puig, Marta Valle, Meritxell DelaVarga, Carmina R. Fumaz, Manuel José Barbanoj, Bonaventura Clotet.  (2006) Variability in non-nucleoside reverse transcriptase and protease inhibitor concentrations among HIV-infected adults in routine clinical practice. <i><span class="NLM_source">British Journal of Clinical Pharmacology</span></i> <b>62</b>:5, 560-566<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1365-2125.2006.02694.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">257</p><p class="content">Bruce R. Schackman, Kelly A. Gebo, Rochelle P. Walensky, Elena Losina, Tammy Muccio, Paul E. Sax, Milton C. Weinstein, George R. Seage, Richard D. Moore, Kenneth A. Freedberg.  (2006) The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States. <i><span class="NLM_source">Medical Care</span></i> <b>44</b>:11, 990-997<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.mlr.0000228021.89490.2a" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">258</p><p class="content">D. Foschi, P. Cellerino, F. Corsi, A. Casali, A. Rizzi, I. Righi, E. Trabucchi.  (2006) Impact of highly active antiretroviral therapy on outcome of cholecystectomy in patients with human immunodeficiency virus infection. <i><span class="NLM_source">British Journal of Surgery</span></i> <b>93</b>:11, 1383-1389<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/bjs.5527" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">259</p><p class="content">J Austin, N Singhal, R Voigt, F Smaill, M J Gill, S Walmsley, I Salit, J Gilmour, W F Schlech, S Choudhri, A Rachlis, J Cohen, S Trottier, E Toma, P Phillips, P M Ford, R Woods, J Singer, D P Zarowny, D W Cameron.  (2006) A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome. <i><span class="NLM_source">European Journal of Clinical Nutrition</span></i> <b>60</b>:11, 1266-1276<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/sj.ejcn.1602447" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">260</p><p class="content">C. L. Miller, P. M. Spittal, E. Wood, K. Chan, M. T. Schechter, J. S. G. Montaner, R. S. Hogg.  (2006) Inadequacies in antiretroviral therapy use among Aboriginal and other Canadian populations. <i><span class="NLM_source">AIDS Care</span></i> <b>18</b>:8, 968-976<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/09540120500481480" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">261</p><p class="content">George Pan, Michael Kilby, Jay M. McDonald.  (2006) Modulation of Osteoclastogenesis Induced by Nucleoside Reverse Transcriptase Inhibitors. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>22</b>:11, 1131-1141<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2006.22.1131" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">262</p><p class="content">Toks Akerele, Grazyna Galatowicz, Catey Bunce, Virginia Calder, William A. Lynn, Susan Lightman.  (2006) Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy. <i><span class="NLM_source">Clinical Immunology</span></i> <b>121</b>:2, 191-197<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.clim.2006.07.008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">263</p><p class="content">Grace PS Kwong, Azra C Ghani, Richard A Rode, Lucy M Bartley, Benjamin J Cowling, Barbara da Silva, Christl A Donnelly, Ard I van Sighem, D William Cameron, Sven A Danner, Frank de Wolf, Roy M Anderson.  (2006) Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use. <i><span class="NLM_source">AIDS</span></i> <b>20</b>:15, 1941-1950<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000247115.81832.a1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">264</p><p class="content">Marco Marziali, Wladimiro De Santis, Rossella Carello, Wilma Leti, Antonella Esposito, Antonella Isgrò, Caterina Fimiani, Maria C Sirianni, Ivano Mezzaroma, Fernando Aiuti.  (2006) T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART. <i><span class="NLM_source">AIDS</span></i> <b>20</b>:16, 2033-2041<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000247588.69438.fd" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">265</p><p class="content">Julie Munakata, Joshua S. Benner, Stephen Becker, Christopher M. Dezii, Elisabeth H. Hazard, Jonothan C. Tierce.  (2006) Clinical and Economic Outcomes of Nonadherence to Highly Active Antiretroviral Therapy in Patients With Human Immunodeficiency Virus. <i><span class="NLM_source">Medical Care</span></i> <b>44</b>:10, 893-899<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.mlr.0000233679.20898.e9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">266</p><p class="content">Roy M. Gulick.  (2006) <i>Editorial Commentary:</i>
              Adherence to Antiretroviral Therapy: How Much Is Enough?. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>43</b>:7, 942-944<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/507549" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">267</p><p class="content">G RAJESWARAN, J BECKER, C MICHAILIDIS, A POZNIAK, S PADLEY.  (2006) The radiology of IRIS (immune reconstitution inflammatory syndrome) in patients with mycobacterial tuberculosis and HIV co-infection: appearances in 11 patients. <i><span class="NLM_source">Clinical Radiology</span></i> <b>61</b>:10, 833-843<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.crad.2006.04.007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">268</p><p class="content">Andrew M. L. Lever. AIDS/HIV, Molecular and Cell Biology. In: Encyclopedia of Molecular Cell Biology and Molecular Medicine. Wiley-VCH Verlag GmbH &amp; Co. KGaA, 2006.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/3527600906.mcb.200300043" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">269</p><p class="content">Robert&nbsp;W. Shafer.  (2006) Rationale and Uses of a Public HIV Drug‐Resistance Database. <i><span class="NLM_source">The Journal of Infectious Diseases</span></i> <b>194</b>:s1, S51-S58<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/505356" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">270</p><p class="content">Arun K. Ghosh, Perali Ramu Sridhar, Nagaswamy Kumaragurubaran, Yasuhiro Koh, Irene T. Weber, Hiroaki Mitsuya.  (2006) Bis-Tetrahydrofuran: a Privileged Ligand for Darunavir and a New Generation of HIV Protease Inhibitors That Combat Drug Resistance. <i><span class="NLM_source">ChemMedChem</span></i> <b>1</b>:9, 939-950<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/cmdc.200600103" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">271</p><p class="content">Douglas D. Richman.  (2006) Antiviral drug resistance. <i><span class="NLM_source">Antiviral Research</span></i> <b>71</b>:2-3, 117-121<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.antiviral.2006.03.004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">272</p><p class="content">Chenglong Liu, Lisette Johnson, David Ostrow, Anthony Silvestre, Barbara Visscher, Lisa P. Jacobson.  (2006) Predictors for Lower Quality of Life in the HAART Era Among HIV-Infected Men. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>42</b>:4, 470-477<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000225730.79610.61" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">273</p><p class="content">J. Bryan Page, Paul Shapshak, E. Margarita Duran, Gaelle Even, Irina Moleon-Borodowski, Renee Llanusa-Cestero.  (2006) Detection of HIV-1 in Injection Paraphernalia: Risk in an Era of Heightened Awareness. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>20</b>:8, 576-585<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.2006.20.576" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">274</p><p class="content">Giota Touloumi, Nikos Pantazis, Anna Antoniou, Heide A. Stirnadel, Sarah A. Walker, Kholoud Porter.  (2006) Highly Active Antiretroviral Therapy Interruption. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>42</b>:5, 554-561<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000230321.85911.db" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">275</p><p class="content">Chenglong Liu, David Ostrow, Roger Detels, Zheng Hu, Lisette Johnson, Lawrence Kingsley, Lisa P. Jacobson.  (2006) Impacts of HIV infection and HAART use on quality of life. <i><span class="NLM_source">Quality of Life Research</span></i> <b>15</b>:6, 941-949<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11136-005-5913-x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">276</p><p class="content">A. Mocroft, C. A. Sabin, M. Youle, S. Madge, M. Tyrer, H. Devereux, J. Deayton, A. Dykhoff, M. C. I. Lipman, A. N. Phillips, M. A. Johnson.  (2006) Changes in AIDS-Defining Illnesses in a London Clinic, 1987???1998. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>21</b>:5, 401<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.pas.0000213299.11649.106" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">277</p><p class="content">J. Stebbing, M. Bower, S. Mandalia, M. Nelson, B. Gazzard.  (2006) Highly active anti-retroviral therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortality. <i><span class="NLM_source">Clinical and Experimental Immunology</span></i> <b>145</b>:2, 271-276<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1365-2249.2006.03147.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">278</p><p class="content">Timothy G. Heckman, Robert Barcikowski, Benjamin Ogles, Julie Suhr, Bruce Carlson, Kenneth Holroyd, John Garske.  (2006) A telephone-delivered coping improvement group intervention for middle-aged and older adults living with HIV/AIDS. <i><span class="NLM_source">Annals of Behavioral Medicine</span></i> <b>32</b>:1, 27-38<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1207/s15324796abm3201_4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">279</p><p class="content">Linda Gorgos, Erica Avery, Keith Bletzer, Charlton Wilson.  (2006) Determinants of Survival for Native American Adults with HIV Infection. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>20</b>:8, 586-594<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.2006.20.586" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">280</p><p class="content">Benjamin Maas, Thomas Kerr, Nadia Fairbairn, Julio Montaner, Evan Wood.  (2006) Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence. <i><span class="NLM_source">Expert Opinion on Drug Metabolism &amp; Toxicology</span></i> <b>2</b>:4, 533-543<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/17425255.2.4.533" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">281</p><p class="content">Santiago Pérez-Hoyos.  (2006) Efecto del tratamiento antirretroviral de gran eficacia en la infección por el VIH: papel de los estudios epidemiológicos. <i><span class="NLM_source">Medicina Clínica</span></i> <b>127</b>:5, 175-176<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1157/13090711" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">282</p><p class="content">Wendy P. Bannister, Ole Kirk, Jose M. Gatell, Brygida Knysz, Jean-Paul Viard, Helene Mens, Antonella D'Arminio Monforte, Andrew N. Phillips, Amanda Mocroft, Jens D. Lundgren.  (2006) Regional Changes Over Time in Initial Virologic Response Rates to Combination Antiretroviral Therapy Across Europe. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>42</b>:2, 229-237<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000214815.95786.31" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">283</p><p class="content">Keith Henry, David Katzenstein, Deborah Weng Cherng, Hernan Valdez, William Powderly, Michelle Blanchard Vargas, Nasreen C. Jahed, Jeffrey M. Jacobson, Laurie S. Myers, John L. Schmitz, Mark Winters, Pablo Tebas.  (2006) A Pilot Study Evaluating Time to CD4 T-cell Count &lt;350 cells/mm3 After Treatment Interruption Following Antiretroviral Therapy ?? Interleukin 2: Results of ACTG A5102. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>42</b>:2, 140-148<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000225319.59652.1e" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">284</p><p class="content">R. Bruno, P. Sacchi, L. Maiocchi, S. Patruno, G. Filice.  (2006) Hepatotoxicity and antiretroviral therapy with protease inhibitors: A review. <i><span class="NLM_source">Digestive and Liver Disease</span></i> <b>38</b>:6, 363-373<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.dld.2006.01.020" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">285</p><p class="content">Rafik Samuel, Robert Bettiker, Byungse Suh.  (2006) Antiretroviral therapy 2006: Pharmacology, applications, and special situations. <i><span class="NLM_source">Archives of Pharmacal Research</span></i> <b>29</b>:6, 431-458<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02969415" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">286</p><p class="content">Kenzo Hirose, Peter G Stock.  (2006) Liver transplantation in the human immunodeficiency virus-positive patient. <i><span class="NLM_source">Current Opinion in Organ Transplantation</span></i> <b>11</b>:3, 241-246<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.mot.0000227839.83710.e5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">287</p><p class="content">Kok Keng Tee, Adeeba Kamarulzaman, Kee Peng Ng.  (2006) Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia. <i><span class="NLM_source">Medical Microbiology and Immunology</span></i> <b>195</b>:2, 107-112<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s00430-005-0010-x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">288</p><p class="content">Loren Kinman, Tot Bui, Kay Larsen, Che-Chung Tsai, David Anderson, William R. Morton, Shiu-Lok Hu, Rodney J. Y. Ho.  (2006) Optimization of Lipid-Indinavir Complexes for Localization in Lymphoid Tissues of HIV-Infected Macaques. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>42</b>:2, 155-161<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000214822.33905.87" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">289</p><p class="content">John K. O'Connor, Lucien A. Nedzi, Ellen L. Zakris.  (2006) Prostate Adenocarcinoma and Human Immunodeficiency Virus: Report of Three Cases and Review of the Literature. <i><span class="NLM_source">Clinical Genitourinary Cancer</span></i> <b>5</b>:1, 85-88<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.3816/CGC.2006.n.023" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">290</p><p class="content">Guruprasad Aithal. Pharmacogenetics in Gastroenterology. In: Pharmacogenetics. CRC Press, 2006:273-294.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.3109/9781420016697-14" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">291</p><p class="content">Evan Wood, Robert S Hogg, Benita Yip, David Moore, P Richard Harrigan, Julio SG Montaner.  (2006) Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts ≥ 200 cells/μl. <i><span class="NLM_source">AIDS</span></i> <b>20</b>:8, 1117-1123<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000226951.49353.ed" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">292</p><p class="content">Mark A. Boyd, Preeyaporn Srasuebkul, Kiat Ruxrungtham, Peter I. Mackenzie, Verawan Uchaipichat, Michael Stek, Joep M.A. Lange, Praphan Phanuphak, David A. Cooper, Wandee Udomuksorn, John O. Miners.  (2006) Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir. <i><span class="NLM_source">Pharmacogenetics and Genomics</span></i> <b>16</b>:5, 321-329<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.fpc.0000197465.14340.d4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">293</p><p class="content">Cristina Mussini.  (2006) Baseline HIV RNA and the when to start question: time to stop asking this question?. <i><span class="NLM_source">AIDS</span></i> <b>20</b>:8, 1197-1198<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000226961.33213.8c" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">294</p><p class="content">Manuel Battegay, Reto Nüesch, Bernard Hirschel, Gilbert R Kaufmann.  (2006) Immunological recovery and antiretroviral therapy in HIV-1 infection. <i><span class="NLM_source">The Lancet Infectious Diseases</span></i> <b>6</b>:5, 280-287<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1473-3099(06)70463-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">295</p><p class="content">Susan S Kaplan, Charles B Hicks.  (2006) Lopinavir/ritonavir: towards simplifying therapy in HIV infection. <i><span class="NLM_source">Future Virology</span></i> <b>1</b>:3, 293-304<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2217/17460794.1.3.293" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">296</p><p class="content">John F. Miller, C. Webster Andrews, Michael Brieger, Eric S. Furfine, Michael R. Hale, Mary H. Hanlon, Richard J. Hazen, Istvan Kaldor, Ed W. McLean, David Reynolds, Douglas M. Sammond, Andrew Spaltenstein, Roger Tung, Elizabeth M. Turner, Robert X. Xu, Ronald G. Sherrill.  (2006) Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385. <i><span class="NLM_source">Bioorganic &amp; Medicinal Chemistry Letters</span></i> <b>16</b>:7, 1788-1794<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.bmcl.2006.01.035" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">297</p><p class="content">Shingo Kato, Hideji Hanabusa, Satoru Kaneko, Koichi Takakuwa, Mina Suzuki, Naoaki Kuji, Masao Jinno, Rie Tanaka, Kenichi Kojima, Mitsutoshi Iwashita, Yasunori Yoshimura, Kenichi Tanaka.  (2006) Complete removal of HIV-1 RNA and proviral DNA from semen by the swim-up method: assisted reproduction technique using spermatozoa free from HIV-1. <i><span class="NLM_source">AIDS</span></i> <b>20</b>:7, 967-973<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000222067.07255.2d" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">298</p><p class="content">Maria Almeida, Miguel Cordero, Julia Almeida, Alberto Orfao.  (2006) Persistent Abnormalities in Peripheral Blood Dendritic Cells and Monocytes from HIV-1-Positive Patients After 1 Year of Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>41</b>:4, 405-415<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000209896.82255.d3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">299</p><p class="content">Niloufar Ameli, Peter Bacchetti, Rhoda Ashley Morrow, Nancy A Hessol, Timothy Wilkin, Mary Young, Mardge Cohen, Howard Minkoff, Stephen J Gange, Ruth M Greenblatt.  (2006) Herpes simplex virus infection in women in the WIHS: Epidemiology and effect of antiretroviral therapy on clinical manifestations. <i><span class="NLM_source">AIDS</span></i> <b>20</b>:7, 1051-1058<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000222078.75867.77" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">300</p><p class="content">Joseph M. Mrus, Bruce R. Schackman, Albert W. Wu, Kenneth A. Freedberg, Joel Tsevat, Michael S. Yi, Robert Zackin.  (2006) Variations in Self-Rated Health Among Patients with HIV Infection. <i><span class="NLM_source">Quality of Life Research</span></i> <b>15</b>:3, 503-514<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11136-005-1946-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">301</p><p class="content">Glenn A. Van den Bosch, Peter Ponsaerts, Guido Vanham, Dirk R. Van Bockstaele, Zwi N. Berneman, Viggo F. I. Van Tendeloo.  (2006) Cellular Immunotherapy for Cytomegalovirus and HIV-1 Infection. <i><span class="NLM_source">Journal of Immunotherapy</span></i> <b>29</b>:2, 107-121<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.cji.0000184472.28832.d3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">302</p><p class="content">Miguel A. Hernan, Emilie Lanoy, Dominique Costagliola, James M. Robins.  (2006) Comparison of Dynamic Treatment Regimes via Inverse Probability Weighting. <i><span class="NLM_source">Basic &lt;html_ent glyph="@amp;" ascii="&amp;"/&gt; Clinical Pharmacology &lt;html_ent glyph="@amp;" ascii="&amp;"/&gt; Toxicology</span></i> <b>98</b>:3, 237-242<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1742-7843.2006.pto_329.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">303</p><p class="content">V. V. Velichenko, D. A. Pritykin.  (2006) Control of the medical treatment of AIDS. <i><span class="NLM_source">Automation and Remote Control</span></i> <b>67</b>:3, 493-511<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1134/S0005117906030131" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">304</p><p class="content">KR Kilaru, A Kumar, N Sippy, AO Carter, TC Roach.  (2006) Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country. <i><span class="NLM_source">HIV Medicine</span></i> <b>7</b>:2, 99-104<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2006.00347.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">305</p><p class="content">Mehrdad Hamidi.  (2006) Simple and sensitive high-performance liquid chromatography method for the quantitation of indinavir in rat plasma and central nervous system. <i><span class="NLM_source">Journal of Separation Science</span></i> <b>29</b>:5, 620-627<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jssc.200500328" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">306</p><p class="content">Alysia A. Chaves, Reshma S. Baliga, Michael J. Mihm, Brandon L. Schanbacher, Anupam Basuray, Cynthia Liu, Angela C. Cook, Leona W. Ayers, John Anthony Bauer.  (2006) Bacterial Lipopolysaccharide Enhances Cardiac Dysfunction but Not Retroviral Replication in Murine AIDS. <i><span class="NLM_source">The American Journal of Pathology</span></i> <b>168</b>:3, 727-736<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2353/ajpath.2006.050794" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">307</p><p class="content">Kok Keng Tee, Adeeba Kamarulzaman, Kee Peng Ng.  (2006) <i>Short Communication:</i>
              Low Prevalence of Genotypic Drug Resistance Mutations among Antiretroviral-Naive HIV Type 1 Patients in Malaysia. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>22</b>:2, 121-124<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2006.22.121" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">308</p><p class="content">Antigoni Katsoulidou, Maria Petrodaskalaki, Vana Sypsa, Eleni Papachristou, Cleo G. Anastassopoulou, Panagiotis Gargalianos, Anastasia Karafoulidou, Marios Lazanas, Theodoros Kordossis, Anastasia Andoniadou, Angelos Hatzakis.  (2006) Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays—LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5. <i><span class="NLM_source">Journal of Virological Methods</span></i> <b>131</b>:2, 168-174<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jviromet.2005.07.014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">309</p><p class="content">David M Moore, Robert S Hogg, Keith Chan, Mark Tyndall, Benita Yip, Julio SG Montaner.  (2006) Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response. <i><span class="NLM_source">AIDS</span></i> <b>20</b>:3, 371-377<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000196180.11293.9a" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">310</p><p class="content">Susan E Krown, Jeannette Y Lee, Lan Lin, Margaret A Fischl, Richard Ambinder, Jamie H. Von Roenn.  (2006) Interferon-??2b With Protease Inhibitor-Based Antiretroviral Therapy in Patients With AIDS-Associated Kaposi Sarcoma. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>41</b>:2, 149-153<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000194237.15831.23" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">311</p><p class="content">Jonathan Elford.  (2006) Changing patterns of sexual behaviour in the era of highly active antiretroviral therapy. <i><span class="NLM_source">Current Opinion in Infectious Diseases</span></i> <b>19</b>:1, 26-32<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qco.0000199018.50451.e1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">312</p><p class="content">Robert F Siliciano. Acquired Immune Deficiency Syndrome (AIDS). In: Encyclopedia of Life Sciences. John Wiley &amp; Sons, Ltd, 2006.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/npg.els.0003998" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">313</p><p class="content">Andrew N Phillips, Jens D Lundgren.  (2006) The CD4 lymphocyte count and risk of clinical progression. <i><span class="NLM_source">Current Opinion in HIV and AIDS</span></i> <b>1</b>:1, 43-49<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.COH.0000194106.12816.b1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">314</p><p class="content">Yo-han OH, Hyo-kyung HAN.  (2006) Altered pharmacokinetics of zalcitabine by concurrent use of NSAIDs in rats1. <i><span class="NLM_source">Acta Pharmacologica Sinica</span></i> <b>27</b>:1, 119-122<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1745-7254.2006.00249.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">315</p><p class="content">Sarah Fidler, Christophe Fraser, Julie Fox, Norbert Tamm, James T Griffin, Jonathan Weber.  (2006) Comparative potency of three antiretroviral therapy regimes in primary HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>20</b>:2, 247-252<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000200530.71737.75" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">316</p><p class="content">Fred J Hellinger.  (2006) Economic Models of Antiretroviral Therapy. <i><span class="NLM_source">PharmacoEconomics</span></i> <b>24</b>:7, 631-642<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00019053-200624070-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">317</p><p class="content">Mary Beth Wire, Mark J Shelton, Scott Studenberg.  (2006) Fosamprenavir. <i><span class="NLM_source">Clinical Pharmacokinetics</span></i> <b>45</b>:2, 137-168<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00003088-200645020-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">318</p><p class="content">Stefano Rusconi, Ottavia Vigano.  (2006) New HIV protease inhibitors for drug-resistant viruses. <i><span class="NLM_source">Therapy</span></i> <b>3</b>:1, 79-88<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1586/14750708.3.1.79" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">319</p><p class="content">Steve A Castillo, Jaime E Hernandez, Cindy H Brothers.  (2006) Long-Term Safety and Tolerability of the Lamivudine/Abacavir Combination as Components of Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Drug Safety</span></i> <b>29</b>:9, 811-826<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00002018-200629090-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">320</p><p class="content">Miyuki Kawado, Shuji Hashimoto, Takuhiro Yamaguchi, Shin-ichi Oka, Kazuyuki Yoshizaki, Satoshi Kimura, Katsuyuki Fukutake, Satoshi Higasa, Takuma Shirasaka.  (2006) Difference of Progression to AIDS According to CD4 Cell Count, Plasma HIV RNA Level and the Use of Antiretroviral Therapy among HIV Patients Infected through Blood Products in Japan. <i><span class="NLM_source">Journal of Epidemiology</span></i> <b>16</b>:3, 101-106<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2188/jea.16.101" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">321</p><p class="content">Justin Stebbing, Mark Bower.  (2006) Comparative pharmacogenomics of antiretroviral and cytotoxic treatments. <i><span class="NLM_source">The Lancet Oncology</span></i> <b>7</b>:1, 61-68<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1470-2045(05)70538-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">322</p><p class="content">Kara Wools-Kaloustian, Silvester Kimaiyo, Lameck Diero, Abraham Siika, John Sidle, Constantin T Yiannoutsos, Beverly Musick, Robert Einterz, Kenneth H Fife, William M Tierney.  (2006) Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. <i><span class="NLM_source">AIDS</span></i> <b>20</b>:1, 41-48<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000196177.65551.ea" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">323</p><p class="content">Emmanouil Papasavvas, Jay R. Kostman, Brian Thiel, Maxwell Pistilli, Agnieszka Mackiewicz, Andrea Foulkes, Robert Gross, Kimberly A. Jordan, Douglas F. Nixon, Robert Grant, Jean-francois Poulin, Joseph M. Mccune, Karam Mounzer, Luis J. Montaner.  (2006) HIV-1-Specific CD4+ T Cell Responses in Chronically HIV-1 Infected Blippers on Antiretroviral Therapy in Relation to Viral Replication Following Treatment Interruption. <i><span class="NLM_source">Journal of Clinical Immunology</span></i> <b>26</b>:1, 40-54<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10875-006-7518-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">324</p><p class="content">Stefano Rusconi, Ottavia Viganò.  (2006) New HIV protease inhibitors for drug-resistant viruses. <i><span class="NLM_source">Therapy</span></i> <b>3</b>:1, 79-88<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2217/14750708.3.1.79" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">325</p><p class="content"> Severe ,  Patrice ,  Leger ,  Paul ,  Charles ,  Macarthur ,  Noel ,  Francine ,  Bonhomme ,  Gerry ,  Bois ,  Gyrlande ,  George ,  Erik ,  Kenel-Pierre ,  Stefan ,  Wright ,  Peter F. ,  Gulick ,  Roy ,  Johnson ,  Warren D.   Jr. ,  Pape ,  Jean William ,  Fitzgerald ,  Daniel W. , .  (2005) Antiretroviral Therapy in a Thousand Patients with AIDS in Haiti. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>353</b>:22, 2325-2334<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMoa051908">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJMoa051908} --></span></p></li><li class="even"><p class="number">326</p><p class="content">Thomas Kerr, John Walsh, Elisa Lloyd-Smith, Evan Wood.  (2005) Measuring adherence to highly active antiretroviral therapy: Implications for research and practice. <i><span class="NLM_source">Current HIV/AIDS Reports</span></i> <b>2</b>:4, 200-205<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11904-005-0017-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">327</p><p class="content">Rajesh Mohey, Louise B. Jørgensen, Bjarne K. Møller, Finn T. Black, Jørgen Kjems, Niels Obel.  (2005) Detection and quantification of proviral HIV-1 184M/V in circulating CD4+ T cells of patients on HAART with a viremia less than 1000 copies/ml. <i><span class="NLM_source">Journal of Clinical Virology</span></i> <b>34</b>:4, 257-267<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jcv.2005.02.015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">328</p><p class="content">Roger Pomerantz, Giuseppe Nunnari. HIV-1 Reservoirs and Residual Viral Replication during Highly Active Antiretroviral Therapy. In: Cell Death During HIV Infection. CRC Press, 2005:457-474.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1201/9781420038156.ch26" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">329</p><p class="content">Samantha Willey, Paul J. Peters, W. Matthew Sullivan, Patrick Dorr, Manos Perros, Paul R. Clapham.  (2005) Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: Effects of viral diversity, target cell and receptor density. <i><span class="NLM_source">Antiviral Research</span></i> <b>68</b>:2, 96-108<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.antiviral.2005.07.006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">330</p><p class="content">David M Moore, Robert S Hogg, Benita Yip, Evan Wood, Mark Tyndall, Paula Braitstein, Julio S. G Montaner.  (2005) Discordant Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy Are Associated With Increased Mortality and Poor Adherence to Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>40</b>:3, 288-293<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000182847.38098.d1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">331</p><p class="content">Margaret V. Ragni, Bijan Eghtesad, Kimberly W. Schlesinger, Igor Dvorchik, John J. Fung.  (2005) Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. <i><span class="NLM_source">Liver Transplantation</span></i> <b>11</b>:11, 1425-1430<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/lt.20534" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">332</p><p class="content">P. E. Sax, R. Islam, R. P. Walensky, E. Losina, M. C. Weinstein, S. J. Goldie, S. N. Sadownik, K. A. Freedberg.  (2005) Should Resistance Testing Be Performed for Treatment-Naive HIV-Infected Patients? A Cost-Effectiveness Analysis. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>41</b>:9, 1316-1323<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/496984" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">333</p><p class="content">Michael F Schneider, Stephen J Gange, Carolyn M Williams, Kathryn Anastos, Ruth M Greenblatt, Lawrence Kingsley, Roger Detels, Alvaro Muñoz.  (2005) Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984–2004. <i><span class="NLM_source">AIDS</span></i> <b>19</b>:17, 2009-2018<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000189864.90053.22" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">334</p><p class="content">Luciane S Velasque, Rita de Cassia E Estrela, Guilherme Suarez-Kurtz, Claudio J Struchiner.  (2005) Estimating the genetic component (RGC) in pharmacokinetic variability of the antiretroviral didanosine among healthy Brazilians. <i><span class="NLM_source">AIDS</span></i> <b>19</b>:Suppl 4, S76-S80<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000191495.89606.2e" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">335</p><p class="content">Orapun Metadilogkul, Vichai Jirathitikal, Aldar S. Bourinbaiar.  (2005) Prolonged survival of end-stage AIDS patients immunized with therapeutic HIV vaccine V-1 Immunitor. <i><span class="NLM_source">Biomedicine &amp; Pharmacotherapy</span></i> <b>59</b>:8, 469-473<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.biopha.2005.07.004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">336</p><p class="content">Bregt S. Kappelhoff, Alwin D. R. Huitema, Sanjay U. C. Sankatsing, Pieter L. Meenhorst, Eric C. M. Van Gorp, Jan W. Mulder, Jan M. Prins, Jos H. Beijnen.  (2005) Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patients. <i><span class="NLM_source">British Journal of Clinical Pharmacology</span></i> <b>60</b>:3, 276-286<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1365-2125.2005.02436.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">337</p><p class="content">Giuseppe Nunnari, Daniela Leto, Julie Sullivan, Yan Xu, Ketti E. Mehlman, Joseph Kulkosky, Roger J. Pomerantz.  (2005) <i>Short Communication:</i>
              Seminal Reservoirs during an HIV Type 1 Eradication Trial. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>21</b>:9, 768-775<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2005.21.768" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">338</p><p class="content">Alok Kumar, Krishna R Kilaru, Namrata Sippy, Anne O Carter, Timothy C Roach.  (2005) Efficacy of Highly Active Antiretroviral Therapy in Nonclinical Trial Setting of a Developing Caribbean Country. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>40</b>:1, 114-116<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000176592.06549.05" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">339</p><p class="content">Richard M. Rutstein, Kelly A. Gebo, Patricia M. Flynn, John A. Fleishman, Victoria L. Sharp, George K. Siberry, Stephen A. Spector.  (2005) Immunologic Function and Virologic Suppression Among Children With Perinatally Acquired HIV Infection on Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Medical Care</span></i> <b>43</b>:suppl, III-15-III-22<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.mlr.0000175636.34524.b9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">340</p><p class="content">Jes??s Castilla, Jorge del Romero, Victoria Hernando, Beatriz Marincovich, Soledad Garc??a, Carmen Rodr??guez.  (2005) Effectiveness of Highly Active Antiretroviral Therapy in Reducing Heterosexual Transmission of HIV. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>40</b>:1, 96-101<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000157389.78374.45" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">341</p><p class="content">Paul E. Sax, Calvin Cohen, Michael D. Hughes, Daniel R. Kuritzkes, Eric S. Daar.  (2005) HIV Clinical Trials. <i><span class="NLM_source">Infectious Diseases in Clinical Practice</span></i> <b>13</b>:5, 224-235<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.idc.0000179884.72506.08" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">342</p><p class="content">US Justesen, IM Hansen, AB Andersen, NA Klitgaard, FT Black, J Gerstoft, LR Mathiesen, C Pedersen.  (2005) The long-term pharmacokinetics and safety of adding low-dose ritonavir to a nelfinavir 1250 mg twice-daily regimen in HIV-infected patients. <i><span class="NLM_source">HIV Medicine</span></i> <b>6</b>:5, 334-340<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2005.00317.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">343</p><p class="content">John F. Miller, Michael Brieger, Eric S. Furfine, Richard J. Hazen, Istvan Kaldor, David Reynolds, Ronald G. Sherrill, Andrew Spaltenstein.  (2005) Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles. <i><span class="NLM_source">Bioorganic &amp; Medicinal Chemistry Letters</span></i> <b>15</b>:15, 3496-3500<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.bmcl.2005.05.129" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">344</p><p class="content">E Girardi, F N Lauria, G Ippolito.  (2005) HIV/AIDS in 2004: the epidemiologist's point of view. <i><span class="NLM_source">Cell Death and Differentiation</span></i> <b>12</b>, 837-844<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/sj.cdd.4401589" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">345</p><p class="content">Giuseppe Nunnari, Julie Sullivan, Yan Xu, Paul Nyirjesy, Joseph Kulkosky, Winston Cavert, Ian Frank, Roger J. Pomerantz.  (2005) HIV Type 1 Cervicovaginal Reservoirs in the Era of HAART. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>21</b>:8, 714-718<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2005.21.714" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">346</p><p class="content">Susan S Kaplan, Charles B Hicks.  (2005) Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection. <i><span class="NLM_source">Expert Opinion on Pharmacotherapy</span></i> <b>6</b>:9, 1573-1585<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/14656566.6.9.1573" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">347</p><p class="content">B Gazzard, .  (2005) British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005). <i><span class="NLM_source">HIV Medicine</span></i> <b>6</b>:S2, 1-61<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2005.0311b.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">348</p><p class="content">Edward R. Garrity, Heidi Boettcher, Eli Gabbay.  (2005) Donor Infection: An Opinion on Lung Donor Utilization. <i><span class="NLM_source">The Journal of Heart and Lung Transplantation</span></i> <b>24</b>:7, 791-797<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.healun.2004.05.007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">349</p><p class="content">DANIEL E. GOLDBERG, LINDSAY M. SMITHEN, ALLISON ANGELILLI, WILLIAM R. FREEMAN.  (2005) HIV-ASSOCIATED RETINOPATHY IN THE HAART ERA. <i><span class="NLM_source">Retina</span></i> <b>25</b>:5, 633-649<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00006982-200507000-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">350</p><p class="content">Evan Wood, Robert S Hogg, Benita Yip, Winnie WY Dong, Brian Wynhoven, Theresa Mo, Chanson J Brumme, Julio SG Montaner, P Richard Harrigan.  (2005) Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use. <i><span class="NLM_source">AIDS</span></i> <b>19</b>:11, 1189-1195<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000176219.48484.f1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">351</p><p class="content">T. Kerr, A. Marshall, J. Walsh, A. Palepu, M. Tyndall, J. Montaner, R. Hogg, E. Wood.  (2005) Determinants of HAART discontinuation among injection drug users. <i><span class="NLM_source">AIDS Care</span></i> <b>17</b>:5, 539-549<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/09540120412331319778" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">352</p><p class="content">Evan Wood, Robert S Hogg, P Richard Harrigan, Julio SG Montaner.  (2005) When to initiate antiretroviral therapy in HIV-1-infected adults: a review for clinicians and patients. <i><span class="NLM_source">The Lancet Infectious Diseases</span></i> <b>5</b>:7, 407-414<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1473-3099(05)70162-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">353</p><p class="content">Paolo Bonfanti, Canio Martinelli, Elena Ricci, Silvia Carradori, Giustino Parruti, Orlando Armignacco, Carlo Magnani, Tiziana Quirino.  (2005) An Italian Approach to Postmarketing Monitoring: Preliminary Results From the SCOLTA (Surveillance Cohort Long-Term Toxicity Antiretrovirals) Project on the Safety of Lopinavir/Ritonavir. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>39</b>:3, 317-320<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000164248.56722.3c" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">354</p><p class="content">Miguel A. Hernán, Stephen R. Cole, Joseph Margolick, Mardge Cohen, James M. Robins.  (2005) Structural accelerated failure time models for survival analysis in studies with time-varying treatments. <i><span class="NLM_source">Pharmacoepidemiology and Drug Safety</span></i> <b>14</b>:7, 477-491<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/pds.1064" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">355</p><p class="content">Jonathan AC Sterne, Miguel A Hernán, Bruno Ledergerber, Kate Tilling, Rainer Weber, Pedram Sendi, Martin Rickenbach, James M Robins, Matthias Egger.  (2005) Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. <i><span class="NLM_source">The Lancet</span></i> <b>366</b>:9483, 378-384<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(05)67022-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">356</p><p class="content">Bernardino Roca, Consol Lapuebla, Barbara Vidal-Tegedor.  (2005) HAART with didanosine once versus twice daily: adherence and efficacy. <i><span class="NLM_source">International Journal of Infectious Diseases</span></i> <b>9</b>:4, 195-200<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.ijid.2004.07.006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">357</p><p class="content">Emanuele Nicastri, Antonio Chiesi, Claudio Angeletti, Loredana Sarmati, Lucia Palmisano, Andrea Geraci, Massimo Andreoni, Stefano Vella, .  (2005) Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>76</b>:2, 153-160<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jmv.20352" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">358</p><p class="content">Alysa Krain, Daniel W. Fitzgerald.  (2005) HIV antiretroviral therapy in resource-limited settings: Experiences from Haiti. <i><span class="NLM_source">Current HIV/AIDS Reports</span></i> <b>2</b>:2, 98-104<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11904-005-0025-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">359</p><p class="content">Jennifer E. Cook, Somsankar Dasgupta, Lawrence D. Middaugh, Elaine C. Terry, Paul R. Gorry, Steven L. Wesselingh, William R. Tyor.  (2005) Highly active antiretroviral therapy and human immunodeficiency virus encephalitis. <i><span class="NLM_source">Annals of Neurology</span></i> <b>57</b>:6, 795-803<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/ana.20479" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">360</p><p class="content">Pablo Barreiro, Vicente Soriano.  (2005) Estrategias terapéuticas en la infección por el virus de la inmunodeficiencia humana. <i><span class="NLM_source">Medicina Clínica</span></i> <b>124</b>:17, 661-667<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1157/13074743" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">361</p><p class="content">Kimberly Struble, Jeffrey Murray, Ben Cheng, Thomas Gegeny, Veronica Miller, Roy Gulick.  (2005) Antiretroviral therapies for treatment-experienced patients: current status and research challenges. <i><span class="NLM_source">AIDS</span></i> <b>19</b>:8, 747-756<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000168968.34810.ca" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">362</p><p class="content">Hema Viswanathan, Rodney Anderson, Joseph Thomas.  (2005) Evaluation of an Antiretroviral Medication Attitude Scale and Relationships Between Medication Attitudes and Medication Nonadherence. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>19</b>:5, 306-316<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.2005.19.306" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">363</p><p class="content">Diane Descamps, Marie-Laure Chaix, Patrice Andr??, V??ronique Brodard, Jacqueline Cottalorda, Christiane Deveau, Martine Harzic, Didier Ingrand, Jacques Izopet, Evelyne Kohli, Bernard Masquelier, Said Mouajjah, Pierre Palmer, Isabelle Pellegrin, Jean-Christophe Plantier, C??cile Poggi, Sylvie Rogez, Annick Ruffault, V??ronique Schneider, Anne Signori-Schm??ck, Catherine Tamalet, Marc Wirden, Christine Rouzioux, Fran??oise Brun-Vezinet, Laurence Meyer, Dominique Costagliola.  (2005) French National Sentinel Survey of Antiretroviral Drug Resistance in Patients With HIV-1 Primary Infection and in Antiretroviral-Naive Chronically Infected Patients in 2001-2002. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>38</b>:5, 545-552<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000155201.51232.2e" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">364</p><p class="content">Linda Ahdieh-Grant, Patrick M Tarwater, Michael F Schneider, Kathryn Anastos, Mardge Cohen, Ann Khalsa, Howard Minkoff, Mary Young, Ruth M Greenblatt.  (2005) Factors and Temporal Trends Associated With Highly Active Antiretroviral Therapy Discontinuation in the Women??s Interagency HIV Study. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>38</b>:4, 500-503<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000138160.91568.19" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">365</p><p class="content">Antonella d??Arminio Monforte, Alessandro Cozzi-Lepri, Andrew Phillips, Andrea De Luca, Rita Murri, Cristina Mussini, Paolo Grossi, Andrea Galli, Tiziano Zauli, Maria Montroni, Paolo Tundo, Mauro Moroni.  (2005) Interruption of Highly Active Antiretroviral Therapy in HIV Clinical Practice. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>38</b>:4, 407-416<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000147529.57240.b0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">366</p><p class="content">Joseph M. Mrus, Paige L. Williams, Joel Tsevat, Susan E. Cohn, Albert W. Wu.  (2005) Gender differences in health-related quality of life in patients with HIV/AIDS. <i><span class="NLM_source">Quality of Life Research</span></i> <b>14</b>:2, 479-491<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11136-004-4693-z" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">367</p><p class="content">S Fournier, C Chaffaut, A Maillard, B Loze, C Lascoux, L Gerard, J Timsit, F David, J-F Bergmann, E Oksenhendler, D Sereni, S Chevret, J-M Molina.  (2005) Factors associated with virological response in HIV-infected patients failing antiretroviral therapy: a prospective cohort study. <i><span class="NLM_source">HIV Medicine</span></i> <b>6</b>:2, 129-134<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2005.00275.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">368</p><p class="content">Carmem Beatriz Wagner Giacoia-Gripp, Ivan Neves, Maria Clara Galhardo, Mariza Gon<img src="untitled" alt="" class="entityD">alves Morgado.  (2005) Flow Cytometry Evaluation of the T-Cell ReceptorV? Repertoire Among HIV-1 Infected Individuals Before and After Antiretroviral Therapy. <i><span class="NLM_source">Journal of Clinical Immunology</span></i> <b>25</b>:2, 116-126<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10875-005-2817-z" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">369</p><p class="content">Bradford A. Navia, Kevin Rostasy.  (2005) The AIDS dementia complex: Clinical and basic Neuroscience with implications for novel molecular therapies. <i><span class="NLM_source">Neurotoxicity Research</span></i> <b>8</b>:1-2, 3-24<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF03033817" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">370</p><p class="content">Jean-Charles Duclos-Vallée, Daniel Vittecoq, Elina Teicher, Cyrille Feray, Anne-Marie Roque-Afonso, Anne Lombès, Claude Jardel, Michelle Gigou, Elisabeth Dussaix, Mylène Sebagh, Catherine Guettier, Daniel Azoulay, René Adam, Philippe Ichaï, Faouzi Saliba, Bruno Roche, Denis Castaing, Henri Bismuth, Didier Samuel.  (2005) Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV–HCV co-infected patients. <i><span class="NLM_source">Journal of Hepatology</span></i> <b>42</b>:3, 341-349<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jhep.2004.11.029" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">371</p><p class="content">Rochelle P. Walensky, Milton C. Weinstein, April D. Kimmel, George R. Seage, Elena Losina, Paul E. Sax, Hong Zhang, Heather E. Smith, Kenneth A. Freedberg, A. David Paltiel.  (2005) Routine human immunodeficiency virus testing: An economic evaluation of current guidelines. <i><span class="NLM_source">The American Journal of Medicine</span></i> <b>118</b>:3, 292-300<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.amjmed.2004.07.055" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">372</p><p class="content">J. Montaner, M. Harris, R. Hogg.  (2005) Structured Treatment Interruptions: A Risky Business. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>40</b>:4, 601-603<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/427707" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">373</p><p class="content"> Paltiel ,  A. David ,  Weinstein ,  Milton C. ,  Kimmel ,  April D. ,  Seage ,  George R.   III ,  Losina ,  Elena ,  Zhang ,  Hong ,  Freedberg ,  Kenneth A. ,  Walensky ,  Rochelle P. , .  (2005) Expanded Screening for HIV in the United States — An Analysis of Cost-Effectiveness. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>352</b>:6, 586-595<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMsa042088">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJMsa042088} --></span></p></li><li class="even"><p class="number">374</p><p class="content"> Sanders ,  Gillian D. ,  Bayoumi ,  Ahmed M. ,  Sundaram ,  Vandana ,  Bilir ,  S. Pinar ,  Neukermans ,  Christopher P. ,  Rydzak ,  Chara E. ,  Douglass ,  Lena R. ,  Lazzeroni ,  Laura C. ,  Holodniy ,  Mark ,  Owens ,  Douglas K. , .  (2005) Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>352</b>:6, 570-585<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMsa042657">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJMsa042657} --></span></p></li><li class="odd"><p class="number">375</p><p class="content">Nonia Pariente, Saleta Sierra, Antero Airaksinen.  (2005) Action of mutagenic agents and antiviral inhibitors on foot-and-mouth disease virus. <i><span class="NLM_source">Virus Research</span></i> <b>107</b>:2, 183-193<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.virusres.2004.11.008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">376</p><p class="content">Ilona Hauber, Dorian Bevec, Jochen Heukeshoven, Friedrich Krätzer, Florian Horn, Axel Choidas, Thomas Harrer, Joachim Hauber.  (2005) Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. <i><span class="NLM_source">Journal of Clinical Investigation</span></i> <b>115</b>:1, 76-85<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1172/JCI200521949" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">377</p><p class="content">Ilona Hauber, Dorian Bevec, Jochen Heukeshoven, Friedrich Krätzer, Florian Horn, Axel Choidas, Thomas Harrer, Joachim Hauber.  (2005) Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. <i><span class="NLM_source">Journal of Clinical Investigation</span></i> <b>115</b>:1, 76-85<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1172/JCI21949" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">378</p><p class="content">Martin Stürmer, Annemarie Berger, Wolfgang Preiser, Hans Wilhelm Doerr.  (2005) Kommerzielle Systeme zur Genotypisierung von humanen Immundefizienzviren Typ 1: Vergleich von ViroSeq (Abbott) und TruGene (Bayer). Commercially available assays for genotyping of human immunodeficiency virus type 1: Comparison of ViroSeq (Abbott) and TruGene (Bayer). <i><span class="NLM_source">LaboratoriumsMedizin</span></i> <b>29</b>:1, 50-62<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1515/JLM.2005.008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">379</p><p class="content">Shizuko Sei.  (2005) Peptide nucleic acids as epigenetic inhibitors of HIV-1. <i><span class="NLM_source">International Journal of Peptide Research and Therapeutics</span></i> <b>10</b>:3, 269-286<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10989-005-4925-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">380</p><p class="content">Jonathan Elford, Graham Hart.  (2005) HAART, viral load and sexual risk behaviour. <i><span class="NLM_source">AIDS</span></i> <b>19</b>:2, 205-207<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200501280-00014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">381</p><p class="content">Jeffrey S Barrett, Line Labb??, Marc Pfister.  (2005) Application and Impact of Population Pharmacokinetics in the Assessment of Antiretroviral Pharmacotherapy. <i><span class="NLM_source">Clinical Pharmacokinetics</span></i> <b>44</b>:6, 591-625<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00003088-200544060-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">382</p><p class="content">Heidi H. Kong, Sarah A. Myers.  (2005) Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients. <i><span class="NLM_source">Dermatologic Therapy</span></i> <b>18</b>:1, 58-66<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1529-8019.2005.05004.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">383</p><p class="content">Tony Antoniou, Alice L Tseng.  (2005) Interactions Between Antiretrovirals and Antineoplastic Drug Therapy. <i><span class="NLM_source">Clinical Pharmacokinetics</span></i> <b>44</b>:2, 111-145<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00003088-200544020-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">384</p><p class="content">JOHANNES C. ROTHLIND, TANYA M. GREENFIELD, ANNE V. BRUCE, DIETER J. MEYERHOFF, DEREK L. FLENNIKEN, JOSELYN A. LINDGREN, MICHAEL W. WEINER.  (2005) Heavy alcohol consumption in individuals with HIV infection:  Effects on neuropsychological performance. <i><span class="NLM_source">Journal of the International Neuropsychological Society</span></i> <b>11</b>:01, <br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1017/S1355617705050095" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">385</p><p class="content">Keith R. Jerome.  (2005) The road to new antiviral therapies. <i><span class="NLM_source">Clinical and Applied Immunology Reviews</span></i> <b>5</b>:1, 65-76<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.cair.2004.10.002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">386</p><p class="content">James D Neaton. Quantitative Science. In: The AIDS Pandemic. Elsevier, 2005:58-89.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-012465271-2/50006-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">387</p><p class="content">Cecilia Yoon, Roy M Gulick, Donald R Hoover, Carlos M Vaamonde, Marshall J Glesby.  (2004) Case-Control Study of Diabetes Mellitus in HIV-Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>37</b>:4, 1464-1469<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000137373.26438.18" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">388</p><p class="content">Anthony J. Busti, Ronald G. Hall, David M. Margolis.  (2004) Atazanavir for the Treatment of Human Immunodeficiency Virus Infection. <i><span class="NLM_source">Pharmacotherapy</span></i> <b>24</b>:12, 1732-1747<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1592/phco.24.17.1732.52347" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">389</p><p class="content">Andrew V. Albright, Francisco González-Scarano.  (2004) Microarray analysis of activated mixed glial (microglia) and monocyte-derived macrophage gene expression. <i><span class="NLM_source">Journal of Neuroimmunology</span></i> <b>157</b>:1-2, 27-38<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jneuroim.2004.09.007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">390</p><p class="content">St??phanie Vincent, Franck Tourniaire, Claire M. El Yazidi, Emmanuel Compe, Olivier Manches, Richard Plannels, R??gis Roche.  (2004) Nelfinavir Induces Necrosis of 3T3F44-2A Adipocytes by Oxidative Stress. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>37</b>:5, 1556-1562<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200412150-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">391</p><p class="content">Aldar S. Bourinbaiar, Vichai Jirathitikal, Orapun Metadilogkul, Penpit Sooksathan, Prapaphan Paiboon, Siriwan Aemsri, Promdevich Prapai, Kotchakan Chaodon.  (2004) Phase II placebo-controlled study of V-1 Immunitor as a therapeutic modality for treatment of HIV. <i><span class="NLM_source">Journal of Clinical Virology</span></i> <b>31</b>, 55-62<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jcv.2004.09.002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">392</p><p class="content">Adriana Weinberg, Renee D. Jesser, Charles L. Edelstein, Jerome R. Bill, David A. Wohl.  (2004) Excess apoptosis of mononuclear cells contributes to the depressed cytomegalovirus-specific immunity in HIV-infected patients on HAART. <i><span class="NLM_source">Virology</span></i> <b>330</b>:1, 313-321<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.virol.2004.09.017" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">393</p><p class="content">J.M. Mir Meda, L. Zamora Tall, M. Tuset Creus, O. Sued, E. Lpez Su, J.L. Blanco Arvalo, F. Garca Alcaide, E. Martnez Chamorro, J. Mallolas Masferrer, J.M. Gatell Artigas.  (2004) Infecci?n por el VIH: tratamiento antirretrov?rico de la infecci?n por el VIH en adultos. <i><span class="NLM_source">Medicine - Programa de Formaci?n M?dica Continuada Acreditado</span></i> <b>9</b>:23, 1461-1480<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0211-3449(04)70225-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">394</p><p class="content">Hans Henriklarsen, Henry Masur, Joseph Kovacs. Current Regimens for Treatment and Prophylaxis of Pneumocystis jirovecii Pneumonia. CRC Press, 2004:505-538.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1201/b14162-21" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">395</p><p class="content">Stephen R. Cole, Rui Li, Kathryn Anastos, Roger Detels, Mary Young, Joan S. Chmiel, Alvaro Muñoz.  (2004) Accounting for leadtime in cohort studies: evaluating when to initiate HIV therapies. <i><span class="NLM_source">Statistics in Medicine</span></i> <b>23</b>:21, 3351-3363<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/sim.1579" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">396</p><p class="content">Daniel J Skiest, Patrick Morrow, Brady Allen, Judith McKinsey, Craig Crosby, Barbara Foster, R Doug Hardy.  (2004) It Is Safe to Stop Antiretroviral Therapy in Patients With Preantiretroviral CD4 Cell Counts &gt;250 cells/??L. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>37</b>:3, 1351-1357<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200411010-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">397</p><p class="content">G. W. Neff, K. E. Sherman, B. Eghtesad, J. Fung.  (2004) Review article: current status of liver transplantation in HIV-infected patients. <i><span class="NLM_source">Alimentary Pharmacology and Therapeutics</span></i> <b>20</b>:10, 993-1000<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1365-2036.2004.02232.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">398</p><p class="content">Isis S Mikhail, Ralph DiClemente, Sharina Person, Susan Davies, Elizabeth Elliott, Gina Wingood, Pauline E Jolly.  (2004) Association of Complementary and Alternative Medicines With HIV Clinical Disease Among a Cohort of Women Living With HIV/AIDS. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>37</b>:3, 1415-1422<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000130549.65946.3d" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">399</p><p class="content">Daniel S. Stein, Yu Lou, Mark Johnson, Sharon Randall, Stephane Blanche, .  (2004) Pharmacokinetic and Pharmacodynamic Analysis of Amprenavir-Containing Combination Therapy in HIV-1-Infected Children. <i><span class="NLM_source">The Journal of Clinical Pharmacology</span></i> <b>44</b>:11, 1301-1308<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1177/0091270004269561" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">400</p><p class="content">L. A. Szczech, D. R. Hoover, J. G. Feldman, M. H. Cohen, S. J. Gange, L. Gooze, N. R. Rubin, M. A. Young, X. Cai, Q. Shi, W. Gao, K. Anastos.  (2004) Association between Renal Disease and Outcomes among HIV-Infected Women Receiving or Not Receiving Antiretroviral Therapy. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>39</b>:8, 1199-1206<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/424013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">401</p><p class="content">John Fung, Bijan Eghtesad, Kusum Patel-Tom, Michael DeVera, Holly Chapman, Margaret Ragni.  (2004) Liver transplantation in patients with HIV infection. <i><span class="NLM_source">Liver Transplantation</span></i> <b>10</b>:S10, S39-S53<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/lt.20261" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">402</p><p class="content">Antigoni Katsoulidou, Eleni Papachristou, Maria Petrodaskalaki, Vana Sypsa, Cleo G. Anastassopoulou, Panagiotis Gargalianos, Anastasia Karafoulidou, Marios Lazanas, Theodoros Kordossis, Anastasia Andoniadou, Angelos Hatzakis.  (2004) Comparison of three current viral load assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. <i><span class="NLM_source">Journal of Virological Methods</span></i> <b>121</b>:1, 93-99<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.jviromet.2004.06.007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">403</p><p class="content">Susan P. Colby-Germinario, Lorraine E. Chalifour, Anthony Antonecchia, Ralph J. Germinario.  (2004) Short Communication: Antiretroviral Protease Inhibitors Prevent L6 Muscle Cell Fusion by Reducing Calpain Activity. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>20</b>:10, 1057-1062<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.2004.20.1057" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">404</p><p class="content">M. J. Silverberg, M. E. Gore, A. L. French, M. Gandhi, M. J. Glesby, A. Kovacs, T. E. Wilson, M. A. Young, S. J. Gange.  (2004) Prevalence of Clinical Symptoms Associated with Highly Active Antiretroviral Therapy in the Women's Interagency HIV Study. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>39</b>:5, 717-724<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/423181" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">405</p><p class="content">Stephen P Raffanti, Jennifer S Fusco, Beth H Sherrill, Nellie I Hansen, Amy C Justice, Richard D???Aquila, Wendy J Mangialardi, Gregory P Fusco.  (2004) Effect of Persistent Moderate Viremia on Disease Progression During HIV Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>37</b>:1, 1147-1154<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000136738.24090.d0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">406</p><p class="content">Marina B Klein, Patrick Willemot, Tanya Murphy, Richard G Lalonde.  (2004) The impact of initial highly active antiretroviral therapy on future treatment sequences in HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>18</b>:14, 1895-1904<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200409240-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">407</p><p class="content">Benjamin Young.  (2004) The Role of Nucleoside and Nucleotide Reverse Transcriptase Inhibitor Backbones in Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>37</b>:Supplement 1, S13-S20<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.qai.0000137002.17634.4e" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">408</p><p class="content">P. M. Coplan, J. R. Cook, G. W. Carides, J. F. Heyse, A. W. Wu, S. M. Hammer, B.-Y. Nguyen, A. R. Meibohm, M. J. DiNubile, .  (2004) Impact of Indinavir on the Quality of Life in Patients with Advanced HIV Infection Treated with Zidovudine and Lamivudine. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>39</b>:3, 426-433<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/422520" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">409</p><p class="content">Andrew V. Albright, Robin M. Vos, Francisco González-Scarano.  (2004) Low-level HIV replication in mixed glial cultures is associated with alterations in the processing of p55Gag. <i><span class="NLM_source">Virology</span></i> <b>325</b>:2, 328-339<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.virol.2004.04.028" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">410</p><p class="content"> Torriani ,  Francesca J. ,  Rodriguez-Torres ,  Maribel ,  Rockstroh ,  Jürgen K. ,  Lissen ,  Eduardo ,  Gonzalez-García ,  Juan ,  Lazzarin ,  Adriano ,  Carosi ,  Giampiero ,  Sasadeusz ,  Joseph ,  Katlama ,  Christine ,  Montaner ,  Julio ,  Sette ,  Hoel   Jr. ,  Passe ,  Sharon ,  De Pamphilis ,  Jean ,  Duff ,  Frank ,  Schrenk ,  Uschi Marion ,  Dieterich ,  Douglas T. , .  (2004) Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>351</b>:5, 438-450<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMoa040842">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJMoa040842} --></span></p></li><li class="odd"><p class="number">411</p><p class="content">L. Ahdieh-Grant, R. Li, A. M. Levine, L. S. Massad, H. D. Strickler, H. Minkoff, M. Moxley, J. Palefsky, H. Sacks, R. D. Burk, S. J. Gange.  (2004) Highly Active Antiretroviral Therapy and Cervical Squamous Intraepithelial Lesions in Human Immunodeficiency Virus-Positive Women. <i><span class="NLM_source">JNCI Journal of the National Cancer Institute</span></i> <b>96</b>:14, 1070-1076<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/jnci/djh192" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">412</p><p class="content">X. Duval, V. Journot, C. Leport, G. Chene, M. Dupon, L. Cuzin, T. May, P. Morlat, A. Waldner, R. Salamon, F. Raffi, .  (2004) Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective Cohort of HIV-Infected Adults Initiating Protease Inhibitor--Containing Therapy. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>39</b>:2, 248-255<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/422141" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">413</p><p class="content">Christian Laurent, Charles Kouanfack, Sinata Koulla-Shiro, Nathalie Nkoué, Anke Bourgeois, Alexandra Calmy, Bernadette Lactuock, Viviane Nzeusseu, Rose Mougnutou, Gilles Peytavin, Florian Liégeois, Eric Nerrienet, Michèle Tardy, Martine Peeters, Isabelle Andrieux-Meyer, Léopold Zekeng, Michel Kazatchkine, Eitel Mpoudi-Ngolé, Eric Delaporte.  (2004) Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. <i><span class="NLM_source">The Lancet</span></i> <b>364</b>:9428, 29-34<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(04)16586-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">414</p><p class="content">A. Weinberg, S. Pahwa, R. Oyomopito, V. J. Carey, B. Zimmer, L. Mofenson, A. Kovacs, S. K. Burchett, .  (2004) Antimicrobial-Specific Cell-Mediated Immune Reconstitution in Children with Advanced Human Immunodeficiency Virus Infection Receiving Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>39</b>:1, 107-114<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/420931" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">415</p><p class="content">C Lynn Besch.  (2004) Antiretroviral Therapy in Drug-Naive Patients Infected with Human Immunodeficiency Virus. <i><span class="NLM_source">The American Journal of the Medical Sciences</span></i> <b>328</b>:1, 3-9<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00000441-200407000-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">416</p><p class="content">X Duval, G Peytavin, I Albert, S Benoliel, J-L Ecobichon, F Brun-Vezinet, F Mentre, C Leport, J-L Vilde.  (2004) Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patients. <i><span class="NLM_source">HIV Medicine</span></i> <b>5</b>:4, 307-313<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2004.00226.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">417</p><p class="content">Kate Buchacz, Dale J. Hu, Suphak Vanichseni, Philip A. Mock, Thanyanan Chaowanachan, La-ong Srisuwanvilai, Roman Gvetadze, Frits van Griensven, Jordan W. Tappero, Dwip Kitayaporn, Jaranit Kaewkungwal, Kachit Choopanya, Timothy D. Mastro.  (2004) Early Markers of HIV-1 Disease Progression in a Prospective Cohort of Seroconverters in Bangkok, Thailand. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>36</b>:3, 853-860<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200407010-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">418</p><p class="content">Wayne TA Enanoria, Cherie Ng, Sona R Saha, John M Colford Jr.  (2004) Treatment outcomes after highly active antiretroviral therapy: a meta-analysis of randomised controlled trials. <i><span class="NLM_source">The Lancet Infectious Diseases</span></i> <b>4</b>:7, 414-425<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1473-3099(04)01057-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">419</p><p class="content">Yolanda Barr??n, Stephen R Cole, Ruth M Greenblatt, Mardge H Cohen, Kathryn Anastos, Jack A DeHovitz, Robert Delapenha, Stephen J Gange.  (2004) Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>18</b>:11, 1579-1584<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.aids.0000131359.37210.1f" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">420</p><p class="content">Grissell Tirado, Gloria Jove, Rakesh Kumar, Richard J Noel, Evelyn Reyes, Gladys Sepulveda, Y Yamamura, Anil Kumar.  (2004) Differential virus evolution in blood and genital tract of HIV-infected females: evidence for the involvement of drug and non-drug resistance-associated mutations. <i><span class="NLM_source">Virology</span></i> <b>324</b>:2, 577-586<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.virol.2004.04.013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">421</p><p class="content">George Pan, Xiaojun Wu, Margaret A. McKenna, Xu Feng, Tim R. Nagy, Jay M. McDonald.  (2004) AZT Enhances Osteoclastogenesis and Bone Loss. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>20</b>:6, 608-620<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/0889222041217482" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">422</p><p class="content">Archana Rao, Susana D’Amico, Ashok Balasubramanyam, Mario Maldonado.  (2004) Fenofibrate Is Effective in Treating Hypertriglyceridemia Associated with HIV Lipodystrophy. <i><span class="NLM_source">The American Journal of the Medical Sciences</span></i> <b>327</b>:6, 315-318<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00000441-200406000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">423</p><p class="content">H. Choremi-Papadopoulou, K. Tsalimalma, U. Dafni, A. Dimitracopoulou, T. Kordossis.  (2004) Limited long-term naive CD4+ T cell reconstitution in patients experiencing viral load rebounds during HAART. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>73</b>:2, 235-243<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jmv.20081" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">424</p><p class="content">S Buckingham.  (2004) Immune reconstitution inflammatory syndrome in HIV-infected patients with mycobacterial infections starting highly active anti-retroviral therapy. <i><span class="NLM_source">Clinical Radiology</span></i> <b>59</b>:6, 505-513<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.crad.2003.12.002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">425</p><p class="content">E. Castillo, A. Palepu, A. Beardsell, L. Akagi, B. Yip, J. S. G. Montaner, R. S. Hogg.  (2004) Outpatient pharmacy care and HIV viral load response among patients on HAART. <i><span class="NLM_source">AIDS Care</span></i> <b>16</b>:4, 446-457<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/09540120410001683385" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">426</p><p class="content">Motasim Badri, Linda-Gail Bekker, Catherine Orrell, Jennifer Pitt, Fran??ois Cilliers, Robin Wood.  (2004) Initiating highly active antiretroviral therapy in sub-Saharan Africa. <i><span class="NLM_source">AIDS</span></i> <b>18</b>:8, 1159-1168<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200405210-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">427</p><p class="content">Andrew M. Tershakovec, Ian Frank, Daniel Rader.  (2004) HIV-related lipodystrophy and related factors. <i><span class="NLM_source">Atherosclerosis</span></i> <b>174</b>:1, 1-10<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0021-9150(03)00246-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">428</p><p class="content">Martin Stürmer, Annemarie Berger, Wolfgang Preiser.  (2004) HIV-1 genotyping: comparison of two commercially available assays. <i><span class="NLM_source">Expert Review of Molecular Diagnostics</span></i> <b>4</b>:3, 281-291<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1586/14737159.4.3.281" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">429</p><p class="content"> Gulick ,  Roy M. ,  Ribaudo ,  Heather J. ,  Shikuma ,  Cecilia M. ,  Lustgarten ,  Stephanie ,  Squires ,  Kathleen E. ,  Meyer ,  William A.   III ,  Acosta ,  Edward P. ,  Schackman ,  Bruce R. ,  Pilcher ,  Christopher D. ,  Murphy ,  Robert L. ,  Maher ,  William E. ,  Witt ,  Mallory D. ,  Reichman ,  Richard C. ,  Snyder ,  Sally ,  Klingman ,  Karin L. ,  Kuritzkes ,  Daniel R. , .  (2004) Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>350</b>:18, 1850-1861<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMoa031772">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJMoa031772} --></span></p></li><li class="even"><p class="number">430</p><p class="content">Roger J. Pomerantz.  (2004) Effects of HIV-1 Vpr on Neuroinvasion and Neuropathogenesis. <i><span class="NLM_source">DNA and Cell Biology</span></i> <b>23</b>:4, 227-238<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/104454904773819815" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">431</p><p class="content">Lisa M. Frenkel, Nicole H. Tobin.  (2004) Understanding HIV-1 Drug Resistance. <i><span class="NLM_source">Therapeutic Drug Monitoring</span></i> <b>26</b>:2, 116-121<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00007691-200404000-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">432</p><p class="content">Jason D. Barbour, Robert M. Grant.  (2004) The clinical implications of reduced viral fitness. <i><span class="NLM_source">Current Infectious Disease Reports</span></i> <b>6</b>:2, 151-158<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11908-996-0012-x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">433</p><p class="content">Michael Kozal.  (2004) Review: Cross-Resistance Patterns Among HIV Protease Inhibitors. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>18</b>:4, 199-208<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/108729104323038874" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">434</p><p class="content"> Clavel ,  François ,  Hance ,  Allan J. , .  (2004) HIV Drug Resistance. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>350</b>:10, 1023-1035<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMra025195">Full Text</a><!-- ${xml_link: 10.1056%2FNEJMra025195} --></span></p></li><li class="odd"><p class="number">435</p><p class="content">Wei Song, Yosuke Maeda, Akira Tenpaku, Shinji Harada, Keisuke Yusa.  (2004) Persistence of mutations during replication of an HIV library containing combinations of selected protease mutations. <i><span class="NLM_source">Antiviral Research</span></i> <b>61</b>:3, 173-180<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.antiviral.2003.10.001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">436</p><p class="content">Evan Wood, Robert S. Hogg, Benita Yip, P. Richard Harrigan, Michael V. O'Shaughnessy, Julio S. G. Montaner.  (2004) The Impact of Adherence on CD4 Cell Count Responses Among HIV-Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>35</b>:3, 261-268<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200403010-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">437</p><p class="content">Walter K. Kraft, Jacqueline B. McCrea, Gregory A. Winchell, Alexandra Carides, Richard Lowry, Eric J. Woolf, Sandra E. Kusma, Paul J. Deutsch, Howard E. Greenberg, Scott A. Waldman.  (2004) Indinavir and Rifabutin Drug Interactions in Healthy Volunteers. <i><span class="NLM_source">The Journal of Clinical Pharmacology</span></i> <b>44</b>:3, 305-313<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1177/0091270003262807" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">438</p><p class="content">Kai Kappert, Evren Caglayan, Anselm T B??umer, Michael S??dkamp, Gerd F??tkenheuer, Stephan Rosenkranz.  (2004) Ritonavir exhibits anti-atherogenic properties on vascular smooth muscle cells. <i><span class="NLM_source">AIDS</span></i> <b>18</b>:3, 403-411<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200402200-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">439</p><p class="content">John F. Miller, Eric S. Furfine, Mary H. Hanlon, Richard J. Hazen, John A. Ray, Laurence Robinson, Vicente Samano, Andrew Spaltenstein.  (2004) Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strains. <i><span class="NLM_source">Bioorganic &amp; Medicinal Chemistry Letters</span></i> <b>14</b>:4, 959-963<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.bmcl.2003.12.008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">440</p><p class="content">G. D'ETTORRE, G. FORCINA, M. ANDREOTTI, L. SARMATI, L. PALMISANO, M. ANDREONI, S. VELLA, C. M. MASTROIANNI, V. VULLO.  (2004) Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy. <i><span class="NLM_source">Clinical and Experimental Immunology</span></i> <b>135</b>:2, 280-285<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1365-2249.2004.02373.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">441</p><p class="content">Esteban Herrero-Mart<img src="untitled" alt="" class="entityD">nez, Caroline A. Sabin, Christine A. Lee, Ian M. Jones, Deenan Pillay, Vincent C. Emery.  (2004) The effect of highly active antiretroviral therapy for HIV on the anti-HCV specific humoral immune response. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>72</b>:2, 187-193<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jmv.10578" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">442</p><p class="content">Andrew N Phillips, A Sarah Walker.  (2004) Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>18</b>:3, 365-370<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200402200-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">443</p><p class="content">Elisabetta Bulgheroni, Francesco Croce, Paola Citterio, Ottavia Viganò, Raffaella Visonà, Eugenio Sala, Massimo Galli, Stefano Rusconi.  (2004) Unusual codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility. <i><span class="NLM_source">Journal of Clinical Virology</span></i> <b>29</b>:1, 27-32<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1386-6532(03)00082-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">444</p><p class="content">Travis C Porco, Jeffrey N Martin, Kimberly A Page-Shafer, Amber Cheng, Edwin Charlebois, Robert M Grant, Dennis H Osmond.  (2004) Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>18</b>:1, 81-88<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200401020-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">445</p><p class="content">C Manegold, S Thomas, H Jablonowski, CB Chiwakata, M Alwazzeh, O Adams, M Dietrich, D Haussinger.  (2004) Determinants of long-term highly active antiretroviral treatment efficacy. <i><span class="NLM_source">HIV Medicine</span></i> <b>5</b>:1, 40-49<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1468-1293.2004.00184.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">446</p><p class="content">Shuji Hashimoto, Miyuki Kawado, Yoshitaka Murakami, Seiichi Ichikawa, Hirokazu Kimura, Yosikazu Nakamura, Masahiro Kihara, Kazuo Fukutomi.  (2004) Numbers of People with HIV/AIDS Reported and Not Reported to Surveillance in Japan. <i><span class="NLM_source">Journal of Epidemiology</span></i> <b>14</b>:6, 182-186<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2188/jea.14.182" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">447</p><p class="content">José AntonioIribarren, Pablo Labarga, Rafael Rubio, Juan Berenguer, JoséM. Miró, Antonio Antela, Juan González, Santiago Moreno, Julio Arrizabalaga, Lourdes Chamorro, Bonaventura Clotet, José M. Gatell, José López-Aldeguer, Esteban Martínez, Rosa Polo, Montserrat Tuset, Pompeyo Viciana, Juan Miguel Santamaría, José María Kindelán, Esteve Ribera, Ferrán Segura.  (2004) Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el VIH (octubre 2004). <i><span class="NLM_source">Enfermedades Infecciosas y Microbiología Clínica</span></i> <b>22</b>:10, 564-642<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0213-005X(04)73163-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">448</p><p class="content">P. Barreiro García, V. Soriano Vázquez.  (2004) Simplificación de los regímenes antirretrovíricos. Una necesidad para garantizar el control de la infección por VIH a largo plazo. <i><span class="NLM_source">Revista Clínica Española</span></i> <b>204</b>:4, 212-214<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0014-2565(04)71437-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">449</p><p class="content">Chang-Heok Soh, James M Oleske, Michael T Brady, Stephen A Spector, William Borkowsky, Sandra K Burchett, Marc D Foca, Edward Handelsman, Eleanor Jiménez, Wayne M Dankner, Michael D Hughes.  (2003) Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. <i><span class="NLM_source">The Lancet</span></i> <b>362</b>:9401, 2045-2051<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(03)15098-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">450</p><p class="content">Miguel Otero, Giuseppe Nunnari, Daniela Leto, Julie Sullivan, Feng-Xiang Wang, Ian Frank, Yan Xu, Charvi Patel, Geethanjali Dornadula, Joseph Kulkosky, Roger J. Pomerantz.  (2003) Peripheral Blood Dendritic Cells Are Not a Major Reservoir for HIV Type 1 in Infected Individuals on Virally Suppressive HAART. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>19</b>:12, 1097-1103<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922203771881194" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">451</p><p class="content">Megan E. O'Brien, Rebecca A. Clark, C. Lynn Besch, Leann Myers, Patricia Kissinger.  (2003) Patterns and Correlates of Discontinuation of the Initial HAART Regimen in an Urban Outpatient Cohort. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>34</b>:4, 407-414<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200312010-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">452</p><p class="content">Loren Kinman, Scott J. Brodie, Che Chung Tsai, Tot Bui, Kay Larsen, Ann Schmidt, David Anderson, William R. Morton, Shiu-Lok Hu, Rodney J. Y. Ho.  (2003) Lipid???Drug Association Enhanced HIV-1 Protease Inhibitor Indinavir Localization in Lymphoid Tissues and Viral Load Reduction: A Proof of Concept Study in HIV-2287-Infected Macaques. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>34</b>:4, 387-397<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200312010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">453</p><p class="content">Viviana Simon, David D. Ho.  (2003) HIV-1 dynamics in vivo: implications for therapy. <i><span class="NLM_source">Nature Reviews Microbiology</span></i> <b>1</b>:3, 181-190<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/nrmicro772" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">454</p><p class="content">Sue J. Goldie, A.David Paltiel, Milton C. Weinstein, Elena Losina, George R. Seage, April D. Kimmel, Rochelle P. Walensky, Paul E. Sax, Kenneth A. Freedberg.  (2003) Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. <i><span class="NLM_source">The American Journal of Medicine</span></i> <b>115</b>:8, 632-641<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/j.amjmed.2003.07.007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">455</p><p class="content">Azra C Ghani.  (2003) Use of observational data in evaluating treatments: antiretroviral therapy and HIV. <i><span class="NLM_source">Expert Review of Anti-infective Therapy</span></i> <b>1</b>:4, 551-562<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1586/14787210.1.4.551" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">456</p><p class="content">J. H. Kempen, D. A. Jabs, L. A. Wilson, J. P. Dunn, S. K. West, J. Tonascia.  (2003) Mortality Risk for Patients with Cytomegalovirus Retinitis and Acquired Immune Deficiency Syndrome. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>37</b>:10, 1365-1373<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/379077" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">457</p><p class="content">Roy M Gulick, Anne Meibohm, Diane Havlir, Joseph J Eron, Audrey Mosley, Jeffrey A Chodakewitz, Robin Isaacs, Charles Gonzalez, Deborah McMahon, Douglas D Richman, Michael Robertson, John W Mellors.  (2003) Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:16, 2345-2349<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200311070-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">458</p><p class="content">B. Castelnuovo, E. Chiesa, S. Rusconi, F. Adorni, M. Bongiovanni, S. Melzi, P. Cicconi, F. Tordato, L. Meroni, T. Bini, A. d’Arminio Monforte.  (2003) Declining Incidence of AIDS and Increasing Prevalence of AIDS Presenters Among AIDS Patients in Italy. <i><span class="NLM_source">European Journal of Clinical Microbiology &amp; Infectious Diseases</span></i> <b>22</b>:11, 663-669<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10096-003-1038-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">459</p><p class="content">George Rutherford, Prerana Sangani, Gail E Kennedy, George Rutherford. Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection. In: Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2003.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/14651858.CD002037" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">460</p><p class="content">M. S. Hirsch, R. T. Steigbigel, S. Staszewski, D. McMahon, M. A. Fischl, B. Hirschel, K. Squires, M. J. DiNubile, C. M. Harvey, J. Chen, R. Y. Leavitt, .  (2003) Long-Term Efficacy, Safety, and Tolerability of Indinavir-Based Therapy in Protease Inhibitor--Naive Adults with Advanced HIV Infection. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>37</b>:8, 1119-1124<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/378063" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">461</p><p class="content">JOS?? MANUEL S??NCHEZ GRANADOS, JOS?? TOM??S RAMOS AMADOR, SIRA FERN??NDEZ DE MIGUEL, MAR??A ISABEL GONZ??LEZ TOM??, PABLO ROJO CONEJO, PALOMA FERRANDO VIVAS, JULI??N CLEMENTE POLL??N, JES??S RUIZ CONTRERAS, ANGEL NOGALES ESPERT.  (2003) Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. <i><span class="NLM_source">The Pediatric Infectious Disease Journal</span></i> <b>22</b>:10, 863-868<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/01.inf.0000091282.70253.5f" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">462</p><p class="content">Dercy J. Sa-Filho, Luciana J. Costa, Carlos F. de Oliveira, Ana Paula C. Guimarães, Conceição A. Accetturi, Amilcar Tanuri, Ricardo S. Diaz.  (2003) Analysis of the protease sequences of HIV-1 infected individuals after Indinavir monotherapy. <i><span class="NLM_source">Journal of Clinical Virology</span></i> <b>28</b>:2, 186-202<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1386-6532(03)00007-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">463</p><p class="content"> (2003) British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. <i><span class="NLM_source">HIV Medicine</span></i> <b>4</b>:S1, 1-41<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.4.s1.3.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">464</p><p class="content">D. C. Rhew, M. Bernal, D. Aguilar, U. Iloeje, M. B. Goetz.  (2003) Association between Protease Inhibitor Use and Increased Cardiovascular Risk in Patients Infected with Human Immunodeficiency Virus: A Systematic Review. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>37</b>:7, 959-972<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/378064" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">465</p><p class="content">Jintanat Ananworanich, Reto Nuesch, Michelle Le Braz, Ploechan Chetchotisakd, Asda Vibhagool, Saijai Wicharuk, Kiat Ruxrungtham, Hansjakob Furrer, David Cooper, Bernard Hirschel.  (2003) Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:15, F33-F37<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200310170-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">466</p><p class="content">Muktar H. Aliyu, Hamisu M. Salihu.  (2003) Tuberculosis and HIV disease: Two decades of a dual epidemic. <i><span class="NLM_source">Wiener Klinische Wochenschrift</span></i> <b>115</b>:19-20, 685-697<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF03040884" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">467</p><p class="content">Pierre Cordelier, Sandra A. Calarota, Roger J. Pomerantz, Jiang Xiaoshan, David S. Strayer.  (2003) Inhibition of HIV-1 in the Central Nervous System by IFN-
              <i>α</i>
              2 Delivered by an SV40 Vector. <i><span class="NLM_source">Journal of Interferon &amp; Cytokine Research</span></i> <b>23</b>:9, 477-488<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/10799900360708605" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">468</p><p class="content">A. G. DiRienzo.  (2003) Nonparametric Comparison of Two Survival-Time Distributions in the Presence of Dependent Censoring. <i><span class="NLM_source">Biometrics</span></i> <b>59</b>:3, 497-504<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/1541-0420.00059" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">469</p><p class="content">Ananthalakshmi Poluri, Marc van Maanen, Richard E Sutton.  (2003) Genetic therapy for HIV/AIDS. <i><span class="NLM_source">Expert Opinion on Biological Therapy</span></i> <b>3</b>:6, 951-963<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/14712598.3.6.951" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">470</p><p class="content">J. Spritzler, D. Mildvan, A. Russo, D. Asthana, D. Livnat, B. Schock, J. Kagan, A. Landay, D. W. Haas, .  (2003) Can Immune Markers Predict Subsequent Discordance between Immunologic and Virologic Responses to Antiretroviral Therapy? Adult AIDS Clinical Trials Group. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>37</b>:4, 551-558<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/376986" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">471</p><p class="content">Harry Michelmore, Sarangapany Jeganathan, Derek Chan, Marijka Batterham.  (2003) Sustained HIV-1 Suppression in Treatment-Naive Patients Undergoing 4- to 3-Drug Induction Maintenance Therapy (INDUMAIN). <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>33</b>:4, 543-544<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200308010-00017" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">472</p><p class="content">Jonathan Elford, Graham Hart.  (2003) If HIV Prevention Works, Why Are Rates of High-Risk Sexual Behavior Increasing among MSM?. <i><span class="NLM_source">AIDS Education and Prevention</span></i> <b>15</b>:4, 294-308<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1521/aeap.15.5.294.23825" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">473</p><p class="content">D. Heather Watts, John Lambert, E. Richard Stiehm, D. Robert Harris, James Bethel, Lynne Mofenson, William A. Meyer, Bonnie Mathieson, Mary Glen Fowler, George Nemo.  (2003) Progression of HIV Disease Among Women Following Delivery. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>33</b>:5, 585-593<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200308150-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">474</p><p class="content">James Tesoriero, Tyler French, Linda Weiss, Mark Waters, Ruth Finkelstein, Bruce Agins.  (2003) Stability of Adherence to Highly Active Antiretroviral Therapy Over Time Among Clients Enrolled in the Treatment Adherence Demonstration Project. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>33</b>:4, 484-493<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200308010-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">475</p><p class="content">C??dric Carbonneil, Albertine Aouba, Marianne Burgard, Sylvain Cardinaud, Christine Rouzioux, Pierre Langlade-Demoyen, Laurence Weiss.  (2003) Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-?? are potent inducers of HIV-specific CD8 T cells. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:12, 1731-1740<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200308150-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">476</p><p class="content">Kiyoto Tsuchiya, Saori Matsuoka-Aizawa, Akira Yasuoka, Yoshimi Kikuchi, Natsuo Tachikawa, Ikumi Genka, Katsuji Teruya, Satoshi Kimura, Shinichi Oka.  (2003) Primary nelfinavir (NFV)-associated resistance mutations during a follow-up period of 108 weeks in protease inhibitor naı&amp;#x0308;ve patients treated with NFV-containing regimens in an HIV clinic cohort. <i><span class="NLM_source">Journal of Clinical Virology</span></i> <b>27</b>:3, 252-262<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1386-6532(02)00179-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">477</p><p class="content">Peter Slasor, Nan Laird.  (2003) Joint models for efficient estimation in proportional hazards regression models. <i><span class="NLM_source">Statistics in Medicine</span></i> <b>22</b>:13, 2137-2148<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/sim.1439" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">478</p><p class="content">Peter J. Piliero, Joseph P. Colagreco.  (2003) Simplified Regimens for Treating HIV Infection and AIDS. <i><span class="NLM_source">Journal of the American Academy of Nurse Practitioners</span></i> <b>15</b>:7, 353-360<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1745-7599.2003.tb00403.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">479</p><p class="content">Gregory J Dore, Ann McDonald, Yueming Li, John M Kaldor, Bruce J Brew.  (2003) Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:10, 1539-1545<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200307040-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">480</p><p class="content">Maria T. Polianova, Francis W. Ruscetti, Candace B. Pert, Rochelle E. Tractenberg, Gifford Leoung, Scott Strang, Michael R. Ruff.  (2003) Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA). <i><span class="NLM_source">Peptides</span></i> <b>24</b>:7, 1093-1098<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0196-9781(03)00176-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">481</p><p class="content">US Justesen, AM Levring, A Thomsen, JA Lindberg, C Pedersen, P Tauris.  (2003) Low-dose indinavir in combination with low-dose ritonavir: steady-state pharmacokinetics and long-term clinical outcome follow-up. <i><span class="NLM_source">HIV Medicine</span></i> <b>4</b>:3, 250-254<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2003.00153.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">482</p><p class="content">Franco Maggiolo, Diego Ripamonti, Laura Ravasio, Giampietro Gregis, Giampaolo Quinzan, Annapaola Callegaro, Claudio Arici, Fredy Suter.  (2003) Outcome of 2 Simplification Strategies for the Treatment of Human Immunodeficiency Virus Type 1 Infection. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>37</b>:1, 41-49<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/375598" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">483</p><p class="content">Naser L. Rezk, Richard R. Tidwell, Angela D.M. Kashuba.  (2003) Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection. <i><span class="NLM_source">Journal of Chromatography B</span></i> <b>791</b>:1-2, 137-147<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1570-0232(03)00224-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">484</p><p class="content">Peter J. Piliero, Joseph P. Colagreco.  (2003) Simplified Regimens for Treating HIV Infection and AIDS. <i><span class="NLM_source">Journal of the American Academy of Nurse Practitioners</span></i> <b>15</b>:7, 305-312<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1745-7599.2003.tb01313.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">485</p><p class="content">Stéphania Koblavi-Dème, Matthieu Maran, Nguessan Kabran, Marie Yolande Borget, Mireille Kalou, Luc Kestens, Chantal Maurice, Madeleine Sassan-Morokro, Ehounou R. Ekpini, Thierry H. Roels, Terence Chorba, John N. Nkengasong.  (2003) Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>17</b>, S17-S22<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200317003-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">486</p><p class="content">Marchina E. van der Ende, Jan M. Prins, Kees Brinkman, Monique Keuter, Jan Veenstra, Sven A. Danner, Hubert G.M. Niesters, Albert D.M.E. Osterhaus, Martin Schutten.  (2003) Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>17</b>, S55-S61<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200317003-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">487</p><p class="content">A. Gavrila, S. Tsiodras, J. Doweiko, G. Sonia Nagy, K. Brodovicz, W. Hsu, A. W. Karchmer, C. S. Mantzoros.  (2003) Exercise and Vitamin E Intake Are Independently Associated with Metabolic Abnormalities in Human Immunodeficiency Virus--Positive Subjects: A Cross-Sectional Study. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>36</b>:12, 1593-1601<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/375225" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">488</p><p class="content">C. L. Cooper, R. P. G. van Heeswijk, K. Gallicano, D. W. Cameron.  (2003) A Review of Low-Dose Ritonavir in Protease Inhibitor Combination Therapy. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>36</b>:12, 1585-1592<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/375233" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">489</p><p class="content">Paul M. Coplan, Alexander Nikas, Anthony Japour, Karen Cormier, Hilal Maradit-Kremers, Ron Lewis, Yi Xu, Mark J. DiNubile.  (2003) Incidence of Myocardial Infarction in Randomized Clinical Trials of Protease Inhibitor-Based Antiretroviral Therapy: An Analysis of Four Different Protease Inhibitors. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>19</b>:6, 449-455<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922203766774487" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">490</p><p class="content">Anthony K. Wutoh, Oluchi Elekwachi, Veronica Clarke-Tasker, Monika Daftary, Nadina J. Powell, Gregorina Campusano.  (2003) Assessment and Predictors of Antiretroviral Adherence in Older HIV-Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>33</b>:Sup 2, S106-S114<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200306012-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">491</p><p class="content">Shizuko Sei.  (2003) Peptide nucleic acids as epigenetic inhibitors of HIV-1. <i><span class="NLM_source">International Journal of Peptide Research and Therapeutics</span></i> <b>10</b>:3-4, 269-286<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s10989-004-4925-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">492</p><p class="content">Lynda Anne Szczech, Robert Kalayjian, Rudolph Rodriguez, Samir Gupta, Joseph Coladonato, Jonathan Winston, .  (2003) The clinical characteristics and antiretroviral dosing patterns of HIV-infected patients receiving dialysis. <i><span class="NLM_source">Kidney International</span></i> <b>63</b>:6, 2295-2301<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1523-1755.2003.00031.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">493</p><p class="content">Carita Savolainen, Soile Blomqvist, Tapani Hovi.  (2003) Human rhinoviruses. <i><span class="NLM_source">Paediatric Respiratory Reviews</span></i> <b>4</b>:2, 91-98<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1526-0542(03)00030-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">494</p><p class="content">A. K. Sullivan, C. T. Burton, M. R. Nelson, G. Moyle, S. Mandalia, F. M. Gotch, B. G. Gazzard, N. Imami.  (2003) Restoration of Human Immunodeficiency Virus-1-Specific Responses in Patients Changing from Protease to Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy. <i><span class="NLM_source">Scandinavian Journal of Immunology</span></i> <b>57</b>:6, 600-607<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-3083.2003.01276.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">495</p><p class="content">Sarah L Pett, Anthony D Kelleher.  (2003) Cytokine therapies in HIV-1 infection: present and future. <i><span class="NLM_source">Expert Review of Anti-infective Therapy</span></i> <b>1</b>:1, 83-96<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1586/14787210.1.1.83" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">496</p><p class="content">Jim A Turpin.  (2003) The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets. <i><span class="NLM_source">Expert Review of Anti-infective Therapy</span></i> <b>1</b>:1, 97-128<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1586/14787210.1.1.97" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">497</p><p class="content">Damien Arnoult, Frédéric Petit, Jean-Daniel Lelièvre, Jérôme Estaquier.  (2003) Mitochondria in HIV-1-induced apoptosis. <i><span class="NLM_source">Biochemical and Biophysical Research Communications</span></i> <b>304</b>:3, 561-574<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0006-291X(03)00629-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">498</p><p class="content">Shizuko Sei.  (2003) Peptide nucleic acids as epigenetic inhibitors of HIV-1. <i><span class="NLM_source">Letters in Peptide Science</span></i> <b>10</b>:3-4, 269-286<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02484563" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">499</p><p class="content">Anna-Bettina Haidich, John P.A Ioannidis.  (2003) Late-starter sites in randomized controlled trials. <i><span class="NLM_source">Journal of Clinical Epidemiology</span></i> <b>56</b>:5, 408-415<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0895-4356(03)00032-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">500</p><p class="content">Roland Landman, Ricarda Schiemann, Safiatou Thiam, Muriel Vray, Anna Canestri, Souleymane Mboup, Coumba Toure Kane, Eric Delaporte, Papa Salif Sow, Mame Awa Faye, Mandoumbe Gueye, Gilles Peytavin, Cecile Dalban, Pierre-Marie Girard.  (2003) Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:7, 1017-1022<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200305020-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">501</p><p class="content">Remko van Leeuwen, Christine Katlama, Robert L Murphy, Kathleen Squires, José Gatell, Andrej Horban, Bonaventura Clotet, Shlomo Staszewski, Arne van Eeden, Nathan Clumeck, Mauro Moroni, Andrew T Pavia, Reinhold E Schmidt, Juan Gonzalez-Lahoz, Julio Montaner, Francisco Antunes, Robert Gulick, Dénes Bánhegyi, Marc van der Valk, Peter Reiss, Liesbeth van Weert, Frank van Leth, Victoria A Johnson, Jean-Pierre Sommadossi, Joep MA Lange.  (2003) A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:7, 987-999<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200305020-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">502</p><p class="content">Heike Gehringer, Klaus Von der Helm, Sigrid Seelmeir, Benedikt Weißbrich, Josef Eberle, Hans Nitschko.  (2003) Development and evaluation of a phenotypic assay monitoring resistance formation to protease inhibitors in HIV-1-infected patients. <i><span class="NLM_source">Journal of Virological Methods</span></i> <b>109</b>:2, 143-152<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-0934(03)00065-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">503</p><p class="content">Michael P. Carey, Peter A. Vanable. AIDS/HIV. In: Handbook of Psychology. John Wiley &amp; Sons, Inc., 2003.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/0471264385.wei0910" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">504</p><p class="content">Kristin Mondy, Pablo Tebas.  (2003) Emerging Bone Problems in Patients Infected with Human Immunodeficiency Virus. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>36</b>:s2, S101-S105<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/367566" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">505</p><p class="content"> (2003) HIV Treatments Optimism Among Gay Men: An International Perspective. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>32</b>:5, 545-550<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200304150-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">506</p><p class="content">Paulo F. Barroso, Mauro Schechter, Phalguni Gupta, Clarisse Bressan, Antonieta Bomfim, Lee H. Harrison.  (2003) Adherence to Antiretroviral Therapy and Persistence of HIV RNA in Semen. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>32</b>:4, 435-440<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200304010-00014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">507</p><p class="content">Massimo Fantoni, Cosmo Del Borgo, Camillo Autore.  (2003) Evaluation and management of metabolic and coagulative disorders in HIV-infected patients receiving highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>17</b>, S162-S169<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200304001-00020" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">508</p><p class="content">Antonia L. Moore, Ole Kirk, Anne M. Johnson, Christine Katlama, Anders Blaxhult, Manfred Dietrich, Robert Colebunders, Antonio Chiesi, Jens D. Lungren, Andrew N. Phillips.  (2003) Virologic, Immunologic, and Clinical Response to Highly Active Antiretroviral Therapy: the Gender Issue Revisited. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>32</b>:4, 452-461<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200304010-00017" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">509</p><p class="content">Juan A Arnaiz, Josep Mallolas, Daniel Podzamczer, Jan Gerstoft, Jens D Lundgren, Pedro Cahn, Gerd Fätkenheuer, Antonella D'Arminio-Monforte, Arnaldo Casiró, Peter Reiss, David M Burger, Michael Stek, José M Gatell.  (2003) Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:6, 831-840<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200304110-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">510</p><p class="content">Anita Palepu, Mark Tyndall, Benita Yip, Michael V. O'Shaughnessy, Robert S. Hogg, Julio S. G. Montaner.  (2003) Impaired Virologic Response to Highly Active Antiretroviral Therapy Associated With Ongoing Injection Drug Use. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>32</b>:5, 522-526<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200304150-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">511</p><p class="content">A. D. McNaghten, Debra L. Hanson, Mark S. Dworkin, Jeffrey L. Jones.  (2003) Differences in Prescription of Antiretroviral Therapy in a Large Cohort of HIV-Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>32</b>:5, 499-505<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200304150-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">512</p><p class="content">Margaret Chesney.  (2003) Adherence to HAART Regimens. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>17</b>:4, 169-177<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/108729103321619773" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">513</p><p class="content">Audrey Brussel, Dominique Mathez, Sophie Broche-Pierre, Rémi Lancar, Thierry Calvez, Pierre Sonigo, Jacques Leibowitch.  (2003) Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:5, 645-652<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200303280-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">514</p><p class="content">Stephen L Becker.  (2003) The role of pharmacological enhancement in protease inhibitor-based highly active antiretroviral therapy. <i><span class="NLM_source">Expert Opinion on Investigational Drugs</span></i> <b>12</b>:3, 401-412<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/13543784.12.3.401" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">515</p><p class="content">Evan Wood, Robert S Hogg, Benita Yip, P Richard Harrigan, Michael V O'Shaughnessy, Julio SG Montaner.  (2003) Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:5, 711-720<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200303280-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">516</p><p class="content">Kristin Mondy, Kevin Yarasheski, William G. Powderly, Michael Whyte, Sherry Claxton, Debra DeMarco, Mary Hoffmann, Pablo Tebas.  (2003) Longitudinal Evolution of Bone Mineral Density and Bone Markers in Human Immunodeficiency Virus–Infected Individuals. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>36</b>:4, 482-490<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/367569" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">517</p><p class="content">Santiago Pérez-Hoyos, Julia del Amo, Roberto Muga, Jorge del Romero, Patricia García de Olalla, Rafael Guerrero, Ildefonso Hernàndez-Aguado.  (2003) Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:3, 353-359<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200302140-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">518</p><p class="content">Rodolphe Thiébaut, Hélène Jacqmin-Gadda, Catherine Leport, Christine Katlama, Dominique Costagliola, Vincent Le Moing, Philippe Morlat, Geneviève Chêne, the APROCO Study Group.  (2003) Bivariate Longitudinal Model For The Analysis Of The Evolution Of Hiv Rna And Cd4 Cell Count In Hiv Infection Taking Into Account Left Censoring Of Hiv Rna Measures. <i><span class="NLM_source">Journal of Biopharmaceutical Statistics</span></i> <b>13</b>:2, 271-282<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1081/BIP-120019271" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">519</p><p class="content">Anna R Thorner, Eric S Rosenberg.  (2003) Early Versus Delayed Antiretroviral Therapy in Patients with HIV Infection. <i><span class="NLM_source">Drugs</span></i> <b>63</b>:13, 1325-1337<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00003495-200363130-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">520</p><p class="content">Ulrik S. Justesen, Niels A. Klitgaard, Kim Brosen, Court Pedersen.  (2003) Pharmacokinetic interaction between amprenavir and delavirdine after multiple-dose administration in healthy volunteers. <i><span class="NLM_source">British Journal of Clinical Pharmacology</span></i> <b>55</b>:1, 100-106<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2125.2003.01734.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">521</p><p class="content">Greg L Plosker, Lesley J Scott.  (2003) Saquinavir. <i><span class="NLM_source">Drugs</span></i> <b>63</b>:12, 1299-1324<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00003495-200363120-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">522</p><p class="content">Velia Ramírez-Amador, Lilly Esquivel-Pedraza, Juan Sierra-Madero, Gabriela Anaya-Saavedra, Imelda González-Ramírez, Sergio Ponce-de-León.  (2003) The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients. <i><span class="NLM_source">Medicine</span></i> <b>82</b>:1, 39-50<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00005792-200301000-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">523</p><p class="content">Ian Sanne, Peter Piliero, Kathleen Squires, Alexandra Thiry, Steven Schnittman.  (2003) Results of a Phase 2 Clinical Trial at 48 Weeks (AI424-007): A Dose-Ranging, Safety, and Efficacy Comparative Trial of Atazanavir at Three Doses in Combination with Didanosine and Stavudine in Antiretroviral-Naive Subjects. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>32</b>:1, 18-29<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200301010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">524</p><p class="content">Peter A Anton, Ronald T Mitsuyasu, Steven G Deeks, David T Scadden, Bridget Wagner, Christine Huang, Catherine Macken, Douglas D Richman, Cindy Christopherson, Flavia Borellini, Richard Lazar, Kristen M Hege.  (2003) Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:1, 53-63<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200301030-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">525</p><p class="content">AC Ghani, CA Donnelly, RM Anderson.  (2003) Patterns of antiretroviral use in the United States of America: analysis of three observational databases. <i><span class="NLM_source">HIV Medicine</span></i> <b>4</b>:1, 24-32<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2003.00129.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">526</p><p class="content">Claudine Buffet-Janvresse, H<img src="untitled" alt="" class="entityD">l<img src="untitled" alt="" class="entityD">ne Peigue-Lafeuille, Jacques Benichou, Astrid Vabret, Michel Branger, Pascale Trimoulet, Odile Goria, Henri Laurichesse, Abdelaziz Abbed, Renaud Verdon, Elisabeth Bouvet, Marie-Edith Lafon, Elisabeth Dussaix, .  (2003) HIV and HCV co-infection: Situation at six French university hospitals in the year 2000. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>69</b>:1, 7-17<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jmv.10268" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">527</p><p class="content">Y. Yazdanpanah, S. J. Goldie, A. D. Paltiel, E. Losina, L. Coudeville, M. C. Weinstein, Y. Gerard, A. D. Kimmel, H. Zhang, R. Salamon, Y. Mouton, K. A. Freedberg.  (2003) Prevention of Human Immunodeficiency Virus–Related Opportunistic Infections in France: A Cost‐Effectiveness Analysis. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>36</b>:1, 86-96<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/344902" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">528</p><p class="content">Tony Antoniou, Laura Y. Park-Wyllie, Alice L. Tseng.  (2003) Tenofovir: A Nucleotide Analog for The Management of Human Immunodeficiency Virus Infection. <i><span class="NLM_source">Pharmacotherapy</span></i> <b>23</b>:1, 29-43<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1592/phco.23.1.29.31915" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">529</p><p class="content">Jade Ghosn, Claire Lamotte, Hocine Ait-Mohand, Marc Wirden, Rachid Agher, Luminita Schneider, François Bricaire, Claudine Duvivier, Vincent Calvez, Gilles Peytavin, Christine Katlama.  (2003) Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>17</b>:2, 209-214<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200301240-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">530</p><p class="content">Simon J. Potter, Dominic E. Dwyer, Nitin K. Saksena.  (2003) Differential Cellular Distribution of HIV-1 Drug Resistance in Vivo: Evidence for Infection of CD8+ T Cells during HAART. <i><span class="NLM_source">Virology</span></i> <b>305</b>:2, 339-352<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/viro.2002.1703" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">531</p><p class="content">Giuseppe Gumina, John S. Cooperwood, Chung K. Chu. Oxathiolane and Dioxolane Nucleosides. In: Antiviral Nucleosides. Elsevier, 2003:191-258.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-044451319-9/50003-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">532</p><p class="content">Daniel A. Johnson, Douglas A. Jabs. Ophthalmologic Aspects of HIV Infection. In: AIDS and Other Manifestations of HIV Infection. Elsevier, 2003:697-730.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-012764051-8/50028-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">533</p><p class="content">Ramón Teira, María M. Cámara, Antonio Escobar, Pepa Muñoz, Josefina López de Munain, Juan M. Santamaría.  (2003) Ensayo clínico comparativo, aleatorizado y abierto sobre la efectividad de indinavir, ritonavir y saquinavir. <i><span class="NLM_source">Medicina Clínica</span></i> <b>121</b>:14, 532-534<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0025-7753(03)74009-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">534</p><p class="content">Joseph Kulkosky, Roger&nbsp;J. Pomerantz.  (2002) Approaching Eradication of Highly Active Antiretroviral Therapy–Persistent Human Immunodeficiency Virus Type 1 Reservoirs with Immune Activation Therapy. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>35</b>:12, 1520-1526<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/344959" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">535</p><p class="content">Kenzo Hirose, Michelle Roland, Laurie L. Carlson, Peter G. Stock.  (2002) Solid organ transplantation in the HIV-positive patient. <i><span class="NLM_source">Current Opinion in Organ Transplantation</span></i> <b>7</b>:4, 332-336<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00075200-200212000-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">536</p><p class="content">Mark A. Jacobson, Hassan Khayam-Bashi, Jeffrey N. Martin, Doug Black, Valerie Ng.  (2002) Effect of Long-Term Highly Active Antiretroviral Therapy in Restoring HIV-Induced Abnormal B-Lymphocyte Function. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>31</b>:5, 472-477<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200212150-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">537</p><p class="content">Benjamin Young, Margaret A. Fischl, Helene M. Wilson, Tyler S. Finn, Erin H. Jensen, Mark J. DiNubile, Robert K. Zeldin.  (2002) Open-Label Study of a Twice-Daily Indinavir 800-mg/Ritonavir 100-mg Regimen in Protease Inhibitor–Naive HIV-Infected Adults. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>31</b>:5, 478-482<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200212150-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">538</p><p class="content">Joel E Gallant.  (2002) Initial therapy of HIV infection. <i><span class="NLM_source">Journal of Clinical Virology</span></i> <b>25</b>:3, 317-333<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1386-6532(02)00024-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">539</p><p class="content">Natasha Press, Mark W. Tyndall, Evan Wood, Robert S. Hogg, Julio S. G. Montaner.  (2002) Virologic and Immunologic Response, Clinical Progression, and Highly Active Antiretroviral Therapy Adherence. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>31</b>, S112-S117<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200212153-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">540</p><p class="content">Miriam Rabkin, Wafaa El-Sadr, David A Katzenstein, Joia Mukherjee, Henry Masur, Peter Mugyenyi, Paulay Munderi, Janet Darbyshire.  (2002) Antiretroviral treatment in resource-poor settings: clinical research priorities. <i><span class="NLM_source">The Lancet</span></i> <b>360</b>:9344, 1503-1505<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(02)11478-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">541</p><p class="content">Melissa Deanne Neuwelt, Melissa Deanne Neuwelt. Efavirenz versus nevirapine as a non-nucleoside reverse transcriptase inhibitor in initial combination antiretroviral therapy for HIV infection. In: The Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2002.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/14651858.CD004246" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">542</p><p class="content">Katherine V. Heath, Joel Singer, Michael V. O'Shaughnessy, Julio S.G. Montaner, Robert S. Hogg.  (2002) Intentional Nonadherence Due to Adverse Symptoms Associated With Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>31</b>:2, 211-217<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200210010-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">543</p><p class="content">Michael L. Green.  (2002) Evaluation and Management of Dyslipidemia in Patients with HIV Infection. <i><span class="NLM_source">Journal of General Internal Medicine</span></i> <b>17</b>:10, 797-810<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1525-1497.2002.20201.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">544</p><p class="content">Evan Wood, Julio SG Montaner, Keith Chan, Mark W Tyndall, Martin T Schechter, David Bangsberg, Michael V O'Shaughnessy, Robert S Hogg.  (2002) Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:15, 2065-2072<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200210180-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">545</p><p class="content">Pierre de Truchis, Gilles Force, Yves Welker, Denis Mechali, Marc Pulik, Kadoudja Chemlal, Elisabeth Rouveix, Alain Devidas, Danielle Praindhui, Jean-Philippe Mamet.  (2002) Efficacy and Safety of a Quadruple Combination Combivir + Abacavir + Efavirenz Regimen in Antiretroviral Treatment–Naive HIV-1–Infected Adults: La Francilienne. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>31</b>:2, 178-182<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200210010-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">546</p><p class="content">Christine Laine, Walter W. Hauck, Barbara J. Turner.  (2002) Outpatient Patterns of Care and Longitudinal Intensity of Antiretroviral Therapy for HIV-Infected Drug Users. <i><span class="NLM_source">Medical Care</span></i> <b>40</b>:10, 976-995<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00005650-200210000-00014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">547</p><p class="content">Scott E. Kellerman, J. Stan Lehman, Amy Lansky, Mark R. Stevens, Frederick M. Hecht, Andrew B. Bindman, Pascale M. Wortley.  (2002) HIV Testing Within At-Risk Populations in the United States and the Reasons for Seeking or Avoiding HIV Testing. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>31</b>:2, 202-210<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200210010-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">548</p><p class="content">Rochelle P. Walensky, Sue J. Goldie, Paul E. Sax, Milton C. Weinstein, A. David Paltiel, April D. Kimmel, George R. Seage, Elena Losina, Hong Zhang, Runa Islam, Kenneth A. Freedberg.  (2002) Treatment for Primary HIV Infection: Projecting Outcomes of Immediate, Interrupted, or Delayed Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>31</b>:1, 27-37<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200209010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">549</p><p class="content">Hernan Valdez, Elizabeth Connick, Kimberly Y Smith, Michael M Lederman, Ronald J Bosch, Ryung S Kim, Marty St. Clair, Daniel R Kuritzkes, Harold Kessler, Lawrence Fox, Michelle Blanchard-Vargas, Alan Landay.  (2002) Limited immune restoration after 3 years’ suppression of HIV-1 replication in patients with moderately advanced disease. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:14, 1859-1866<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200209270-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">550</p><p class="content">Gilbert R Kaufmann, Don Smith, Heiner C Bucher, Praphan Phanuphak, Pedram P Sendi, Edward K Mbidde, David A Cooper, Manuel Battegay.  (2002) Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries. <i><span class="NLM_source">Expert Opinion on Investigational Drugs</span></i> <b>11</b>:9, 1303-1313<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/13543784.11.9.1303" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">551</p><p class="content">Peter J Piliero.  (2002) Atazanavir: a novel HIV-1 protease inhibitor. <i><span class="NLM_source">Expert Opinion on Investigational Drugs</span></i> <b>11</b>:9, 1295-1301<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/13543784.11.9.1295" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">552</p><p class="content">Audrey Demoustier, Brigitte Gubler, Olivier Lambotte, Marie-Ghislaine de Goër, Christine Wallon, Cécile Goujard, Jean-François Delfraissy, Yassine Taoufik.  (2002) In patients on prolonged HAART, a significant pool of HIV infected CD4 T cells are HIV-specific. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:13, 1749-1754<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200209060-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">553</p><p class="content">Kara K. Bennett, Victor G. DeGruttola, Ian C. Marschner, Diane V. Havlir, Douglas D. Richman.  (2002) Baseline Predictors of CD4 T-Lymphocyte Recovery With Combination Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>31</b>:1, 20-26<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200209010-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">554</p><p class="content">Raymond T Chung, Scott R Evans, Yijun Yang, Dickens Theodore, Hernan Valdez, Rebecca Clark, Cecilia Shikuma, Thomas Nevin, Kenneth E Sherman.  (2002) Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:14, 1915-1923<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200209270-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">555</p><p class="content">Gabriella d'Ettorre, Gabriele Forcina, Mauro Andreotti, Loredana Sarmati, Lucia Palmisano, Clementina M Galluzzo, Emanuele Nicastri, Claudio M Mastroianni, Vincenzo Vullo, Stefano Vella, Massimo Andreoni.  (2002) Discordant response to antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:14, 1877-1885<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200209270-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">556</p><p class="content">Jesús Castilla, Paz Sobrino, Luis de la Fuente, Isabel Noguer, Luis Guerra, Francisco Parras.  (2002) Late diagnosis of HIV infection in the era of highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:14, 1945-1951<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200209270-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">557</p><p class="content">Emilia Marchei, Luisa Valvo, Roberta Pacifici, Manuela Pellegrini, Gianna Tossini, Piergiorgio Zuccaro.  (2002) Simultaneous determination of zidovudine and nevirapine in human plasma by RP-LC. <i><span class="NLM_source">Journal of Pharmaceutical and Biomedical Analysis</span></i> <b>29</b>:6, 1081-1088<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0731-7085(02)00149-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">558</p><p class="content">Rolf P. G. van Heeswijk, Henriëtte J. Scherpbier, Linda A. de Koning, Hugo S. A. Heymans, Joep M. A. Lange, Jos H. Beijnen, Richard M. W. Hoetelmans.  (2002) The Pharmacokinetics of Nelfinavir in HIV-1—Infected Children. <i><span class="NLM_source">Therapeutic Drug Monitoring</span></i> <b>24</b>:4, 487-491<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00007691-200208000-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">559</p><p class="content">Janet M. Raboud, Sandra Rae, Ryan Woods, Marianne Harris, Julio S. G. Montaner.  (2002) Consecutive rebounds in plasma viral load are associated with virological failure at 52 weeks among HIV-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:12, 1627-1632<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200208160-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">560</p><p class="content">Luis Menéndez-Arias.  (2002) Targeting HIV: antiretroviral therapy and development of drug resistance. <i><span class="NLM_source">Trends in Pharmacological Sciences</span></i> <b>23</b>:8, 381-388<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0165-6147(02)02054-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">561</p><p class="content">Leslie A Lenert, Martin Feddersen, Ann Sturley, Daniel Lee.  (2002) Adverse effects of medications and trade-offs between length of life and quality of life in human immunodeficiency virus infection. <i><span class="NLM_source">The American Journal of Medicine</span></i> <b>113</b>:3, 229-232<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0002-9343(02)01156-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">562</p><p class="content">D Johnson.  (2002) Therapeutic management of HIV. <i><span class="NLM_source">Oral Diseases</span></i> <b>8</b>:s2, 17-20<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1034/j.1601-0825.2002.00005.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">563</p><p class="content">Mia Talmor, Lloyd A. Hoffman, Gregory S. LaTrenta.  (2002) Facial Atrophy in HIV-Related Fat Redistribution Syndrome: Anatomic Evaluation and Surgical Reconstruction. <i><span class="NLM_source">Annals of Plastic Surgery</span></i> <b>49</b>:1, 11-18<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00000637-200207000-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">564</p><p class="content">H. Rasokat, N. H. Brockmeyer.  (2002) Betreuung HIV-infizierter Patienten in der Dermato-Venerologischen Praxis. . Care for HIV-Infected Persons by the Dermato-Venerologist. <i><span class="NLM_source">H&lt;html_ent glyph="@amp;" ascii="&amp;"/&gt;G Zeitschrift fur Hautkrankheiten</span></i> <b>77</b>:6, 278-287<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1439-0353.2002.02551.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">565</p><p class="content">Michael Louie, Martin Markowitz.  (2002) Goals and milestones during treatment of HIV-1 infection with antiretroviral therapy: a pathogenesis-based perspective. <i><span class="NLM_source">Antiviral Research</span></i> <b>55</b>:1, 15-25<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(02)00022-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">566</p><p class="content">C.J. Cohen, A. Dusek, J. Green, E.L. Johns, E. Nelson, M.A. Recny.  (2002) Long-Term Treatment with Subcutaneous T-20, a Fusion Inhibitor, in HIV-Infected Patients: Patient Satisfaction and Impact on Activities of Daily Living. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>16</b>:7, 327-335<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/108729102320231162" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">567</p><p class="content">Elisabeta Vergu, Alain Mallet, Jean-Louis Golmard.  (2002) The Role of Resistance Characteristics of Viral Strains in the Prediction of the Response to Antiretroviral Therapy in HIV Infection. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>30</b>:3, 263-270<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200207010-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">568</p><p class="content">Matthias Egger, Margaret May, Geneviève Chêne, Andrew N Phillips, Bruno Ledergerber, François Dabis, Dominique Costagliola, Antonella D'Arminio Monforte, Frank de Wolf, Peter Reiss, Jens D Lundgren, Amy C Justice, Schlomo Staszewski, Catherine Leport, Robert S Hogg, Caroline A Sabin, M John Gill, Bernd Salzberger, Jonathan AC Sterne.  (2002) Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. <i><span class="NLM_source">The Lancet</span></i> <b>360</b>:9327, 119-129<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(02)09411-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">569</p><p class="content">E Voigt, A Wickesberg, J-C Wasmuth, P Gute, L Locher, B Salzberger, A Wohrmann, A Adam, L Weitner, JK Rockstroh.  (2002) First-line ritonavir/indinavir 100/800 mg twice daily plus nucleoside reverse transcriptase inhibitors in a German multicentre study: 48-week results. <i><span class="NLM_source">HIV Medicine</span></i> <b>3</b>:4, 277-282<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2002.00123.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">570</p><p class="content">Paul J Weidle, Samuel Malamba, Raymond Mwebaze, Catherine Sozi, Gideon Rukundo, Robert Downing, Debra Hanson, Dorothy Ochola, Peter Mugyenyi, Jonathan Mermin, Badara Samb, Eve Lackritz.  (2002) Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. <i><span class="NLM_source">The Lancet</span></i> <b>360</b>:9326, 34-40<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(02)09330-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">571</p><p class="content">Jonathan Elford, Graham Bolding, Lorraine Sherr.  (2002) High-risk sexual behaviour increases among London gay men between 1998 and 2001: what is the role of HIV optimism?. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:11, 1537-1544<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200207260-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">572</p><p class="content">Christian Laurent, Ndella Diakhaté, Ndeye Fatou Ngom Gueye, Mame Awa Touré, Papa Salif Sow, Mame Awa Faye, Mandoumbé Gueye, Isabelle Lanièce, Coumba Touré Kane, Florian Liégeois, Laurence Vergne, Souleymane Mboup, Salif Badiane, Ibrahima Ndoye, Eric Delaporte.  (2002) The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:10, 1363-1370<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200207050-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">573</p><p class="content">HC Bucher, M Bichsel, P Taffe, H Furrer, A Telenti, B Hirschel, R Weber, E Bernasconi, P Vernazza, C Minder, M Battegay, .  (2002) Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study. <i><span class="NLM_source">HIV Medicine</span></i> <b>3</b>:4, 247-253<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2002.00113.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">574</p><p class="content">Spencer Lieb, Robert G. Brooks, Richard S. Hopkins, Dan Thompson, Landis K. Crockett, Thomas Liberti, Asim A. Jani, Jeffrey P. Nadler, Vikas M. Virkud, Karen C. West, Gayle McLaughlin.  (2002) Predicting Death From HIV/AIDS: A Case-Control Study From Florida Public HIV/AIDS Clinics. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>30</b>:3, 351-358<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200207010-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">575</p><p class="content">Milos Opravil, Bruno Ledergerber, Hansjakob Furrer, Bernard Hirschel, Alexander Imhof, Serge Gallant, Thomas Wagels, Enos Bernasconi, Fabian Meienberg, Martin Rickenbach, Rainer Weber.  (2002) Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count &gt; 350 × 106/l. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:10, 1371-1381<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200207050-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">576</p><p class="content">DANNY Y. LIN, JOHN F. WARREN, LAURA C. LAZZERONI, RICHARD A. WOLITZ, SAM E. MANSOUR.  (2002) CYTOMEGALOVIRUS RETINITIS AFTER INITIATION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN HIV-INFECTED PATIENTS. <i><span class="NLM_source">Retina</span></i> <b>22</b>:3, 268-277<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00006982-200206000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">577</p><p class="content">Bin Fan, James T. Stewart.  (2002) Determination of zidovudine/lamivudine/nevirapine in human plasma using ion-pair HPLC. <i><span class="NLM_source">Journal of Pharmaceutical and Biomedical Analysis</span></i> <b>28</b>:5, 903-908<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0731-7085(01)00708-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">578</p><p class="content">J. R. Ickovics, C. S. Meade.  (2002) Adherence to HAART among patients with HIV: Breakthroughs and barriers. <i><span class="NLM_source">AIDS Care</span></i> <b>14</b>:3, 309-318<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/09540120220123685" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">579</p><p class="content">Guy W. Neff, Dushyantha Jayaweera, Andreas G. Tzakis.  (2002) Liver transplantation for HIV-infected patients with end-stage liver disease. <i><span class="NLM_source">Current Opinion in Organ Transplantation</span></i> <b>7</b>:2, 114-123<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00075200-200206000-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">580</p><p class="content">P. Trimoulet, D. Neau, B. Le Bail, A. Rullier, M. Winnock, T. Galperine, E. Legrand, E. Schvoerer, M. Dupon, J.M. Ragnaud, P. Bioulac-Sage, G. Ch<img src="untitled" alt="" class="entityD">ne, H. Fleury, M.E. Lafon.  (2002) Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>67</b>:2, 143-151<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jmv.2203" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">581</p><p class="content">Evan Wood, Robert S. Hogg, Benita Yip, Mark W. Tyndall, Christopher H. Sherlock, Richard P. Harrigan, Michael V. O'Shaughnessy, Julio S.G. Montaner.  (2002) “Discordant” Increases in CD4 Cell Count Relative to Plasma Viral Load in a Closely Followed Cohort of Patients Initiating Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>30</b>:2, 159-166<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200206010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">582</p><p class="content">H PALACIO.  (2002) Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature*1. <i><span class="NLM_source">Public Health Reports</span></i> <b>117</b>:3, 233-251<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0033-3549(04)50158-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">583</p><p class="content">M. PERUZZI, C. AZZARI, L. GALLI, A. VIERUCCI, M. DE MARTINO.  (2002) Highly active antiretroviral therapy restores
              <i>in vitro</i>
              mitogen and antigen-specific T-lymphocyte responses in HIV-1 perinatally infected children despite virological failure. <i><span class="NLM_source">Clinical &amp; Experimental Immunology</span></i> <b>128</b>:2, 365-371<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2249.2002.01814.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">584</p><p class="content">Robert S. Hogg, Katherine Heath, David Bangsberg, Benita Yip, Natasha Press, Michael V. O'Shaughnessy, Julio S. G. Montaner.  (2002) Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:7, 1051-1058<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200205030-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">585</p><p class="content">Mira Johri, A. David Paltiel, Sue J. Goldie, Kenneth A. Freedberg.  (2002) State AIDS Drug Assistance Programs. <i><span class="NLM_source">Medical Care</span></i> <b>40</b>:5, 429-441<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00005650-200205000-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">586</p><p class="content">Alexander J. Frater, David T. Dunn, Alison J. Beardall, Koya Ariyoshi, John R. Clarke, Myra O. McClure, Jonathan N. Weber.  (2002) Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:8, 1139-1146<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200205240-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">587</p><p class="content">Simon Paul, Holly M. Gilbert, Leah Lande, Carlos M. Vaamonde, Jonathan Jacobs, Sharp Malak, Kent A. Sepkowitz.  (2002) Impact of Antiretroviral Therapy on Decreasing Hospitalization Rates of HIV-Infected Patients in 2001. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>18</b>:7, 501-506<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922202317406646" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">588</p><p class="content">Jean-Michel Tassie, Sophie Grabar, Rémi Lancar, Jacqueline Deloumeaux, Michèle Bentata, Dominique Costagliola.  (2002) Time to AIDS From 1992 to 1999 in HIV-1–Infected Subjects With Known Date of Infection. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>30</b>:1, 81-87<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200205010-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">589</p><p class="content">Henry K. Tam, Zuo-Feng Zhang, Lisa P. Jacobson, Joseph B. Margolick, Joan S. Chmiel, Charles Rinaldo, Roger Detels.  (2002) Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. <i><span class="NLM_source">International Journal of Cancer</span></i> <b>98</b>:6, 916-922<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/ijc.10274" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">590</p><p class="content">Francis Mandy, Jan Nicholson, Brigitte Autran, George Janossy.  (2002) T-cell subset counting and the fight against AIDS: Reflections over a 20-year struggle. <i><span class="NLM_source">Cytometry</span></i> <b>50</b>:2, 39-45<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/cyto.10097" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">591</p><p class="content">L. P. Jacobson.  (2002) Evaluation of the Effectiveness of Highly Active Antiretroviral Therapy in Persons with Human Immunodeficiency Virus using Biomarker-based Equivalence of Disease Progression. <i><span class="NLM_source">American Journal of Epidemiology</span></i> <b>155</b>:8, 760-770<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/aje/155.8.760" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">592</p><p class="content">Gregory J. Dore, Yueming Li, Ann McDonald, Hugo Ree, John M. Kaldo.  (2002) Impact of Highly Active Antiretroviral Therapy on Individual AIDS-Defining Illness Incidence and Survival in Australia. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>29</b>:4, 388-395<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200204010-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">593</p><p class="content">Montserrat Plana, Catalina Martínez, Felipe García, María J. Maleno, Juan J. Barceló, Ana García, Marylène Lejeune, Carmen Vidal, Anna Cruceta, José M. Miró, Tomás Pumarola, Teresa Gallart, José M. Gatell.  (2002) Immunologic Reconstitution After 1 Year of Highly Active Antiretroviral Therapy, With or Without Protease Inhibitors. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>29</b>:5, 429-434<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200204150-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">594</p><p class="content">Javier Martinez-Picado, Kristina Morales-Lopetegi, Terri Wrin, Julia G. Prado, Simon D. W. Frost, Christos J. Petropoulos, Bonaventura Clotet, Lidia Ruiz.  (2002) Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:6, 895-899<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200204120-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">595</p><p class="content">G. LI PIRA, D. FENOGLIO, L. BOTTONE, P. TERRANOVA, E. PONTALI, F. CAROLI, M. SERI, J.-C. CAILLIEZ, G. KOOPMAN, R. ACCOLLA, F. DEL GALDO, G. ABBATE, R. DE PALMA, F. MANCA.  (2002) Preservation of clonal heterogeneity of the
              <i>Pneumocystis carinii</i>
              -specific CD4 T cell repertoire in HIV infected, asymptomatic individuals. <i><span class="NLM_source">Clinical &amp; Experimental Immunology</span></i> <b>128</b>:1, 155-162<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2249.2002.01799.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">596</p><p class="content">S. Kinloch-de Loes, B. Autran.  (2002) HIV-1 Therapeutic Vaccines. <i><span class="NLM_source">Journal of Infection</span></i> <b>44</b>:3, 152-159<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1053/jinf.2002.0987" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">597</p><p class="content">Mary Kathryn Cowles.  (2002) Bayesian estimation of the proportion of treatment effect captured by a surrogate marker. <i><span class="NLM_source">Statistics in Medicine</span></i> <b>21</b>:6, 811-834<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/sim.1057" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">598</p><p class="content">Simona La Seta Catamancio, Stefano Rusconi.  (2002) HIV-1 protease inhibitors in development. <i><span class="NLM_source">Expert Opinion on Investigational Drugs</span></i> <b>11</b>:3, 387-395<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/13543784.11.3.387" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">599</p><p class="content">Courtney V. Fletcher, Peter L. Anderson, Thomas N. Kakuda, Timothy W. Schacker, Keith Henry, Cynthia R. Gross, Richard C. Brundage.  (2002) Concentration-controlled compared with conventional antiretroviral therapy for HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:4, 551-560<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200203080-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">600</p><p class="content">David E. Ostrow, Kelly J. Fox, Joan S. Chmiel, Anthony Silvestre, Barbara R. Visscher, Peter A. Vanable, Lisa P. Jacobson, Steffanie A. Strathdee.  (2002) Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:5, 775-780<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200203290-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">601</p><p class="content">Mitchell H. Katz, Sandra K. Schwarcz, Timothy A. Kellogg, Jeffrey D. Klausner, James W. Dilley, Steven Gibson, William McFarland.  (2002) Impact of Highly Active Antiretroviral Treatment on HIV Seroincidence Among Men Who Have Sex With Men: San Francisco. <i><span class="NLM_source">American Journal of Public Health</span></i> <b>92</b>:3, 388-394<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2105/AJPH.92.3.388" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">602</p><p class="content">Patrick Taffé, Martin Rickenbach, Bernard Hirschel, Milos Opravil, Hansjakob Furrer, Pascal Janin, Florence Bugnon, Bruno Ledergerber, Thomas Wagels, Philippe Sudre.  (2002) Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:5, 747-755<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200203290-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">603</p><p class="content">Robert S. Hogg, Diane Havlir, Veronica Miller, Julio S. G. Montaner.  (2002) To stop or not to stop: That is the question, but what is the answer?. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:5, 787-789<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200203290-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">604</p><p class="content">Guislaine Carcelain, Lucile Mollet, Brigitte Autran. Immune Reconstitution in HIV Infection. In: AIDS Vaccine Research. CRC Press, 2002:153-171.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.3109/9780203908778-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">605</p><p class="content">Giuseppina Liuzzi, Antonio Chirianni, Massimo Clementi, Mauro Zaccarelli, Andrea Antinori, Marcello Piazza.  (2002) Reduction of HIV-1 viral load in saliva by indinavir-containing antiretroviral regimen. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:3, 503-504<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200202150-00031" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">606</p><p class="content">Lena Serghides, Salima Nathoo, Sharon Walmsley, Kevin C. Kain.  (2002) CD36 deficiency induced by antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:3, 353-358<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200202150-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">607</p><p class="content">Jean-François Gagné, André Désormeaux, Sylvie Perron, Michel J Tremblay, Michel G Bergeron.  (2002) Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes. <i><span class="NLM_source">Biochimica et Biophysica Acta (BBA) - Biomembranes</span></i> <b>1558</b>:2, 198-210<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0005-2736(01)00432-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">608</p><p class="content">Joel N. Blankson, Deborah Persaud, Robert F. Siliciano.  (2002) T
              <scp xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">HE</scp>
              C
              <scp xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">HALLENGE OF</scp>
              V
              <scp xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">IRAL</scp>
              R
              <scp xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ESERVOIRS IN</scp>
              HIV-1 I
              <scp xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">NFECTION</scp>. <i><span class="NLM_source">Annual Review of Medicine</span></i> <b>53</b>:1, 557-593<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1146/annurev.med.53.082901.104024" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">609</p><p class="content">RAM YOGEV, SOPHIA LEE, ANDREW WIZNIA, SHARON NACHMAN, KENNETH STANLEY, STEPHEN PELTON, LYNNE MOFENSON, SUSAN FISCUS, ELEANOR JIMENEZ, MOBEEN H. RATHORE, MARY ELIZABETH SMITH, LIN YE SONG, KENNETH MCINTOSH.  (2002) Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection. <i><span class="NLM_source">The Pediatric Infectious Disease Journal</span></i> <b>21</b>:2, 119-125<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00006454-200202000-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">610</p><p class="content">B Gröschel, J Cinatl, C Périgaud, G Gosselin, J.-L Imbach, H.W Doerr, J Cinatl.  (2002) S-acyl-2-thioethyl (SATE) pronucleotides are potent inhibitors of HIV-1 replication in T-lymphoid cells cross-resistant to deoxycytidine and thymidine analogs. <i><span class="NLM_source">Antiviral Research</span></i> <b>53</b>:2, 143-152<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(01)00205-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">611</p><p class="content">Peter Brocklehurst, Peter Brocklehurst. Interventions for reducing the risk of mother-to-child transmission of HIV infection. In: Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2002.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/14651858.CD000102" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">612</p><p class="content">Alan L. Landay, Daniel Bettendorf, Ellen Chan, John Spritzler, John L. Schmitz, R. Pat Bucy, Charles J. Gonzalez, Carol T. Schnizlein-Bick, Tom Evans, Kate E. Squires, John P. Phair.  (2002) Evidence of Immune Reconstitution in Antiretroviral Drug-Experienced Patients with Advanced HIV Disease. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>18</b>:2, 95-102<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/08892220252779638" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">613</p><p class="content">Vincent Le&nbsp;Moing, Geneviève Chêne, Catherine Leport, Charlotte Lewden, Ségolène Duran, Michel Garré, Bernard Masquelier, Michel Dupon, François Raffi, .  (2002) Impact of Discontinuation of Initial Protease Inhibitor Therapy on Further Virological Response in a Cohort of Human Immunodeficiency Virus–Infected Patients. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>34</b>:2, 239-247<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/324354" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">614</p><p class="content">Gail V. Matthews, Caroline. A. Sabin, Sundhiya Mandalia, Fiona Lampe, Andrew N. Phillips, Mark R. Nelson, Mark Bower, Margaret A. Johnson, Brian G. Gazzard.  (2002) Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:1, 53-61<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200201040-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">615</p><p class="content">L Weiss, M Burgard, YD Cahen, ML Chaix, D Laureillard, J Gilquin, C Piketty, JP Viard, MD Kazatchkine, PM Girard, C Rouzioux.  (2002) Immunological and virological features of HIV-infected patients with increasing CD4 cell numbers despite virological failure during protease inhibitor-based therapy. <i><span class="NLM_source">HIV Medicine</span></i> <b>3</b>:1, 12-20<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1464-2662.2001.00095.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">616</p><p class="content">Lisa P. Jacobson, John P. Phair, Traci E. Yamashita.  (2002) Virologic and immunologic response to highly active antiretroviral therapy. <i><span class="NLM_source">Current Infectious Disease Reports</span></i> <b>4</b>:1, 88-96<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11908-002-0072-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">617</p><p class="content">Giuseppe Nunnari, Miguel Otero, Geethanjali Dornadula, Michelle Vanella, Hui Zhang, Ian Frank, Roger J. Pomerantz.  (2002) Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:1, 39-45<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200201040-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">618</p><p class="content">Vincent Le Moing, Geneviève Chêne, Maria P. Carrieri, Ahmadou Alioum, Françoise Brun-Vézinet, Lionel Piroth, Jill P. Cassuto, Jean-Paul Moatti, François Raffi, Catherine Leport.  (2002) Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:1, 21-29<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200201040-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">619</p><p class="content">Jason S. Ellis, Charles W. Caldwell, Adam L. Asare.  (2002) A Decision-Support System for Flow Cytometry Immunophenotyping. <i><span class="NLM_source">American Journal of Clinical Pathology</span></i> <b>118</b>:4, 567-573<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1309/0N45-CC0E-R802-D9NG" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">620</p><p class="content">Régis Roche, Isabelle Poizot-Martin, Claire Martin-El Yazidi, Emmanuel Compe, Jean-Albert Gastaut, Janine Torresani, Richard Planells.  (2002) Effects of antiretroviral drug combinations on the differentiation of adipocytes. <i><span class="NLM_source">AIDS</span></i> <b>16</b>:1, 13-20<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200201040-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">621</p><p class="content">Milomir Djokic.  (2002) Savremena antiretrovirusna terapija. <i><span class="NLM_source">Vojnosanitetski pregled</span></i> <b>59</b>:4, 417-422<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2298/VSP0204417D" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">622</p><p class="content">Phillip M. Boiselle, Galit Aviram, Joel E. Fishman.  (2002) Update on lung disease in AIDS. <i><span class="NLM_source">Seminars in Roentgenology</span></i> <b>37</b>:1, 54-71<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1053/sroe.2002.29586" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">623</p><p class="content">Rafael Rubio, Juan Berenguer, José M. Miró, Antonio Antela, José Antonio Iribarren, Juan González, Luis Guerra, Santiago Moreno, Julio Arrizabalaga, Buenaventura Clotet, José M. Gatell, Fernando Laguna, Esteban Martínez, Francisco Parras, Juan Miguel Santamaría, Montserrat Tuset, Pompeyo Viciana.  (2002) Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el virus de la inmunodeficiencia humana en el año 2002. <i><span class="NLM_source">Enfermedades Infecciosas y Microbiología Clínica</span></i> <b>20</b>:6, 244-303<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0213-005X(02)72804-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">624</p><p class="content">A. Antela López.  (2002) Infección por el virus de la inmunodeficiencia humana. <i><span class="NLM_source">Medicine - Programa de Formación Médica Continuada Acreditado</span></i> <b>8</b>:73, 3923-3932<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0304-5412(02)70727-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">625</p><p class="content">Ling C. Hsu, Eric Vittinghoff, Mitch H. Katz, Sandra K. Schwarcz.  (2001) Predictors of Use of Highly Active Antiretroviral Therapy (HAART) Among Persons With AIDS in San Francisco, 1996–1999. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>28</b>:4, 345-350<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200112010-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">626</p><p class="content">C.&nbsp;Robert Horsburgh,&nbsp;Jr., Jill Gettings, Lorraine&nbsp;N. Alexander, Jeffrey&nbsp;L. Lennox.  (2001) Disseminated
              <i>Mycobacterium avium</i>
              Complex Disease among Patients Infected with Human Immunodeficiency Virus, 1985–2000. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>33</b>:11, 1938-1943<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/324508" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">627</p><p class="content">Loredana Sarmati, Emanuele Nicastri, Saverio Giuseppe Parisi, Gabriella D'Ettorre, Pasquale Narciso, Giorgio Mancino, Isa Gallo, Vincenzo Abbadessa, Nogare Ernesto Renato Dalle, Cino Traina, Vincenzo Vullo, Massimo Andreoni.  (2001) Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-Like HIV-1 resistance mutations. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>65</b>:4, 631-636<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/jmv.2083" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">628</p><p class="content">L. Garattini, F. Tediosi, E. Di Cintio, D. Yin, F. Parazzini.  (2001) Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy. <i><span class="NLM_source">AIDS Care</span></i> <b>13</b>:6, 733-741<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/09540120120076896" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">629</p><p class="content">Elizabeth Connick.  (2001) Immune Reconstitution in HIV-1-Infected Individuals Treated with Potent Antiretroviral Therapy. <i><span class="NLM_source">Journal of Investigative Dermatology Symposium Proceedings</span></i> <b>6</b>:3, 212-218<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.0022-202x.2001.00049.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">630</p><p class="content"> Gortmaker ,  Steven L. ,  Hughes ,  Michael ,  Cervia ,  Joseph ,  Brady ,  Michael ,  Johnson ,  George M. ,  Seage ,  George R.   III ,  Song ,  Lin Ye ,  Dankner ,  Wayne M. ,  Oleske ,  James M. , .  (2001) Effect of Combination Therapy Including Protease Inhibitors on Mortality among Children and Adolescents Infected with HIV-1. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>345</b>:21, 1522-1528<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMoa011157">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJMoa011157} --></span></p></li><li class="odd"><p class="number">631</p><p class="content">J. Takamatsu, H. Toyoda, Y. Fukuda, I. Nakano, S. Yokozaki, K. Hayashi, H. Saito.  (2001) Effects of HAART on hepatitis C, hepatitis G, and TT virus in multiply coinfected HIV-positive patients with haemophilia. <i><span class="NLM_source">Haemophilia</span></i> <b>7</b>:6, 575-581<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2516.2001.00567.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">632</p><p class="content">Howard Minkoff, Linda Ahdieh, L. Stewart Massad, Kathryn Anastos, D. Heather Watts, Sandra Melnick, Laila Muderspach, Robert Burk, Joel Palefsky.  (2001) The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:16, 2157-2164<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200111090-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">633</p><p class="content">Giuseppina Li Pira, Laura Bottone, Daniela Fenoglio, Paola Terranova, Emanuele Pontali, Federico Ivaldi, Francesco Del Galdo, Lorenzo Mortara, Arianna Loregian, Giorgio Palù, Annalisa Kunkl, Roberto Accolla, Raffaele De Palma, Fabrizio Manca.  (2001) Analysis of the antigen specific T cell repertoires in HIV infection. <i><span class="NLM_source">Immunology Letters</span></i> <b>79</b>:1-2, 85-91<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0165-2478(01)00269-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">634</p><p class="content">Nesrina Imami, Gareth Hardy, Catherine Burton, Antonio Pires, Jeffrey Pido-Lopez, Ron Moss, Brian Gazzard, Frances Gotch.  (2001) Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination. <i><span class="NLM_source">Immunology Letters</span></i> <b>79</b>:1-2, 63-76<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0165-2478(01)00267-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">635</p><p class="content">Alain Landau, Dominique Batisse, Christophe Piketty, Jean Paul Duong Van Huyen, Francis Bloch, Laurent Belec, Patrick Bruneval, Laurence Weiss, Raymond Jian, Michel D. Kazatchkine.  (2001) Long-term efficacy of combination therapy with interferon-α2b and ribavirin for severe chronic hepatitis C in HIV-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:16, 2149-2155<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200111090-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">636</p><p class="content">Linda Ahdieh Grant, Michael J. Silverberg, Herminia Palacio, Howard Minkoff, Kathryn Anastos, Mary A. Young, Marek Nowicki, Andrea Kovacs, Mardge Cohen, Alvaro Muñoz.  (2001) Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levels. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:16, 2101-2108<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200111090-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">637</p><p class="content">D. J. S. King, E. -L. Larsson-Sciard.  (2001) Clonal evolution of CD8+ T-cell expansions in HIV-infected patients on long-term HAART. <i><span class="NLM_source">Clinical and Experimental Immunology</span></i> <b>126</b>:2, 280-286<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2249.2001.01665.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">638</p><p class="content">GIUSEPPE IPPOLITO, VINCENZO GALATI, DIEGO SERRAINO, ENRICO GIRARDI.  (2001) The Changing Picture of the HIV/AIDS Epidemic. <i><span class="NLM_source">Annals of the New York Academy of Sciences</span></i> <b>946</b>:1, 1-12<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1749-6632.2001.tb03899.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">639</p><p class="content">S. D. Zucker.  (2001) Mechanism of indinavir-induced hyperbilirubinemia. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>98</b>:22, 12671-12676<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.231140698" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">640</p><p class="content"> (2001) British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. <i><span class="NLM_source">HIV Medicine</span></i> <b>2</b>:4, 276-313<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1464-2662.2001.00083.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">641</p><p class="content">Michael S. Saag, Pablo Tebas, Michael Sension, Marcus Conant, Robert Myers, Sharon K. Chapman, Robert Anderson.  (2001) Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511). <i><span class="NLM_source">AIDS</span></i> <b>15</b>:15, 1971-1978<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200110190-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">642</p><p class="content">Sarah L Pett, Sean Emery.  (2001) Immunomodulators as adjunctive therapy for HIV-1 infection. <i><span class="NLM_source">Journal of Clinical Virology</span></i> <b>22</b>:3, 289-295<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1386-6532(01)00201-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">643</p><p class="content">Eva Lonn.  (2001) The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseases. <i><span class="NLM_source">Pharmacoepidemiology and Drug Safety</span></i> <b>10</b>:6, 497-508<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/pds.654" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">644</p><p class="content">Pratibha V. Nerurkar, Cecilia M. Shikuma, Vivek R. Nerurkar.  (2001) Sterol regulatory element-binding proteins and reactive oxygen species: potential role in highly-active antiretroviral therapy (HAART)-associated lipodystrophy. <i><span class="NLM_source">Clinical Biochemistry</span></i> <b>34</b>:7, 519-529<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0009-9120(01)00239-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">645</p><p class="content">Pythia T. Nieuwkerk, Elisabeth H. Gisolf, Monique H.E. Reijers, Joep M.A. Lange, Sven A. Danner.  (2001) Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:15, 1985-1991<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200110190-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">646</p><p class="content">Alicia M. Johnston, Megan E. Valentine, Janet Ottinger, Ruth Baydo, Victoria Gryszowka, Cindy Vavro, Kent Weinhold, Marty St. Clair, Ross E. McKinney.  (2001) Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study. <i><span class="NLM_source">The Pediatric Infectious Disease Journal</span></i> <b>20</b>:10, 941-946<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00006454-200110000-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">647</p><p class="content">Anne M. Mijch, Jennifer Hoy, Kerrie Watson, Amanda Dunne, Suzanne Crowe, Steven L. Wesselingh.  (2001) Does plasma HIV RNA predict outcome in a cohort of treated HIV-infected individuals followed over 3 years?. <i><span class="NLM_source">Journal of Clinical Virology</span></i> <b>22</b>:3, 271-278<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1386-6532(01)00199-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">648</p><p class="content">Secondo Sonza, Suzanne M. Crowe.  (2001) Reservoirs for HIV Infection and Their Persistence in the Face of Undetectable Viral Load. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>15</b>:10, 511-518<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/108729101753205676" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">649</p><p class="content">Emilia Marchei, Roberta Pacifici, Gianna Tossini, Rita Di Fava, Luisa Valvo, Piergiorgio Zuccaro.  (2001) SIMULTANEOUS LIQUID CHROMATOGRAPHIC DETERMINATION OF INDINAVIR, SAQUINAVIR, AND RITONAVIR IN HUMAN PLASMA WITH COMBINED ULTRAVIOLET ABSORBANCE AND ELECTROCHEMICAL DETECTION. <i><span class="NLM_source">Journal of Liquid Chromatography &amp; Related Technologies</span></i> <b>24</b>:15, 2325-2336<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1081/JLC-100105144" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">650</p><p class="content">J.&nbsp;Michael Kilby.  (2001) Human Immunodeficiency Virus Pathogenesis: Insights from Studies of Lymphoid Cells and Tissues. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>33</b>:6, 873-884<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/322647" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">651</p><p class="content">Diane Descamps, Vincent Calvez, Jacques Izopet, Claudine Buffet-Janvresse, Anne Schmuck, Philippe Colson, Annick Ruffault, Anne Maillard, Bernard Masquelier, Jacqueline Cottalorda, Martine Harzic, Françoise Brun-Vézinet, Dominique Costagliola.  (2001) Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:14, 1777-1782<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200109280-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">652</p><p class="content">David D. Celentano, Noya Galai, Ajay K. Sethi, Nina G. Shah, Steffanie A. Strathdee, David Vlahov, Joel E. Gallant.  (2001) Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:13, 1707-1715<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200109070-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">653</p><p class="content">Luciléia Teixeira, Hernan Valdez, Joseph M. McCune, Richard A. Koup, Andrew D. Badley, Marc K. Hellerstein, Laura A. Napolitano, Daniel C. Douek, Georgina Mbisa, Steven Deeks, Jeffrey M. Harris, Jason D. Barbour, Barry H. Gross, Isaac R. Francis, Robert Halvorsen, Robert Asaad, Michael M. Lederman.  (2001) Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:14, 1749-1756<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200109280-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">654</p><p class="content">Smita A. Ghanekar, Sharon A. Stranford, June C. Ong, Joshua M. Walker, Vernon C. Maino, Jay A. Levy.  (2001) Decreased HIV-specific CD4 T cell proliferation in long-term HIV-infected individuals on antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:14, 1885-1887<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200109280-00021" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">655</p><p class="content">Joel Witter.  (2001) Primary Care of the HIV-Infected Patient. <i><span class="NLM_source">Primary Care Case Reviews</span></i> <b>4</b>:3, 142-153<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00129300-200109000-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">656</p><p class="content">John A. Fleishman, Fred J. Hellinger.  (2001) Trends in HIV-Related Inpatient Admissions From 1993 to 1997: A Seven-State Study. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>28</b>:1, 73-80<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200109010-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">657</p><p class="content">James G. Kahn, Brain Haile, Jennifer Kates, Sophia Chang.  (2001) Health and Federal Budgetary Effects of Increasing Access to Antiretroviral Medications for HIV by Expanding Medicaid. <i><span class="NLM_source">American Journal of Public Health</span></i> <b>91</b>:9, 1464-1473<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2105/AJPH.91.9.1464" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">658</p><p class="content">Maria Dorrucci, Patrizio Pezzotti, Benvenuto Grisorio, Cristina Minardi, M. Stella Muro, Vincenzo Vullo, Antonella d'Arminio Monforte.  (2001) Time to discontinuation of the first highly active antiretroviral therapy regimen: a comparison between protease inhibitor- and non-nucleoside reverse transcriptase inhibitor-containing regimens. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:13, 1733-1736<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200109070-00020" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">659</p><p class="content">Edward Lew, Laura Gallagher, Matthew Kuehnert, David Rimland, Marjorie Hubbard, Bharat Parekh, Elisabeth Zell, William Jarvis, Janine Jason.  (2001) Intracellular cytokines in the acute response to highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:13, 1665-1670<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200109070-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">660</p><p class="content">Robert J Essey, Brenda R McDougall, W.Edward Robinson.  (2001) Mismatched double-stranded RNA (polyI-polyC12U) is synergistic with multiple anti-HIV drugs and is active against drug-sensitive and drug-resistant HIV-1 in vitro. <i><span class="NLM_source">Antiviral Research</span></i> <b>51</b>:3, 189-202<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(01)00150-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">661</p><p class="content">Bruce R. Schackman, Sue J. Goldie, Milton C. Weinstein, Elena Losina, Hong Zhang, Kenneth A. Freedberg.  (2001) Cost-Effectiveness of Earlier Initiation of Antiretroviral Therapy for Uninsured HIV-Infected Adults. <i><span class="NLM_source">American Journal of Public Health</span></i> <b>91</b>:9, 1456-1463<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2105/AJPH.91.9.1456" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">662</p><p class="content"> Albrecht ,  Mary A. ,  Bosch ,  Ronald J. ,  Hammer ,  Scott M. ,  Liou ,  Song-Heng ,  Kessler ,  Harold ,  Para ,  Michael F. ,  Eron ,  Joseph ,  Valdez ,  Hernan ,  Dehlinger ,  Marjorie ,  Katzenstein ,  David A. , .  (2001) Nelfinavir, Efavirenz, or Both after the Failure of Nucleoside Treatment of HIV Infection. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>345</b>:6, 398-407<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM200108093450602">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM200108093450602} --></span></p></li><li class="odd"><p class="number">663</p><p class="content">Esteban Martínez, Mireia Arnedo, Vicente Giner, Cristina Gil, Miguel Caballero, Llòcia Alós, Felipe García, Christopher Holtzer, Josep Mallolas, José M. Miró, Tomás Pumarola, José M. Gatell.  (2001) Lymphoid tissue viral burden and duration of viral suppression in plasma. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:12, 1477-1482<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200108170-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">664</p><p class="content">David Rey, Marie-Paule Schmitt, Marialuisa Partisani, Georgette Hess-Kempf, Véronique Krantz, Erik de Mautort, Claudine Bernard-Henry, Michéle Priester, Christine Cheneau, Jean-Marie Lang.  (2001) Efavirenz as a Substitute for Protease Inhibitors in HIV-1–Infected Patients With Undetectable Plasma Viral Load on HAART: A Median Follow-Up of 64 Weeks. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>27</b>:5, 459-462<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200108150-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">665</p><p class="content">Paul M. Coplan, Alexander A. Nikas, Randi Y. Leavitt, Louise Doll, Michael L. Nessly, Mark J. DiNubile, Harry A. Guess.  (2001) Indinavir did not increase the short-term risk of adverse cardiovascular events relative to nucleoside reverse transcriptase inhibitor therapy in four phase III clinical trials. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:12, 1584-1586<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200108170-00020" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">666</p><p class="content">Philippa J. Easterbrook, Roger Newson, Natalie Ives, Scott Pereira, Graeme Moyle, Brian G. Gazzard.  (2001) Comparison of Virologic, Immunologic, and Clinical Response to Five Different Initial Protease Inhibitor-Containing and Nevirapine-Containing Regimens. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>27</b>:4, 350-364<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200108010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">667</p><p class="content">Philippa J. Easterbrook, Roger Newson, Natalie Ives, Scott Pereira, Graeme Moyle, Brian G. Gazzard.  (2001) Comparison of Virologic, Immunologic, and Clinical Response to Five Different Initial Protease Inhibitor-Containing and Nevirapine-Containing Regimens. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>27</b>:4, 350-364<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200108010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">668</p><p class="content">Nathan Clumeck, Frank Goebel, Willy Rozenbaum, Jan Gerstoft, Schlomo Staszewski, Julio Montaner, Margaret Johnson, Brian Gazzard, Chris Stone, Rayma Athisegaran, Sarah Moore.  (2001) Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:12, 1517-1526<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200108170-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">669</p><p class="content">David Rey, Marie-Paule Schmitt, Marialuisa Partisani, Georgette Hess-Kempf, Véronique Krantz, Erik de Mautort, Claudine Bernard-Henry, Michéle Priester, Christine Cheneau, Jean-Marie Lang.  (2001) Efavirenz as a Substitute for Protease Inhibitors in HIV-1–Infected Patients With Undetectable Plasma Viral Load on HAART: A Median Follow-Up of 64 Weeks. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>27</b>:5, 459-462<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200108150-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">670</p><p class="content">Sue J. Goldie, Kenneth A. Freedberg, Milton C. Weinstein, Thomas C. Wright, Karen M. Kuntz.  (2001) Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus. <i><span class="NLM_source">The American Journal of Medicine</span></i> <b>111</b>:2, 140-149<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0002-9343(01)00780-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">671</p><p class="content">Jerome H. Kim, John R. Mascola, Silvia Ratto-Kim, Thomas C. VanCott, Lawrence Loomis-Price, Josephine H. Cox, Nelson L. Michael, Linda Jagodzinski, Clifton Hawkes, Douglas Mayers, Bruce L. Gilliam, Deborah C. Birx, Merlin L. Robb.  (2001) Selective Increases in HIV-Specific Neutralizing Antibody and Partial Reconstitution of Cellular Immune Responses during Prolonged, Successful Drug Therapy of HIV Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>17</b>:11, 1021-1034<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922201300343708" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">672</p><p class="content">Nadine D. Mathiot, Romano Krueger, Martyn A. French, Patricia Price.  (2001) Percentage of CD3
              <sup>+</sup>
              CD4
              <sup>-</sup>
              CD8
              <sup>-</sup>
              <i>γδ</i>
              TCR
              <sup>-</sup>
              T Cells Is Increased by HIV Disease. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>17</b>:10, 977-980<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922201750290096" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">673</p><p class="content">Rino Bellocco, Marcello Pagano.  (2001) Multinomial analysis of smoothed HIV back-calculation models incorporating uncertainty in the AIDS incidence. <i><span class="NLM_source">Statistics in Medicine</span></i> <b>20</b>:13, 2017-2033<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/sim.818" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">674</p><p class="content">Larry Mole, Don Schmidgall, Mark Holodniy.  (2001) A Pilot Trial of Indinavir, Ritonavir, Didanosine, and Lamivudine in a Once-Daily Four-Drug Regimen for HIV Infection. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>27</b>:3, 260-265<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200107010-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">675</p><p class="content">E. Herrero Mart<img src="untitled" alt="" class="entityD">nez.  (2001) Hepatitis B and hepatitis C co-infection in patients with HIV. <i><span class="NLM_source">Reviews in Medical Virology</span></i> <b>11</b>:4, 253-270<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/rmv.323" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">676</p><p class="content">Lynda&nbsp;Anne Szczech.  (2001) Renal Diseases Associated with Human Immunodeficiency Virus Infection: Epidemiology, Clinical Course, and Management. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>33</b>:1, 115-119<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/320893" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">677</p><p class="content">Roger J. Pomerantz.  (2001) Residual HIV-1 infection during antiretroviral therapy: the challenge of viral persistence. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:10, 1201-1211<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200107060-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">678</p><p class="content">Ralph A. DeMasi, Neil M. Graham, Jerry M. Tolson, Sissi V. Pham, George A. Capuano, Robin L. Fisher, Mark S. Shaefer, Gary E. Pakes, Gosford A. Sawyerr, Joseph J. Eron.  (2001) Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome. <i><span class="NLM_source">Advances in Therapy</span></i> <b>18</b>:4, 163-173<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02850110" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">679</p><p class="content">Larry Mole, Don Schmidgall, Mark Holodniy.  (2001) A Pilot Trial of Indinavir, Ritonavir, Didanosine, and Lamivudine in a Once-Daily Four-Drug Regimen for HIV Infection. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>27</b>:3, 260-265<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200107010-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">680</p><p class="content">Xuechun Zhang, Nouri Neamati, Young K Lee, Ann Orr, Ryan D Brown, Noel Whitaker, Yves Pommier, Terrence R Burke.  (2001) Arylisothiocyanate-Containing esters of caffeic acid designed as affinity ligands for HIV-1 integrase. <i><span class="NLM_source">Bioorganic &amp; Medicinal Chemistry</span></i> <b>9</b>:7, 1649-1657<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0968-0896(01)00075-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">681</p><p class="content">C.S. Rabkin.  (2001) AIDS and cancer in the era of highly active antiretroviral therapy (HAART). <i><span class="NLM_source">European Journal of Cancer</span></i> <b>37</b>:10, 1316-1319<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0959-8049(01)00104-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">682</p><p class="content"> Sepkowitz ,  Kent A. , .  (2001) AIDS — The First 20 Years. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>344</b>:23, 1764-1772<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM200106073442306">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM200106073442306} --></span></p></li><li class="odd"><p class="number">683</p><p class="content">Chaiwat Ungsedhapand, Eugene D. M. B. Kroon, Surapol Suwanagool, Kiat Ruxrungtham, Nongluk Yimsuan, Areerat Sonjai, Sasiwimol Ubolyam, Supranee Buranapraditkun, Surapee Tiengrim, Nadine Pakker, Chaiyos Kunanusont, Joep M. A. Lange, David A. Cooper, Praphan Phanuphak.  (2001) A Randomized, Open-Label, Comparative Trial of Zidovudine Plus Lamivudine Versus Zidovudine Plus Lamivudine Plus Didanosine in Antiretroviral-Naive HIV-1–Infected Thai Patients. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>27</b>:2, 116-123<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200106010-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">684</p><p class="content">M. Savès, P. Morlat, G. Chêne, E. Peuchant, I. Pellegrin, F. Bonnet, N. Bernard, D. Lacoste, R. Salamon, J. Beylot.  (2001) Prognostic Value of Plasma Markers of Immune Activation in Patients with Advanced HIV Disease Treated by Combination Antiretroviral Therapy. <i><span class="NLM_source">Clinical Immunology</span></i> <b>99</b>:3, 347-352<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/clim.2001.5033" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">685</p><p class="content">Sheryl L. Catz, Karen L. Meredith, Linda M. Mundy.  (2001) Women's HIV Transmission Risk Perceptions and Behaviors in the Era of Potent Antiretroviral Therapies. <i><span class="NLM_source">AIDS Education and Prevention</span></i> <b>13</b>:3, 239-251<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1521/aeap.13.3.239.19746" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">686</p><p class="content">Julie Johanson, Klara Abravaya, William Caminiti, Dwight Erickson, Richard Flanders, Gregor Leckie, Eve Marshall, Carolyn Mullen, Yoshihiro Ohhashi, Robert Perry, Julie Ricci, John Salituro, Andrea Smith, Ning Tang, Marilyn Vi, John Robinson.  (2001) A new ultrasensitive assay for quantitation of HIV-1 RNA in plasma. <i><span class="NLM_source">Journal of Virological Methods</span></i> <b>95</b>:1-2, 81-92<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-0934(01)00297-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">687</p><p class="content">Chaiwat Ungsedhapand, Eugene D. M. B. Kroon, Surapol Suwanagool, Kiat Ruxrungtham, Nongluk Yimsuan, Areerat Sonjai, Sasiwimol Ubolyam, Supranee Buranapraditkun, Surapee Tiengrim, Nadine Pakker, Chaiyos Kunanusont, Joep M. A. Lange, David A. Cooper, Praphan Phanuphak.  (2001) A Randomized, Open-Label, Comparative Trial of Zidovudine Plus Lamivudine Versus Zidovudine Plus Lamivudine Plus Didanosine in Antiretroviral-Naive HIV-1–Infected Thai Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>27</b>:2, 116-123<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200106010-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">688</p><p class="content">Valerie E. Stone, Fadi F. Mansourati, Roy M. Poses, Kenneth H. Mayer.  (2001) Relation of Physician Specialty and HIV/AIDS Experience to Choice of Guideline-Recommended Antiretroviral Therapy*. <i><span class="NLM_source">Journal of General Internal Medicine</span></i> <b>16</b>:6, 360-368<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1525-1497.2001.016006360.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">689</p><p class="content">Azra C. Ghani, William E. Henley, Christl A. Donnelly, Steven Mayer, Roy M. Anderson.  (2001) Comparison of the effectiveness of non-nucleoside reverse transcriptase inhibitor-containing and protease inhibitor-containing regimens using observational databases. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:9, 1133-1142<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200106150-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">690</p><p class="content">Pere Domingo, Olga H Torres, Josep Ris, Guillermo Vazquez.  (2001) Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection. <i><span class="NLM_source">The American Journal of Medicine</span></i> <b>110</b>:8, 605-609<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0002-9343(01)00703-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">691</p><p class="content">Robert W Ross, Mary E Wright, Jorge A Tavel.  (2001) Ongoing trials of immune-based therapies for HIV infection in adults. <i><span class="NLM_source">Expert Opinion on Biological Therapy</span></i> <b>1</b>:3, 413-424<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/14712598.1.3.413" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">692</p><p class="content">Barbara J. Turner, Daozhi Zhang, Christine Laine, Roger J. Pomerantz, Leon Cosler, Walter W. Hauck.  (2001) Association of Provider and Patient Characteristics With HIV-Infected Women's Antiretroviral Therapy Regimen. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>27</b>:1, 20-29<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200105010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">693</p><p class="content">Barbara J. Turner, Daozhi Zhang, Christine Laine, Roger J. Pomerantz, Leon Cosler, Walter W. Hauck.  (2001) Association of Provider and Patient Characteristics With HIV-Infected Women's Antiretroviral Therapy Regimen. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>27</b>:1, 20-29<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200105010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">694</p><p class="content">Ole Kirk, Amanda Mocroft, Christian Pradier, Johan N. Bruun, Robert Hemmer, Bonaventura Clotet, Veronica Miller, Jean-Paul Viard, Andrew N. Phillips, Jens D. Lundgren.  (2001) Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:8, 999-1008<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200105250-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">695</p><p class="content">Brian M. Sadler, Peter J. Piliero, Sandra L. Preston, Peggy P. Lloyd, Yu Lou, Daniel S. Stein.  (2001) Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:8, 1009-1018<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200105250-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">696</p><p class="content">Philip Keiser, Naiel Nassar, Mary Beth Kvanli, Dianna Turner, James W. Smith, Daniel Skiest.  (2001) Long-Term Impact of Highly Active Antiretroviral Therapy on HIV-Related Health Care Costs. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>27</b>:1, 14-19<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200105010-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">697</p><p class="content">Paul C. Kuo, Peter G. Stock.  (2001) Transplantation in the HIV+ Patient. <i><span class="NLM_source">American Journal of Transplantation</span></i> <b>1</b>:1, 13-17<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1034/j.1600-6143.2001.010104.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">698</p><p class="content">Katharina Maria Huster, Frank-D. Goebel.  (2001) Die Bedeutung der HIV-Proteaseinhibitoren in der Kombinationstherapie: Gute, allerdings nebenwirkungsreiche Medikamente. <i><span class="NLM_source">Pharmazie  in unserer Zeit</span></i> <b>30</b>:3, 217-220<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/1615-1003(200105)30:3&amp;lt;217::AID-PAUZ217&amp;gt;3.0.CO;2-P" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">699</p><p class="content"> (2001) Use of antiretroviral therapies among HIV-infected men who have sex with men: a household-based sample of 4 major American cities. <i><span class="NLM_source">American Journal of Public Health</span></i> <b>91</b>:5, 767-773<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2105/AJPH.91.5.767" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">700</p><p class="content">Philip Keiser, Naiel Nassar, Mary Beth Kvanli, Dianna Turner, James W. Smith, Daniel Skiest.  (2001) Long-Term Impact of Highly Active Antiretroviral Therapy on HIV-Related Health Care Costs. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>27</b>:1, 14-19<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200105010-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">701</p><p class="content">Marina Núñez, Rafael Rodríguez-Rosado, Vincent Soriano.  (2001) Intensification of Antiretroviral Therapy. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>17</b>:6, 499-506<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/08892220151126544" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">702</p><p class="content">Terence L. Chorba, Robert C. Holman, Matthew J. Clarke, Bruce L. Evatt.  (2001) Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States. <i><span class="NLM_source">American Journal of Hematology</span></i> <b>66</b>:4, 229-240<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/ajh.1050" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">703</p><p class="content">Rhonda G. Kost, Arlene Hurley, Linqi Zhang, Mika Vesanen, Andrew Talal, Scott Furlan, Paul Caldwell, Judy Johnson, Lynn Smiley, David Ho, Martin Markowitz.  (2001) Open-Label Phase II Trial of Amprenavir, Abacavir, and Fixed-Dose Zidovudine/Lamivudine in Newly and Chronically HIV-1–Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>26</b>:4, 332-339<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200104010-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">704</p><p class="content">Heidemarie Pernerstorfer-Schoen, Bernd Jilma, Alina Perschler, Sibylle Wichlas, Karin Schindler, Andreas Schindl, Armin Rieger, Oswald F. Wagner, Peter Quehenberger.  (2001) Sex differences in HAART-associated dyslipidaemia. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:6, 725-734<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200104130-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">705</p><p class="content">Patrizio Pezzotti, Marilena Pappagallo, Andrew N. Phillips, Stefano Boros, Catia Valdarchi, Alessandro Sinicco, Mauro Zaccarelli, Giovanni Rezza.  (2001) Response to Highly Active Antiretroviral Therapy According to Duration of HIV Infection. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>26</b>:5, 473-479<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200104150-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">706</p><p class="content">Hernando Knobel, Ana Guelar, Alexia Carmona, Mercedes Espona, Alicia González, José L. López-Colomés, Pedro Saballs, Juan L. Gimeno, Adolfo Díez.  (2001) Virologic Outcome and Predictors of Virologic Failure of Highly Active Antiretroviral Therapy Containing Protease Inhibitors. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>15</b>:4, 193-199<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/10872910151133729" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">707</p><p class="content">Christiane Adjé, Rachanee Cheingsong, Thierry H. Roels, Chantal Maurice, Gaston Djomand, Werner Verbiest, Kurt Hertogs, Brendan Larder, Ben Monga, Martine Peeters, Serge Eholie, Emmanuel Bissagene, Makan Coulibaly, Richard Respess, Stefan Z. Wiktor, Terence Chorba, John N. Nkengasong.  (2001) High Prevalence of Genotypic and Phenotypic HIV-1 Drug-Resistant Strains Among Patients Receiving Antiretroviral Therapy in Abidjan, Côte d'Ivoire. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>26</b>:5, 501-506<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200104150-00018" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">708</p><p class="content">Christiane Adjé, Rachanee Cheingsong, Thierry H. Roels, Chantal Maurice, Gaston Djomand, Werner Verbiest, Kurt Hertogs, Brendan Larder, Ben Monga, Martine Peeters, Serge Eholie, Emmanuel Bissagene, Makan Coulibaly, Richard Respess, Stefan Z. Wiktor, Terence Chorba, John N. Nkengasong.  (2001) High Prevalence of Genotypic and Phenotypic HIV-1 Drug-Resistant Strains Among Patients Receiving Antiretroviral Therapy in Abidjan, Côte d'Ivoire. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>26</b>:5, 501-506<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200104150-00018" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">709</p><p class="content">De Smith, J Bell, M Johnson, M Youle, B Gazzard, S Tchamouroff, G Frechette, W Schlech, S Miller, D Spencer, W Seifert, M Peeters, K De Beule.  (2001) A randomized, double-blind, placebo-controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection. <i><span class="NLM_source">HIV Medicine</span></i> <b>2</b>:2, 78-83<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2001.00060.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">710</p><p class="content">Rhonda G. Kost, Arlene Hurley, Linqi Zhang, Mika Vesanen, Andrew Talal, Scott Furlan, Paul Caldwell, Judy Johnson, Lynn Smiley, David Ho, Martin Markowitz.  (2001) Open-Label Phase II Trial of Amprenavir, Abacavir, and Fixed-Dose Zidovudine/Lamivudine in Newly and Chronically HIV-1–Infected Patients. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>26</b>:4, 332-339<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200104010-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">711</p><p class="content">Patrizio Pezzotti, Marilena Pappagallo, Andrew N. Phillips, Stefano Boros, Catia Valdarchi, Alessandro Sinicco, Mauro Zaccarelli, Giovanni Rezza.  (2001) Response to Highly Active Antiretroviral Therapy According to Duration of HIV Infection. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>26</b>:5, 473-479<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200104150-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">712</p><p class="content">Traci E. Yamashita, John P. Phair, Alvaro Muñoz, Joseph B. Margolick, Roger Detels, Stephen J. O'Brien, John W. Mellors, Steven M. Wolinsky, Lisa P. Jacobson.  (2001) Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:6, 735-746<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200104130-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">713</p><p class="content">B. Gröschel, A. Kaufmann, J. Cinatl, H. W. Doerr.  (2001) CYTARABINE TREATMENT OF HUMAN T-LYMPHOID CELLS INDUCES DECREASED HIV-1 RECEPTOR EXPRESSION AND REDUCED HIV-1 SUSCEPTIBILITY. <i><span class="NLM_source">Nucleosides, Nucleotides and Nucleic Acids</span></i> <b>20</b>:4-7, 1433-1437<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1081/NCN-100002571" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">714</p><p class="content">B. Gröschel, G. Höver, H. W. Doerr, J. Cinatl.  (2001) ZIDOVUDINE (AZT) RESISTANCE IN H9 CELLS DUE TO DECREASED TK EXPRESSION IS ASSOCIATED WITH HYPERMETHYLATION OF TK GENE. <i><span class="NLM_source">Nucleosides, Nucleotides and Nucleic Acids</span></i> <b>20</b>:4-7, 487-492<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1081/NCN-100002323" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">715</p><p class="content"> Freedberg ,  Kenneth A. ,  Losina ,  Elena ,  Weinstein ,  Milton C. ,  Paltiel ,  A. David ,  Cohen ,  Calvin J. ,  Seage ,  George R. ,  Craven ,  Donald E. ,  Zhang ,  Hong ,  Kimmel ,  April D. ,  Goldie ,  Sue J. , .  (2001) The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>344</b>:11, 824-831<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM200103153441108">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM200103153441108} --></span></p></li><li class="even"><p class="number">716</p><p class="content">Carol A. Kemper, Mallory D. Witt, Phillip H. Keiser, Michael P. Dubé, Donald N. Forthal, Matthew Leibowitz, D. Scott Smith, Andrew Rigby, Nicholas S. Hellmann, Yolanda S. Lie, John Leedom, Douglas Richman, J. Allen McCutchan, Richard Haubrich.  (2001) Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:5, 609-615<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200103300-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">717</p><p class="content">Toshiyuki Goto, Takashi Nakano, Takehiro Kohno, Shinichi Morimatsu, Chizuko Morita, Wu Hong, Yoshiaki Kiso, Masuyo Nakai, Kouichi Sano.  (2001) Targets of a protease inhibitor, KNI-272, in HIV-1-infected cells. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>63</b>:3, 203-209<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/1096-9071(200103)63:3&amp;lt;203::AID-JMV1001&amp;gt;3.0.CO;2-F" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">718</p><p class="content">H. Aladdin, C. S. Larsen, P. Schjerling, B. K. Møller, M. R. Buhl, J Gerstoft, B.&nbsp;K. Pedersen, H. Ullum.  (2001) Effects of Subcutaneous IL-2 Therapy on Telomere Lengths in PBMC in HIV-Infected Patients. <i><span class="NLM_source">Scandinavian Journal of Immunology</span></i> <b>53</b>:3, 315-319<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-3083.2001.00876.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">719</p><p class="content">A. David Paltiel, S. J. Goldie, E. Losina, M. C. Weinstein, G. R. Seage, A. D. Kimmel, H. Zhang, K. A. Freedberg.  (2001) Preevaluation of Clinical Trial Data: The Case of Preemptive Cytomegalovirus Therapy in Patients with Human Immunodeficiency Virus. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>32</b>:5, 783-793<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/319223" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">720</p><p class="content">Veronica Miller.  (2001) Resistance to Protease Inhibitors. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i>S34-S50<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200103011-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">721</p><p class="content">Michael G. Sension, Charles Farthing, Alan G. Shaffer, Edwin Graham, Peggy Siemon-Hryczyk, Robert S. Pilson.  (2001) Challenges of Antiretroviral Treatment in Transient and Drug-Using Populations: The SUN Study. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>15</b>:3, 129-136<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/108729101750123580" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">722</p><p class="content">Mary E. Temple, Katalin I. Koranyi, Milap C. Nahata.  (2001) The Safety and Antiviral Effect of Protease Inhibitors in Children. <i><span class="NLM_source">Pharmacotherapy</span></i> <b>21</b>:3, 287-294<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1592/phco.21.3.287.34202" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">723</p><p class="content">Veronica Miller.  (2001) Resistance to Protease Inhibitors. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>26</b>, S34-S50<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200103011-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">724</p><p class="content">Clive Loveday.  (2001) Nucleoside Reverse Transcriptase Inhibitor Resistance. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>26</b>, S10-S24<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200103011-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">725</p><p class="content">Clive Loveday.  (2001) Nucleoside Reverse Transcriptase Inhibitor Resistance. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i>S10-S24<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200103011-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">726</p><p class="content">Pablo Tebas, Keith Henry, Robert Nease, Robert Murphy, John Phair, William G. Powderly.  (2001) Timing of antiretroviral therapy. Use of Markov modeling and decision analysis to evaluate the long-term implications of therapy. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:5, 591-599<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200103300-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">727</p><p class="content">Jose-Tomas Navarro, Josep-Maria Ribera, Albert Oriol, Manuel Vaquero, Joan Romeu, Montserrat Batlle, Alonso Flores, Fuensanta Milla, Evarist Feliu.  (2001) Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone. <i><span class="NLM_source">British Journal of Haematology</span></i> <b>112</b>:4, 909-915<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2141.2001.02656.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">728</p><p class="content">Inez C. J. van der Sandt, Catherine M. P. Vos, Lobna Nabulsi, Margret C. M. Blom-Roosemalen, Heleen H. Voorwinden, Albertus G. de Boer, Douwe D. Breimer.  (2001) Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood???brain barrier. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:4, 483-491<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200103090-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">729</p><p class="content">R. de la Rosa, J. A. Pineda, J. Delgado, J. Macias, F. Morillas, J. Martin-Sanchez, M. Leal, A. Sanchez-Quijano, E. Lissen.  (2001) Influence of Highly Active Antiretroviral Therapy on the Outcome of Subclinical Visceral Leishmaniasis in Human Immunodeficiency Virus-Infected Patients. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>32</b>:4, 633-635<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/318708" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">730</p><p class="content">Sean Philpott, Barbara Weiser, Kathryn Anastos, Christina Michelle Ramirez Kitchen, Esther Robison, William A. Meyer, Henry S. Sacks, Usha Mathur-Wagh, Cheryl Brunner, Harold Burger.  (2001) Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy. <i><span class="NLM_source">Journal of Clinical Investigation</span></i> <b>107</b>:4, 431-438<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1172/JCI11526" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">731</p><p class="content">Christian M. Leutenegger, Joanne Higgins, Timothy B. Matthews, Alice F. Tarantal, Paul A. Luciw, Niels C. Pedersen, Thomas W. North.  (2001) Real-Time TaqMan PCR as a Specific and More Sensitive Alternative to the Branched-Chain DNA Assay for Quantitation of Simian Immunodeficiency Virus RNA. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>17</b>:3, 243-251<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922201750063160" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">732</p><p class="content">Manuel Battegay.  (2001) Critical issues of HIV treatment in the era of highly active antiretroviral therapy. <i><span class="NLM_source">Expert Opinion on Investigational Drugs</span></i> <b>10</b>:2, 175-183<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/13543784.10.2.175" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">733</p><p class="content">Patricia Price, Niamh M Keane, Shelley F Stone, Karey Y.M Cheong, Martyn A French.  (2001) MHC haplotypes affect the expression of opportunistic infections in HIV patients. <i><span class="NLM_source">Human Immunology</span></i> <b>62</b>:2, 157-164<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0198-8859(00)00239-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">734</p><p class="content">Mark E. Sharkey, Mario Stevenson.  (2001) Two long terminal repeat circles and persistent HIV-1 replication. <i><span class="NLM_source">Current Opinion in Infectious Diseases</span></i> <b>14</b>:1, 5-11<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00001432-200102000-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">735</p><p class="content"> (2001) An Open-Label Randomized Trial to Evaluate Different Therapeutic Strategies of Combination Therapy in HIV-1 Infection Design, Rationale, and Methods of the Initio Trial. <i><span class="NLM_source">Controlled Clinical Trials</span></i> <b>22</b>:2, 160-175<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0197-2456(00)00123-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">736</p><p class="content">A d’Arminio Monforte, F Adorni, L Meroni, T Bini, L Testa, E Chiesa, S Melzi, S Rusconi, S Sollima, M Galli, M Moroni.  (2001) Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimen. <i><span class="NLM_source">Biomedicine &amp; Pharmacotherapy</span></i> <b>55</b>:1, 16-22<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0753-3322(00)00017-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">737</p><p class="content">D Feigal.  (2001) Who's on First? What's on Second?. <i><span class="NLM_source">Controlled Clinical Trials</span></i> <b>22</b>:2, 139-141<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0197-2456(01)00115-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">738</p><p class="content">Julio Collazos, Jose Mayo, Eduardo Martinez.  (2001) The Evolving Mode of Presentation of HIV-Infected Patients to Health Services of Northern Spain: 1985 through December 1999. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>15</b>:2, 67-71<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/108729101300003654" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">739</p><p class="content">R.J Pomerantz.  (2001) Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. <i><span class="NLM_source">Biomedicine &amp; Pharmacotherapy</span></i> <b>55</b>:1, 7-15<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0753-3322(00)00016-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">740</p><p class="content">Koyu Hara, Mayumi Shiota, Hiroshi Kido, Yasushi Ohtsu, Takahito Kashiwagi, Jun Iwahashi, Nobuyuki Hamada, Kazutoshi Mizoue, Naoki Tsumura, Hirohisa Kato, Tetsuya Toyoda.  (2001) Influenza virus RNA polymerase PA subunit is a novel serine protease with Ser624 at the active site. <i><span class="NLM_source">Genes to Cells</span></i> <b>6</b>:2, 87-97<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2443.2001.00399.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">741</p><p class="content">Roger Detels, Patrick Tarwater, John P. Phair, Joseph Margolick, Sharon A. Riddler, Alvaro Mu??oz.  (2001) Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:3, 347-355<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200102160-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">742</p><p class="content">R. Pat Bucy, J. Michael Kilby.  (2001) Perspectives on inducing efficient immune control of HIV-1 replication - a new goal for HIV therapeutics?. <i><span class="NLM_source">AIDS</span></i> <b>15</b>, S36-S42<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200102002-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">743</p><p class="content">Rodger D MacArthur, Li Chen, Douglas L Mayers, C.Lynn Besch, Richard Novak, Mary van den Berg-Wolf, Teresa Yurik, Grace Peng, Barry Schmetter, Barbara Brizz, Donald Abrams.  (2001) The Rationale and Design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) Trial. <i><span class="NLM_source">Controlled Clinical Trials</span></i> <b>22</b>:2, 176-190<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0197-2456(01)00111-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">744</p><p class="content">Laura M Smeaton, Victor DeGruttola, Gregory K Robbins, Robert W Shafer.  (2001) ACTG (AIDS Clinical Trials Group) 384. <i><span class="NLM_source">Controlled Clinical Trials</span></i> <b>22</b>:2, 142-159<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0197-2456(00)00126-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">745</p><p class="content">Gilbert R. Kaufmann, John Zaunders, John Murray, Anthony D. Kelleher, Sharon R. Lewin, Ajantha Solomon, Don Smith, David A. Cooper.  (2001) Relative Significance of Different Pathways of Immune Reconstitution in HIV Type 1 Infection as Estimated by Mathematical Modeling. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>17</b>:2, 147-159<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/08892220150217238" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">746</p><p class="content">M. Narita, J. J. Stambaugh, E. S. Hollender, A. E. Pitchenik, D. Ashkin.  (2001) Reply. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>32</b>:2, 323-323<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/318466" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">747</p><p class="content">Teri J. Liegler, Matthew S. Hayden, Kok H. Lee, Rebecca Hoh, Steven G. Deeks, Robert M. Grant.  (2001) Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytes. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:2, 179-184<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200101260-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">748</p><p class="content">Greg L. Plosker, Caroline M. Perry, Karen L. Goa.  (2001) Efavirenz. <i><span class="NLM_source">PharmacoEconomics</span></i> <b>19</b>:4, 421-436<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00019053-200119040-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">749</p><p class="content">Ah Miners, Ca Sabin, P Trueman, M Youle, A Mocroft, M Johnson, Ej Beck.  (2001) Assessing the cost-effectiveness of HAART for adults with HIV in England. <i><span class="NLM_source">HIV Medicine</span></i> <b>2</b>:1, 52-58<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2001.00048.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">750</p><p class="content">Amanda Mocroft, Michael Youle, Antonia Moore, Caroline A. Sabin, Sara Madge, Alessandro Cozzi Lepri, Mervyn Tyrer, Clinton Chaloner, Debbie Wilson, Clive Loveday, Margaret A. Johnson, Andrew N. Phillips.  (2001) Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:2, 185-194<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200101260-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">751</p><p class="content">Katherine V. Heath, Robert S. Hogg, Keith J. Chan, Marianne Harris, Valerie Montessori, Michael V. O'Shaughnessy, Julio S. G. Montaner.  (2001) Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:2, 231-239<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200101260-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">752</p><p class="content">P Bossi, V Martinez, C Strady, F Bricaire.  (2001) Actualités sur les traitements antirétroviraux. <i><span class="NLM_source">La Revue de Médecine Interne</span></i> <b>22</b>:1, 42-52<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0248-8663(00)00284-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">753</p><p class="content">Michael J. Green, Steven Fong, David T. Mauger, Peter A. Ubel.  (2001) Rationing HIV Medications: What Do Patients and the Public Think About Allocation Policies?. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>26</b>:1, 56-62<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200101010-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">754</p><p class="content">John R Brechtl, William Breitbart, Michelle Galietta, Suzanne Krivo, Barry Rosenfeld.  (2001) The Use of Highly Active Antiretroviral Therapy (HAART) in Patients With Advanced HIV Infection. <i><span class="NLM_source">Journal of Pain and Symptom Management</span></i> <b>21</b>:1, 41-51<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0885-3924(00)00245-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">755</p><p class="content">Michael J. Green, Steven Fong, David T. Mauger, Peter A. Ubel.  (2001) Rationing HIV Medications: What Do Patients and the Public Think About Allocation Policies?. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>26</b>:1, 56-62<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200101010-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">756</p><p class="content">Robert L. Murphy, Scott Brun, Charles Hicks, Joseph J. Eron, Roy Gulick, Martin King, A. Clinton White, Constance Benson, Melanie Thompson, Harold A. Kessler, Scott Hammer, Richard Bertz, Ann Hsu, Anthony Japour, Eugene Sun.  (2001) ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:1, F1-F9<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200101050-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">757</p><p class="content">Julio S. G. Montaner, P. Richard Harrigan, Natalie Jahnke, Janet Raboud, Eliana Castillo, Robert S. Hogg, Benita Yip, Marianne Harris, Val Montessori, Michael V. O'Shaughnessy.  (2001) Multiple drug rescue therapy for HIV-infected individuals with prior virologic failure to multiple regimens. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:1, 61-69<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200101050-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">758</p><p class="content">Sandra Suarez, Laurence Baril, Bruno Stankoff, Mehdi Khellaf, Bruno Dubois, Catherine Lubetzki, François Bricaire, Jean-Jacques Hauw.  (2001) Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>15</b>:2, 195-200<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200101260-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">759</p><p class="content">O Kirk, J Gerstoft, C Pedersen, H Nielsen, N Obel, Tl Katzenstein, L Mathiesen, Jd Lundgren.  (2001) Low body weight and type of protease inhibitor predict discontinuation and treatment-limiting adverse drug reactions among HIV-infected patients starting a protease inhibitor regimen: consistent results from a randomized trial and an observational cohort. <i><span class="NLM_source">HIV Medicine</span></i> <b>2</b>:1, 43-51<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2001.00045.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">760</p><p class="content">Kit Simpson, Eberhard Voit, Russell Goodman, Elinor Chumney. Estimating the social and economic benefits of pharmaceutical innovation: modeling clinical trial results in hiv disease. Emerald (MCB UP ), 2001:175-196.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0194-3960(01)14008-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">761</p><p class="content">Cynthia M. Hingtgen, Karen L. Roos. Chapter 12 Clinical Trials in Central Nervous System Infections. Elsevier, 2001:237-259.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1877-3419(09)70019-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">762</p><p class="content">J.I. Cuende.  (2001) Estudio de casos de infección por el virus de la inmunodeficiencia humana en prisiones de Castilla y León. <i><span class="NLM_source">Revista Clínica Española</span></i> <b>201</b>:5, 249-255<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0014-2565(01)70811-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">763</p><p class="content">Xabier Camino, José Antonio Iribarren, Julio Arrizabalaga, Francisco Rodríguez, Miguel Angel von Wichmann.  (2001) Causas de mortalidad de los pacientes infectados por el virus de la inmunodeficiencia humana en la era del tratamiento antirretrovírico de gran actividad. <i><span class="NLM_source">Enfermedades Infecciosas y Microbiología Clínica</span></i> <b>19</b>:2, 85-86<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0213-005X(01)72572-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">764</p><p class="content">Thomas W. Mc Closkey. Flow cytometry for evaluation and investigation of human immunodeficiency virus infection. Elsevier, 2001:567-592.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0091-679X(01)64030-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">765</p><p class="content">Joel R. Huff, James Kahn. Discovery and clinical development of HIV-1 protease inhibitors. Elsevier, 2001:213-251.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0065-3233(01)56007-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">766</p><p class="content">James E. Weiel, James M. Lenhard. Chapter 13. In vitro and in vivo approaches to studying antiretroviral therapy (ART)-induced metabolic complications. Elsevier, 2001:129-137.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0065-7743(01)36053-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">767</p><p class="content">Karen T. Tashima, Theresa C. Fiore.  (2000) Sustained Responses to Dual Nucleoside Therapy in Women. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i>371-372<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200012010-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">768</p><p class="content">Dennis C. Mynarcik, Margaret A. McNurlan, Roy T. Steigbigel, Jack Fuhrer, Marie C. Gelato.  (2000) Association of Severe Insulin Resistance With Both Loss of Limb Fat and Elevated Serum Tumor Necrosis Factor Receptor Levels in HIV Lipodystrophy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i>312-321<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200012010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">769</p><p class="content">Michael O. Rigsby, Marc I. Rosen, John E. Beauvais, Joyce A. Cramer, Petrie M. Rainey, Stephanie S. O'Malley, Kevin D. Dieckhaus, Bruce J. Rounsaville.  (2000) Cue-dose Training with Monetary Reinforcement: Pilot Study of an Antiretroviral Adherence Intervention. <i><span class="NLM_source">Journal of General Internal Medicine</span></i> <b>15</b>:12, 841-847<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1525-1497.2000.00127.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">770</p><p class="content">Karen T. Tashima, Theresa C. Fiore.  (2000) Sustained Responses to Dual Nucleoside Therapy in Women. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>25</b>:4, 371-372<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200012010-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">771</p><p class="content">Julia M. Dayton, Michael H. Merson.  (2000) GLOBAL DIMENSIONS OF THE AIDS EPIDEMIC:. <i><span class="NLM_source">Infectious Disease Clinics of North America</span></i> <b>14</b>:4, 791-808<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0891-5520(05)70134-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">772</p><p class="content">Gilbert R. Kaufmann, John J. Zaunders, Philip Cunningham, Anthony D. Kelleher, Pat Grey, Don Smith, Andrew Carr, David A. Cooper.  (2000) Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:17, 2643-2651<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200012010-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">773</p><p class="content">Michael M. Lederman, Ray McKinnis, Dennis Kelleher, Amy Cutrell, John Mellors, Mike Neisler, Elizabeth Cooney, David W. Haas, Richard Haubrich, James Stanford, James Horton, Alan Landay, William Spreen.  (2000) Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:17, 2635-2642<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200012010-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">774</p><p class="content">François Biron, Bénédicte Ponceau, Damien Bouhour, André Boibieux, Bernard Verrier, Dominique Peyramond.  (2000) Long-Term Safety and Antiretroviral Activity of Hydroxyurea and Didanosine in HIV-Infected Patients. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>25</b>:4, 329-336<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200012010-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">775</p><p class="content">Jacques Baillargeon, Michael&nbsp;J. Borucki, Stephanie Zepeda, Hal&nbsp;B. Jenson, Charles&nbsp;T. Leach.  (2000) Antiretroviral Prescribing Patterns in the Texas Prison System. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>31</b>:6, 1476-1481<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/317478" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">776</p><p class="content">Nicholas A. Kartsonis, Richard T. D'Aquila.  (2000) CLINICAL MONITORING OF HIV-1 INFECTION IN THE ERA OF ANTIRETROVIRAL RESISTANCE TESTING. <i><span class="NLM_source">Infectious Disease Clinics of North America</span></i> <b>14</b>:4, 879-899<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0891-5520(05)70138-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">777</p><p class="content">Sabine Yerly, Thomas V. Perneger, Samir Vora, Bernard Hirschel, Luc Perrin.  (2000) Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:18, 2805-2812<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200012220-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">778</p><p class="content">Elisabeth H. Gisolf, Rieneke M. E. van Praag, Suzanne Jurriaans, Peter Portegies, Jaap Goudsmit, Sven A. Danner, Joep M. A. Lange, Jan M. Prins.  (2000) Increasing Cerebrospinal Fluid Chemokine Concentrations Despite Undetectable Cerebrospinal Fluid HIV RNA in HIV-1–Infected Patients Receiving Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>25</b>:5, 426-433<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200012150-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">779</p><p class="content">A Lombardi, L Drago, M.R Bartolone, M.R Gismondo.  (2000) Cytomegalovirus pp65 antigenemia in HIV patients: retrospective on 3 years study. <i><span class="NLM_source">International Journal of Antimicrobial Agents</span></i> <b>16</b>:4, 461-462<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0924-8579(00)00275-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">780</p><p class="content">Dennis C. Mynarcik, Margaret A. McNurlan, Roy T. Steigbigel, Jack Fuhrer, Marie C. Gelato.  (2000) Association of Severe Insulin Resistance With Both Loss of Limb Fat and Elevated Serum Tumor Necrosis Factor Receptor Levels in HIV Lipodystrophy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>25</b>:4, 312-321<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200012010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">781</p><p class="content">Salvatore T. Butera.  (2000) Therapeutic targeting of human immunodeficiency virus type-1 latency: current clinical realities and future scientific possibilities. <i><span class="NLM_source">Antiviral Research</span></i> <b>48</b>:3, 143-176<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(00)00133-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">782</p><p class="content">Fran??ois Biron, B??n??dicte Ponceau, Damien Bouhour, Andr?? Boibieux, Bernard Verrier, Dominique Peyramond.  (2000) Long-Term Safety and Antiretroviral Activity of Hydroxyurea and Didanosine in HIV-Infected Patients. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i>329-336<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200012010-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">783</p><p class="content">Xiao-Jian Zhou, Diane V. Havlir, Douglas D. Richman, Edward P. Acosta, Martin Hirsch, Ann C. Collier, Pablo Tebas, Jean-Pierre Sommadossi.  (2000) Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:18, 2869-2876<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200012220-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">784</p><p class="content">Elisabeth H. Gisolf, Rieneke M. E. van Praag, Suzanne Jurriaans, Peter Portegies, Jaap Goudsmit, Sven A. Danner, Joep M. A. Lange, Jan M. Prins.  (2000) Increasing Cerebrospinal Fluid Chemokine Concentrations Despite Undetectable Cerebrospinal Fluid HIV RNA in HIV-1???Infected Patients Receiving Antiretroviral Therapy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i>426-433<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200012150-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">785</p><p class="content">Anding Shen, Janet D. Siliciano, Theodore C. Pierson, Christopher B. Buck, Robert F. Siliciano.  (2000) Establishment of Latent HIV-1 Infection of Resting CD4+ T Lymphocytes Does Not Require Inactivation of Vpr. <i><span class="NLM_source">Virology</span></i> <b>278</b>:1, 227-233<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/viro.2000.0650" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">786</p><p class="content">M. Floridia, C. Tomino, R. Bucciardini, D. Ricciardulli, V. Fragola, M. F. Pirillo, R. Amici, G. Giannini, C. M. Galluzzo, M. Andreotti, A. C. Seeber, A. Ammassari, A. Cingolani, A. Lazzarin, G. Scalise, A. Cargnel, F. Suter, F. Milazzo, G. Pastore, M. Moroni, R. Ciammarughi, R. Pini, G. Carosi, C. D'Amato, L. Contu, E. Concia, L. Bonazzi, F. Aiuti, G. Vigevani, S. Vella.  (2000) A Randomized Trial Comparing the Introduction of Ritonavir or Indinavir in 1251 Nucleoside-Experienced Patients with Advanced HIV Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:17, 1809-1820<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/08892220050195775" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">787</p><p class="content">F. Raffi, B. Bonnet, V. Ferre, J.-L. Esnault, P. Perre, V. Reliquet, S. Leautez, C. Bouillant, O. Vergnoux, P. Weinbreck.  (2000) Substitution of a Nonnucleoside Reverse Transcriptase Inhibitor for a Protease Inhibitor in the Treatment of Patients with Undetectable Plasma Human Immunodeficiency Virus Type 1 RNA. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>31</b>:5, 1274-1278<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/317424" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">788</p><p class="content">Kai Riecke, Thomas G. Schulz, Mehdi Shakibaei, Bernd Krause, Ibrahim Chahoud, Ralf Stahlmann.  (2000) Developmental toxicity of the HIV-protease inhibitor indinavir in rats. <i><span class="NLM_source">Teratology</span></i> <b>62</b>:5, 291-300<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/1096-9926(200011)62:5&amp;lt;291::AID-TERA3&amp;gt;3.0.CO;2-A" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">789</p><p class="content">Brita E. Lundberg, Arthur J. Davidson, William J. Burman.  (2000) Epidemiology of Pneumocystis carinii pneumonia in an era of effective prophylaxis: the relative contribution of non-adherence and drug failure. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:16, 2559-2566<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200011100-00019" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">790</p><p class="content">Anat R. Feingold, Richard M. Rutstein, Debrah Meislich, Teneille Brown, Bret J. Rudy.  (2000) Protease Inhibitor Therapy in HIV-Infected Children. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>14</b>:11, 589-593<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/10872910050193761" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">791</p><p class="content">Richard B. Pollard.  (2000) Didanosine once daily: potential for expanded use. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:16, 2421-2428<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200011100-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">792</p><p class="content">Hans-J??rgen Stellbrink, David A. Hawkins, Nathan Clumeck, David A. Cooper, Robert Myers, J.-F. Delfraissy, M. John Gill, Carlos Ramirez-Ronda, Stefano Vella, Miklos Salgo, Keith Bragman.  (2000) Randomised, Multicentre Phase III Study of Saquinavir plus Zidovudine plus Zalcitabine in Previously Untreated or Minimally Pretreated HIV-Infected Patients. <i><span class="NLM_source">Clinical Drug Investigation</span></i> <b>20</b>:5, 295-307<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00044011-200020050-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">793</p><p class="content">Raffaella Bucciardini, Albert W. Wu, Marco Floridia, Vincenzo Fragola, Daniela Ricciardulli, Carlo Tomino, Liliana E. Weimer, Maria F. Pirillo, Marco Mirra, Massimo Marzi, Giacomo Giannini, Clementina M. Galluzzo, Mauro Andreotti, Maurizio Massella, Stefano Vella.  (2000) Quality of life outcomes of combination zidovudine???didanosine???nevirapine and zidovudine???didanosine for antiretroviral-naive advanced HIV-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:16, 2567-2574<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200011100-00020" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">794</p><p class="content">Felipe Garc??a, Hernando Knobel, Maria Antonia Sambeat, Julio Arrizabalaga, Miquel Aranda, Joan Romeu, David Dalmau, Ferran Segura, Juan Luis Gomez-Sirvent, Elena Ferrer, Anna Cruceta, Teresa Gallart, Tomas Pumarola, Jose M Mir??, Jose M Gatell.  (2000) Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan Study. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:16, 2485-2494<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200011100-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">795</p><p class="content">David W. Haas, Lisa A. Clough, Benjamin W. Johnson, Victoria L. Harris, Paul Spearman, Grant R. Wilkinson, Courtney V. Fletcher, Susan Fiscus, Stephen Raffanti, Ruth Donlon, Judy McKinsey, Janet Nicotera, Dennis Schmidt, Ronald E. Shoup, Robert E. Kates, Robert M. Lloyd, Brendan Larder.  (2000) Evidence of a Source of HIV Type 1 within the Central Nervous System by Ultraintensive Sampling of Cerebrospinal Fluid and Plasma. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:15, 1491-1502<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922200750006010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">796</p><p class="content">Thomas J. Birk, Angele McGrady, Rodger D. MacArthur, Sadik Khuder.  (2000) The Effects of Massage Therapy Alone and in Combination with Other Complementary Therapies on Immune System Measures and Quality of Life in Human Immunodeficiency Virus. <i><span class="NLM_source">The Journal of Alternative and Complementary Medicine</span></i> <b>6</b>:5, 405-414<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/acm.2000.6.405" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">797</p><p class="content">Neil M. Graham.  (2000) Metabolic Disorders Among HIV-Infected Patients Treated With Protease Inhibitors: A Review. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>25</b>, S4-S11<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200010001-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">798</p><p class="content">Pierre‐Marie Girard, Marguerite Guiguet, Diane Bollens, Isabelle Goderel, Marie‐Caroline Meyohas, Isabelle Lecomte, Gilles Raguin, Jacques Frottier, Willy Rozenbaum, Patrice Jaillon.  (2000) Long‐Term Outcome and Treatment Modifications in a Prospective Cohort of Human Immunodeficiency Virus Type 1–Infected Patients on Triple‐Drug Antiretroviral Regimens. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>31</b>:4, 987-994<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/318154" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">799</p><p class="content">P Mercié.  (2000) Atherogen lipid profile in HIV-1-infected patients with lipodystrophy syndrome. <i><span class="NLM_source">European Journal of Internal Medicine</span></i> <b>11</b>:5, 257-263<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0953-6205(00)00103-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">800</p><p class="content">Neil M. Graham.  (2000) Metabolic Disorders Among HIV-Infected Patients Treated With Protease Inhibitors: A Review. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i>S4-S11<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200010001-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">801</p><p class="content">Craig&nbsp;J. Hoesley, Michael&nbsp;S. Saag, Ashlee Chatham, J.&nbsp;Michael Kilby.  (2000) Prolonged Suppression of Human Immunodeficiency Virus Type 1 RNA during Dual Nucleoside Reverse‐Transcriptase–Inhibitor Therapy in Clinical Practice. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>31</b>:4, 1095-1097<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/318143" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">802</p><p class="content">Homira Behbahani, Alan Landay, Bruce K. Patterson, Paul Jones, John Pottage, Michelle Agnoli, Jan Andersson, Anna-Lena Spetz.  (2000) Normalization of Immune Activation in Lymphoid Tissue Following Highly Active Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>25</b>:2, 150-156<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200010010-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">803</p><p class="content">Rafik Samuel, Byungse Suh.  (2000) Antiretroviral therapy 2000. <i><span class="NLM_source">Archives of Pharmacal Research</span></i> <b>23</b>:5, 425-437<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02976566" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">804</p><p class="content">G. Paolo Rizzardi, Giuseppe Tambussi, Pierre-Alexandre Bart, Aude G. Chapuis, Adriano Lazzarin, Giuseppe Pantaleo.  (2000) Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:15, 2257-2263<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200010200-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">805</p><p class="content">Jan-Olof Svensson, Anders S??nnerborg, Lars St??hle.  (2000) Rapid and Simple Determination of Indinavir in Serum, Urine, and Cerebrospinal Fluid Using High-Performance Liquid Chromatography. <i><span class="NLM_source">Therapeutic Drug Monitoring</span></i> <b>22</b>:5, 626-629<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00007691-200010000-00020" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">806</p><p class="content">Gilbert R Kaufmann, David A Cooper.  (2000) Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic options. <i><span class="NLM_source">Current Opinion in Microbiology</span></i> <b>3</b>:5, 508-514<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1369-5274(00)00131-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">807</p><p class="content">Dewey C. Scheid, Robert M. Hamm, Kevin W. Stevens.  (2000) Cost Effectiveness of Human Immunodeficiency Virus Postexposure Prophylaxis for Healthcare Workers. <i><span class="NLM_source">PharmacoEconomics</span></i> <b>18</b>:4, 355-368<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00019053-200018040-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">808</p><p class="content"> (2000) Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE. <i><span class="NLM_source">HIV Medicine</span></i> <b>1</b>:4, 224-231<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2000.00033.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">809</p><p class="content">Linqi Zhang, Chris Chung, Bor-Shen Hu, Tian He, Yong Guo, Alexandria J. Kim, Eva Skulsky, Xia Jin, Arlene Hurley, Bharat Ramratnam, Martin Markowitz, David D. Ho.  (2000) Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy. <i><span class="NLM_source">Journal of Clinical Investigation</span></i> <b>106</b>:7, 839-845<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1172/JCI10565" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">810</p><p class="content">Homira Behbahani, Alan Landay, Bruce K. Patterson, Paul Jones, John Pottage, Michelle Agnoli, Jan Andersson, Anna-Lena Spetz.  (2000) Normalization of Immune Activation in Lymphoid Tissue Following Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i>150-156<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200010010-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">811</p><p class="content">Peter L. Anderson, Richard C. Brundage, Lane Bushman, Thomas N. Kakuda, Rory P. Remmel, Courtney V. Fletcher.  (2000) Indinavir plasma protein binding in HIV-1-infected adults. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:15, 2293-2297<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200010200-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">812</p><p class="content">T. Wong, M. A. Chiasson, A. Reggy, R. J. Simonds, J. Heffess, V. Loo.  (2000) Antiretroviral therapy and declining AIDS mortality in New York City. <i><span class="NLM_source">Journal of Urban Health</span></i> <b>77</b>:3, 492-500<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02386756" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">813</p><p class="content">Jürgen Kurt Rockstroh.  (2000) Antiretrovirale Therapie der HIV-Infektion. <i><span class="NLM_source">Pharmazie  in unserer Zeit</span></i> <b>29</b>:5, 284-296<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/1615-1003(200009)29:5&amp;lt;284::AID-PAUZ284&amp;gt;3.0.CO;2-T" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">814</p><p class="content">Marina Núñez, Vincent Soriano.  (2000) Salvage Therapy for HIV Infection: When and How. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>14</b>:9, 465-476<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/108729100438845" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">815</p><p class="content">Elisabetta Rapiti, Daniela Porta, Francesco Forastiere, Danilo Fusco, Carlo A. Perucci.  (2000) Socioeconomic Status and Survival of Persons with AIDS before and after the Introduction of Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Epidemiology</span></i> <b>11</b>:5, 496-501<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00001648-200009000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">816</p><p class="content">Troy Suarez, Finetta L. Reese.  (2000) Coping, psychological adjustment, and complementary and alternative medicine use in persons living with hiv and aids. <i><span class="NLM_source">Psychology &amp; Health</span></i> <b>15</b>:5, 635-649<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1080/08870440008405476" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">817</p><p class="content">Veronica Miller, Caroline A. Sabin, Andrew N. Phillips, Carsten Rottmann, Holger Rabenau, Eckard Weidmann, Volker Rickerts, Stephan Findhammer, Eilke B. Helm, Schlomo Staszewski.  (2000) The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:14, 2129-2136<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200009290-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">818</p><p class="content">Enrico Girardi, Alessandro Sampaolesi, Marco Gentile, Giuseppina Nurra, Giuseppe Ippolito.  (2000) Increasing Proportion of Late Diagnosis of HIV Infection Among Patients With AIDS in Italy Following Introduction of Combination Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>25</b>:1, 71-76<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200009010-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">819</p><p class="content">Pierre-Alexandre Bart, G. Paolo Rizzardi, Giuseppe Tambussi, Jean-Philippe Chave, Aude G Chapuis, Cecilia Graziosi, Jean-Marc Corpataux, Nermin Halkic, Jean-Yves Meuwly, Miguel Munoz, Pascal Meylan, William Spreen, Hugh McDade, Sabine Yerly, Luc Perrin, Adriano Lazzarin, Giuseppe Pantaleo.  (2000) Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:13, 1887-1897<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200009080-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">820</p><p class="content">Enrico Girardi, Giorgio Antonucci, Paola Vanacore, Marco Libanore, Isabella Errante, Alberto Matteelli, Giuseppe Ippolito.  (2000) Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:13, 1985-1991<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200009080-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">821</p><p class="content">David W Haas, Eduardo Arathoon, Melanie A Thompson, Rogiero de Jesus Pedro, Joel E Gallant, David E Uip, Judith Currier, L. Miguel Noriega, David S Lewi, Patricia Uribe, Jorge Benetucci, Pedro Cahn, David Paar, A. Clinton White, Ann C Collier, Carlos H Ramirez-Ronda, Charlotte Harvey, Mi-ok Chung, Devan Mehrotra, Jeffrey Chodakewitz, Bach-Yen Nguyen.  (2000) Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:13, 1973-1978<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200009080-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">822</p><p class="content">Rebecca M. D?Amato, Richard T. D?Aquila, Lawrence M. Wein.  (2000) Management of Antiretroviral Therapy for HIV Infection: Analyzing When to Change Therapy. <i><span class="NLM_source">Management Science</span></i> <b>46</b>:9, 1200-1213<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1287/mnsc.46.9.1200.12235" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">823</p><p class="content">Peter B Gilbert, Heather J Ribaudo, Lisa Greenberg, George Yu, Ronald J Bosch, Camlin Tierney, Daniel R Kuritzkes.  (2000) Considerations in choosing a primary endpoint that measures durability of virological suppression in an antiretroviral trial. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:13, 1961-1972<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200009080-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">824</p><p class="content">Enrico Girardi, Alessandro Sampaolesi, Marco Gentile, Giuseppina Nurra, Giuseppe Ippolito.  (2000) Increasing Proportion of Late Diagnosis of HIV Infection Among Patients With AIDS in Italy Following Introduction of Combination Antiretroviral Therapy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i>71-76<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200009010-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">825</p><p class="content">K. H. Mayer, J. D. Passalaris, K. A. Sepkowitz, M. J. Glesby.  (2000) Coronary Artery Disease and Human Immunodeficiency Virus Infection. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>31</b>:3, 787-797<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313995" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">826</p><p class="content">Marek Fischer, Huldrych F. Günthard, Milos Opravil, Beda Joos, Werner Huber, Leslie R. Bisset, Peter Ott, Jürg Böni, Rainer Weber, Richard W. Cone.  (2000) Residual HIV-RNA Levels Persist for Up to 2.5 Years in Peripheral Blood Mononuclear Cells of Patients on Potent Antiretroviral Therapy. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:12, 1135-1140<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922200414974" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">827</p><p class="content">Andrew Wiznia, Kenneth Stanley, Paul Krogstad, George Johnson, Sophia Lee, James McNamara, John Moye, J. Brooks Jackson, Hermann Mendez, Rosaura Aguayo, Arry Dieudonne, Andrea Kovacs, Mahrukh Bamji, Elaine Abrams, Sohail Rana, John Sever, Sharon Nachman.  (2000) Combination Nucleoside Analog Reverse Transcriptase Inhibitor(s) Plus Nevirapine, Nelfinavir, or Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: Week 24 Results of a Randomized Controlled Trial - PACTG 377. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:12, 1113-1121<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922200414956" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">828</p><p class="content">David Muir, David White, Julie King, Neville Verlander, Deenan Pillay.  (2000) Predictive value of the ultrasensitive HIV viral load assay in clinical practice. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>61</b>:4, 411-416<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/1096-9071(200008)61:4&amp;lt;411::AID-JMV1&amp;gt;3.0.CO;2-M" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">829</p><p class="content">A. Mocroft, M. J. Gill, W. Davidson, A. N. Phillips.  (2000) Are There Gender Differences in Starting Protease Inhibitors, HAART, and Disease Progression Despite Equal Access to Care?. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:5, 475-482<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200008150-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">830</p><p class="content">Frederick M. Hecht, Margaret A. Chesney, J. Stan Lehman, Dennis Osmond, Karen Vranizan, Shoshana Colman, Dennis Keane, Arthur Reingold, Andrew B. Bindman.  (2000) Does HIV reporting by name deter testing?. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:12, 1801-1808<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200008180-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">831</p><p class="content">A. Mocroft, M. J. Gill, W. Davidson, A. N. Phillips.  (2000) Are There Gender Differences in Starting Protease Inhibitors, HAART, and Disease Progression Despite Equal Access to Care?. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:5, 475-482<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200008150-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">832</p><p class="content">Alexandra M. Levine, Ping Li, Tony Cheung, Anil Tulpule, Jamie Von Roenn, Bharat N. Nathwani, Lee Ratner.  (2000) Chemotherapy Consisting of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine With Granulocyte–Colony-Stimulating Factor in HIV-Infected Patients With Newly Diagnosed Hodgkin's Disease: A Prospective, Multi-institutional AIDS Clinical Trials Group Study (ACTG 149). <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:5, 444-450<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200008150-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">833</p><p class="content">Alexandra M. Levine, Ping Li, Tony Cheung, Anil Tulpule, Jamie Von Roenn, Bharat N. Nathwani, Lee Ratner.  (2000) Chemotherapy Consisting of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine With Granulocyte–Colony-Stimulating Factor in HIV-Infected Patients With Newly Diagnosed Hodgkin's Disease: A Prospective, Multi-institutional AIDS Clinical Trials Group Study (ACTG 149). <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:5, 444-450<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200008150-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">834</p><p class="content">Charles Dumon, Caroline Solas, Isabelle Thuret, Hervé Chambost, Bruno Lacarelle, Gerard Michel, Alain Durand.  (2000) Relationship Between Efficacy, Tolerance, and Plasma Drug Concentration of Ritonavir in Children With Advanced HIV Infection. <i><span class="NLM_source">Therapeutic Drug Monitoring</span></i> <b>22</b>:4, 402-408<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00007691-200008000-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">835</p><p class="content">Janet Darbyshire, Mary Foulkes, Richard Peto, William Duncan, Abdel Babiker, Rory Collins, Mike Hughes, Tim EA Peto, Sarah A Walker, Janet Darbyshire. Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults. In: Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2000.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/14651858.CD002038" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">836</p><p class="content">G. Gavazzi, O. Bouchard, P. Leclercq, C. Morel-Baccard, A. Bosseray, N. Dutertre, M. Micoud, P. Morand.  (2000) Change in Transaminases in Hepatitis C Virus- and HIV-Coinfected Patients after Highly Active Antiretroviral Therapy: Differences between Complete and Partial Virologic Responders?. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:11, 1021-1023<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/08892220050075264" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">837</p><p class="content">D.A. Katzenstein, H. Hughes, M. Albrecht, S. Hammer, M. Para, R. Murphy, H. Valdez, R. Haubrich, S. Liou.  (2000) Virologic and CD4
              <sup>+</sup>
              Cell Responses to New Nucleoside Regimens: Switching to Stavudine or Adding Lamivudine after Prolonged Zidovudine Treatment of Human Immunodeficiency Virus Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:11, 1031-1037<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/08892220050075282" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">838</p><p class="content">S. K. Schwarcz.  (2000) Impact of Protease Inhibitors and Other Antiretroviral Treatments on Acquired Immunodeficiency Syndrome Survival in San Francisco, California, 1987-1996. <i><span class="NLM_source">American Journal of Epidemiology</span></i> <b>152</b>:2, 178-185<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1093/aje/152.2.178" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">839</p><p class="content">PAL Voltersvik, ANNE MA Dyrhol-Riise, LEIF Bostad, BÅRD I. RØSok, JAN Olofsson, BIRGITTA ÅSjÖ.  (2000) Changes in tonsillar tissue in early HIV-1 infection and during 3 years of antiretroviral therapy. <i><span class="NLM_source">APMIS</span></i> <b>108</b>:7-8, 539-550<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1034/j.1600-0463.2000.01087-8539.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">840</p><p class="content">Joseph J. Eron, Robert L. Murphy, Dolores Peterson, John Pottage, David M. Parenti, Joseph Jemsek, Susan Swindells, Gladys Sepulveda, Nicholaos Bellos, Bruce C. Rashbaum, Jim Esinhart, Nancy Schoellkopf, Robert Grosso, Michael Stevens.  (2000) A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: Selection of thymidine analog regimen therapy (START II)*. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:11, 1601-1610<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200007280-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">841</p><p class="content">Jeffrey L. Jones, Debra L. Hanson, Mark S. Dworkin, Harold W. Jaffe.  (2000) Incidence and Trends in Kaposi's Sarcoma in the Era of Effective Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:3, 270-274<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200007010-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">842</p><p class="content">Nikola J. Ostrop, M. John Gill.  (2000) Antiretroviral Medication Adherence and Persistence with Respect to Adherence Tool Usage. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>14</b>:7, 351-358<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/108729100413220" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">843</p><p class="content">Amanda Mocroft, Helen Devereux, Sabine Kinloch-de-Loes, Debbie Wilson, Sara Madge, Michael Youle, Mervyn Tyrer, Clive Loveday, Andrew N. Phillips, Margaret A. Johnson.  (2000) Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:11, 1545-1552<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200007280-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">844</p><p class="content">Janet Darbyshire.  (2000) Therapeutic interventions in HIV infection - a critical view. <i><span class="NLM_source">Tropical Medicine and International Health</span></i> <b>5</b>:7, A26-A31<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-3156.2000.00597.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">845</p><p class="content">M Youle.  (2000) Optimizing indinavir regimens. <i><span class="NLM_source">HIV Medicine</span></i> <b>1</b>:Supplement 2, 7-11<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2000.00005.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">846</p><p class="content"> (2000) HIV transmission and the cost-effectiveness of methadone maintenance. <i><span class="NLM_source">American Journal of Public Health</span></i> <b>90</b>:7, 1100-1111<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2105/AJPH.90.7.1100" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">847</p><p class="content"> (2000) Highly active antiretroviral therapy including protease inhibitors does not confer a unique CD4 cell benefit. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:10, 1383-1388<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200007070-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">848</p><p class="content">Bg Gazzard.  (2000) What are the perceived advantages and disadvantages of non-nucleoside reverse transcriptase inhibitors as first-line therapy?. <i><span class="NLM_source">HIV Medicine</span></i> <b>1</b>:Supplement 1, 11-14<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2000.00009.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">849</p><p class="content">Kathleen E. Squires, Roy Gulick, Pablo Tebas, Jorge Santana, Victor Mulanovich, Rebecca Clark, Bienvenido Yangco, Steven I. Marlowe, David Wright, Calvin Cohen, Timothy Cooley, Joseph Mauney, Katharina Uffelman, Nancy Schoellkopf, Robert Grosso, Michael Stevens.  (2000) A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I). <i><span class="NLM_source">AIDS</span></i> <b>14</b>:11, 1591-1600<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200007280-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">850</p><p class="content">Jeffrey L. Jones, Debra L. Hanson, Mark S. Dworkin, Harold W. Jaffe.  (2000) Incidence and Trends in Kaposi's Sarcoma in the Era of Effective Antiretroviral Therapy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>24</b>:3, 270-274<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200007010-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">851</p><p class="content">Robert Harrington, Lilly Wu, Heather Pullen, Michael Emerman.  (2000) Direct detection of infectious HIV-1 in blood using a centrifugation-indicator cell assay. <i><span class="NLM_source">Journal of Virological Methods</span></i> <b>88</b>:1, 111-115<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-0934(00)00181-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">852</p><p class="content">Hideji Hanabusa, Naoaki Kuji, Shingo Kato, Hisamichi Tagami, Satoru Kaneko, Hiroaki Tanaka, Yasunori Yoshimura.  (2000) An evaluation of semen processing methods for eliminating HIV-1. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:11, 1611-1616<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200007280-00017" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">853</p><p class="content">Barbara Greenberg, Ruth Mccorkle, David Vlahov, Peter A. Selwyn.  (2000) Palliative care for HIV disease in the era of highly active antiretroviral therapy. <i><span class="NLM_source">Journal of Urban Health</span></i> <b>77</b>:2, 150-165<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02390527" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">854</p><p class="content">B. Conway.  (2000) Initial Therapy with Protease Inhibitor-Sparing Regimens: Evaluation of Nevirapine and Delavirdine. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>30</b>:Supplement 2, S130-S134<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313850" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">855</p><p class="content">Rieneke M. E. van Praag, Gerrit J. Weverling, Peter Portegies, Suzanne Jurriaans, Xiao-Jian Zhou, Michele L. Turner-Foisy, Jean-Pierre Sommadossi, David M. Burger, Joep M. A. Lange, Richard M. W. Hoetelmans, Jan M. Prins.  (2000) Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:9, 1187-1194<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200006160-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">856</p><p class="content">Keola K. Beale, W.Edward Robinson.  (2000) Combinations of reverse transcriptase, protease, and integrase inhibitors can be synergistic in vitro against drug-sensitive and RT inhibitor-resistant molecular clones of HIV-1. <i><span class="NLM_source">Antiviral Research</span></i> <b>46</b>:3, 223-232<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(00)00083-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">857</p><p class="content">A. Carr.  (2000) HIV Protease Inhibitor-Related Lipodystrophy Syndrome. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>30</b>:Supplement 2, S135-S142<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313854" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">858</p><p class="content">Andrew Carr, John Chuah, Jeff Hudson, Martyn French, Jennifer Hoy, Matthew Law, David Sayer, Sean Emery, David A. Cooper.  (2000) A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:9, 1171-1180<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200006160-00014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">859</p><p class="content">W. A. O'Brien.  (2000) Resistance against Reverse Transcriptase Inhibitors. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>30</b>:Supplement 2, S185-S192<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313858" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">860</p><p class="content">Stefano Menzo, Stefano Rusconi, Alessia Monachetti, Maria Chiara Colombo, Michela Violin, Patrizia Bagnarelli, Pietro E. Varaldo, Mauro Moroni, Massimo Galli, Claudia Balotta, Massimo Clementi.  (2000) Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:9, 1101-1110<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200006160-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">861</p><p class="content">S. G. Deeks.  (2000) Determinants of Virological Response to Antiretroviral Therapy: Implications for Long-Term Strategies. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>30</b>:Supplement 2, S177-S184<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313855" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">862</p><p class="content">J??rgen K. Rockstroh, Frank Bergmann, Werner Wiesel, Ansgar Rieke, Albert Theisen, Gerd F??tkenheuer, Mark Oette, Horst Carls, Stefan Fenske, Mathias Nadler, Heribert Knechten.  (2000) Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:9, 1181-1185<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200006160-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">863</p><p class="content">J. J. Eron.  (2000) HIV-1 Protease Inhibitors. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>30</b>:Supplement 2, S160-S170<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313853" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">864</p><p class="content">Gilbert R. Kaufmann, Mark Bloch, John J. Zaunders, Don Smith, David A. Cooper.  (2000) Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:8, 959-969<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200005260-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">865</p><p class="content">M. Narita, J. J. Stambaugh, E. S. Hollender, D. Jones, A. E. Pitchenik, D. Ashkin.  (2000) Use of Rifabutin with Protease Inhibitors for Human Immunodeficiency Virus-Infected Patients with Tuberculosis. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>30</b>:5, 779-783<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313771" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">866</p><p class="content">Nina Khanna, Thomas Klimkait, Veronique Schiffer, Jose Irigoyen, Amalio Telenti, Bernard Hirschel, Manuel Battegay.  (2000) Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:7, 791-799<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200005050-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">867</p><p class="content">Elisabeth H. Gisolf, Rolf P. G. van Heeswijk, Richard W. M. Hoetelmans, Sven A. Danner.  (2000) Decreased exposure to saquinavir in HIV-1-infected patients after long-term antiretroviral therapy including ritonavir and saquinavir. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:7, 801-805<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200005050-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">868</p><p class="content">Rodolphe Thi??baut, Philippe Morlat, H??l??ne Jacqmin-Gadda, Didier Neau, Patrick Merci??, Fran??ois Dabis, Genevi??ve Ch??ne.  (2000) Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:8, 971-978<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200005260-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">869</p><p class="content">Quan Dong Nguyen, John H Kempen, Stephen G Bolton, James P Dunn, Douglas A Jabs.  (2000) Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. <i><span class="NLM_source">American Journal of Ophthalmology</span></i> <b>129</b>:5, 634-639<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0002-9394(00)00356-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">870</p><p class="content"> El-Sadr ,  Wafaa M. ,  Burman ,  William J. ,  Grant ,  Lisa Bjorling ,  Matts ,  John P. ,  Hafner ,  Richard ,  Crane ,  Lawrence ,  Zeh ,  Doug ,  Gallagher ,  Barbara ,  Mannheimer ,  Sharon B. ,  Martinez ,  Ana ,  Gordin ,  Fred , .  (2000) Discontinuation of Prophylaxis against <em>Mycobacterium avium</em> Complex Disease in HIV-Infected Patients Who Have a Response to Antiretroviral Therapy. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>342</b>:15, 1085-1092<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM200004133421503">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM200004133421503} --></span></p></li><li class="odd"><p class="number">871</p><p class="content">M. S. Avidan, N. Jones, A. L. Pozniak.  (2000) The implications of HIV for the anaesthetist and the intensivist. <i><span class="NLM_source">Anaesthesia</span></i> <b>55</b>:4, 344-354<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2044.2000.01265.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">872</p><p class="content">Christophe Fraser, Neil M. Ferguson, Azra C. Ghani, Jan M. Prins, Joep M. A. Lange, Jaap Goudsmit, Roy M. Anderson, Frank de Wolf.  (2000) Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:6, 659-669<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200004140-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">873</p><p class="content">Josephine A. Mauskopf, Jerry M. Tolson, Kit N. Simpson, Sissi V. Pham, James Albright.  (2000) Impact of Zidovudine-Based Triple Combination Therapy on an AIDS Drug Assistance Program. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:4, 302-313<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200004010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">874</p><p class="content">Laura M. Bogart, Jeffrey A. Kelly, Sheryl L. Catz, James M. Sosman.  (2000) Impact of Medical and Nonmedical Factors on Physician Decision Making for HIV/AIDS Antiretroviral Treatment. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:5, 396-404<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200004150-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">875</p><p class="content">W. Jeffrey Fessel, John F. Krowka, Haynes W. Sheppard, Marianne Gesner, Sebastian Tongson, Samuel Weinstein, Michael Ascher, Shirley Kwok, Cindy Christopherson.  (2000) Dissociation of Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:4, 314-320<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200004010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">876</p><p class="content">Jorge A Tavel.  (2000) Ongoing trials in HIV protease inhibitors. <i><span class="NLM_source">Expert Opinion on Investigational Drugs</span></i> <b>9</b>:4, 917-928<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/13543784.9.4.917" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">877</p><p class="content">Joseph J. Eron, Ellen S. Yetzer, Peter J. Ruane, Stephen Becker, Gosford A. Sawyerr, Robin L. Fisher, Jerry M. Tolson, Mark S. Shaefer.  (2000) Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:6, 671-681<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200004140-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">878</p><p class="content">Richard D. Moore.  (2000) Cost Effectiveness of Combination HIV Therapy. <i><span class="NLM_source">PharmacoEconomics</span></i> <b>17</b>:4, 325-330<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.2165/00019053-200017040-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">879</p><p class="content">Josephine A. Mauskopf, Jerry M. Tolson, Kit N. Simpson, Sissi V. Pham, James Albright.  (2000) Impact of Zidovudine-Based Triple Combination Therapy on an AIDS Drug Assistance Program. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:4, 302-313<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200004010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">880</p><p class="content">W. Jeffrey Fessel, John F. Krowka, Haynes W. Sheppard, Marianne Gesner, Sebastian Tongson, Samuel Weinstein, Michael Ascher, Shirley Kwok, Cindy Christopherson.  (2000) Dissociation of Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:4, 314-320<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200004010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">881</p><p class="content">Theodore Pierson, Justin McArthur, Robert F. Siliciano.  (2000) Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral Therapy. <i><span class="NLM_source">Annual Review of Immunology</span></i> <b>18</b>:1, 665-708<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1146/annurev.immunol.18.1.665" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">882</p><p class="content">M. S. Saag, R. J. Graybill, R. A. Larsen, P. G. Pappas, J. R. Perfect, W. G. Powderly, J. D. Sobel, W. E. Dismukes, .  (2000) Practice Guidelines for the Management of Cryptococcal Disease. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>30</b>:4, 710-718<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313757" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">883</p><p class="content">Laura M. Bogart, Jeffrey A. Kelly, Sheryl L. Catz, James M. Sosman.  (2000) Impact of Medical and Nonmedical Factors on Physician Decision Making for HIV/AIDS Antiretroviral Treatment. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:5, 396-404<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200004150-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">884</p><p class="content">Judith&nbsp;S. Currier.  (2000) Discontinuing Prophylaxis for Opportunistic Infection: Guiding Principles. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>30</b>:s1, S66-S71<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313846" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">885</p><p class="content"> (2000) British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. <i><span class="NLM_source">HIV Medicine</span></i> <b>1</b>:2, 76-101<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.2000.00013.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">886</p><p class="content">G. Paolo Rizzardi, Rob J. De Boer, Shelley Hoover, Giuseppe Tambussi, Aude Chapuis, Nermin Halkic, Pierre-Alexandre Bart, Veronica Miller, Schlomo Staszewski, Daan W. Notermans, Luc Perrin, Cecil H. Fox, Joep M.A. Lange, Adriano Lazzarin, Giuseppe Pantaleo.  (2000) Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA. <i><span class="NLM_source">Journal of Clinical Investigation</span></i> <b>105</b>:6, 777-782<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1172/JCI9079" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">887</p><p class="content">Elisabeth H. Gisolf, Suzanne Jurriaans, Jolanda Pelgrom, Filip van Wanzeele, Marchina E. van der Ende, Kees Brinkman, Marie-Jos?? Borst, Frank de Wolf, Anthony J. Japour, Sven A. Danner.  (2000) The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:4, 405-413<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200003100-00014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">888</p><p class="content">Susan Cu-Uvin, Angela M. Caliendo, Steven Reinert, Albert Chang, Catherine Juliano-Remollino, Timothy P. Flanigan, Kenneth H. Mayer, Charles C. J. Carpenter.  (2000) Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:4, 415-421<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200003100-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">889</p><p class="content">A. Fraternale, A. Casabianca, A. Tonelli, G. Vallanti, L. Chiarantini, G. Brandi, A. G. Celeste, M. Magnani.  (2000) Inhibition of Murine AIDS by Alternate Administration of Azidothymidine and Fludarabine Monophosphate. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:3, 209-220<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200003010-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">890</p><p class="content">Jonathan B. Angel, Kevin High, Frank Rhame, David Brand, James B. Whitmore, Jan M. Agosti, Mark J. Gilbert, Stanley Deresinski.  (2000) Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:4, 387-395<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200003100-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">891</p><p class="content">Antonella d'Arminio Monforte, Alessandro Cozzi Lepri, Giovanni Rezza, Patrizio Pezzotti, Andrea Antinori, Andrew N. Phillips, Gioacchino Angarano, Vincenzo Colangeli, Andrea De Luca, Giuseppe Ippolito, Liliana Caggese, Fabrizio Soscia, Gaetano Filice, Francesco Gritti, Pasquale Narciso, Umberto Tirelli, Mauro Moroni.  (2000) Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral na??ve patients. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:5, 499-507<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200003310-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">892</p><p class="content">A. Fraternale, A. Casabianca, A. Tonelli, G. Vallanti, L. Chiarantini, G. Brandi, A. G. Celeste, M. Magnani.  (2000) Inhibition of Murine AIDS by Alternate Administration of Azidothymidine and Fludarabine Monophosphate. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:3, 209-220<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200003010-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">893</p><p class="content">Jonathan Elford, Graham Bolding, Mark Maguire, Lorraine Sherr.  (2000) Combination Therapies for HIV and Sexual Risk Behavior Among Gay Men. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:3, 266-271<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200003010-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">894</p><p class="content">S. K. Cinti, D. R. Kaul, P. E. Sax, L. R. Crane, P. H. Kazanjian.  (2000) Recurrence of Mycobacterium avium Infection in Patients Receiving Highly Active Antiretroviral Therapy and Antimycobacterial Agents. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>30</b>:3, 511-514<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313705" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">895</p><p class="content">Jonathan Elford, Graham Bolding, Mark Maguire, Lorraine Sherr.  (2000) Combination Therapies for HIV and Sexual Risk Behavior Among Gay Men. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:3, 266-271<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200003010-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">896</p><p class="content"> (2000) AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:4, 367-374<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200003100-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">897</p><p class="content">M. Louise Markert, Charles B. Hicks, John A. Bartlett, J. Les Harmon, Laura P. Hale, Michael L. Greenberg, Guido Ferrari, Janet Ottinger, Andreas Boeck, Amy L. Kloster, Tanya M. M, Laughlin, Karen B. Bleich, Ross M. Ungerleider, H. Kim Lyerly, William E. Wilkinson, Franck S. Rousseau, M Argo E. Heath-Chiozzi, John M. Leonard, Ashley T. Haase, George M ., R. Pat Bucy, Daniel C. Douek, Richard A. Koup, Barton F. Haynes, Dani P. Bolognesi, Kent J. Weinhold.  (2000) Effect of Highly Active Antiretroviral Therapy and Thymic Transplantation on Immunoreconstitution in HIV Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:5, 403-413<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922200309061" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">898</p><p class="content">Paolo Bonfanti, Laura Valsecchi, Fabio Parazzini, Silvia Carradori, Luigi Pusterla, Paolo Fortuna, Lia Timillero, Federica Alessi, Giancarlo Ghiselli, Andrea Gabbuti, Elisabetta Di Cintio, Canio Martinelli, Ivano Faggion, Simona Landonio, Tiziana Quirino.  (2000) Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort Study. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:3, 236-245<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200003010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">899</p><p class="content">Paolo Bonfanti, Laura Valsecchi, Fabio Parazzini, Silvia Carradori, Luigi Pusterla, Paolo Fortuna, Lia Timillero, Federica Alessi, Giancarlo Ghiselli, Andrea Gabbuti, Elisabetta Di Cintio, Canio Martinelli, Ivano Faggion, Simona Landonio, Tiziana Quirino.  (2000) Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort Study. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:3, 236-245<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200003010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">900</p><p class="content">Alfredo G. Tomasselli, Robert L. Heinrikson.  (2000) Targeting the HIV-protease in AIDS therapy: a current clinical perspective. <i><span class="NLM_source">Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology</span></i> <b>1477</b>:1-2, 189-214<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0167-4838(99)00273-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">901</p><p class="content">David W. Haas, James Lavelle, Jeffrey P. Nadler, Stephen B. Greenberg, Peter Frame, Norman Mustafa, Marty St. Clair, Ray McKinnis, Lynn Dix, Mary Elkins, James Rooney.  (2000) A Randomized Trial of Interferon alpha Therapy for HIV Type 1 Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:3, 183-190<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922200309278" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">902</p><p class="content">Anne Ma Dyrhol-Riise, Pal Voltersvik, Bard I. Rosok, Jan Olofsson, Birgitta Asjo.  (2000) Normalization of CD4
              <sup>+</sup>
              Cell Numbers and Reduced Levels of Memory CD8
              <sup>+</sup>
              Cells in Blood and Tonsillar Tissue after Highly Active Antiretroviral Therapy in Early HIV Type-1 Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>16</b>:3, 191-201<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922200309287" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">903</p><p class="content">F. Garcia, C. Vidal, M. Plana, A. Cruceta, M. T. Gallart, T. Pumarola, J. M. Miro, J. M. Gatell.  (2000) Residual Low-Level Viral Replication Could Explain Discrepancies between Viral Load and CD4+ Cell Response in Human Immunodeficiency Virus--Infected Patients Receiving Antiretroviral Therapy. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>30</b>:2, 392-394<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313660" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">904</p><p class="content">Sabine Yerly, Laurent Kaiser, Thomas V. Perneger, Richard W. Cone, Milos Opravil, Jean-Philippe Chave, Hansjakob Furrer, Bernard Hirschel, Luc Perrin.  (2000) Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:3, 243-249<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200002180-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">905</p><p class="content">Dyrhol-Riise, Brantsaeter, Dunlop, Baklien, Skar, Asjo, Bruun, Rosok.  (2000) Early Changes in Peripheral Blood T Cell Subsets Induced by Antiretroviral Treatment of Human Immunodeficiency Virus-1 Positive Individuals. <i><span class="NLM_source">Scandinavian Journal of Immunology</span></i> <b>51</b>:2, 195-201<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-3083.2000.00659.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">906</p><p class="content">Klaus E. Monkemuller, Stephanie A. Call, Audrey J. Lazenby, C. Mel Wilcox.  (2000) Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy. <i><span class="NLM_source">The American Journal of Gastroenterology</span></i> <b>95</b>:2, 457-462<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1572-0241.2000.01768.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">907</p><p class="content">JM Parkin, M Murphy, J Anderson, S El-Gadi, G Forster, AJ Pinching.  (2000) Tolerability and side-effects of post-exposure prophylaxis for HIV infection. <i><span class="NLM_source">The Lancet</span></i> <b>355</b>:9205, 722-723<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(99)05005-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">908</p><p class="content">P. Phanuphak, M. L. Grayson, S. Sirivichayakul, S. Suwanagool, K. Ruxrungtham, M. Hanvanich, W. Ratanasuwan, S. Ubolyam, M. D. Hughes, C. A. Wanke, S. M. Hammer.  (2000) A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia. <i><span class="NLM_source">Australian and New Zealand Journal of Medicine</span></i> <b>30</b>:1, 11-20<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1445-5994.2000.tb01048.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">909</p><p class="content">R.J. Pomerantz.  (2000) Residual HIV-1 replication. <i><span class="NLM_source">Biomedicine &amp; Pharmacotherapy</span></i> <b>54</b>:1, 13-15<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0753-3322(00)88635-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">910</p><p class="content">Francesc Puig-Basagoiti, Marta Cabana, Magda Guilera, Mireia Giménez-Barcons, Guillem Sirera, Cristina Tural, Bonaventura Clotet, José-María Sánchez-Tapias, Juan Rodés, Juan-Carlos Saiz, Miguel-Angel Martínez.  (2000) Prevalence and Route of Transmission of Infection With a Novel DNA Virus (TTV), Hepatitis C Virus, and Hepatitis G Virus in Patients Infected With HIV. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:1, 89-94<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200001010-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">911</p><p class="content">Jean-Baptiste Hubert, Marianne Burgard, Elisabeth Dussaix, Catherine Tamalet, Christiane Deveau, Jérôme Le Chenadec, Marie-Laure Chaix, Eric Marchadier, Jean-Louis Vildé, Jean-François Delfraissy, Laurence Meyer, Christine Rouzioux.  (2000) Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:2, 123-131<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200001280-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">912</p><p class="content">Javier Ena, Concepción Benito.  (2000) Achieving plasma HIV RNA below the level of detection in clinical practice. <i><span class="NLM_source">British Journal of Clinical Governance</span></i> <b>5</b>:2, 100-105<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1108/14664100010343971" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">913</p><p class="content">Francesc Puig-Basagoiti, Marta Cabana, Magda Guilera, Mireia Giménez-Barcons, Guillem Sirera, Cristina Tural, Bonaventura Clotet, José-María Sánchez-Tapias, Juan Rodés, Juan-Carlos Saiz, Miguel-Angel Martínez.  (2000) Prevalence and Route of Transmission of Infection With a Novel DNA Virus (TTV), Hepatitis C Virus, and Hepatitis G Virus in Patients Infected With HIV. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:1, 89-94<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200001010-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">914</p><p class="content">Javier Ena, Concepción Benito.  (2000) Achieving plasma HIV RNA below the level of detection in clinical practice. <i><span class="NLM_source">Clinical Performance and Quality Healthcare</span></i> <b>8</b>:2, 100-105<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1108/10630270010800804" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">915</p><p class="content">Kathleen Mulligan, Carl Grunfeld, Viva W. Tai, Heather Algren, Miyin Pang, David N. Chernoff, Joan C. Lo, Morris Schambelan.  (2000) Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:1, 35-43<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200001010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">916</p><p class="content">Mayte Pérez-Olmeda, Javier García-Samaniego, Vincent Soriano.  (2000) Hepatitis C viraemia in HIV–HCV co-infected patients having immune restoration with highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:2, 212<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200001280-00023" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">917</p><p class="content">Milos Opravil, Richard W. Cone, Marek Fischer, Pietro L. Vernazza, Stefano Bassetti, Patrizio Lorenzi, Leslie R. Bisset, Peter Ott, Werner Huber, Marlyse C. Knuchel, Malgorzata Roos, Ruedi Lüthy, Rainer Weber.  (2000) Effects of Early Antiretroviral Treatment on HIV-1 RNA in Blood and Lymphoid Tissue: A Randomized Trial of Double Versus Triple Therapy. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:1, 17-25<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-200001010-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">918</p><p class="content">Hernan Valdez, Kimberly Y. Smith, Alan Landay, Elizabeth Connick, Daniel R. Kuritzkes, Harold Kessler, Lawrence Fox, John Spritzler, Joana Roe, Miriam B. Lederman, Howard M. Lederman, Thomas G. Evans, Margo Heath-Chiozzi, Michael M. Lederman.  (2000) Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:1, 11-21<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200001070-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">919</p><p class="content">Francesca J. Torriani, William R. Freeman, J. Christopher Macdonald, Marietta P. Karavellas, Deborah M. Durand, Douglas D. Jeffrey, Pascal R. A. Meylan, Rachel D. Schrier.  (2000) CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:2, 173-180<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200001280-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">920</p><p class="content">Mario Clerici, Elena Seminari, Fredy Suter, Francesco Castelli, Angelo Pan, Mara Biasin, Fulvia Colombo, Daria Trabattoni, Franco Maggiolo, Giampiero Carosi, Renato Maserati.  (2000) Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:2, 109-116<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200001280-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">921</p><p class="content">Sophie Grabar, Christian Pradier, Emmanuelle Le Corfec, Rémi Lancar, Clotilde Allavena, Michelle Bentata, Patricia Berlureau, Caroline Dupont, Pascale Fabbro-Peray, Isabelle Poizot-Martin, Dominique Costagliola.  (2000) Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:2, 141-149<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200001280-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">922</p><p class="content">Monique H.E. Reijers, Hugo M. Weigel, Augustinus A.M. Hart, Reinier W. Ten Kate, Jan Willem Mulder, Peter Reiss, Hanneke Schuitemaker, Richard M.W. Hoetelmans, Gerrit Jan Weverling, Joep M.A. Lange.  (2000) Toxicity and drug exposure in a quadruple drug regimen in HIV–1 infected patients participating in the ADAM study. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:1, 59-68<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200001070-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">923</p><p class="content">Pythia T. Nieuwkerk, Elisabeth H. Gisolf, Robert Colebunders, Albert W. Wu, Sven A. Danner, Mirjam A. Sprangers.  (2000) Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:2, 181-187<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200001280-00014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">924</p><p class="content">Christine Armbruster, Harald Vorbach, Ibrahim El Menyawi, F.-Thomas Meisl, Irmgard Neumann.  (2000) Pharmacokinetics of nelfinavir during haemodialysis in a patient with HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:1, 99-101<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200001070-00018" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">925</p><p class="content">Kathleen Mulligan, Carl Grunfeld, Viva W. Tai, Heather Algren, Miyin Pang, David N. Chernoff, Joan C. Lo, Morris Schambelan.  (2000) Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:1, 35-43<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200001010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">926</p><p class="content">Thierry Saint-Marc, Maria Partisani, Isabelle Poizot-Martin, Olivier Rouviere, F. Bruno, R. Avellaneda, Jean-Marie Lang, Jean-Albert Gastaut, Jean-Louis Touraine.  (2000) Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO* study. <i><span class="NLM_source">AIDS</span></i> <b>14</b>:1, 37-49<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-200001070-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">927</p><p class="content">Milos Opravil, Richard W. Cone, Marek Fischer, Pietro L. Vernazza, Stefano Bassetti, Patrizio Lorenzi, Leslie R. Bisset, Peter Ott, Werner Huber, Marlyse C. Knuchel, Malgorzata Roos, Ruedi Lüthy, Rainer Weber.  (2000) Effects of Early Antiretroviral Treatment on HIV-1 RNA in Blood and Lymphoid Tissue: A Randomized Trial of Double Versus Triple Therapy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>23</b>:1, 17-25<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-200001010-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">928</p><p class="content">Maurizia Debiaggi, Francesca Zara, Angela Pistorio, Raffaele Bruno, Paolo Sacchi, Savino F.A. Patruno, Giorgio Achilli, Egidio Romero, Gaetano Filice.  (2000) Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy. <i><span class="NLM_source">International Journal of Infectious Diseases</span></i> <b>4</b>:4, 187-193<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1201-9712(00)90107-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">929</p><p class="content">François Clavel, Esther Race, Fabrizio Mammano. HIV drug resistance and viral fitness. Elsevier, 2000:41-66.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1054-3589(00)49023-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">930</p><p class="content">Osama Abu-ata, Jihad Slim, Geirge Perez, Stephen M. Smith. HIV therapeutics: Past, present, and future. Elsevier, 2000:1-40.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1054-3589(00)49022-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">931</p><p class="content">N. M. Ferguson, F. deWolf, A. C. Ghani, C. Fraser, C. A. Donnelly, P. Reiss, J. M. A. Lange, S. A. Danner, G. P. Garnett, J. Goudsmit, R. M. Anderson.  (1999) Antigen-driven CD4+ T cell and HIV-1 dynamics: Residual viral replication under highly active antiretroviral therapy. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>96</b>:26, 15167-15172<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.96.26.15167" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">932</p><p class="content"> Staszewski ,  Schlomo ,  Morales-Ramirez ,  Javier ,  Tashima ,  Karen T. ,  Rachlis ,  Anita ,  Skiest ,  Daniel ,  Stanford ,  James ,  Stryker ,  Richard ,  Johnson ,  Philip ,  Labriola ,  Dominic F. ,  Farina ,  Dianne ,  Manion ,  Douglas J. ,  Ruiz ,  Nancy M. , .  (1999) Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>341</b>:25, 1865-1873<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199912163412501">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199912163412501} --></span></p></li><li class="odd"><p class="number">933</p><p class="content">Richard J.C. Gilson, Jerome L. Shupack, Alvin E. Friedman-Kien, Marcus A. Conant, Jonathon N. Weber, Andrew T. Nayagam, Robert V. Swann, Diane C. Pietig, Michael H. Smith, Mary L. Owens.  (1999) A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:17, 2397-2404<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199912030-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">934</p><p class="content">Heidemarie Pernerstorfer-Schoen, Karin Schindler, Bernhard Parschalk, Andreas Schindl, Sylvia Thoeny-Lampert, Katja Wunderer, Ibrahim Elmadfa, Erwin Tschachler, Bernd Jilma.  (1999) Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:17, 2389-2396<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199912030-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">935</p><p class="content">Wayne A Marasco, Joyce LaVecchio, Aaron Winkler.  (1999) Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS. <i><span class="NLM_source">Journal of Immunological Methods</span></i> <b>231</b>:1-2, 223-238<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0022-1759(99)00159-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">936</p><p class="content">Kevin Maher, N. Klimas, M. A. Fletcher, V. Cohen, C. M. Maggio, J. Triplett, R. Valenzuela, G. Dickinson.  (1999) Disease Progression, Adherence, and Response to Protease Inhibitor Therapy for HIV Infection in an Urban Veterans Affairs Medical Center. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:4, 358<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199912010-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">937</p><p class="content">Richard Haubrich, Melanie Thompson, Robert Schooley, William Lang, Allan Stein, Daniel Sereni, Marchina E. van der Ende, Francisco Antunes, Douglas Richman, Grace Pagano, Lesley Kahl, Anny Fetter, David J. Brown, Nathan Clumeck.  (1999) A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:17, 2411-2420<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199912030-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">938</p><p class="content">Rita Murri, Massimo Fantoni, Cosmo Del Borgo, Immacolata Izzi, Raffaella Visonà, Fredy Suter, Maria Cristina Banfi, Enrico Barchi, Nicoletta Orchi, Oliviero Bosco, Albert W. Wu.  (1999) Intravenous Drug Use, Relationship With Providers, and Stage of HIV Disease Influence the Prescription Rates of Protease Inhibitors. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:5, 461<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199912150-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">939</p><p class="content">Rita Murri, Massimo Fantoni, Cosmo Del Borgo, Immacolata Izzi, Raffaella Visonà, Fredy Suter, Maria Cristina Banfi, Enrico Barchi, Nicoletta Orchi, Oliviero Bosco, Albert W. Wu.  (1999) Intravenous Drug Use, Relationship With Providers, and Stage of HIV Disease Influence the Prescription Rates of Protease Inhibitors. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:5, 461<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199912150-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">940</p><p class="content">Einar Martin Aandahl, Pål Aukrust, Fredrik Müller, Vidar Hansson, Kjetil Taskén, Stig S. Frøland.  (1999) Additive effects of IL-2 and protein kinase A type I antagonist on function of T cells from HIV-infected patients on HAART. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:17, 109-114<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199912030-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">941</p><p class="content">Kevin Maher, N. Klimas, M. A. Fletcher, V. Cohen, C. M. Maggio, J. Triplett, R. Valenzuela, G. Dickinson.  (1999) Disease Progression, Adherence, and Response to Protease Inhibitor Therapy for HIV Infection in an Urban Veterans Affairs Medical Center. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:4, 358<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199912010-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">942</p><p class="content">Brian S.N. Blank, Pieter L. Meenhorst, Gerrit Jan Weverling, Anneke A.M. Stout-Zonneveld, Wouter Pauw, Jan Willem Mulder, Willemien C. van Dijk, Paul Smits, Joep M.A. Lange.  (1999) Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:18, 2533-2539<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199912240-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">943</p><p class="content">Amanda Mocroft, Sara Madge, Anne M. Johnson, Adriano Lazzarin, Nathan Clumeck, Frank-Detlef Goebel, Jean-Paul Viard, Jose Gatell, Anders Blaxhult, Jens D. Lundgren.  (1999) A Comparison of Exposure Groups in the EuroSIDA Study: Starting Highly Active Antiretroviral Therapy (HAART), Response to HAART, and Survival. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:4, 369<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199912010-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">944</p><p class="content">Amanda Mocroft, Sara Madge, Anne M. Johnson, Adriano Lazzarin, Nathan Clumeck, Frank-Detlef Goebel, Jean-Paul Viard, Jose Gatell, Anders Blaxhult, Jens D. Lundgren.  (1999) A Comparison of Exposure Groups in the EuroSIDA Study: Starting Highly Active Antiretroviral Therapy (HAART), Response to HAART, and Survival. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:4, 369<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199912010-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">945</p><p class="content">Gaetano Romano, Margaret Kasten, Giulia De Falco, Pietro Micheli, Kamel Khalili, Antonio Giordano.  (1999) Regulatory functions of Cdk9 and of cyclin T1 in HIV Tat transactivation pathway gene expression. <i><span class="NLM_source">Journal of Cellular Biochemistry</span></i> <b>75</b>:3, 357-368<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/(SICI)1097-4644(19991201)75:3&amp;lt;357::AID-JCB1&amp;gt;3.0.CO;2-K" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">946</p><p class="content">Noshena Khan, Shyamal R. Bastola, Kevin G. Witter, Peter Scheiner.  (1999) Diastereoselective synthesis of l-(+)-homolamivudine. <i><span class="NLM_source">Tetrahedron Letters</span></i> <b>40</b>:51, 8989-8992<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0040-4039(99)01935-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">947</p><p class="content">Barbara Greenberg, Alan Berkman, Rogelio Thomas, David Hoos, Ruth Finkelstein, Jacquie Astemborski, David Vlahov.  (1999) Evaluating supervised haart in late-stage HIV among drug users: A preliminary report. <i><span class="NLM_source">Journal of Urban Health</span></i> <b>76</b>:4, 468-480<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02351504" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">948</p><p class="content">Amy E. Weber, Raja Alakawaf, Julio S.G. Montaner, Michael V. O‚Shaughnessy, Robert S. Hogg.  (1999) Bitter pill: the current state of antiretroviral care in selected nations around the globe. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:17, 2480<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199912030-00024" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">949</p><p class="content">Felipe García, Joan Romeu, Inmaculada Grau, María Antonia Sambeat, David Dalmau, Hernado Knobel, Juan Luis Gomez-Sirvent, Julio Arrizabalaga, Anna Cruceta, Bonaventura Clotet, Daniel Podzamczer, Tomás Pumarola, Teresa Gallart, William A. O‚Brien, José M Miró, José M Gatell.  (1999) A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:17, 2377-2388<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199912030-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">950</p><p class="content">Marta Cabana, Bonaventura Clotet, Miguel-Angel Mart<img src="untitled" alt="" class="entityD">nez.  (1999) Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>59</b>:4, 480-490<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/(SICI)1096-9071(199912)59:4&amp;lt;480::AID-JMV10&amp;gt;3.0.CO;2-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">951</p><p class="content">Zelalem Temesgen, Alan J. Wright.  (1999) Antiretrovirals. <i><span class="NLM_source">Mayo Clinic Proceedings</span></i> <b>74</b>:12, 1284-1301<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.4065/74.12.1284" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">952</p><p class="content">Ivano Mezzaroma, Maurizio Carlesimo, Elena Pinter, Donatella Santini Muratori, Fiorella Di Sora, Flavia Chiarotti, Maria Giovanna Cunsolo, Giovanna Sacco, Fernando Aiuti.  (1999) Clinical and Immunologic Response without Decrease in Virus Load in Patients with AIDS after 24 Months of Highly Active Antiretroviral Therapy. <i><span class="NLM_source">Clinical Infectious Diseases</span></i> <b>29</b>:6, 1423-1430<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1086/313520" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">953</p><p class="content">Alessandra Viganò, Len Dally, Dorella Bricalli, Natascia Sala, Maria Pirillo, Marina Saresella, Daria Trabattoni, Stefano Vella, Mario Clerici, Nicola Principi.  (1999) Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection. <i><span class="NLM_source">The Journal of Pediatrics</span></i> <b>135</b>:6, 675-682<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0022-3476(99)70084-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">954</p><p class="content">Susan S Schiffman, Jennifer Zervakis, Elizabeth Shaio, Alison E Heald.  (1999) Effect of the nucleoside analogs zidovudine, didanosine, stavudine, and lamivudine on the sense of taste. <i><span class="NLM_source">Nutrition</span></i> <b>15</b>:11-12, 854-859<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0899-9007(99)00182-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">955</p><p class="content">Antonio Chiesi, Amanda Mocroft, Len G. Dally, Veronica Miller, Christine Katlama, Bruno Ledergerber, Court Pedersen, Andrew N. Phillips, Romano Arcieri, Jens D. Lundgren.  (1999) Regional survival differences across Europe In HIV-positive people: the EuroSIDA study. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:16, 2281-2288<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199911120-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">956</p><p class="content">Shaker Itani, John A. Bartlett.  (1999) STRATEGIES OF ANTIRETROVIRAL THERAPY IN ADULTS. <i><span class="NLM_source">Urologic Clinics of North America</span></i> <b>26</b>:4, 809-820<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0094-0143(05)70221-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">957</p><p class="content">Richard Elion, Sanjeev Kaul, Catherine Knupp, Myra Adler, Anne P. Cross, Lisa M. Dunkle, Thomas Kelleher.  (1999) The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection. <i><span class="NLM_source">Clinical Therapeutics</span></i> <b>21</b>:11, 1853-1863<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0149-2918(00)86733-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">958</p><p class="content">Katy H. P. Moore, Jo E. Barrett, Shuching Shaw, Gary E. Pakes, Richard Churchus, Anu Kapoor, Judy Lloyd, Michael G. Barry, David Back.  (1999) The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:16, 2239-2250<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199911120-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">959</p><p class="content">Surendra J. Chavan, Seetha L. Tamma, Mark Kaplan, Merril Gersten, Savita G. Pahwa.  (1999) Reduction in T Cell Apoptosis in Patients with HIV Disease Following Antiretroviral Therapy. <i><span class="NLM_source">Clinical Immunology</span></i> <b>93</b>:1, 24-33<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/clim.1999.4770" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">960</p><p class="content">Yves Benhamou, Marie Bochet, Vincent Di Martino, Frederic Charlotte, Felipe Azria, Anne Coutellier, Michel Vidaud, Fran<img src="untitled" alt="" class="entityD">ois Bricaire, Pierre Opolon, Christine Katlama, Thierry Poynard, .  (1999) Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. <i><span class="NLM_source">Hepatology</span></i> <b>30</b>:4, 1054-1058<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/hep.510300409" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">961</p><p class="content">A. Mocroft, CA. Sabin, M. Youle, L. Swaden, M. Tyrer, D. Wilson, S. Madge, MA. Johnson, AN. Phillips.  (1999) Changing treatment patterns among patients with HIV: Royal Free Hospital 1987-97. <i><span class="NLM_source">HIV Medicine</span></i> <b>1</b>:1, 32-39<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1468-1293.1999.00006.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">962</p><p class="content">Richard D. Moore, Richard E. Chaisson.  (1999) Natural history of HIV infection in the_era of combination antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:14, 1933-1942<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199910010-00017" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">963</p><p class="content">Valerio Tozzi, Pietro Balestra, Simonetta Galgani, Pasquale Narciso, Fabrizio Ferri, Gabriella Sebastiani, Carmelo D‚Amato, Cesare Affricano, Francesco Pigorini, Franca Maria Pau, Annapaola De Felici, Arrigo Benedetto.  (1999) Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:14, 1889-1897<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199910010-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">964</p><p class="content">Susan S Schiffman, Jennifer Zervakis, Sean Heffron, Alison E Heald.  (1999) Effect of protease inhibitors on the sense of taste. <i><span class="NLM_source">Nutrition</span></i> <b>15</b>:10, 767-772<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0899-9007(99)00152-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">965</p><p class="content">Andrew N. Phillips, Sophie Grabar, Jean-Michel Tassie, Dominique Costagliola, Jens D. Lundgren, Matthias Egger.  (1999) Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:15, 2075-2082<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199910220-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">966</p><p class="content">Jeffrey S.A Stringer, Sten H Vermund.  (1999) Prevention of mother-to-child transmission of HIV-1. <i><span class="NLM_source">Current Opinion in Obstetrics and Gynecology</span></i> <b>11</b>:5, 427-434<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00001703-199910000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">967</p><p class="content">William G. Powderly, Michael S. Saag, Sharon Chapman, George Yu, Barry Quart, Neil J. Clendeninn.  (1999) Predictors of optimal virological response to potent antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:14, 1873-1880<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199910010-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">968</p><p class="content">Hug, Naef, Bucher, Sponagel, Lehmann, Battegay.  (1999) Treatment for human immunodeficiency virus with indinavir may cause relevant urological side-effects, effectively treatable by rehydration. <i><span class="NLM_source">BJU International</span></i> <b>84</b>:6, 610-614<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1464-410x.1999.00263.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">969</p><p class="content">Soo Aleman, Ubaldo Visco-Comandini, Karin Lore, Anders Sonnerborg.  (1999) Long-Term Effects of Antiretroviral Combination Therapy on HIV Type 1 DNA Levels. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>15</b>:14, 1249-1254<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922299310142" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">970</p><p class="content">Neil E Bowles, Debra L Kearney, Jiyuan Ni, Antonio R Perez-Atayde, Mark W Kline, J.Timothy Bricker, Nancy A Ayres, Steven E Lipshultz, William T Shearer, Jeffrey A Towbin.  (1999) The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease. <i><span class="NLM_source">Journal of the American College of Cardiology</span></i> <b>34</b>:3, 857-865<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0735-1097(99)00264-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">971</p><p class="content">Kathryn Anastos, Leslie A. Kalish, Nancy Hessol, Barbara Weiser, Sandra Melnick, David Burns, Robert Delapenha, Jack DeHovitz, Mardge Cohen, William Meyer, James Bremer, Andrea Kovacs.  (1999) The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women‚s interagency HIV study. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:13, 1717-1726<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199909100-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">972</p><p class="content">A. D. McNaghten, Debra L. Hanson, Jeffery L. Jones, Mark S. Dworkin, John W. Ward.  (1999) Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:13, 1687-1695<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199909100-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">973</p><p class="content">Ole Kirk, Jens D. Lundgren, Court Pedersen, Henrik Nielsen, Jan Gerstoft.  (1999) Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:13, 1647-1651<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199909100-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">974</p><p class="content">Thierry Saint-Marc, Maria Partisani, Isabelle Poizot-Martin, Franck Bruno, Olivier Rouviere, Jean-Marie Lang, Jean-Albert Gastaut, Jean-Louis Touraine.  (1999) A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:13, 1659-1667<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199909100-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">975</p><p class="content">NIKOLA J. OSTROP, ELLEN BURGESS, M. JOHN GILL.  (1999) The Use of Antiretroviral Agents in Patients with Renal Insufficiency. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>13</b>:9, 517-526<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.1999.13.517" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">976</p><p class="content">Maria Dorrucci, Maria Balducci, Patrizio Pezzotti, Alessandro Sinicco, Francesco Alberici, Giovanni Rezza.  (1999) Temporal Changes in the Rate of Progression to Death Among Italians With Known Date of HIV Seroconversion: Estimates of the Population Effect of Treatment. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>22</b>:1, 65<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199909010-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">977</p><p class="content">Bruce K. Patterson, Dennis J. Carlo, Mark H. Kaplan, Maria Marecki, Savita Pawha, Ronald B. Moss.  (1999) Cell-associated HIV-1 messenger RNA and DNA in T-helper cell and monocytes in asymptomatic HIV-1-infected subjects on HAART plus an inactivated HIV-1 immunogen. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:13, 1607-1611<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199909100-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">978</p><p class="content">Duncan R. Churchill, Alexander S. Pym, Sarah Galpin, Russell Foxall, Chris Stainsby, John R. Clarke, Steve Kaye, Stuart Bloor, Brendan A. Larder, Ben Wills, Eugene Sun, Abdel G. Babiker, David J. Back, Jonathan N. Weber.  (1999) The Rabbit Study: Ritonavir and Saquinavir in Combination in Saquinavir-Experienced and Previously Untreated Patients. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>15</b>:13, 1181-1189<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922299310278" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">979</p><p class="content">Raffaele Bruno, P. Sacchi, S. F. A. Patruno, U. Luzio Paparatti, M. Font, P. Piacentini, F. Zara, P. Legnazzi, G. Filice.  (1999) HAART (zidovudina, lamivudina, indinavir): analisi dei costi in una popolazione di pazienti HIV positivi con conta linfocitaria CD4+ &lt; 200/mmc. <i><span class="NLM_source">PharmacoEconomics Italian Research Articles</span></i> <b>1</b>:1, 35-41<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF03320517" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">980</p><p class="content">Cynthia A. Derdeyn, Caroline Costello, J. Michael Kilby, Greg Sfakianos, Michael S. Saag, Richard Kaslow, R. Pat Bucy.  (1999) Correlation between Circulating Stromal Cell-Derived Factor 1 Levels and CD4+ Cell Count in Human Immunodeficiency Virus Type 1-Infected Individuals. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>15</b>:12, 1063-1071<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922299310359" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">981</p><p class="content">Deepali Kumar, Karl Parato, Ashok Kumar, Eugene Sun, D. William Cameron, Jonathan B. Angel.  (1999) Sustained Suppression of Plasma HIV RNA Is Associated with an Increase in the Production of Mitogen-Induced MIP-1alpha and MIP-1beta. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>15</b>:12, 1073-1077<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922299310368" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">982</p><p class="content">B. Rosenwirth, W.M.J.M. Bogers, I.G. Nieuwenhuis, P. Haaft, H. Niphuis, E.M. Kuhn, N. Bischofberger, V. Erfle, G. Sutter, P. Berglund, P. Liljestrom, K. Uberla, J.L. Heeney.  (1999) An anti-HIV strategy combining chemotherapy and therapeutic vaccination. <i><span class="NLM_source">Journal of Medical Primatology</span></i> <b>28</b>:4-5, 195-205<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1600-0684.1999.tb00270.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">983</p><p class="content">DOUGLAS C. WATSON, JOHN J. FARLEY.  (1999) Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. <i><span class="NLM_source">The Pediatric Infectious Disease Journal</span></i> <b>18</b>:8, 682-689<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00006454-199908000-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">984</p><p class="content">A. Mocroft, C. A. Sabin, M. Youle, S. Madge, M. Tyrer, H. Devereux, J. Deayton, A. Dykhoff, M. C. I. Lipman, A. N. Phillips, M. A. Johnson.  (1999) Changes in AIDS-Defining Illnesses in a London Clinic, 1987–1998. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>21</b>:5, 401<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199908150-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">985</p><p class="content">S Yerly, L Kaiser, E Race, J-P Bru, F Clavel, L Perrin.  (1999) Transmission of antiretroviral-drug-resistant HIV-1 variants. <i><span class="NLM_source">The Lancet</span></i> <b>354</b>:9180, 729<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(98)12262-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">986</p><p class="content">Kevin Rostasy, Laura Monti, Constantin Yiannoutsos, Michelle Kneissl, Jeanne Bell, Thomas L. Kemper, John C. Hedreen, Bradford A. Navia.  (1999) Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex. <i><span class="NLM_source">Annals of Neurology</span></i> <b>46</b>:2, 207-216<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/1531-8249(199908)46:2&amp;lt;207::AID-ANA10&amp;gt;3.0.CO;2-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">987</p><p class="content">Christian Pradier, Alain Pesce, Patrizia Carrieri, Jacqueline Cottalorda, Patrice Boyer, Christian Senesi, Jean-Gabriel Fuzibet, Pierre Dellamonica, Jill-Patrice Cassuto.  (1999) Effect of indinavir and higher CD4+ T-cell count on viral load response after 6 months of highly active Antiretroviral Therapy. <i><span class="NLM_source">Clinical Therapeutics</span></i> <b>21</b>:8, 1313-1320<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0149-2918(99)80032-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">988</p><p class="content">Herminia Palacio, Caroline H. Shiboski, Edward H. Yelin, Nancy A. Hessol, Ruth M. Greenblatt.  (1999) Access to and Utilization of Primary Care Services Among HIV-Infected Women. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>21</b>:4, 293<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199908010-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">989</p><p class="content">A. Mocroft, C. A. Sabin, M. Youle, S. Madge, M. Tyrer, H. Devereux, J. Deayton, A. Dykhoff, M. C. I. Lipman, A. N. Phillips, M. A. Johnson.  (1999) Changes in AIDS-Defining Illnesses in a London Clinic, 1987–1998. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes</span></i> <b>21</b>:5, 401<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199908150-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">990</p><p class="content">Serge Doan, Isabelle Cochereau, Nurhayat Guvenisik, Marie-Christine Diraison, Haı̈ssam Mousalatti, Thanh Hoang-Xuan.  (1999) Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy. <i><span class="NLM_source">American Journal of Ophthalmology</span></i> <b>128</b>:2, 250-251<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0002-9394(99)00102-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">991</p><p class="content">Jean-Marie Poirier, Pascal Robidou, Patrice Jaillon.  (1999) Determination of Indinavir in Plasma by Solid-phase Extraction and Column Liquid Chromatography. <i><span class="NLM_source">Therapeutic Drug Monitoring</span></i> <b>21</b>:4, 404-410<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00007691-199908000-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">992</p><p class="content">Hernan Valdez.  (1999) Immune reconstitution after combination antiretroviral therapy. <i><span class="NLM_source">Clinical Immunology Newsletter</span></i> <b>19</b>:8-9, 93-98<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0197-1859(00)88206-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">993</p><p class="content">G. Foulds, L. LaBoy-Goral, G.C.G. Wei, G. Apeseloff.  (1999) The Effect of Azithromycin on the Pharmacokinetics of Indinavir. <i><span class="NLM_source">Journal of Clinical Pharmacology</span></i> <b>39</b>:8, 842-847<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1177/00912709922008371" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">994</p><p class="content">Marinunzia Catucci, Giulietta Venturi, Laura Romano, Maria Letizia Riccio, Angelo De Milito, Pier E. Valensin, Maurizio Zazzi.  (1999) Development and Significance of the HIV-1 Reverse Transcriptase M184V Mutation During Combination Therapy With Lamivudine, Zidovudine, and Protease Inhibitors. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>21</b>:3, 203<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199907010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">995</p><p class="content">Ivano Mezzaroma, Maurizio Carlesimo, Elena Pinter, Cecilia Alario, Giovanna Sacco, Donatella Santini Muratori, Maria Livia Bernardi, Roberto Paganelli, Fernando Aiuti.  (1999) Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:10, 1187-1193<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199907090-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">996</p><p class="content">Abby H. Shevitz, Tamsin A. Knox, Donna Spiegelman, Ronenn Roubenoff, Sherwood L. Gorbach, Paul R. Skolnik.  (1999) Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:11, 1351-1357<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199907300-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">997</p><p class="content">Christophe Piketty, Esther Race, Philippe Castiel, Laurent Belec, Gilles Peytavin, Ali Si-Mohamed, Gustavo Gonzalez-Canali, Laurence Weiss, François Clavel, Michel D. Kazatchkine.  (1999) Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:11, F71-F77<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199907300-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">998</p><p class="content">Gregory J. Dore, Patricia K. Correll, Yueming Li, John M. Kaldor, David A. Cooper, Bruce J. Brew.  (1999) Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:10, 1249-1253<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199907090-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">999</p><p class="content">Zelalem Temesgen.  (1999) Overview of HIV infection. <i><span class="NLM_source">Annals of Allergy, Asthma &amp; Immunology</span></i> <b>83</b>:1, 1-7<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1081-1206(10)63503-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1000</p><p class="content">Stephen I. Pelton, Daniel Johnson, Ellen Chadwick, Zachary Baldwin, Ram Yogev.  (1999) A ONE YEAR EXPERIENCE: T CELL RESPONSES AND VIRAL REPLICATION IN CHILDREN WITH ADVANCED HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 DISEASE TREATED WITH COMBINATION THERAPY INCLUDING RITONAVIR. <i><span class="NLM_source">The Pediatric Infectious Disease Journal</span></i> <b>18</b>:7, 650-652<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00006454-199907000-00019" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1001</p><p class="content">Amanda Mocroft, Simon Barry, Caroline A. Sabin, Alessandro Cozzi Lepri, Sabine Kinloch, Anthony Drinkwater, Marc Lipman, Michael Youle, Margaret A. Johnson, Andrew N. Phillips.  (1999) The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:10, 1255-1261<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199907090-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1002</p><p class="content">Kevin E. Yarasheski, Pablo Tebas, Catherine Sigmund, Samuel Dagogo-Jack, Alan Bohrer, John Turk, Philippe A. Halban, Philip E. Cryer, William G. Powderly.  (1999) Insulin Resistance in HIV Protease Inhibitor–Associated Diabetes. <i><span class="NLM_source">JAIDS Journal of Acquired Immune Deficiency Syndromes</span></i> <b>21</b>:3, 209<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199907010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1003</p><p class="content">Achim Schwenk, Gisela Kremer, Oliver Cornely, Volker Diehl, Gerd Fätkenheuer, Bernd Salzberger.  (1999) Body weight changes with protease inhibitor treatment in undernourished HIV-infected patients. <i><span class="NLM_source">Nutrition</span></i> <b>15</b>:6, 453-457<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0899-9007(99)00083-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1004</p><p class="content">Lori A. Panther, Robert W. Coombs, Sandra A. Aung, Corazone dela Rosa, David Gretch, Lawrence Corey.  (1999) Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: Relative effect of recombinant CD4, zidovudine, and saquinavir in vitro. <i><span class="NLM_source">Journal of Medical Virology</span></i> <b>58</b>:2, 165-173<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/(SICI)1096-9071(199906)58:2&amp;lt;165::AID-JMV11&amp;gt;3.0.CO;2-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1005</p><p class="content">Guislaine Carcelain, Catherine Blanc, Jacques Leibowitch, Philippe Mariot, Dominique Mathez, Véronique Schneider, Adrien Gérard Saimot, Florence Damond, François Simon, Patrice Debré, Brigitte Autran, Pierre-Marie Girard.  (1999) T cell changes after combined nucleoside analogue therapy in HIV primary infection. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:9, 1077-1081<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199906180-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1006</p><p class="content">JULIO COLLAZOS, JOSE MAYO, EDUARDO MARTÍNEZ.  (1999) Changing Spectrum of HIV Infection and Its Associated Conditions in Spain: The End of the Beginning?. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>13</b>:6, 347-353<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.1999.13.347" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1007</p><p class="content">Angela Ibáñez, Teresa Puig, Johannes Elias, Bonaventura Clotet, Lidia Ruiz, Miguel-Angel Martínez.  (1999) Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:9, 1045-1049<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199906180-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1008</p><p class="content">Michael E. Jones.  (1999) HIV and the Returning Expatriate. <i><span class="NLM_source">Journal of Travel Medicine</span></i> <b>6</b>:2, 99-106<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1708-8305.1999.tb00840.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1009</p><p class="content"> (1999) Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised e vidence. <i><span class="NLM_source">The Lancet</span></i> <b>353</b>:9169, 2014-2025<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(98)12263-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1010</p><p class="content">Wenzhe Li, Robert W. Coombs, Ann C. Collier, Vidmantas A. Raisys.  (1999) Determination of Indinavir, A HIV-1 Protease Inhibitor, in Human Plasma Using Ion-pair Reversed-phase High-Performance Liquid Chromatography. <i><span class="NLM_source">Therapeutic Drug Monitoring</span></i> <b>21</b>:3, 360<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00007691-199906000-00021" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1011</p><p class="content">Richard H. Haubrich, Susan J. Little, Judith S. Currier, Donald N. Forthal, Carol A. Kemper, Gildon N. Beall, Debra Johnson, Michael P. Dubé, Jimmy Y. Hwanga, J. Allen McCutchan.  (1999) The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:9, 1099-1107<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199906180-00014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1012</p><p class="content">MURLI PURSWANI, ROSEMARY JOHANN-LIANG, JOSEPH CERVIA, GARY J. NOEL.  (1999) Effect of changing antiretroviral therapy on human immunodeficiency virus viral load: experience with fifty-four perinatally infected children. <i><span class="NLM_source">The Pediatric Infectious Disease Journal</span></i> <b>18</b>:6, 512-516<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00006454-199906000-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1013</p><p class="content">Edward P. Acosta, Keith Henry, Leslie Baken, Linda M. Page, Courtney V. Fletcher.  (1999) Indinavir Concentrations and Antiviral Effect. <i><span class="NLM_source">Pharmacotherapy</span></i> <b>19</b>:6, 708-712<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1592/phco.19.9.708.31544" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1014</p><p class="content">G.C. Mistry, A. Laurent, A.T. Sterrett, P.J. deutsch.  (1999) Effect of Indinavir on the Single-Dose Pharmacokinetics of Theophylline in Healthy Subjects. <i><span class="NLM_source">Journal of Clinical Pharmacology</span></i> <b>39</b>:6, 636-642<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1177/00912709922008146" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1015</p><p class="content"> Zhang ,  Linqi ,  Ramratnam ,  Bharat ,  Tenner-Racz ,  Klara ,  He ,  Yuxian ,  Vesanen ,  Mika ,  Lewin ,  Sharon ,  Talal ,  Andrew ,  Racz ,  Paul ,  Perelson ,  Alan S. ,  Korber ,  Bette T. ,  Markowitz ,  Martin ,  Guo ,  Yong ,  Duran ,  Margarita ,  Hurley ,  Arlene ,  Tsay ,  John ,  Huang ,  Yu-Ching ,  Wang ,  Chia-Ching ,  Ho ,  David D. , .  (1999) Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>340</b>:21, 1605-1613<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199905273402101">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199905273402101} --></span></p></li><li class="even"><p class="number">1016</p><p class="content">N Dupin, V Rubin De Cervens, I Gorin, V Calvez, E Pessis, M Grandadam, C Rabian, J P Viard, J M Huraux, J Escande.  (1999) The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma. <i><span class="NLM_source">British Journal of Dermatology</span></i> <b>140</b>:5, 875-881<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2133.1999.02818.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1017</p><p class="content">R. Pat Bucy, Richard D. Hockett, Cynthia A. Derdeyn, Michael S. Saag, Kathleen Squires, Michael Sillers, Ronald T. Mitsuyasu, J. Michael Kilby.  (1999) Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. <i><span class="NLM_source">Journal of Clinical Investigation</span></i> <b>103</b>:10, 1391-1398<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1172/JCI5863" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1018</p><p class="content">Dennis A. Revicki, Graeme Moyle, Hans-Jurgen Stellbrink, Chris Barker.  (1999) Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:7, 851-858<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199905070-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1019</p><p class="content">Mary Ann Chiasson, Louise Berenson, Wenhui Li, Steven Schwartz, Tejinder Singh, Susan Forlenza, Benjamin A. Mojica, Margaret A. Hamburg.  (1999) Declining HIV/AIDS Mortality in New York City. <i><span class="NLM_source">JAIDS: Journal of Acquired Immune Deficiency Syndromes</span></i> <b>21</b>:1, 59-64<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00126334-199905010-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1020</p><p class="content">Jeffrey S. Murray, Michael R. Elashoff, Lauren C. Iacono-Connors, Therese A. Cvetkovich, Kimberly A. Struble.  (1999) The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:7, 797-804<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199905070-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1021</p><p class="content">P. Richard Harrigana, Mark Whaley, Julio S.G. Montaner.  (1999) Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:8, F59-F62<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199905280-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1022</p><p class="content">Schlomo Staszewski, Veronica Miller, Caroline Sabin, Christine Schlecht, Peter Gute, Silke Stamm, Thomas Leder, Annemarie Berger, Eckhart Weidemann, Andrew Hill, Andrew Phillips.  (1999) Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:8, 951-956<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199905280-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1023</p><p class="content">Duncan Churchill, Jonathan Weber.  (1999) Measurement of plasma HIV viral load — Clinical applications. <i><span class="NLM_source">Journal of Infection</span></i> <b>38</b>:3, 147-150<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0163-4453(99)90241-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1024</p><p class="content">Frederick L. Altice, Gerald H. Friedland, Elizabeth L. Cooney.  (1999) Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:8, 957-962<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199905280-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1025</p><p class="content">Hoori C Hovanessian.  (1999) New Developments in the Treatment of HIV Disease: An Overview. <i><span class="NLM_source">Annals of Emergency Medicine</span></i> <b>33</b>:5, 546-555<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0196-0644(99)70341-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1026</p><p class="content">HOMER L. TWIGG, DIAA M. SOLIMAN, RICHARD B. DAY, KENNETH S. KNOX, RODNEY J. ANDERSON, DAVID S. WILKES, CAROL T. SCHNIZLEIN-BICK.  (1999) Lymphocytic Alveolitis, Bronchoalveolar Lavage Viral Load, and Outcome in Human Immunodeficiency Virus Infection. <i><span class="NLM_source">American Journal of Respiratory and Critical Care Medicine</span></i> <b>159</b>:5, 1439-1444<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1164/ajrccm.159.5.9808031" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1027</p><p class="content">John Cook, Erik Dasbach, Paul Coplan, Leona Markson, Dongping Yin, Anne Meibohm, Bach-Yen Nguyen, Jeffrey Chodakewitz, John Mellors.  (1999) Modeling the Long-Term Outcomes and Costs of HIV Antiretroviral Therapy Using HIV RNA Levels: Application to a Clinical Trial. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>15</b>:6, 499-508<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922299311024" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1028</p><p class="content"> Martin ,  Daniel F. ,  Kuppermann ,  Baruch D. ,  Wolitz ,  Richard A. ,  Palestine ,  Alan G. ,  Li ,  Hong ,  Robinson ,  Charles A. , the Roche Ganciclovir Study Group.  (1999) Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir Implant. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>340</b>:14, 1063-1070<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199904083401402">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199904083401402} --></span></p></li><li class="odd"><p class="number">1029</p><p class="content">Sarah Palmer, Robert W. Shafer, Thomas C. Merigan.  (1999) Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:6, 611-667<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199904160-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1030</p><p class="content">Graeme J Moyle.  (1999) Efavirenz: shifting the HAART paradigm in adult HIV-1 infection. <i><span class="NLM_source">Expert Opinion on Investigational Drugs</span></i> <b>8</b>:4, 473-486<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/13543784.8.4.473" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1031</p><p class="content">Peter P. Sendi, Heiner C. Bucher, Bruce A. Craig, Dominik Pfluger, Manuel Battegay.  (1999) Estimating AIDS-Free Survival in a Severely Immunosuppressed Asymptomatic HIV-Infected Population in the Era of Antiretroviral Triple Combination Therapy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>20</b>:4, 376-381<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199904010-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1032</p><p class="content">Marc Renaud, Christine Katlama, Alain Mallet, Vincent Calvez, Guislaine Carcelain, Roland Tubiana, Marc Jouan, Eric Caumes, Henri Agut, François Bricaire, Patrice Debré, Brigitte Autran.  (1999) Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:6, 669-676<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199904160-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1033</p><p class="content">Avidan U. Neumann, Roland Tubiana, Vincent Calvez, Catherine Robert, Tai-Sheng Li, Henri Agut, Brigitte Autran, Christine Katlama.  (1999) HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:6, 677-683<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199904160-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1034</p><p class="content"> (1999) An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:5, 565-573<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199904010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1035</p><p class="content">Steven G. Deeks, Frederick M. Hecht, Melinda Swanson, Tarek Elbeik, Richard Loftus, P. T. Cohen, Robert M. Grant.  (1999) HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:6, F35-F43<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199904160-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1036</p><p class="content">Marco Macchia, Guido Antonelli, Aldo Balsamo, Silvia Barontini, Federico Calvani, Daniela Gentili, Adriano Martinelli, Armando Rossello, Ombretta Turriziani, Ramon Tesoro.  (1999) Synthesis and HIV-1 inhibitory properties of new tetrahydrobenzoquinazolinedione and tetrahydrobenzocycloheptenuracil derivatives and of their thioxo analogues. <i><span class="NLM_source">Il Farmaco</span></i> <b>54</b>:4, 242-247<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0014-827X(99)00024-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1037</p><p class="content">Kari Williamson, Annette C. Reboli, Steven M. Manders.  (1999) Protease inhibitor–induced lipodystrophy. <i><span class="NLM_source">Journal of the American Academy of Dermatology</span></i> <b>40</b>:4, 635-636<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0190-9622(99)70452-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1038</p><p class="content">Richard L. Hengel, Bonnie M. Jones, M. Susan Kennedy, Marjorie R. Hubbard, J. Steven Mcdougal.  (1999) Lymphocyte Kinetics and Precursor Frequency-Dependent Recovery of CD4+CD45RA+CD62L+ Naive T Cells Following Triple-Drug Therapy for HIV Type 1 Infection. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>15</b>:5, 435-443<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922299311187" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1039</p><p class="content">A.R. Mackenzie, R.B.S. Laing, S.J. Urbaniak, P.J. Molyneaux, J.G. Douglas, C.C. Smith.  (1999) Epidemiology and outcome of HIV infection in North-East Scotland (1985–1997). <i><span class="NLM_source">Journal of Infection</span></i> <b>38</b>:2, 107-110<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0163-4453(99)90077-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1040</p><p class="content">Marc Vaillancourt, David Irlbeck, Terri Smith, Robert W. Coombs, Ronald Swanstrom.  (1999) The HIV Type 1 Protease Inhibitor Saquinavir Can Select for Multiple Mutations that Confer Increasing Resistance. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>15</b>:4, 355-363<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/088922299311321" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1041</p><p class="content">R.W. Shafer, D.A Vuitton.  (1999) Highly active antiretroviral therapy (Haart) for the treatment of infection with human immunodeficiency virus type 1. <i><span class="NLM_source">Biomedicine &amp; Pharmacotherapy</span></i> <b>53</b>:2, 73-86<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0753-3322(99)80063-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1042</p><p class="content">Anton L. Pozniak, Rob Miller, Peter L. Ormerod.  (1999) The treatment of tuberculosis in HIV-infected persons. <i><span class="NLM_source">Aids</span></i> <b>13</b>:4, 435-445<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199903110-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1043</p><p class="content">P. Bonfanti, A. Capetti, G. Rizzardini.  (1999) HIV disease treatment in the era of HAART. <i><span class="NLM_source">Biomedicine &amp; Pharmacotherapy</span></i> <b>53</b>:2, 93-105<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0753-3322(99)80066-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1044</p><p class="content">P. Vanhems, D. Baratin, C. Trépo, D. Peyramond, J. L. Touraine, E. Marceillac, J. Fabry.  (1999) Recent Dramatic Decrease in AIDS Cases and HIV-Related Deaths Contrasts With Stable Rate of New HIV-Positive Patients Detected in Lyon, France, From 1988 to 1997. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>20</b>:3, 316-317<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199903010-00017" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1045</p><p class="content">Ian C. Marschner, Rebecca A. Betensky, Victor DeGruttola, Scott M. Hammer, Daniel R. Kuritzkes.  (1999) Clinical Trials Using HIV-1 RNA-Based Primary Endpoints: Statistical Analysis and Potential Biases. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>20</b>:3, 220-227<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199903010-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1046</p><p class="content">Bruno Ledergerber, Matthias Egger, Milos Opravil, Amalio Telenti, Bernard Hirschel, Manuel Battegay, Pietro Vernazza, Philippe Sudre, Markus Flepp, Hansjakob Furrer, Patrick Francioli, Rainer Weber.  (1999) Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. <i><span class="NLM_source">The Lancet</span></i> <b>353</b>:9156, 863-868<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(99)01122-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1047</p><p class="content">Daniel R. Kaul, Sandro K. Cinti, Peggy L. Carver, Powel H. Kazanjian.  (1999) HIV Protease Inhibitors: Advances in Therapy and Adverse Reactions, Including Metabolic Complications. <i><span class="NLM_source">Pharmacotherapy</span></i> <b>19</b>:3, 281-298<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1592/phco.19.4.281.30937" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1048</p><p class="content">P. Morlat.  (1999) Avancées thérapeutiques vis-à-vis de l'infection VIH et implications pour la recherche clinique. <i><span class="NLM_source">La Revue de Médecine Interne</span></i> <b>20</b>:3, 217-219<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0248-8663(99)83048-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1049</p><p class="content">E. N. van Roon, J. M. Verzijl, J. R. Juttmann, A. W. Lenderink, M. J. Blans, A. C. G. Egberts.  (1999) Incidence of Discontinuation of Highly Active Antiretroviral Combination Therapy (HAART) and Its Determinants. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>20</b>:3, 290-294<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199903010-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1050</p><p class="content">Cristina Gervasoni, Anna Lisa Ridolfo, Giuliana Trifirò, Sara Santambrogio, Guido Norbiato, Massimo Musicco, Mario Clerici, Massimo Galli, Mauro Moroni.  (1999) Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. <i><span class="NLM_source">Aids</span></i> <b>13</b>:4, 465-471<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199903110-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1051</p><p class="content">Barton F. Haynes, Laura P. Hale, Kent J. Weinhold, Dhavalkumar D. Patel, Hua-Xin Liao, Peter B. Bressler, Dawn M. Jones, James F. Demarest, Kristin Gebhard-Mitchell, Ashley T. Haase, John A. Bartlett.  (1999) Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. <i><span class="NLM_source">Journal of Clinical Investigation</span></i> <b>103</b>:4, 453-460<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1172/JCI5201" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1052</p><p class="content"> Havlir ,  Diane V. ,  Barnes ,  Peter F. , .  (1999) Tuberculosis in Patients with Human Immunodeficiency Virus Infection. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>340</b>:5, 367-373<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199902043400507">Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199902043400507} --></span></p></li><li class="odd"><p class="number">1053</p><p class="content">Schlomo Staszewski, Veronica Miller, Caroline Sabin, Amina Carlebach, Anna-Marie Berger, Eckhart Weidmann, Eilke B. Helm, Andrew Hill, Andrew Phillips.  (1999) Virological response to protease inhibitor therapy in an HIV clinic cohort. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:3, 367-373<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902250-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1054</p><p class="content">Frédéric Martinon, Christian Michelet, Isabelle Peguillet, Yassine Taoufik, Philippe Lefebvre, Cécile Goujard, Jean-Gérard Guillet, Jean-François Delfraissy, Olivier Lantz.  (1999) Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:2, 185-194<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902040-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1055</p><p class="content">Eleftherios Mylonakis, Brian P. Dickinson, Maria D. Mileno, Timothy Flanigan, Fred J. Schiffman, Anthony Mega, Josiah D. Rich.  (1999) Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: Complete remission associated with highly active antiretroviral therapy. <i><span class="NLM_source">American Journal of Hematology</span></i> <b>60</b>:2, 164-166<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/(SICI)1096-8652(199902)60:2&amp;lt;164::AID-AJH16&amp;gt;3.0.CO;2-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1056</p><p class="content">Jonathan M. Schapiro, Mark A. Winters, Jody Lawrence, Thomas C. Merigan.  (1999) Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:3, 359-365<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902250-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1057</p><p class="content">Y Gérard, L Maulin, L Dubreuil, Y Mouton.  (1999) Inhibiteurs de protéase du VIH : interactions médicamenteuses. <i><span class="NLM_source">La Revue de Médecine Interne</span></i> <b>20</b>:2, 141-150<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0248-8663(99)83031-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1058</p><p class="content">William Cameron, Anthony J. Japour, Yi Xu, Ann Hsu, John Mellors, Charles Farthing, Calvin Cohen, Donald Poretz, Martin Markowitz, Steve Follansbee, Jonathan B. Angel, Deborah McMahon, David Ho, Viswanath Devanarayan, Richard Rode, Miklos P. Salgo, Dale J. Kempf, Richard Granneman, John M. Leonard, Eugene Sun.  (1999) Ritonavir and saquinavir combination therapy for the treatment of HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:2, 213-224<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902040-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1059</p><p class="content">Norbert A. Foudraine, Egbert Hovenkamp, Daan W. Notermans, Pieter L. Meenhorst, Michèl R. Klein, Joep M.A. Lange, Frank Miedema, Peter Reiss.  (1999) Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:2, 177-184<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902040-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1060</p><p class="content">Pablo Tebas, Amy K. Patick, Ellen M. Kane, Michael K. Klebert, Janet H. Simpson, Alejo Erice, William G. Powderly, Keith Henry.  (1999) Virologic responses to a ritonavir-saquinavir-containing regimen in patients who had previously failed nelfinavir. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:2, F23-F28<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902040-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1061</p><p class="content">Veronica Miller, Schlomo Staszewski, Gabriella Nisius, Alessandro Cozzi Lepri, Caroline Sabin, Andrew N Phillips.  (1999) Risk of new AIDS diseases in people on triple therapy. <i><span class="NLM_source">The Lancet</span></i> <b>353</b>:9151, 463<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(98)04954-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1062</p><p class="content">Joel Blankson, Deborah Persaud, Robert F. Siliciano.  (1999) Latent reservoirs for HIV-1. <i><span class="NLM_source">Current Opinion in Infectious Diseases</span></i> <b>12</b>:1, 5-11<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00001432-199902000-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1063</p><p class="content">Carol Dukes Hamilton.  (1999) Recent developments in epidemiology, treatment, and diagnosis of tuberculosis. <i><span class="NLM_source">Current Infectious Disease Reports</span></i> <b>1</b>:1, 80-88<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/s11908-999-0014-6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1064</p><p class="content">Gary Marks, Scott Burris, Thomas A. Peterman.  (1999) Reducing sexual transmission of HIV from those who know they are infected: the need for personal and collective responsibility. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:3, 297-306<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902250-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1065</p><p class="content">Simon Paul, Holly M. Gilbert, Wendy Ziecheck, Jonathan Jacobs, Kent A. Sepkowitz.  (1999) The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:3, 415-418<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902250-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1066</p><p class="content">Patrizio Pezzotti, Pier Angela Napoli, Serenella Acciai, Stefano Boros, Roberta Urciuoli, Vera Lazzeri, Giovanni Rezza.  (1999) Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:2, 249-255<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199902040-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1067</p><p class="content">Philip Keiser, Mary Beth Kvanli, Dianna Turner, Joan Reisch, James W. Smith, Naiel Nassar, Clark Gregg, Daniel Skiest.  (1999) Protease Inhibitor-Based Therapy Is Associated With Decreased HIV-Related Health Care Costs in Men Treated at a Veterans Administration Hospital. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>20</b>:1, 28-33<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199901010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1068</p><p class="content">Cecilia Simonelli, Stefania Zanussi, Simonetta Sandri, Manola Comar, Antonio Lucenti, Renato Talamini, Maria Teresa Bortolin, Mauro Giacca, Paolo De Paoli, Umberto Tirelli.  (1999) Concomitant Therapy With Subcutaneous Interleukin-2 and Zidovudine Plus Didanosine in Patients With Early Stage HIV Infection. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>20</b>:1, 20-27<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199901010-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1069</p><p class="content">Isabelle Thuret, Gerard Michel, Hervé Chambost, Catherine Tamalet, Patricia Giraud, Corinne Brunet, Henri Perrimond.  (1999) Combination antiretroviral therapy including ritonavir in children infected with human immunodeficiency. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:1, 81-87<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199901140-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1070</p><p class="content">T.T.Y. HO, K.C.W. CHAN, K.H. WONG, S.S. LEE.  (1999) Indinavir-Associated Facial Lipodystrophy in HIV-Infected Patients. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>13</b>:1, 11-16<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.1999.13.11" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1071</p><p class="content">O. O. Aalen, V. T. Farewell, D. De Angelis, N. E. Day, O. N. Gill.  (1999) New therapy explains the fall in AIDS incidence with a substantial rise in number of persons on treatment expected. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:1, 103-108<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199901140-00014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1072</p><p class="content">Steven Forsythe, Charles Gilks.  (1999) Economic issues and antiretroviral therapy in developing countries. <i><span class="NLM_source">Transactions of the Royal Society of Tropical Medicine and Hygiene</span></i> <b>93</b>:1, 1-3<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0035-9203(99)90157-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1073</p><p class="content">Mauro Schechter, Cláudio J. Struchiner, Lee H. Harrison.  (1999) Protease inhibitors as initial therapy for individuals with an intermediate risk of HIV disease progression: is more necessarily better?. <i><span class="NLM_source">AIDS</span></i> <b>13</b>:1, 97-102<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199901140-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1074</p><p class="content">Manuel Battegay, Thomas Harr, Lucas Sponagel.  (1999) Salvage treatment against human immunodeficiency virus. <i><span class="NLM_source">Annals of Medicine</span></i> <b>31</b>:4, 253-260<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.3109/07853899908995888" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1075</p><p class="content">Mark P Wallis, Naheed Mahmood, William Fraser.  (1999) Synthesis and anti-HIV activity of C4-modified pyrimidine nucleosides. <i><span class="NLM_source">Il Farmaco</span></i> <b>54</b>:1-2, 83-89<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0014-827X(98)00107-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1076</p><p class="content">A.N. Phillips. HIV Dynamics. In: HIV and the New Viruses. Elsevier, 1999:59-74.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-012200741-5/50006-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1077</p><p class="content">Ian V.D. Weller. The Impact of Antiviral Therapy on HIV Disease. In: HIV and the New Viruses. Elsevier, 1999:189-206.<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/B978-012200741-5/50014-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1078</p><p class="content">Peiyuan Wang, Joon H Hong, John S Cooperwood, Chung K Chu.  (1998) Recent advances in l-nucleosides: chemistry and biology. <i><span class="NLM_source">Antiviral Research</span></i> <b>40</b>:1-2, 19-44<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(98)00041-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1079</p><p class="content">Douglas A. Jabs, Stephen G. Bolton, J.P. Dunn, Alan G. Palestine.  (1998) Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. <i><span class="NLM_source">American Journal of Ophthalmology</span></i> <b>126</b>:6, 817-822<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0002-9394(98)00285-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1080</p><p class="content">M. Battegay, M. Wirz, M. H. Steuerwald, M. Egger, M. Egger.  (1998) Early participation in an HIV cohort study slows disease progression and improves survival. <i><span class="NLM_source">Journal of Internal Medicine</span></i> <b>244</b>:6, 479-487<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1111/j.1365-2796.1998.00392.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1081</p><p class="content">Julio SG Montaner, Robert Hogg, Janet Raboud, Richard Harrigan, Michael O'Shaughnessy.  (1998) Antiretroviral treatment in 1998. <i><span class="NLM_source">The Lancet</span></i> <b>352</b>:9144, 1919-1922<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(98)07532-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1082</p><p class="content">Pilar Miralles, Juan Berenguer, Darío García de Viedma, Belén Padilla, Jaime Cosin, Juan Carlos López-Bernaldo de Quirós, Lucía Muñoz, Santiago Moreno, Emilio Bouza.  (1998) Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:18, 2467-2472<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199818000-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1083</p><p class="content">Barton F. Haynes, Laura P. Hale.  (1998) The human thymus. <i><span class="NLM_source">Immunologic Research</span></i> <b>18</b>:3, 175-192<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02788778" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1084</p><p class="content">Keith Henry, Alejo Erice, Camlin Tierney, Henry H. Balfour, Margaret A. Fischl, Anne Kmack, Song-Heng Liou, Antoinette Kenton, Martin S. Hirsch, John Phair, Ana Martinez, James O. Kahn.  (1998) A Randomized, Controlled, Double-Blind Study Comparing the Survival Benefit of Four Different Reverse Transcriptase Inhibitor Therapies (Three-Drug, Two-Drug, and Alternating Drug) for the Treatment of Advanced AIDS. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>19</b>:4, 339-349<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199812010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1085</p><p class="content">Karim Boubaker, Philippe Sudre, Frank Bally, Gerard Vogel, Jean-Yves Meuwly, Michel P. Glauser, Amalio Telenti.  (1998) Changes in renal function associated with indinavir. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:18, F249-F254<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199818000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1086</p><p class="content">XIAOYAN ZHANG, YASUMASA IWATANI, TAKASHI SHIMAYA, RYO YAMADA, ATSUSHI KOITO, YOUNONG XU, HIROYUKI SAKAI, TAKASHI UCHIYAMA, TOSHIO HATTORI.  (1998) Phosphorothioate Hammerhead Ribozymes Targeting a Conserved Sequence in the V3 Loop Region Inhibit HIV-1 Entry. <i><span class="NLM_source">Antisense and Nucleic Acid Drug Development</span></i> <b>8</b>:6, 441-450<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/oli.1.1998.8.441" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1087</p><p class="content">Sharon B. Brodie, Marla J. Keller, Bruce M. Ewenstein, Paul E. Sax.  (1998) Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:18, 2433-2437<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199818000-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1088</p><p class="content">Donna B. Jeffe, Karen L. Meredith, Linda M. Mundy, Victoria J. Fraser.  (1998) Factors Associated With HIV-Infected Patients' Recognition and Use of HIV Medications. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>19</b>:4, 350-360<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199812010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1089</p><p class="content">Xiaoqi Chen, Dale J. Kempf, Hing L. Sham, Brian E. Green, Akhteruzaman Molla, Marina Korneyeva, Sudthida Vasavanonda, Norman E. Wideburg, Ayda Saldivar, Kennan C. Marsh, Edith McDonald, Daniel W. Norbeck.  (1998) Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands. <i><span class="NLM_source">Bioorganic &amp; Medicinal Chemistry Letters</span></i> <b>8</b>:24, 3531-3536<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0960-894X(98)00653-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1090</p><p class="content">WEN-ZHE HO, JIAN-PING LAI, MOHAMAD BOUHAMDAN, LINGXUN DUAN, ROGER J. POMERANTZ, STUART E. STARR.  (1998) Inhibition of HIV Type 1 Replication in Chronically Infected Monocytes and Lymphocytes by Retrovirus-Mediated Gene Transfer of Anti-Rev Single-Chain Variable Fragments. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>14</b>:17, 1573-1580<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.1998.14.1573" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1091</p><p class="content">Louis Bernard, Gilles Peytavin, Albert Vuagnat, Pierre de Truchis, Christian Perronne.  (1998) Indinavir concentrations in hair from patients receiving highly active antiretroviral therapy. <i><span class="NLM_source">The Lancet</span></i> <b>352</b>:9142, 1757-1758<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(05)79831-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1092</p><p class="content">Göran Bratt, Anders Karlsson, Ann-Charlotte Leandersson, Jan Albert, Britta Wahren, Eric Sandström.  (1998) Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:16, 2193-2202<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199816000-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1093</p><p class="content">J. Michael Kilby, Sam Hopkins, Thomas M. Venetta, Betty DiMassimo, Gretchen A. Cloud, Jeannette Y. Lee, Leslie Alldredge, Eric Hunter, Dennis Lambert, Dani Bolognesi, Thomas Matthews, M. Ross Johnson, Martin A. Nowak, George M. Shaw, Michael S. Saag.  (1998) Potent suppression of HIV-1 replication in humans by T-20,  a peptide
inhibitor of gp41-mediated virus entry. <i><span class="NLM_source">Nature Medicine</span></i> <b>4</b>:11, 1302-1307<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/3293" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1094</p><p class="content">JOHN STANSELL, JAMES M. BARRETT, ELIZABETH HAMEL, DIANE LAPINS, RICHARD DALY.  (1998) Impact of Protease Inhibitor—Containing Antiretroviral Therapy on Healthcare Costs of HIV-Infected Patients in a Multisite U.S. Sample. <i><span class="NLM_source">Disease Management</span></i> <b>1</b>:6, 269-276<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/dis.1998.1.269" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1095</p><p class="content">Geneviève Chêne, Christine Binquet, Jean-François Moreau, Didier Neau, Isabelle Pellegrin, Denis Malvy, Joël Ceccaldi, Denis Lacoste, François Dabis.  (1998) Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:17, 2313-2320<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199817000-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1096</p><p class="content">Mina John, James Flexman, Martyn A.H. French.  (1998) Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:17, 2289-2293<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199817000-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1097</p><p class="content">Amanda Mocroft, M John Gill, William Davidson, Andrew N. Phillips.  (1998) Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:16, 2161-2167<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199816000-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1098</p><p class="content">JULIO COLLAZOS, JOSE MAYO, EDUARDO MARTÍNEZ.  (1998) Hospitalization Parameters in Patients Infected with HIV: An Analysis of the Period 1992-1997. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>12</b>:11, 861-866<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.1998.12.861" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1099</p><p class="content">Samuel R. Friedman, Mark A. Wainberg, Ernest Drucker.  (1998) Therapeutic ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medications. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:16, 2089-2093<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199816000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1100</p><p class="content">Robert S. Hogg, Amy E. Weber, Kevin J.P. Craib, Aslam H. Anis, Michael V. OʼShaughnessy, Martin T. Schechter, Julio S.G. Montaner.  (1998) One world, one hope. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:16, 2203-2209<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199816000-00016" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1101</p><p class="content">A Mocroft, S Vella, TL Benfield, A Chiesi, V Miller, P Gargalianos, A d'Arminio Monforte, I Yust, JN Bruun, AN Phillips, JD Lundgren.  (1998) Changing patterns of mortality across Europe in patients infected with HIV-1. <i><span class="NLM_source">The Lancet</span></i> <b>352</b>:9142, 1725-1730<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(98)03201-2" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1102</p><p class="content"> Havlir ,  Diane V. ,  Marschner ,  Ian C. ,  Hirsch ,  Martin S. ,  Collier ,  Ann C. ,  Tebas ,  Pablo ,  Bassett ,  Roland L. ,  Ioannidis ,  John P.A. ,  Holohan ,  M.K. ,  Leavitt ,  Randi ,  Boone ,  Gloria ,  Richman ,  Douglas D. , .  (1998) Maintenance Antiretroviral Therapies in HIV-Infected Subjects with Undetectable Plasma HIV RNA after Triple-Drug Therapy. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>339</b>:18, 1261-1268<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199810293391801">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199810293391801} --></span></p></li><li class="odd"><p class="number">1103</p><p class="content"> Pialoux ,  Gilles ,  Raffi ,  François ,  Brun-Vezinet ,  Françoise ,  Meiffrédy ,  Vincent ,  Flandre ,  Philippe ,  Gastaut ,  Jean-Albert ,  Dellamonica ,  Pierre ,  Yeni ,  Patrick ,  Delfraissy ,  Jean-François ,  Aboulker ,  Jean-Pierre , .  (1998) A Randomized Trial of Three Maintenance Regimens Given after Three Months of Induction Therapy with Zidovudine, Lamivudine, and Indinavir in Previously Untreated HIV-1–Infected Patients. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>339</b>:18, 1269-1276<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199810293391802">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199810293391802} --></span></p></li><li class="even"><p class="number">1104</p><p class="content"> Cooper ,  David A. ,  Emery ,  Sean , .  (1998) Therapeutic Strategies for HIV Infection — Time to Think Hard. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>339</b>:18, 1319-1321<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199810293391810">Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199810293391810} --></span></p></li><li class="odd"><p class="number">1105</p><p class="content">CLAY SMITH, SCOTT LILLY, G. DIEGO MIRALLES.  (1998) <b>Minireview</b>
              : Treatment of HIV Infection with Cytoreductive Agents. <i><span class="NLM_source">AIDS Research and Human Retroviruses</span></i> <b>14</b>:15, 1305-1313<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/aid.1998.14.1305" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1106</p><p class="content">Schlomo Staszewski, Ralph DeMasi, Andrew M. Hill, Debra Dawson.  (1998) HIV-1 RNA, CD4 cell count and the risk of progression to AIDS and death during treatment with HIV-1 reverse transcriptase inhibitors. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:15, 1991-1997<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199815000-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1107</p><p class="content">Christian Michelet, Cedric Arvieux, Cecile François, Jean Marc Besnier, Jean Philippe Rogez, Jean Philippe Breux, Faouzi Souala, Clotilde Allavena, François Raffi, Michel Garre, François Cartier.  (1998) Opportunistic infections occurring during highly active antiretroviral treatment. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:14, 1815-1822<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199814000-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1108</p><p class="content">Barton F. Haynes, Laura P. Hale.  (1998) The human thymus. <i><span class="NLM_source">Immunologic Research</span></i> <b>18</b>:2, 61-78<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02788750" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1109</p><p class="content">Michael D. Hughes, Michael J. Daniels, Margaret A. Fischl, Soyeon Kim, Robert T. Schooley.  (1998) CD4 cell count as a surrogate endpoint in HIV clinical trials. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:14, 1823-1832<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199814000-00014" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1110</p><p class="content">Franck Carbonnel, Caroline Maslo, Laurent Beaugerie, Fabrice Carrat, Edith Wirbel, Christian Aussel, Jean Gérard Gobert, Pierre Marie Girard, Jean Pierre Gendre, Jacques Cosnes, Willy Rozenbaum.  (1998) Effect of indinavir on HIV-related wasting. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:14, 1777-1784<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199814000-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1111</p><p class="content">Joseph J. Eron, Pietro L. Vernazza, David M. Johnston, Françoise Seillier-Moiseiwitsch, Timothy M. Alcorn, Susan A. Fiscus, Myron S. Cohen.  (1998) Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:15, F181-F189<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199815000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1112</p><p class="content">Jose L. Casado, Maria J. Perez-Elías, Paloma Martí-Belda, Antonio Antela, Marta Suarez, Esther Ciancas, Begoña Frutos, Maria D. Perez, Antonio Guerrero.  (1998) Improved Outcome of Cytomegalovirus Retinitis in AIDS Patients After Introduction of Protease Inhibitors. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>19</b>:2, 130-134<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199810010-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1113</p><p class="content">BRUCE L. LEVINE, JULIO COTTE, CAROLYNN C. SMALL, RICHARD G. CARROLL, JAMES L. RILEY, WENDY B. BERNSTEIN, DENNIS E. VAN EPPS, R. ALAN HARDWICK, CARL H. JUNE.  (1998) Large-Scale Production of CD4+ T Cells from HIV-1-Infected Donors After CD3/CD28 Costimulation*. <i><span class="NLM_source">Journal of Hematotherapy</span></i> <b>7</b>:5, 437-448<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/scd.1.1998.7.437" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1114</p><p class="content">Thomas G Evans, William Bonnez, Harold R Soucier, Theresa Fitzgerald, David C Gibbons, Richard C Reichman.  (1998) Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells. <i><span class="NLM_source">Antiviral Research</span></i> <b>39</b>:3, 163-173<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(98)00035-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1115</p><p class="content">Ole Kirk, Amanda Mocroft, Terese L. Katzenstein, Adriano Lazzarin, Francisco Antunes, Patrick Francioli, Ray P. Brettle, Jacqueline M. Parkin, Juan Gonzales-Lahoz, Jens D. Lundgren.  (1998) Changes in use of antiretroviral therapy in regions of Europe over time. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:15, 2031-2039<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199815000-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1116</p><p class="content">Olivia Keita-Perse, Pierre-Marie Roger, Christian Pradier, Pascal Pugliese, Jacqueline Cottalorda, Pierre Dellamonica.  (1998) Do viral load and CD8 cell count at initiation of tritherapy influence the increase of CD4 T-cell count?. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:15, F175-F179<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199815000-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1117</p><p class="content">Stephen Kravcik, Gary Victor, Sandra Houston, Donald Sutherland, Gary E. Garber, Nanci Hawley-Foss, Jonathan B. Angel, D. William Cameron.  (1998) Effect of Antiretroviral Therapy and Viral Load on the Perceived Risk of HIV Transmission and the Need for Safer Sexual Practices. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>19</b>:2, 124-129<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199810010-00004" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1118</p><p class="content">Antonella dʼArminio Monforte, Letizia Testa, Fulvio Adorni, Elisabetta Chiesa, Teresa Bini, G Carla Moscatelli, Clara Abeli, Stefano Rusconi, Salvatore Sollima, Claudia Balotta, Massimo Musicco, Massimo Galli, Mauro Moroni.  (1998) Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:13, 1631-1637<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199813000-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1119</p><p class="content">Gilbert R. Kaufmann, Chris Duncombe, Philip Cunningham, Alexander Beveridge, Andrew Carr, David Sayer, Martyn French, David A. Cooper.  (1998) Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:13, 1625-1630<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199813000-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1120</p><p class="content">Valerie E. Stone, Jennifer Clarke, Joan Lovell, Kathleen A. Steger, Lisa R. Hirschhorn, Stephen Boswell, Alicia D. Monroe, Michael D. Stein, Tamra J. Tyree, Kenneth H. Mayer.  (1998) HIV/AIDS Patients' Perspectives on Adhering to Regimens Containing Protease Inhibitors. <i><span class="NLM_source">Journal of General Internal Medicine</span></i> <b>13</b>:9, 586-593<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1525-1497.1998.00180.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1121</p><p class="content">Carmen Vidal, Felipe García, José María Gatell, Manuel Leal, Bonaventura Clotet, Tomás Pumarola, José María Miró, José Mallolas, Lídia Ruiz, Anna Cruceta, Cecilia Tortajada.  (1998) Predictive Factors Influencing Peak Viral Load Drop in Response to Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral-Naive HIV-1-Infected Patients. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>19</b>:1, 55-60<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199809010-00009" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1122</p><p class="content">Marisela Silva, Paul R. Skolnik, Sherwood L. Gorbach, Donna Spiegelman, Ira B. Wilson, M Gabriela Fernández-DiFranco, Tamsin A. Knox.  (1998) The effect of protease inhibitors on weight and body composition in HIV-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:13, 1645-1651<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199813000-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1123</p><p class="content">Courtney V. Fletcher, Edward P. Acosta, Keith Henry, Linda M. Page, Cynthia R. Gross, Sagar P. Kawle, Rory P. Remmel, Alejo Erice, Henry H. Balfour.  (1998) Concentration-controlled zidovudine therapy*. <i><span class="NLM_source">Clinical Pharmacology &amp; Therapeutics</span></i> <b>64</b>:3, 331-338<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0009-9236(98)90182-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1124</p><p class="content">Robert T. Dodge, Kenneth W. Shipp, G. Diego Miralles.  (1998) Improved gastrointestinal tolerance and palatability of didanosine in adults by the use of pediatric powder formulation. <i><span class="NLM_source">Journal of the Association of Nurses in AIDS Care</span></i> <b>9</b>:5, 27-31<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1055-3290(98)80030-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1125</p><p class="content">G J. Moyle, J Gill, M Nelson.  (1998) Once weekly azithromycin as prophylaxis against recurrence of non-tuberculous mycobacterial infections in HIV-1-positive individuals. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:12, 1555-1557<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199812000-00022" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1126</p><p class="content">Adriana Ammassari, Giancarlo Scoppettuolo, Rita Murri, Patrizio Pezzotti, Antonella Cingolani, Cosmo Del Borgo, Andrea De Luca, Andrea Antinori, Luigi Ortona.  (1998) Changing Disease Patterns in Focal Brain Lesion-Causing Disorders in AIDS. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>18</b>:4, 365-371<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199808010-00008" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1127</p><p class="content">Ahmed M. Bayoumi, Donald A. Redelmeier.  (1998) Preventing Mycobacterium avium complex in patients who are using protease inhibitors. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:12, 1503-1512<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199812000-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1128</p><p class="content">Howard L. Minkoff.  (1998) Human immunodeficiency virus infection in pregnancy. <i><span class="NLM_source">Seminars in Perinatology</span></i> <b>22</b>:4, 293-308<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0146-0005(98)80018-9" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1129</p><p class="content">Isabelle Heard, Valérie Schmitz, Dominique Costagliola, Gérard Orth, Michel D. Kazatchkine.  (1998) Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:12, 1459-1464<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199812000-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1130</p><p class="content">Rosemary Spira, Catherine Marimoutou, Christine Binquet, Denis Lacoste, François Dabis.  (1998) Rapid Change in the Use of Antiretroviral Agents and Improvement in a Population of HIV-Infected Patients: France, 1995 to 1997. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>18</b>:4, 358-364<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199808010-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1131</p><p class="content">W Edward Robinson.  (1998) l-Chicoric acid, an inhibitor of human immunodeficiency virus type 1 (HIV-1) integrase, improves on the in vitro anti-HIV-1 effect of Zidovudine plus a protease inhibitor (AG1350). <i><span class="NLM_source">Antiviral Research</span></i> <b>39</b>:2, 101-111<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(98)00037-0" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1132</p><p class="content"> Cohen ,  Oren J. ,  Fauci ,  Anthony S. , .  (1998) Transmission of Multidrug-Resistant Human Immunodeficiency Virus — The Wake-Up Call. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>339</b>:5, 341-343<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199807303390511">Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199807303390511} --></span></p></li><li class="odd"><p class="number">1133</p><p class="content"> Hecht ,  Frederick M. ,  Grant ,  Robert M. ,  Petropoulos ,  Christos J. ,  Dillon ,  Beth ,  Chesney ,  Margaret A. ,  Tian ,  Huan ,  Hellmann ,  Nicholas S. ,  Bandrapalli ,  Nirmala I. ,  Digilio ,  Laura ,  Branson ,  Bernard ,  Kahn ,  James O. , .  (1998) Sexual Transmission of an HIV-1 Variant Resistant to Multiple Reverse-Transcriptase and Protease Inhibitors. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>339</b>:5, 307-311<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199807303390504">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199807303390504} --></span></p></li><li class="even"><p class="number">1134</p><p class="content">T.-W. Chun, D. Engel, M. M. Berrey, T. Shea, L. Corey, A. S. Fauci.  (1998) Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection. <i><span class="NLM_source">Proceedings of the National Academy of Sciences</span></i> <b>95</b>:15, 8869-8873<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1073/pnas.95.15.8869" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1135</p><p class="content">Wayne A. Marasco, SiYi Chen, Jennifer H. Richardson, Urban Ramstedt, Susan Dana Jones.  (1998) Intracellular Antibodies Against HIV-1 Envelope Protein for AIDS Gene Therapy. Dana Farber Cancer Institute, Boston, Massachusetts. <i><span class="NLM_source">Human Gene Therapy</span></i> <b>9</b>:11, 1627-1642<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/hum.1998.9.11-1627" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1136</p><p class="content">J M. Guardiola, M A. Mangues, P Domingo, E Martínez, J L. Barrio.  (1998) Indinavir pharmacokinetics in haemodialysis-dependent end-stage renal failure. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:11, 1395<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199811000-00025" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1137</p><p class="content">Paul C. Bellman.  (1998) Clinical experience with adding delavirdine to combination therapy in patients in whom multiple antiretroviral treatment including protease inhibitors has failed. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:11, 1333-1340<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199811000-00015" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1138</p><p class="content">Brian Gazzard, Graeme Graeme.  (1998) 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. <i><span class="NLM_source">The Lancet</span></i> <b>352</b>:9124, 314-316<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(98)04084-7" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1139</p><p class="content">M. V. RAGNI.  (1998) Progression of HIV in haemophilia. <i><span class="NLM_source">Haemophilia</span></i> <b>4</b>:4, 601-609<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2516.1998.440601.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1140</p><p class="content">Sylvain Fleury, Rob J. De Boer, G. Paolo Rizzardi, Katja C. Wolthers, Sigrid A. Otto, Craig C. Welbon, Cecilia Graziosi, Christian Knabenhans, Hugo Soudeyns, Piere-Alexander Bart, Serge Gallant, Jean-Marc Corpataux, Michel Gillet, Pascal Meylan, Pierre Schnyder, Jean-Yves Meuwly, William Spreen, Michel P. Glauser, Frank Miedema, Giuseppe Pantaleo.  (1998) Limited CD4+ T-cell renewal in early HIV-1 infection: Effect of highly active antiretroviral therapy. <i><span class="NLM_source">Nature Medicine</span></i> <b>4</b>:7, 794-801<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1038/nm0798-794" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1141</p><p class="content">S. VELLA.  (1998) HIV treatment - a rational approach to the use of antiretroviral agents. <i><span class="NLM_source">Haemophilia</span></i> <b>4</b>:4, 616-618<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2516.1998.440616.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1142</p><p class="content"> (1998) Long-term follow-up of randomized trials of immediate versus deferred zidovudine in symptom-free HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:11, 1259???1265<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199811000-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1143</p><p class="content">Gerrit J. Weverling, Joep M.A. Lange, Suzanne Jurriaans, Jan M. Prins, Vladimir V. Lukashov, Daan W. Notermans, Marijke Roos, Hanneke Schuitemaker, Richard M.W. Hoetelmans, Sven A. Danner, Jaap Goudsmit, Frank de Wolf.  (1998) Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:11, F117-F122<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199811000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1144</p><p class="content">Alessandro Cozzi Lepri, George Davey Smith, Amanda Mocroft, Caroline A. Sabin, Richard W. Morris, Andrew N. Phillips.  (1998) A practical approach to adjusting for attrition bias in HIV clinical trials with serial marker responses. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:10, 1155-1161<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199810000-00007" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1145</p><p class="content">Akhteruzzaman Molla, G Richard Granneman, Eugene Sun, Dale J Kempf.  (1998) Recent developments in HIV protease inhibitor therapy. <i><span class="NLM_source">Antiviral Research</span></i> <b>39</b>:1, 1-23<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0166-3542(98)00011-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1146</p><p class="content">Steven G. Deeks, Robert M. Grant, George W. Beatty, Christopher Horton, Jill Detmer, Scott Eastman.  (1998) Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:10, F97-F102<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199810000-00002" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1147</p><p class="content">A K. Sullivan, M D. Feher, M R. Nelson, B G. Gazzard.  (1998) Marked hypertriglyceridaemia associated with ritonavir therapy. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:11, 1393-1394<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199811000-00024" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1148</p><p class="content">Jose L. Casado, Maria J. Perez-Elías, Antonio Antela, Raquel Sabido, Paloma Martí-Belda, Fernando Dronda, Jesús Blazquez, Carmen Quereda.  (1998) Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:11, F131-F135<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199811000-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1149</p><p class="content">Matthew K. Wynia, John P.A. Ioannidis, Joseph Lau.  (1998) Analysis of life-long strategies to prevent Pneumocystis carinii pneumonia in patients with variable HIV progression rates. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:11, 1317-1325<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199811000-00013" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1150</p><p class="content">Martin Gebhardt, Martin Rickenbach, Matthias Egger.  (1998) Impact of antiretroviral combination therapies on AIDS surveillance reports in Switzerland. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:10, 1195-1201<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199810000-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1151</p><p class="content">Monique HE Reijers, Gerrit Jan Weverling, Suzanne Jurriaans, Ferdinand WNM Wit, Hugo M Weigel, Reinier W Ten Kate, Jan Willem Mulder, PH Jos Frissen, Remko van Leeuwen, Peter Reiss, Hanneke Schuitemaker, Frank de Wolf, Joep MA Lange.  (1998) Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study. <i><span class="NLM_source">The Lancet</span></i> <b>352</b>:9123, 185-190<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(98)06193-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1152</p><p class="content">UWE WINTERGERST, FLORIAN HOFFMANN, BRIGITTE SÖLDER, GUNDULA NOTHEIS, THEONI PETROPOULOU, JOSEF EBERLE, LUTZ GÜRTLER, BERND H. BELOHRADSKY.  (1998) Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus. <i><span class="NLM_source">The Pediatric Infectious Disease Journal</span></i> <b>17</b>:6, 495-499<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00006454-199806000-00012" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1153</p><p class="content">Brian Conway, Rafick-Pierre Sékaly.  (1998) Combination therapy for HIV: towards long term control of disease progression. <i><span class="NLM_source">Expert Opinion on Investigational Drugs</span></i> <b>7</b>:6, 941-961<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/13543784.7.6.941" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1154</p><p class="content">TS Li, R Tubiana, C Katlama, V Calvez, H Ait Mohand, B Autran.  (1998) Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. <i><span class="NLM_source">The Lancet</span></i> <b>351</b>:9117, 1682-1686<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(97)10291-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1155</p><p class="content">Bryn Duffy, Chad Schwietert, Alex France, Niti Mann, Krista Culbertson, Benjamin Harmon, John P. McCue.  (1998) Transition metals as protease inhibitors. <i><span class="NLM_source">Biological Trace Element Research</span></i> <b>64</b>:1-3, 197-213<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02783336" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1156</p><p class="content">William L. Barrett, Thomas D. Callahan, Bruce A. Orkin.  (1998) Perianal manifestations of human immunodeficiency virus infection. <i><span class="NLM_source">Diseases of the Colon &amp; Rectum</span></i> <b>41</b>:5, 606-611<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF02235268" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1157</p><p class="content">Olivier T. Rutschmann, Milos Opravil, Anne Iten, Raffaele Malinverni, Pietro L. Vernazza, Heiner C. Bucher, Enos Bernasconi, Philippe Sudre, Dominique Leduc, Sabine Yerly, Luc H. Perrin, Bernard Hirschel.  (1998) A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:8, F71-77<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199808000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1158</p><p class="content">Christophe Piketty, Philippe Castiel, Laurent Belec, Dominique Batisse, Ali Si Mohamed, Jacques Gilquin, Gustavo Gonzalez-Canali, Didier Jayle, Marina Karmochkine, Laurence Weiss, Jean Pierre Aboulker, Michel D. Kazatchkine.  (1998) Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:7, 745-750<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199807000-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1159</p><p class="content">Andrew Carr, Katherine Samaras, Samantha Burton, Matthew Law, Judith Freund, Donald J. Chisholm, David A. Cooper.  (1998) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:7, F51-F58<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199807000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1160</p><p class="content">M. Battegay.  (1998) Human immunodeficiency virus mutation and changes in CD4 T-cell levels during antiretroviral therapy. <i><span class="NLM_source">European Journal of Clinical Microbiology &amp; Infectious Diseases</span></i> <b>17</b>:5, 301-303<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1007/BF01709450" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1161</p><p class="content">ANDREW P. KEAVENY, MICHAEL S. KARASIK.  (1998) Hepatobiliary and Pancreatic Infections in AIDS: Part One. <i><span class="NLM_source">AIDS Patient Care and STDs</span></i> <b>12</b>:5, 347-357<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1089/apc.1998.12.347" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1162</p><p class="content"> Flexner ,  Charles .  (1998) HIV-Protease Inhibitors. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>338</b>:18, 1281-1293<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199804303381808">Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199804303381808} --></span></p></li><li class="odd"><p class="number">1163</p><p class="content">Stephanie A. Rhone, Robert S. Hogg, Benita Yip, Chris Sherlock, Brian Conway, Martin T. Schechter, Michael V. OʼShaughnessy, Julio S.G. Montaner.  (1998) The antiviral effect of ritonavir and saquinavir incombination amongst HIV-infected adults. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:6, 619-624<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199806000-00011" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1164</p><p class="content">Elizabeth M Race, Anthony J Japour.  (1998) Highly active antiretroviral therapy. <i><span class="NLM_source">The Lancet</span></i> <b>351</b>:9108, 1058-1059<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(05)79025-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1165</p><p class="content">Beulah E. Perdue, Paul J. Weidle, Robyn E. Everson-Mays, Pamela S. Bozek.  (1998) Evaluating the Cost of Medications for Ambulatory HIV-Infected Persons in Association With Landmark Changes in Antiretroviral Therapy. <i><span class="NLM_source">Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology</span></i> <b>17</b>:4, 354-360<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00042560-199804010-00010" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1166</p><p class="content">David E. Ott, Suzanne M. Hewes, W.Gregory Alvord, Louis E. Henderson, Larry O. Arthur.  (1998) Inhibition of Friend Virus Replication by a Compound That Reacts with the Nucleocapsid Zinc Finger: Anti-Retroviral Effect Demonstratedin Vivo. <i><span class="NLM_source">Virology</span></i> <b>243</b>:2, 283-292<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1006/viro.1998.9062" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1167</p><p class="content">Gary S Reiter.  (1998) Human immunodeficiency virus (HIV) in America, 1981 to 1997: Epidemiologic and therapeutic considerations. <i><span class="NLM_source">Seminars in Ultrasound, CT and MRI</span></i> <b>19</b>:2, 122-127<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0887-2171(98)90054-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1168</p><p class="content"> Palella ,  Frank J.   Jr. ,  Delaney ,  Kathleen M. ,  Moorman ,  Anne C. ,  Loveless ,  Mark O. ,  Fuhrer ,  Jack ,  Satten ,  Glen A. ,  Aschman ,  Diane J. ,  Holmberg ,  Scott D. , the HIV Outpatient Study Investigators.  (1998) Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>338</b>:13, 853-860<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199803263381301">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199803263381301} --></span></p></li><li class="odd"><p class="number">1169</p><p class="content">Dale J. Kempf, Richard A. Rode, Yi Xu, Eugene Sun, Margo E. Heath-Chiozzi, Joaquin Valdes, Anthony J. Japour, Sven Danner, Charles Boucher, Akhteruzzaman Molla, John M. Leonard.  (1998) The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:5, F9-F14<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199805000-00001" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1170</p><p class="content">Graeme Moyle.  (1998) The role of combinations of HIV protease inhibitors in the management of persons with HIV infection. <i><span class="NLM_source">Expert Opinion on Investigational Drugs</span></i> <b>7</b>:3, 413-426<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1517/13543784.7.3.413" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1171</p><p class="content">Julio S.G. Montaner, Ralph DeMasi, Andrew M. Hill.  (1998) The effects of lamivudine treatment on HIV-1 disease progression are highly correlated with plasma HIV-1 RNA and CD4 cell count. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:5, F23-F28<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199805000-00003" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1172</p><p class="content">Daniel Kaufmann, Giuseppe Pantaleo, Philippe Sudre, Amalio Telenti.  (1998) CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). <i><span class="NLM_source">The Lancet</span></i> <b>351</b>:9104, 723-724<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(98)24010-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1173</p><p class="content">M. Barry, F. Mulcahy, D. J. Back.  (1998) Antiretroviral therapy for patients with HIV disease. <i><span class="NLM_source">British Journal of Clinical Pharmacology</span></i> <b>45</b>:3, 221-228<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1365-2125.1998.00673.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1174</p><p class="content">Anton Pozniak.  (1998) Surrogacy in HIV-1 clinical trials. <i><span class="NLM_source">The Lancet</span></i> <b>351</b>:9102, 536-537<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(98)22008-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1175</p><p class="content">Götz Bucher, Andreas Gansäuer, Peter R. Schreiner, Carlo Unvergzagt, Karsten Krohn, Karamali Khanbabaee, Heinz Stadtmüller, Stefan Peters, Christoph Hoenke, Volkhard Austel, Thomas Brumby, Wolfgang Halfbrodt, Harlmut Rehwinkel.  (1998) Organische Chemie 1997. <i><span class="NLM_source">Nachrichten aus Chemie, Technik und Laboratorium</span></i> <b>46</b>:2, 156-181<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1002/nadc.19980460211" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1176</p><p class="content">Robert S. Hogg, Stephanie A. Rhone, Benita Yip, Chris Sherlock, Brian Conway, Martin T. Schechter, Michael V. OʼShaughnessy, Julio S.G. Montaner.  (1998) Antiviral effect of double and triple drug combinations amongst HIV-infected adults. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:3, 279-284<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199803000-00005" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1177</p><p class="content">Warren A. Andiman.  (1998) Medical management of the pregnant woman infected with human immunodeficiency virus type 1 and her child. <i><span class="NLM_source">Seminars in Perinatology</span></i> <b>22</b>:1, 72-86<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0146-0005(98)80009-8" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1178</p><p class="content">D William Cameron, Margo Heath-Chiozzi, Sven Danner, Calvin Cohen, Stephen Kravcik, Clement Maurath, Eugene Sun, David Henry, Richard Rode, Amy Potthoff, John Leonard.  (1998) Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. <i><span class="NLM_source">The Lancet</span></i> <b>351</b>:9102, 543-549<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(97)04161-5" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1179</p><p class="content"> (1998) A Controlled Trial of Double versus Triple Therapy for HIV. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>338</b>:3, 196-197<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199801153380313">Free Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199801153380313} --></span></p></li><li class="even"><p class="number">1180</p><p class="content"> (1998) Übersicht. <i><span class="NLM_source">LaboratoriumsMedizin</span></i> <b>22</b>:1, 6-13<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1515/labm.1998.22.1.6" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1181</p><p class="content">Mark A. Wainberg, D. William Cameron.  (1998) HIV resistance to antiviral drugs: public health implications. <i><span class="NLM_source">Drug Resistance Updates</span></i> <b>1</b>:2, 104-108<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S1368-7646(98)80025-3" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1182</p><p class="content">Daan W. Notermans, Suzanne Jurriaans, Frank de Wolf, Norbert A. Foudraine, Jacques J. de Jong, Winston Cavert, Caspar M. Schuwirth, Robert H. Kauffmann, Pieter L. Meenhorst, Hugh McDade, Carolyn Goodwin, John M. Leonard, Jaap Goudsmit.  (1998) Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. <i><span class="NLM_source">AIDS</span></i> <b>12</b>:2, 167-173<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1097/00002030-199802000-00006" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1183</p><p class="content"> (1997) End-of-Life Care in HIV Disease Let's Talk. <i><span class="NLM_source">Journal of General Internal Medicine</span></i> <b>12</b>:12, 784-786<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1046/j.1525-1497.1997.07166.x" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1184</p><p class="content">A MELVIN, L FRENKEL.  (1997) PEDIATRIC HIV-1 INFECTION. <i><span class="NLM_source">Obstetrics and Gynecology Clinics of North America</span></i> <b>24</b>:4, 911-924<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0889-8545(05)70351-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1185</p><p class="content">RL Hengel, NB Watts, JL Lennox.  (1997) Benign symmetric lipomatosis associated with protease inhibitors. <i><span class="NLM_source">The Lancet</span></i> <b>350</b>:9091, 1596<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(05)64011-1" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1186</p><p class="content">Robert S Hogg, Aslam Anis, Amy E Weber, Michael V Schechter, Martin T Schechter.  (1997) Triple-combination antiretroviral therapy in sub-Saharan Africa. <i><span class="NLM_source">The Lancet</span></i> <b>350</b>:9088, 1406<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(05)65188-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="odd"><p class="number">1187</p><p class="content">David Katzenstein.  (1997) Combition therapies for HIV infection and genomic durg resistance. <i><span class="NLM_source">The Lancet</span></i> <b>350</b>:9083, 970-971<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(97)22040-4" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li><li class="even"><p class="number">1188</p><p class="content"> Steinbrook ,  Robert , .  (1997) Battling HIV on Many Fronts. <i><span class="NLM_source">New England Journal of Medicine</span></i> <b>337</b>:11, 779-781<br><span class="CbLinks"><a class="ref nowrap" href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199709113371109">Full Text</a><!-- ${xml_link: 10.1056%2FNEJM199709113371109} --></span></p></li><li class="lastChild odd"><p class="number">1189</p><p class="content">Paul A Volberding.  (1997) Protease inhibitors vindicated. <i><span class="NLM_source">The Lancet</span></i> <b>350</b>, SIII10<br><span class="CbLinks"><!--noindex--><a class="ref" href="http://dx.doi.org.libgate.library.nuigalway.ie/10.1016/S0140-6736(97)90043-X" target="_top" title="Opens new window"> CrossRef </a><!--/noindex--></span></p></li></ol></div></dd><dd style="display: none;" class="lastChild" id="letters"><div class="letterContent" rel="10.1056/NEJM199709113371101"><a name="articleTop" rel="10.1056/NEJM199801153380313"></a><h1>A Controlled Trial of Double versus Triple Therapy for HIV</h1><p class="citationLine"><span class="citation">N Engl J Med 1998;  338:196-197</span><a href="http://www.nejm.org.libgate.library.nuigalway.ie/toc/nejm/338/3/">January 15, 1998</a><span class="doi">DOI:  10.1056/NEJM199801153380313</span></p><dl class="articleTabs tabPanel"><dt class="active article" id="articleTab">Article</dt><dd id="article"><div class="letter"><h3>To the Editor:</h3><div class="section"> <p>  With respect to the report by Hammer et al. (Sept. 11 issue),<span class="ref"><a href="#ref1-SA1" class="showRefLayer" rel="#refLayer">1</a></span> we are troubled by the randomization of patients with human immunodeficiency virus (HIV) infection and CD4 cell counts of 50 or fewer per cubic millimeter to a group without a protease inhibitor. Data indicating that the addition of ritonavir to the regimens of patients who have received antiretroviral therapy reduces AIDS-defining events and mortality had been reported at two international meetings<span class="ref"><a href="#ref2-SA1" class="showRefLayer" rel="#refLayer">2,3</a></span> and reviewed by the Food and Drug Administration's Antiviral Drugs Advisory Committee before closure of the randomization period and the first review. Was demonstrating that indinavir has the same effect worth the expected additional mortality in this group? If so, might this not have been more appropriately studied by the pharmaceutical industry than by the National Institutes of Health? Indinavir could have been compared with ritonavir.</p> <p>Second, despite the prospective stratification of groups according to the CD4 cell count, the study was terminated in both groups, though there was no statistically significant difference in those with CD4 cell counts of 51 to 200 cells per cubic millimeter. The clinical benefit of aggressive antiviral therapy in this subgroup is unknown. Although one might assume that with longer follow-up, a statistically significant difference would have been seen in this subgroup, the overlapping confidence interval in the analysis of viral load in those studied at 40 weeks makes us uncomfortable with this assumption. It seems unwarranted to state in the abstract that “treatment with indinavir, zidovudine, and lamivudine as compared with zidovudine and lamivudine alone significantly slows the progression of HIV-1 disease in patients with 200 CD4 cells or fewer per cubic millimeter and prior exposure to zidovudine” and that “the effects of treatment were similar in both CD4 cell strata.” A more precise statement of the conclusions might be that for people with CD4 cell counts of 50 or fewer per cubic millimeter who are taking zidovudine, the addition of indinavir and lamivudine reduces mortality and slows progression of HIV disease as compared with the addition of lamivudine alone.</p> </div><div class="section"><p>Marta Feldmesser, M.D.<br>Albert Einstein College of Medicine, Bronx, NY 10461<br></p><p>John Falkenberg, R.N., M.B.A.<br>360 E. 65th St., New York, NY 10021<br></p></div><div class="section section-back"></div><span class="moreLink"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/toggleRef" class="toggleRef">3 References</a></span><div class="letterReferences hidden"><div class="section"><ol class="striped"><a name="ref1-SA1"></a><li class="odd" id="refItem1-SA1"><p class="number">1</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hammer SM</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Squires KE</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Hughes MD</contrib>, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. <span class="NLM_source">N Engl J Med</span> 1997;337:725-733<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r001&amp;dbid=20&amp;doi=10.1056%2FNEJM199801153380313&amp;key=10.1056%2FNEJM199709113371101" onclick="newWindow(this.href);return false">Free Full Text</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r001&amp;dbid=128&amp;doi=10.1056%2FNEJM199801153380313&amp;key=A1997XV17400001" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r001&amp;dbid=8&amp;doi=10.1056%2FNEJM199801153380313&amp;key=9287227" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref2-SA1"></a><li class="even" id="refItem2-SA1"><p class="number">2</p><p class="content">Cameron B, Heath-Chiozzi M, Kravcik S, et al. Prolongation of life and prevention of AIDS in advanced HIV immunodeficiency with ritonavir. In: Program and abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections, Washington, D.C., January 28–February 2, 1996:162. abstract.<br></p></li><a name="ref3-SA1"></a><li class="odd" id="refItem3-SA1"><p class="number">3</p><p class="content">Cameron DW, Heath-Chiozzi M, Kravcik S, et al. Prolongation of life and prevention of AIDS complications in advanced HIV immunodeficiency with ritonavir: update. In: Volume 1 of the Abstracts of the XI International Conference on AIDS, Vancouver, B.C., July 7–12, 1996:24. abstract.<br></p></li></ol></div></div></div><div class="letter"><h3>To the Editor:</h3><div class="section"> <p>  Hammer et al. indicate that substitution of stavudine for zidovudine was permitted in the event of drug-associated toxicity at any point after randomization or if clinical progression of HIV disease occurred, but they do not give the number of patients in whom this substitution occurred or the duration of treatment with zidovudine before the switch. The mean duration of zidovudine therapy before enrollment was 21 months (interquartile range, 10 to 42). Therefore, many patients may have had resistance to zidovudine at the time of enrollment.<span class="ref"><a href="#ref1-SA2" class="showRefLayer" rel="#refLayer">1</a></span> These patients received only two useful drugs if they were in the zidovudine, lamivudine, and indinavir group and only one useful drug if they were in the zidovudine, lamivudine, and placebo group. However, those who were switched from zidovudine to stavudine would have received real triple therapy if they were in the former group and double therapy if they were in the latter group. Were those patients equally distributed between the two groups in the study? If not, this is a possible source of bias.</p> </div><div class="section"><p>José Alberto Arranz Caso, Ph.D.<br>Hospital Universitario Príncipe de Asturias, 28805 Alcalá de Henares, Spain<br></p></div><div class="section section-back"></div><span class="moreLink"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/toggleRef" class="toggleRef">1 Reference</a></span><div class="letterReferences hidden"><div class="section"><ol class="striped"><a name="ref1-SA2"></a><li class="odd" id="refItem1-SA2"><p class="number">1</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Coffin JM</contrib>. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. <span class="NLM_source">Science</span> 1995;267:483-489<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r004&amp;dbid=16&amp;doi=10.1056%2FNEJM199801153380313&amp;key=10.1126%2Fscience.7824947" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r004&amp;dbid=128&amp;doi=10.1056%2FNEJM199801153380313&amp;key=A1995QD40300031" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r004&amp;dbid=8&amp;doi=10.1056%2FNEJM199801153380313&amp;key=7824947" onclick="newWindow(this.href);return false">Medline</a></p></li></ol></div></div></div><div class="letter"><h3>To the Editor:</h3><div class="section"> <p>  Hammer et al. conclude that “treatment with indinavir, zidovudine, and lamivudine as compared with zidovudine and lamivudine alone significantly slows the progression of HIV-1 disease in patients with 200 CD4 cells or fewer per cubic millimeter and prior exposure to zidovudine.” However, the analysis stratified according to CD4 counts shows that among patients with CD4 counts of 51 to 200 cells per cubic millimeter who were treated with indinavir and both nucleoside analogues there was a trend toward fewer AIDS-defining events or deaths than among those treated with the two nucleoside analogues alone (P = 0.08). There were no differences in mortality between these two treatment groups. Hence, a better conclusion would be that treatment with indinavir, zidovudine, and lamivudine as compared with zidovudine and lamivudine alone slows the progression of HIV-1 disease in patients with 50 CD4 cells or fewer per cubic millimeter and prior exposure to zidovudine.</p> <p>It was also surprising that neutropenia was significantly more frequent among patients treated with zidovudine and lamivudine (15 percent) than among those treated with zidovudine, lamivudine, and indinavir (5 percent) (P&lt;0.001). How do the authors explain that finding?</p> </div><div class="section"><p>Marcial Delgado Fernández, M.D.<br>José Luis Zambrana García, M.D., Ph.D.<br>Felipe Díez García, M.D., Ph.D.<br>Hospital de Poniente, 04700 El Ejido, Almería, Spain<br></p></div><div class="section section-back"></div></div><div class="replyContainer"><div class="reply"><h3>Author/Editor Response</h3><p>The authors reply:</p><p> <em>To the Editor:</em> Feldmesser and Falkenberg do not appear to appreciate the difference in design between the AIDS Clinical Trials Group 320 study and the Abbott-sponsored M94-247 trial.<span class="ref"><a href="#ref1-SA4" class="showRefLayer" rel="#refLayer">1</a></span> In the latter study, ritonavir or placebo was added to the regimens of patients who were receiving stable nucleoside-analogue therapy or no therapy. In our study, all patients received therapy to which they had not previously been exposed: lamivudine or indinavir plus lamivudine. Although one would not currently advocate the simple addition of lamivudine to a regimen of zidovudine, this approach clearly represented active treatment in the control group, as evidenced by the rate of disease progression, the positive responses in terms of CD4 cell counts and plasma HIV-1 RNA concentrations, and the independent confirmation of the benefit from lamivudine.<span class="ref"><a href="#ref2-SA4" class="showRefLayer" rel="#refLayer">2</a></span> </p><p>With respect to the two strata of CD4 cell counts, the primary analysis and the prespecified early-stopping guideline were planned for the overall study population for which the difference in disease progression between the two groups was clearly significant. That this difference was driven by a higher event rate in the lower CD4 cell stratum is to be expected. The hazard ratios for the time to progression to AIDS or death for the overall population (0.50) and the two CD4 cell strata (0.49 and 0.51) were very similar. This finding, along with the similar CD4 cell and plasma HIV-1 RNA responses in the two strata, provides evidence of a similar treatment effect across the entire study population. However, we were careful to state that the possibility of differential effects could not be ruled out, since the study did not have the power to address this question.</p><p>In response to Arranz Caso: we did provide the numbers of patients for whom stavudine was substituted for zidovudine: 109 of 1156 patients (3 at randomization and 106 after randomization). Sixty-nine of the post-randomization substitutions occurred in the dual-nucleoside group and 37 in the indinavir-containing group, at a respective median of 4.3 and 3.6 months of follow-up. Only three of these patients (all in the dual-nucleoside group) had disease progression. Thus, it is unlikely that the use of stavudine had a major impact on the results or the conclusions of the study. The relation of the presence of zidovudine resistance at base line to the outcome is currently under study.</p><p>In response to Delgado Fernández et al.: we do not have an explanation for the difference in the proportion of patients with neutropenia but can only postulate that the hematologic toxicity of zidovudine in the group that included indinavir may have been mitigated by the greater antiretroviral activity of this combination, which may have positively affected marrow function. A similar observation was made in a study of zidovudine and didanosine as compared with zidovudine alone.<span class="ref"><a href="#ref3-SA4" class="showRefLayer" rel="#refLayer">3</a></span> </p><div class="section"><p>Scott M. Hammer, M.D.<br>Harvard Medical School, Boston, MA 02115<br></p><p>Kathleen E. Squires, M.D.<br>University of Alabama at Birmingham, Birmingham, AL 35294<br></p><p>Margaret A. Fischl, M.D.<br>University of Miami, Miami, FL 33101<br></p></div><div class="section section-back"></div><span class="moreLink"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/toggleRef" class="toggleRef">3 References</a></span><div class="letterReferences hidden"><div class="section"><ol class="striped"><a name="ref1-SA4"></a><li class="odd" id="refItem1-SA4"><p class="number">1</p><p class="content">Cameron DW, Heath-Chiozzi M, Kravcik S, et al. Prolongation of life and prevention of AIDS complications in advanced HIV immunodeficiency with ritonavir: update. In: Volume 1 of the Abstracts of the XI International Conference on AIDS, Vancouver, B.C., July 7–12, 1996:24. abstract.<br></p></li><a name="ref2-SA4"></a><li class="even" id="refItem2-SA4"><p class="number">2</p><p class="content"><contrib-group xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><contrib contrib-type="author">CAESAR Coordinating Committee</contrib></contrib-group>. Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial. <span class="NLM_source">Lancet</span> 1997;349:1413-1421<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r006&amp;dbid=16&amp;doi=10.1056%2FNEJM199801153380313&amp;key=10.1016%2FS0140-6736%2897%2904441-3" onclick="newWindow(this.href);return false">CrossRef</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r006&amp;dbid=128&amp;doi=10.1056%2FNEJM199801153380313&amp;key=A1997WZ76500008" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r006&amp;dbid=8&amp;doi=10.1056%2FNEJM199801153380313&amp;key=9164314" onclick="newWindow(this.href);return false">Medline</a></p></li><a name="ref3-SA4"></a><li class="odd" id="refItem3-SA4"><p class="number">3</p><p class="content"><contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Collier AC</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Coombs RW</contrib>, <contrib xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" contrib-type="author">Fischl MA</contrib>, et al. Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection. <span class="NLM_source">Ann Intern Med</span> 1993;119:786-793<br><a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r007&amp;dbid=128&amp;doi=10.1056%2FNEJM199801153380313&amp;key=A1993MB49600003" onclick="newWindow(this.href);return false">Web of Science</a> | <a href="http://www.nejm.org.libgate.library.nuigalway.ie/servlet/linkout?suffix=r007&amp;dbid=8&amp;doi=10.1056%2FNEJM199801153380313&amp;key=8379600" onclick="newWindow(this.href);return false">Medline</a></p></li></ol></div></div></div></div></dd><!--DiscussionReplacer_Tab_--></dl></div></dd></dl>
    





    


</div>


        
        





<div id="rightRail" class="">
    <!-- omit the institutional logo from the following pages -->
    
            
            <div id="institutionBox">
                
                <p>Access Provided By:<br><span class="institutionName">National University Ireland Galway  - IREL</span></p>
                
                <div style="clear: both;"></div>
            </div>
            
        
    
                        











<!-- toolsContainer -->
<div id="toolsContainer">
	<!-- toolsBox -->
	<div id="toolsBox">
		<h3>Tools</h3>
		<ul class="firstGroup">
			
			<li class="downloadPDF firstChild">
				<a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/pdf/10.1056/NEJM199709113371101" class="zone-tools-articlePdf">

					
					PDF
				</a>
			</li>
			
			
			<li class="printPage">
				<a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199709113371101" class="viewType-Print viewClass-Print zone-tools-articlePrint">

					
					Print
				</a>
			</li>
			
			<li class="downloadCitation lastChild">
				<a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showCitFormats?doi=10.1056%2FNEJM199709113371101" class="viewType-Layer viewClass-MediumLayer zone-tools-downloadCitation event-layer-downloadCitation-open">

					
					Download Citation
				</a>
			</li>
			
			
			
			
			
            
		</ul>
		<ul class="secondGroup">
			<li class="emailPage firstChild">
				<a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/showMailPage?href=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;title=A+Controlled+Trial+of+Two+Nucleoside+Analogues+plus+Indinavir+in+Persons+with+Human+Immunodeficiency+Virus+Infection+and+CD4+Cell+Counts+of+200+per+Cubic+Millimeter+or+Less&amp;doi=10.1056%2FNEJM199709113371101" class="viewType-Layer viewClass-MediumLayer zone-tools-articleEmail">

					
					
					
					E-Mail
				</a>
			</li>
			
			<li class="savePage">
				<a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/addTag?uactid=savePage&amp;uacturi=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;doi=10.1056%2FNEJM199709113371101" id="savePage" class="viewType-Layer viewClass-MediumLayer zone-tools-articleSave">

					
						
						
					
					Save
				</a>
			</li>
			
			<li class="getAlert">
				<a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/addCitationAlert?context=add&amp;uactid=getAlert&amp;uacturi=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;doi=10.1056%2FNEJM199709113371101" id="getAlert" class="viewType-Layer viewClass-MediumLayer zone-tools-articleEmailAlert">

					
					
						
						
					
					Article Alert
				</a>
			</li>
			
			
			
			
			<li class="reprints"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/page/about-nejm/reprints" class="zone-tools-reprints">Reprints</a></li>
            <li class="permissions"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/https%3A%2F%2Fs100.copyright.com%2FAppDispatchServlet%3Fauthor%3DScott%2BM.%2BHammer%252C%2BKathleen%2BE.%2BSquires%252C%2BMichael%2BD.%2BHughes%252C%2Bet%2Bal.%26contentID%3D10.1056%252FNEJM199709113371101%26issueNum%3D11%26orderBeanReset%3Dtrue%26publication%3Dnejm%26publicationDate%3D09%252F11%252F1997%26publisherName%3Dmassmed%26title%3DA%2BControlled%2BTrial%2Bof%2BTwo%2BNucleoside%2BAnalogues%2Bplus%2BIndinavir%2Bin%2BPersons%2Bwith%2BHuman%2BImmunodeficiency%2BVirus%2BInfection%2Band%2BCD4%2BCell%2BCounts%2Bof%2B200%2Bper%2BCubic%2BMillimeter%2Bor%2BLess%26volumeNum%3D337" class="zone-tools-permissions">Permissions</a></li>
			<li class="addThisIcon lastChild"><a href="http://www.addthis.com/bookmark.php" class="addthis_button zone-tools-share-click" target="_top">Share/Bookmark</a></li>
		</ul>
	</div>
	<!-- /toolsBox -->
	<!-- toolsAd -->
	<div class="toolsAd">
		

<div class="bottomAd">
    
    <div class="ad">
        














<div id="CM8ShowAd1369847718025" title="MicroTools" class="MicroTools CM8">
<noscript><a href="http://web.checkm8.com/adam/ep/click/mms.nej.articles/MicroTools"><img src="http://web.checkm8.com/adam/noscript?cat=mms.nej.articles&amp;page=1369847718025&amp;format=MicroTools" border="0" alt="Advertisement" /></a></noscript>

</div>
    </div>
</div>
	</div>
	<!-- /toolsAd -->
</div>
<!-- /toolsContainer -->

                    
                









<div id="related"><div id="relatedContent"><h3>Related Articles</h3><ul><li class="firstChild"><p class="articleType"><pub-title xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" title-type="toc-heading-title" title-length="standard" title-usage="default" translit-method="none" is-translated="false" media-type="text-xml" source="default" xml:lang="EN">Editorial</pub-title></p><p class="articleLink"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199709113371109">Battling HIV on Many Fronts</a></p><p class="articleDate">September 11, 1997 | R. Steinbrook</p></li><li class="lastChild"><p class="articleType"><pub-title xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" title-type="toc-heading-title" title-length="standard" title-usage="default" translit-method="none" is-translated="false" media-type="text-xml" source="default" xml:lang="EN">Correspondence</pub-title></p><p class="articleLink"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJM199801153380313">A Controlled Trial of Double versus Triple Therapy for HIV</a></p><p class="articleDate">January 15, 1998</p></li></ul></div><div id="topics"><h3>Topics</h3><ul><li class="firstChild lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/browse?subtopic=18_3">HIV/​AIDS</a></li></ul></div><div id="moreIn"><h3>More In</h3><ul><li class="firstChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/browse?category=research">Research</a></li><li class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/toc/nejm/337/11/">September 11, 1997</a></li></ul></div></div>

                
                    
                
        
                


<div id="rightRailAd">
<div class="bannerAdTower">
<div class="rightTower">















<div id="CM8ShowAd1369847718026" title="MedRectangle" class="MedRectangle CM8">
<noscript><a href="http://web.checkm8.com/adam/ep/click/mms.nej.articles/MedRectangle"><img src="http://web.checkm8.com/adam/noscript?cat=mms.nej.articles&amp;page=1369847718026&amp;format=MedRectangle" border="0" alt="Advertisement" /></a></noscript>

</div>
</div>
</div>
</div>
                



















<div id="trendsMod" class="mod pad">
    <div class="modHead">
        <h3>Trends</h3>
        
                <h4>Most Viewed (Last Week)</h4>
            
    </div>
    <div class="modBody">
        
        <ul class="csf">
            
            <li class="firstChild">
                <div class="articleType">Original Article</div>
                <div class="articleLink">
                    <a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMoa1214103">Prone Positioning in Severe Acute Respiratory Distress Syndrome</a>
                </div>

                
                
                        <div class="articleDate">May 20, 2013
                            
                                | C. Guérin and Others
                            
                        </div>
                    


            </li>
            
            <li>
                <div class="articleType">Case Records of the Massachusetts General Hospital</div>
                <div class="articleLink">
                    <a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMcpc1215971">Case Challenge</a>
                </div>

                
                
                        <div class="articleDate">May 22, 2013
                            
                                | null
                            
                        </div>
                    


            </li>
            
            <li class="lastChild">
                <div class="articleType">Review Article</div>
                <div class="articleLink">
                    <a href="http://www.nejm.org.libgate.library.nuigalway.ie/doi/full/10.1056/NEJMra1216063">Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy</a>
                </div>

                
                
                        <div class="articleDate">May 23, 2013
                            
                                | P. Libby
                            
                        </div>
                    


            </li>
            
        </ul>
    </div>
    <div class="modFoot">
        <p class="moreLink"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/journal-articles">More Trends</a></p>
    </div>
    

<div class="bottomAd">
    
    <div class="ad">
        














<div id="CM8ShowAd1369847718053" title="MicroTrends" class="MicroTrends CM8">
<noscript><a href="http://web.checkm8.com/adam/ep/click/mms.nej.articles/MicroTrends"><img src="http://web.checkm8.com/adam/noscript?cat=mms.nej.articles&amp;page=1369847718053&amp;format=MicroTrends" border="0" alt="Advertisement" /></a></noscript>

</div>
    </div>
</div>
</div>


                
                
                        












<script type="text/javascript" src="untitled_001.dat"></script><div id="nejm_jobs">  <div style="padding: 0px; margin: 0px; background: none repeat ; 0% rgb(255, 51, 0); clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-width: none; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 300px; border: 1px solid rgb(255, 51, 0); height: 1px; max-height: 1px; overflow: hidden; line-height: 1px; font-size: 1px;"></div> <!-- top red rectangle --><div id="nejm-widget" style="padding: 0px; margin: 0px; background: none repeat ; 0% rgb(255, 255, 255); clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; vertical-align: baseline; font-weight: normal; float: none; height: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 300px; border-right: 1px solid rgb(207, 207, 207); border-width: medium 1px 1px; border-style: none solid solid; border-color: -moz-use-text-color rgb(207, 207, 207) rgb(207, 207, 207); -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; border-image: none; line-height: 12px; font-size: 14px;"><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 10px; line-height: 10px;">&nbsp;</div><div style="padding: 0px; margin: 0px 0px 0px 10px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;">	<a target="nejm-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; line-height: 1px; text-decoration: none;" href="http://www.nejmcareercenter.org/?query=fjw">		<img alt="CareerCenter" style="background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: inline; margin: 0px; padding: 0px; border: medium none;" src="nejmCCID-JobsWidget.gif">	</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 10px; line-height: 10px;">&nbsp;</div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border-right: medium none; border-left: medium none; -moz-border-top-colors: none; -moz-border-right-colors: none; -moz-border-bottom-colors: none; -moz-border-left-colors: none; border-image: none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 100%; border-width: 1px medium; border-style: solid none; border-color: rgb(207, 207, 207) -moz-use-text-color;"> <!-- content --><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 10px; line-height: 10px;">&nbsp;</div><div style="padding: 0px; margin: 0px 0px 4px 10px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: 'Times New Roman',Times,serif; font-size: 11px; color: rgb(51, 51, 51); font-weight: bold;">PHYSICIAN JOBS</div><div style="padding: 0px; margin: 0px 0px 0px 10px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 10px; color: rgb(102, 102, 102);">May 29, 2013</div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 8px; line-height: 8px;">&nbsp;</div><div style="padding: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; margin: 0px 10px;"><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Tahoma; font-size: 9px; color: black; font-weight: bold;">Faculty/Research</span></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><a target="nejm-job-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 11px; color: rgb(0, 104, 146); text-decoration: none;" onmouseover="jlho(this);" onmouseout="jlou(this);" href="http://www.nejmcareercenter.org/job/16970/clinician-educator-general-internal-medicine-division/?query=fjwp">CLINICIAN-EDUCATOR, GENERAL INTERNAL MEDICINE DIVISION</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 10px; color: rgb(51, 51, 51); text-transform: uppercase;">Massachusetts</span></div></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 8px; line-height: 8px;">&nbsp;</div><div style="padding: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; margin: 0px 10px;"><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Tahoma; font-size: 9px; color: black; font-weight: bold;">Faculty/Research</span></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><a target="nejm-job-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 11px; color: rgb(0, 104, 146); text-decoration: none;" onmouseover="jlho(this);" onmouseout="jlou(this);" href="http://www.nejmcareercenter.org/job/16956/academic-nocturnalist/?query=fjwp">ACADEMIC NOCTURNALIST</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 10px; color: rgb(51, 51, 51); text-transform: uppercase;">New York</span></div></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 8px; line-height: 8px;">&nbsp;</div><div style="padding: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; margin: 0px 10px;"><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Tahoma; font-size: 9px; color: black; font-weight: bold;">Family Medicine</span></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><a target="nejm-job-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 11px; color: rgb(0, 104, 146); text-decoration: none;" onmouseover="jlho(this);" onmouseout="jlou(this);" href="http://www.nejmcareercenter.org/job/16806/family-medicine-connecticut/?query=fjwf">FAMILY MEDICINE, CONNECTICUT</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 10px; color: rgb(51, 51, 51); text-transform: uppercase;">Connecticut</span></div></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 8px; line-height: 8px;">&nbsp;</div><div style="padding: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; margin: 0px 10px;"><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Tahoma; font-size: 9px; color: black; font-weight: bold;">Infectious Disease</span></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><a target="nejm-job-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 11px; color: rgb(0, 104, 146); text-decoration: none;" onmouseover="jlho(this);" onmouseout="jlou(this);" href="http://www.nejmcareercenter.org/job/16621/infectious-disease-practice-orlando-florida/?query=fjwf">INFECTIOUS DISEASE PRACTICE, ORLANDO, FLORIDA</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 10px; color: rgb(51, 51, 51); text-transform: uppercase;">Florida</span></div></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 8px; line-height: 8px;">&nbsp;</div><div style="padding: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; margin: 0px 10px;"><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Tahoma; font-size: 9px; color: black; font-weight: bold;">Surgery, General</span></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><a target="nejm-job-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 11px; color: rgb(0, 104, 146); text-decoration: none;" onmouseover="jlho(this);" onmouseout="jlou(this);" href="http://www.nejmcareercenter.org/job/16968/general-surgery-cambridge-health-alliance-cambridge-massachusetts/?query=fjws">GENERAL SURGERY, CAMBRIDGE HEALTH ALLIANCE, CAMBRIDGE, MASSACHUSETTS</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 10px; color: rgb(51, 51, 51); text-transform: uppercase;">Massachusetts</span></div></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 8px; line-height: 8px;">&nbsp;</div><div style="padding: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; margin: 0px 10px;"><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Tahoma; font-size: 9px; color: black; font-weight: bold;">Nephrology</span></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><a target="nejm-job-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 11px; color: rgb(0, 104, 146); text-decoration: none;" onmouseover="jlho(this);" onmouseout="jlou(this);" href="http://www.nejmcareercenter.org/job/17027/nephrology-opportunities-nationwide/?query=fjws">NEPHROLOGY OPPORTUNITIES NATIONWIDE</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"><span style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: Arial; font-size: 10px; color: rgb(51, 51, 51); text-transform: uppercase;">Alabama</span></div></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 10px; line-height: 10px;">&nbsp;</div></div> <!-- content --><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block;"> <!-- footer --><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 5px; line-height: 5px;">&nbsp;</div><div style="padding: 0px; margin: 0px 10px 0px 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; text-align: right;"><a target="nejm-win" style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; float: none; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; font-family: 'Times New Roman',Times,serif; font-size: 13px; color: rgb(255, 51, 0); text-decoration: none; text-align: right;" href="http://www.nejmcareercenter.org/?query=fjw">nejmcareercenter.org</a></div><div style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; border: medium none; vertical-align: baseline; font-weight: normal; float: none; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; width: 10px; font-size: 1px; height: 9px; line-height: 9px;">&nbsp;</div></div> <!-- footer --><img style="padding: 0px; margin: 0px; background: none repeat ; 0% transparent; clear: none; bottom: auto; font-family: Arial,Helvetica,sans-serif; font-style: normal; min-height: 0px; min-width: 0px; font-size: 11px; border: medium none; vertical-align: baseline; line-height: 14px; font-weight: normal; height: auto; width: auto; letter-spacing: normal; max-height: none; max-width: none; overflow: visible; position: static; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; visibility: visible; white-space: normal; z-index: auto; display: block; float: none;" src="__utm.gif" height="1" width="1"></div> <!-- nejm-widget --></div>

                    
                
                



<!-- placeholder id=null, description=N-siteWide-email -->
    <div class="emailAlert"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=4138&amp;url=https%3A%2F%2Fcdf.nejm.org%2Fcampaigns%2Fgenericlp.aspx%3Fcpc%3DGMAAALLV0612C%26alertType%3Dcollection%26rcpc%3DFMAAALLV0612C%26rpromo%3DONFQSU24%26URL%3Dhttp%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJM199709113371101&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258"><img src="AlertsAndUpdates.gif"></a>


</div>



	
      		<!-- placeholder id=null, description=N-ad-article-rightRail-1 -->
    			  <a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=5017&amp;url=%2Fpage%2Fglobal-health&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258"><img src="GlobalHealth_GH4World_300x150.jpg"></a>
    		
      	
    
</div>

   




    
<script type="text/javascript">

    $("#cdfRegister").attr("href", $("#cdfRegister").attr('href') + "&url=" + window.location.href);
</script>


</div>



<div id="footer">
    <!-- placeholder id=null, description=N-ad-footer-1 -->
        <div class="rightAd"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=2078&amp;url=%2Fcontinuing-medical-education&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258"><img src="CME_300Exams_175x48.gif"></a></div>
    
    <!-- placeholder id=null, description=N-footer -->
        <dl>
  <dt class="firstChild">Content:</dt>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2F&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" tabindex="100">Home</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Ftoc%2Fnejm%2Fmedical-journal&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Current Issue</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fmedical-article-index&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Articles</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fmedical-index&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Issue Index</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fmedical-specialties&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Specialties &amp; Topics</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fmultimedia&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Multimedia &amp; Images</a></dd>
  <dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fmedical-index&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Archive 1812-1989</a></dd>
</dl>
<dl>
  <dt class="firstChild">Information For:</dt>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3DauthorCenter&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Authors</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3DauthorCenter&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Reviewers</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fproducts-and-services&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Subscribers</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Finstitution%2Fresource-center&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Institutions</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fmedia&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Media</a></dd>
  <dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fhow-to-advertise&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Advertisers</a></dd>
</dl>
<dl>
  <dt class="firstChild">Services:</dt>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3Dsubscribe%26promo%3DONFLRNA4&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Subscribe</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3Drenew%26promo%3DONFLRNA1&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Renew</a></dd> 

  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3DpayBill%26promo%3DBNFLNBA1&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" rel="nofollow">Pay Bill</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3Dactivate%26promo%3DONFLNAA1&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Activate Subscription</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fnejm-account&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" rel="nofollow">Create or Manage Account</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fnejm-alerts&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Alerts</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FshowPodcastsFeeds&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">RSS &amp; Podcasts</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3DauthorCenter&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" rel="nofollow">Submit a Manuscript</a></dd>
  <dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fmobile-applications&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" rel="nofollow">Mobile</a></dd>
</dl>
<dl>
  <dt class="firstChild">Resources:</dt>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=http%3A%2F%2Fwww.nejmjobs.org%2F&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Physician Jobs</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Freprints&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" rel="nofollow">Reprints</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fpermissions&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" rel="nofollow">Permissions</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fmedical-conference&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Medical Meetings</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fupcoming-medical-conventions&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Conventions</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Ffrequently-asked-questions&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" rel="nofollow">FAQs</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=http%3A%2F%2Fwww.jwatch.org%2F&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Journal Watch</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fhelp&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" rel="nofollow">Help</a></dd>
<dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fcontact-nejm&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" rel="nofollow">Contact Us</a></dd>
</dl>
<dl>
  <dt class="firstChild">NEJM:</dt>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fhistory-and-mission&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">About</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fproducts-and-services&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Product Information</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Feditors-and-publishers&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" rel="nofollow">Editors &amp; Publishers</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2F200th-anniversary-about&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" rel="nofollow">200th Anniversary</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fterms-of-use&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" rel="nofollow">Terms of Use</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fprivacy-policy&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" rel="nofollow">Privacy Policy</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fcopyright-information&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" rel="nofollow">Copyright</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fabout-nejm%2Fadvertising-policy&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" rel="nofollow">Advertising Policies</a></dd>
   <dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=http%3A%2F%2Fnejmgroup.org%2F&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">NEJM Group</a></dd>
</dl>
<dl>
  <dt class="firstChild">CME:</dt>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fcme%2Fweekly-cme-program&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Weekly CME Program</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fcontinuing-medical-education&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Browse Weekly Exams</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fcontinuing-medical-education%2Fcme-info&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Your CME Activity</a></dd>
  <dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Faction%2FcdfProxy%3Faction%3DcmeWeekly%26promo%3DONF4NA1V&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Purchase Exams</a></dd>
  <dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=%2Fpage%2Fcme%2Freview-cme&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Review CME Program</a></dd>
</dl>


<div class="socialNetworking">
  <div class="head">Follow us</div>
  <ul>
    <li class="firstChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=http%3A%2F%2Fwww.facebook.com%2FTheNewEnglandJournalofMedicine&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" class="facebook"><img src="facebook.gif" alt="Facebook"></a></li>
    <li><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=http%3A%2F%2Ftwitter.com%2Fnejm&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" class="twitter"><img src="twitter.gif" alt="Twitter"></a></li>
    <li><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=http%3A%2F%2Fwww.youtube.com%2Fnejmvideo&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" class="youTube"><img src="youtube.gif" alt="YouTube"></a></li>
    <li class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3589&amp;url=http%3A%2F%2Fblogs.nejm.org%2Fnow%2F&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258" class="nowNejmBlog"><img src="nowatnejm.gif" alt="Now@NEJM Blog"></a></li>
  </ul>
</div>
    
    <!-- placeholder id=null, description=N-ad-footer-2 -->
        <div class="rightAd2"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=3261&amp;url=http%3A%2F%2Fwww.nejmgroup.org%2F&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258"><img src="NEJMgroup.gif"></a></div>
    
</div>










<div class="corners dropDown dropDown-myNejm">


	
<div class="wrap"><div class="topRow tl"><div class="tr"><div class="t">&nbsp;</div></div></div><div class="middleRow l"><div class="r"><div class="content"><dl class="column firstChild lastChild">
		<!-- placeholder id=null, description=N-menu-MyNEJM -->
	</dl></div></div></div><div class="bottomRow bl"><div class="br"><div class="b">&nbsp;</div></div></div></div></div>



<div class="corners dropDown dropDown-articles">



<div class="wrap"><div class="topRow tl"><div class="tr"><div class="t">&nbsp;</div></div></div><div class="middleRow l"><div class="r"><div class="content"><dl class="column more firstChild">
<dt class="firstChild">Article Category</dt>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-articles/research">Research</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-articles/review">Reviews</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-articles/clinical-cases">Clinical Cases</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-articles/perspective">Perspective</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-articles/commentary">Commentary</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-articles/other">Other</a></dd>
<dd class="moreLink lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-article-index">Browse all articles</a></dd>
</dl><dl class="column multimedia more lastChild">
<dt class="firstChild">Multimedia</dt>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/multimedia/medical-videos">Videos in Clinical Medicine</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/multimedia/images-in-clinical-medicine">Images in Clinical Medicine</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/multimedia/interactive-medical-case">Interactive Medical Cases</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/multimedia/audio-summary">Weekly Audio Summaries</a></dd>
<dd class="moreLink lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/multimedia">Browse all multimedia</a></dd>
</dl></div></div></div><div class="bottomRow bl"><div class="br"><div class="b">&nbsp;</div></div></div></div></div>


<div class="corners dropDown dropDown-issueArchive">

<div class="wrap"><div class="topRow tl"><div class="tr"><div class="t">&nbsp;</div></div></div><div class="middleRow l"><div class="r"><div class="content"><dl class="column more firstChild lastChild">
<dd class="firstChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/toc/nejm/medical-journal">This Week</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/toc/nejm/lastweek">Last Week</a></dd>
<dd class="moreLink lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/medical-index">Browse full index</a></dd>
</dl></div></div></div><div class="bottomRow bl"><div class="br"><div class="b">&nbsp;</div></div></div></div></div>


<div class="corners dropDown dropDown-topics">






<div class="wrap"><div class="topRow tl"><div class="tr"><div class="t">&nbsp;</div></div></div><div class="middleRow l"><div class="r"><div class="content"><dl class="column more firstChild">
    <!-- placeholder id=null, description=N-menu-selectedSpecialties -->
        <dt class="firstChild">Selected Specialties</dt>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fcardiology&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Cardiology</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fendocrinology&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Endocrinology</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fgastroenterology&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Gastroenterology</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fgenetics&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Genetics</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Foncology-hematology&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Hematology/Oncology</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Finfectious-disease&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Infectious Disease</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fnephrology&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Nephrology</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fneurology-neurosurgery&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Neurology/Neurosurgery</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fgynecology-obstetrics&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Obstetrics/Gynecology</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fpediatrics&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Pediatrics</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fclinical-practice-center&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Primary Care/Hospitalist</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fpulmonary&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Pulmonary/Critical Care</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fsurgery&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Surgery</a></dd>
<dd class="moreLink lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1367&amp;url=%2Fmedical-specialties&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Browse all Specialties &amp; Topics</a></dd>
    
</dl><dl class="column more lastChild">
    <!-- placeholder id=null, description=N-menu-featuredTopics -->
        <dt class="firstChild">Featured Topics</dt>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1366&amp;url=%2Fclinical-practice-center&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Clinical Practice Center</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1366&amp;url=%2Fhealth-policy-and-reform&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Health Policy and Reform</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1366&amp;url=%2Fmedicine-and-society&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Medicine and Society</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1366&amp;url=%2Fpage%2Fglobal-health&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Global Health</a></dd>
<dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/clickThrough?id=1366&amp;url=%2Fpage%2Finfluenza&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJM199709113371101&amp;pubId=40005258">Influenza A (H7N9)</a></dd>
    
</dl></div></div></div><div class="bottomRow bl"><div class="br"><div class="b">&nbsp;</div></div></div></div></div>



<div class="corners dropDown dropDown-authors">

<div class="wrap"><div class="topRow tl"><div class="tr"><div class="t">&nbsp;</div></div></div><div class="middleRow l"><div class="r"><div class="content"><dl class="firstChild lastChild">
<dd class="firstChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/cdfProxy?action=authorCenter">Author Center</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/cdfProxy?action=authorCenter">Submit a Manuscript or Letter</a></dd>
<dd><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/cdfProxy?action=authorCenter">Track a Manuscript</a></dd>
<dd class="lastChild"><a href="http://www.nejm.org.libgate.library.nuigalway.ie/action/cdfProxy?action=authorCenter">Help</a></dd>
</dl></div></div></div><div class="bottomRow bl"><div class="br"><div class="b">&nbsp;</div></div></div></div></div>


























<script type="text/javascript">

/* <![CDATA[ */
var google_conversion_id = 1070139620;
var google_conversion_language = "en";
var google_conversion_format = "3";
var google_conversion_color = "666666";
var google_conversion_label = "_s1RCLTo-QEQ5JGk_gM";
var google_conversion_value = 0;
/* ]]> */
</script>
<script type="text/javascript" src="conversion.js">
</script><img src="untitled_002.dat" border="0" height="1" width="1">
<noscript>

<div style="display:inline;">
<img height="1" width="1" style="border-style:none;" alt="" src="http://www.googleadservices.com/pagead/conversion/1070139620/?value=0&amp;label=_s1RCLTo-QEQ5JGk_gM&amp;guid=ON&amp;script=0"/>
</div>
</noscript>







<div id="copyright">
    
    
            <p>Copyright © 2013 <a href="http://www.massmed.org/">Massachusetts Medical Society</a>. All rights reserved.</p>
        
</div>
<!--[if IE]></div><![endif]-->
<script language="javascript" src="searchbox_suggest_v1.js" type="text/javascript"></script>
<script language="javascript" type="text/javascript">

    try {
        __SLI_customisations[ __SLI_ApplicationName ][ 'ShowBrandingFooter' ] = false;
        sli_load();
    }
    catch (ex) {
        // If SLI scripts cannot be loaded, disable search hints
    }
</script>

<input id="showLayers" value="true" type="hidden">


    <!-- placeholder id=null, description=N-Layers_CONFIG -->
    <!-- placeholder id=null, description=N-ad-lauchLayer-1 -->
    <!-- placeholder id=null, description=N-ad-promoLayer-1 -->
    
    
    

    <input id="IsInstitution" value="true" type="hidden">
    <input id="IsSubscriber" value="false" type="hidden">
    <input id="CustomerId" value="" type="hidden">
    <input id="firstAd" value="" type="hidden">
    <input id="secondAd" value="" type="hidden">




<script type="text/javascript">

        jQuery.extend(jQuery.mmsLayers.config, {
        rules: [{
                "name": "Launch Layer Ad",
                "frequency": 30,
                "showOnPage": 5,
                "enabled": false,
                "cookieName": "MarketingLaunchLayer",
                "styleClass": "launchLayer"
        },
        {
                "name": "Promo Layer Ad",
                "frequency": 42,
                "enabled": true,
                "cookieName": "PromoLayer",
                "styleClass": "promoLayer"
        },
        {
                "name": "Iperceptions - Ion Layer Ad",
                "showOnPage": 1,
                 "enabled": true,
               "test": false,
               "cookieName":"Iperceptions"
        }]
     });
    </script>

<script type="text/javascript">

    var _sf_async_config={uid:36099,domain:"nejm.org"};
    (function(){
        function loadChartbeat() {
            window._sf_endpt=(new Date()).getTime();
            var e = document.createElement('script');
            e.setAttribute('language', 'javascript');
            e.setAttribute('type', 'text/javascript');
            e.setAttribute('src',
                    (("https:" == document.location.protocol) ?
                            "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" :
                            "http://static.chartbeat.com/") +
                            "js/chartbeat.js");
            document.body.appendChild(e);
        }
        var oldonload = window.onload;
        window.onload = (typeof window.onload != 'function') ?
                loadChartbeat : function() { oldonload(); loadChartbeat(); };
    })();

</script>

<!-- Load Footer JS via Ad Placeholders -->
<!-- placeholder id=null, description=N-config-js-global-bottom -->





        
<div style="position: absolute; display: none;" id="cluetip-waitimage"></div><div style="display: none; position: absolute;" id="cluetip"><div style="z-index: 1999; opacity: 0.1; top: 1px; left: 1px; position: absolute; background-color: rgb(0, 0, 0);"></div><div style="z-index: 1999; opacity: 0.1; top: 2px; left: 2px; position: absolute; background-color: rgb(0, 0, 0);"></div><div style="z-index: 1999; opacity: 0.1; top: 3px; left: 3px; position: absolute; background-color: rgb(0, 0, 0);"></div><div style="z-index: 1999; opacity: 0.1; top: 4px; left: 4px; position: absolute; background-color: rgb(0, 0, 0);"></div><div style="z-index: 1999; opacity: 0.1; top: 5px; left: 5px; position: absolute; background-color: rgb(0, 0, 0);"></div><div style="z-index: 1999; opacity: 0.1; top: 6px; left: 6px; position: absolute; background-color: rgb(0, 0, 0);"></div><div style="position: relative; z-index: 2000;" id="cluetip-outer"><h3 id="cluetip-title"></h3><div id="cluetip-inner"></div></div><div id="cluetip-extra"></div><div id="cluetip-arrows" class="cluetip-arrows"></div></div><div id="ui-datepicker-div" class="ui-datepicker ui-widget ui-widget-content ui-helper-clearfix ui-corner-all ui-helper-hidden-accessible"></div><script src="chartbeat.js" type="text/javascript" language="javascript"></script></body>
</html>
